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ABSTRACT 
Quiescence affects development to term of cloned embryos. There are 
suggestions that developmental potential of cloned embryos and changes in their 
epigenetic status may be correlated. This project aimed at finding a well-characterised 
model of cell quiescence and use it to investigate effects of quiescence on epigenetic 
status of cloned embryos. 
Different synchronization methods were used to synchronize Mouse Foetal 
fibroblasts in GO and Gi. Specific positive (p130, p27) and negative markers of 
quiescence (FITC) were used to characterise cells. Serum starvation was the best 
method to synchronize cells in GO, whereas incubation for 24h with 4mM hydroxyurea 
or 800uM mimosine, was used to synchronize cells in Gi. However, Mouse Foetal 
Fibroblasts did not represent a good model of quiescence. Serum starvation and 
synchronization with mimosine and hydroxyurea produced mixed populations of diploid 
(2N) and tetraploid cells (4N). Furthermore, serum starvation produced a mixed 
population of quiescent and non-quiescent cells. 
T-lymphocytes were used as an alternative model of cell quiescence and 
Interleukin-2 receptor a or CD25 was used as a negative marker of quiescence. 
Synchronization in GI was obtained by activation for 24h with 8ug/ml 
phythoemagglutinin and 4nM IL-2 in the presence of 1mM hydroxyurea, and 
subsequent selection of CD25 cells by magnetic cell sorting. In the GI population 
>90% cells were diploid and non-quiescent (CD25 4 ). Freshly isolated T-lymphocytes 
were synchronized in GO, with >90% of the cells being diploid and quiescent (CD25). 
Comparison of well-characterised quiescent and non-quiescent T-cell 
populations showed that quiescence has great effects on sub-nuclear localisation of non-
histone proteins and post-translational histone modifications. Proteins of the 
Heterochromatin 1 (HP1) family are non-histone proteins that colocalise with 
pericentromeric heterochromatin and non-constitutive chromatin so changes in their 
distribution associate with changes in chromatin organisation. Immunolocalisation 
studies of HP1 proteins showed that all three isoforms, M31IhHPfl3, mHPlcdhHPla, 
M32/hHPly, had a condensed distribution in quiescent nuclei and became dispersed in 
non-quiescent cells. Changes in M31 distribution were the most consistent and were 
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correlated with expression of the activation markers CD25 and PCNA, confirming the 
association between quiescence and chromatin status. In CD257PCNK cells, M31 had a 
more condensed sub-nuclear distribution than in CD25/PCNA cells. 
Quiescence also altered the acetylation status of histone H4 on lysines 2-4, 5 
and 12. Immunolocalisation studies showed that, under conditions that induce 
expression of CD25 and PCNA, histone H4 became hyperacetylated. 
Finally, GO and GI lymphocytes were used in nuclear transfer experiments. 
Quiescence affected timing of premature chromosome condensation in cloned embryos. 
Time of metaphase plate formation and chromosome condensation were delayed in GO-
derived embryos, compared to G1 embryos. Rates of development to blastocyst were 
very low (<5%), regardless of cell cycle stage of donor cells, and similar abnormalities 
were observed in developmentally arrested GO and Gi-derived embryos. No post-
implantation development was observed from 2-cell embryo transfers, regardless of cell 
cycle. The effects of quiescence might have been masked by the overall low efficiency 
of T-cells for nuclear transfer. 
Quiescence affected epigenetic status of cloned embryos. M31 distribution 
patterns were similar in control and cloned embryos at the 2-cell stage. However at the 
4-cell stage none of the GI-derived embryos and 33% of GO embryos had M31 
distribution patterns similar to controls. Differences observed between GO and Gi-
derived embryos showed that GO chromatin might be more favourable to remodelling. 
Changes in the acetylation levels of histone H4, on lysines 5 and 12, observed in the 
first 3h after reconstruction and at the 2 and 4-cell stages, were similar in control and 
nuclear transfer embryos, derived from both GO and GI T-cells. However, significant 
differences were observed in acetylation patterns at the 2 and 4-cell stage, associated 
with transcriptional activation. A low proportion of cloned embryos (0-33%) had 
acetylation patterns similar to those of control embryos, at the 2 and 4-cell stages. 
Differences were also observed in GO and GI-derived nuclear transfer embryos Gi-
derived embryos were similar to controls at the 2-cell stage, but failed to retain the 
typical peripheral, acetylation pattern at the 4-cell stage. In GO-derived embryos, 
appearance of acetylation patterns similar to controls was delayed till the 4-cell stage. 
The pattern of H4 acetylation is dependent on DNA replication and transcriptional 
activation. A possible explanation is that abnormal acetylation patterns may reflect 
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abnormalities in the spatial and temporal regulation of DNA replication and/or 
transcriptional activation of the donor cell genome. 
Although quiescence did not affect in vitro developmental potential of cloned 
embryos it induced changes in non-histone and histone proteins that might affect post-
implantation development. 
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1.1 NUCLEAR TRANSFER EFFICIENCY 
Although cloning has been used to produce healthy and fertile offspring, it is still a 
very inefficient technique (Table 1.1). Pre-implantation development (blastocyst 
rate) does not seem to be a problem in most mammals (40% mice, 20% sheep and 
cattle) with the only exception of pigs (1%-5%). The main losses occur during post-
implantation development and after birth. Foetal survival rates (7.5%-8%sheep; 
1.1%-6.7% mice; 9%-14 % cattle) are significantly lower than those obtained after 
natural mating (92%, sheep; Walker et al., 1992) and JVF (39% cattle Wells et at., 
1998a). Foetal losses as a consequence of NT procedures are usually associated, in 
most species (sheep, cattle, mouse), with the Large Offspring Syndrome (LOS; 
Young et at., 1998) characterised by oversized foetuses and placentas. This abnormal 
foetal phenotype is a common feature of IVF and NT derived foetuses and has been 
partially correlated with in vitro embryo culture conditions (Walker et al., 1996; 
Garry et at., 1996). However recent reports in mouse (Eggan et al., 2001) have 
shown that, although the birth and placental weights of IVF derived foetuses are 
significantly higher than control, in vivo derived foetuses, these are still significantly 
lower than those of nuclear transfer derived foetuses. The same observation was 
made in sheep where weights of cloned lambs were found to be higher than the 
average expected with in vitro produced sheep embryos (Thomson et al., 1995; Holm 
et al., 1996). 
Nuclear transfer efficiency is further reduced by the poor rates of survival to 
adulthood of cloned animals ranging from 62%-65% in cattle and sheep to 45% in 
mice (Tab 1.1). These perinatal survival rates are lower than the ones obtained from 
natural mating (92%, sheep; Nash et at., 1996). Most deaths are associated with 
respiratory failure, with the appearance of froth in the airways (sheep, Wells et at., 
1998b; Wilmut et at., 1997; cattle, Wells et at., 1998a; Cibelli et al., 1998; mouse, 
1 
Table 1.1 Somatic Cell Nuclear Transfer 
Species 	Cell type 	Stage of 	Cell cycle 	Recipient 	Activation Fused or injected\ 	Blastocyst\fused 	Live births 	Surviving oflspring\ 	Reference 
development stage cytoplast time 	reconstructed (%) 	or injected (%) n° transferred Live births 
Mice ES E Cycling Mil FBA 1l0\? 15\110(13.6) 7\15 (46.7) Rideoutetal. (2000) 
Mice ES E G0\G1 Mil FBA 1300\? 181\1300 (13.9) 4\179 (2.2) 4\4 (100) Wakayama at al. (1999) 
Mice ES E G2\M MI! FBA 465\? 142\465 (30.5) 4\135 (0.7) 1\4 (25) Wakayama et al. (1999) 
Mice ES E M M11+2-cell FBA 162\275 (59.0) 90\162 (55.5) 1\81 (1.2) 0\1 (0) Amano etal. (2001a) 
Mice ES E M Ml! FBA 393\885 (44.4) 142\393 (36.1) 1\73 (1.3) 0\l (0) Amano etal. (2001a) 
Mice ES E M Ml! FBA 3620\4852 (74.6) 2007\3620 (55.4) 19\1903 (1.0) 3\19 (15.8) Amano at al. (2001b) 
Mice Sertoli A G0\G1 Mll FBA I 189\ (70-80%) 297\1 189 (24.9) 7\215 (3.3) 7\7 (100) Ogura at al. (2000) 
Mice Sertoli A Cycling Mil FBA 501\ (70-80%) 119\501 (23.7) 2\126 (1.6) 2\2 (100) Ogura at al. (2000) 
Mice Sertoli A G0\G1 MI! FBA 156\(70-80%) 20\156 (50) 7\105 (6.7) 7\7 (100) Ogura at al. (2000) 
Mice Cumulus A G0\G 1 Mil FBA 2468\? (79-95) 1385\2468 3 1\1 385 (2.2) 22\31 (71.0) Wakayama etal. (1998) 
Mice Tail tip cells A G0\G1 MI! FBA 633\717(88.3) 241\633 (38.0) 3\274 (1.1) 1\3 (33.3) Wakayama and Yanagimachi (1999) 
Cycling 
Mice B-lymphocyte 4 A G0\G1 Mil FBA 630\? 21\630 (3.3) 16\159 (10.1) 13\l6 (81.2) Hochedlingerand Jaenisch (2002) 
Mice T-lymphocyte 4 A G0\G1 Mil FBA 350\? 20\350 (5.7) 1\101 (0.9 0\1 (0.0) Hochedlinger and Jaenisch (2002) 
Sheep Epithelial-like E G0\G1 Til or AF, ABF, 244\? 34\244 (13.9) 5\34 (14.7) 3'5 (60.0) Campbell at al. (1996a) 
MI! FBA 
Sheep Epithelial-like E G0\G1 MI! A'F 385\465 (82.8) 126\385 (32.7) 4\87 (4.6) 4\4 (100) Wilmut etal. (1997) 
Sheep Epithelial-like E G0\G1 MI! AW 386\665 (58) 75\386 (19.4) 3\75 (4) 2\.3 (66.7) Wells etal. (I 998b) 
Sheep Fibroblast-like E G0\GI Mu AW 345\589 (58.6) 90\345 (26.1) 10\81 (12.3) 3\10 (30.0) Wells etal. (I 998b) 
Sheep Fibroblast F G0\G1 Mu A\F 507\ 69\507 (13.6) 7\67 (10.4) 5\7 (71.4) Schnieke etal. (1997) 
Sheep Fibroblast F G0\G1 Mu A\F 417\ 80\417 (19.2) 14\80 (17.5) 3\14 (21.4) McCreath at al. (2000) 
Sheep Fibroblast F G0\G1 Mu A\F 172\203 (84.7) 47\l72 (27.3) 3\40 (7.5) 2\3 (66.7) Wilmut at al. (1997) 
Sheep Mammary gland A G0\G 1 Mu A'F 277\ 434 (63.8) 29\277 (10.5) 1\29 (3.4) l\l (100) Wilmut etal. (1997) 
Muflon Granulosa A G0\G1 MI! A'F 23\ 7\23 (30.3) 1\7 (14.3) l\l (100) Loi etal., 2001 
Goat Fibroblast F G0\G1 M11 or AW 157\285 (55) 112\157 (71.3) 3\1 12 (2.7) 3\3 (100) Baguisi etal. (1999) 
Til 
Low t',broblast F Cycling Mil FBA 174\242 (71.9) 35\174 (20.1) 2\7 (28%) 1\2 (50.0) Zakhartchenko etal.. (I 999a) 
Cow Fibroblast F Cycling Mil FBA 276\? 33\276 (12) 4\28 (14.3) 3\4 (75.0) Cibelli etal. (1998) 
Cow Mammary gland A G0\G1 Mil FBA 140\223 (63) 36\140 (26) 1\4 (25) l\l (100) Zakhartchenko etal. (1999b) 
Cow Ear skin A G0\Gl MI! FBA 82\92 (89) 49\82 (59.7) 1\16 (6) 0\1 (0.0) Zakhartchenko etal.. (I 999b) 
Cow Ear skin A G0\G1 Mu AW 338\821 (41.1) 103\338(30.4) 6\39(15.4) 4\6 (66.7) Kubota etal. (2000) 
Cow Muscle A G0\G1 Mu A\F or ABF 346\515 (67.1) 73\346 (21) 4\26 (15.4,) 4\4 (100) Shiga etal. (1999) 
Cycling III 
Cow Oviduct A G0\G1 Mu A\F 94\150(63) 20\94 (21.2) 3\4 (75) 2\3 (66.7) Kato etal. (1998) 
Cow Cumulus A G0\GI ME A\F 47\99 (47) 18\47 (38.3) 5\6 (83.3) 2\5 (40.0) Kato etal. (1998) 
Cow Granulosa A G0\G1 Mll FBA 412\434 (95) 164\412 (39) 2\74 (9) 1'2 (50.0) Wells at al. (1998a) 
Cow Granulosa A G0\G1 MU FBA 552\713 (77.4) 282\552 (51) 10\100 (10) 10\10 (100) Wells at al. (1999) 
Cow Lymphocyte A G0\G1 MI!+TIV FBA 316'353 (90) 60\316 (19) 1\19 (5.2) l\l (100) Galli etal. (1999) 
Pig Granulosa A Cycling MII+ A\F 401\1368 (29.3) - 5\401 (1.2) 5\5 (100) Polejaeva etal., 2000 
Donor cells in the table are differentiated, somatic cells. Stem cells (ES-cells) were included for completeness. Donor cells were of embryonic (E), foetal (F) or adult (A) origin. 
Recipient cytoplasts were either metaphase II (MIT, non-activated) or telophase 11(111, activated) oocytes. In some experiments 1,2,3  nuclei were transferred to a MIT oocyte and then 
blastomeres were transferred either to a Til oocyte, a zygote or a 2-cell embryo (re-cloning). Activation occurred at the time of fusion (A\F), before fusion (ABF) or after fusion 
(FBA). In one experiment 4  development to term was obtained by combining the Nuclear Transfer and tetraploid aggregation (Nagy et al., 1993) techniques. 
Eggan et al., 2001) and with abnormalities of the system immune (Renard et al., 
1999). These features have not been described before as a result of in vitro embryo 
culture and they are likely to result entirely from incomplete and abnormal 
reprogramming of the donor nucleus. There are two main elements that may affect 
reprogramming and nuclear transfer efficiency: 
Embryonic ploidy (cytogenetic effect); 
Reprogramming of donor nucleus (epigenetic effect); 
Maintenance of correct ploidy has an immediate effect on pre-implantation 
development (blastocyst rate), whereas correct and complete reprogramming is 
essential for post-implantation development and perinatal survival, though it may 
also affect pre-implantation development. Both LOS and cloned offspring syndromes 
have been associated with presence of abnormal embryo epigenetic status and, in 
particular, with abnormal methylation of imprinted genes and genomic DNA (Young 
et al., 1998). 
Many factors may affect nuclear transfer efficiency by influencing the 
ploidy and/or the reprogramming process in the cloned embryos (for review see Sun 
and Moor, 1995; Colman, 2000): developmental stage of donor cells 
(reprogramming); cell type (reprogramming); cell cycle stage of recipient oocyte 
(ploidy and reprogramming); cell cycle stage of the donor cell (ploidy and 
reprogramming); genetic background (Eggan et al., 2001). 
1.2 EFFECT OF CELL CYCLE COORDINATION ON 
NUCLEAR TRANSFER EFFICIENCY 
1.2.1 Cell cycle stage of recipient cytoplast 
Nuclear changes taking place during oocyte maturation/meiosis and after 
fertilisation or activation are associated with changes of the cytoplasmic 
environment. Particularly important for nuclear transfer are changes occurring in the 
state of activation of the maturation/meiosis/mitosis promoting factor (MPF; Masui 
and Markert, 1971; Nurse, 1990) that is a potential reprogramming factor. MPF is a 
protein kinase complex formed by a Cyclin-Dependent Kinase (CDK), 
p34cdc2/cDK 1, and by its regulatory subunit, cyclin B 1. Activation of this complex 
leads to cell cycle resumption and progression through the G2IM-phase. MPF kinase 
activity (Campbell et at., 1996b) and localisation (Hagtin et al., 1998) vary according 
to cell cycle stage of the oocyte. In mature oocytes (Mu), MPF is activated (high 
kinase activity) and is localised in the oocyte nucleus. Upon fertilisation or 
activation, after the nuclear envelope breaks down, MPF is released into the 
cytoplasm where it remains active for a short period, reaching a basal level of 
activity upon pronuclear formation. Once in the cytoplasm, MPF becomes associated 
with the microtubules and centrosomes and then, in the zygote, it is sequestered by 
the pronuclei. The levels of MPF will then increase transiently during M-phase of 
each embryonic cell cycle. 
MPF activity declines over a 6h period, after Sr 2 activation, in mouse; a 5h 
period, after electrical activation (Liu et al., 1997), in sheep; a 12 h period, after 
electrical activation (Lai et al., 2001), in pigs; a lOh period, after electrical 
activation, in cattle (Barnes et at., 1993). MPF levels also decline as a result of 
oocyte aging (Kikuchi et at., 2000). This explains why the decline in MPF levels 
induced by activation is quicker in aged oocytes (Tian et at., 2002) and suggests that 
assessment of the right combination of oocyte age and activation stimuli is required 
to achieve optimal activation (e.g. pig, Ikeda and Takahashi, 2001). 
Nuclear transfer experiments involve the fusion or injection of a single cell 
or nucleus (karyoplast) into a recipient cytoplast obtained by enucleation of a MIT 
oocyte, with high levels of MPF activity, or a pre-activated, oocyte or zygote with 
low levels of MPF activity. According to the different states of activation of the 
oocyte and the different levels of MPF activity three different NT systems can be 
identified: 
1) 	Short exposure (minutes) to high MPF activity, that occurs when non- 
activated (MIT) oocytes are used as recipients and fusion and activation are 
simultaneous (e.g. electrofusion) or occur at very short distance (AF system; 
review by Prather and First, 1990). This method is the most commonly used 
in agricultural animals (Campbell et at., 1995; 1996a; Wilmut et al, 1997; 
Collas and Robl, 1991; Prather et al., 1990; Kanka et al., 1991). 
Prolonged exposure (>lh) to high MPF activity, that occurs when non-
activating fusion methods are used and fusion and activation are carried out 
hours (1-6h) apart (fusion before activation or FBA system). This method 
has been mainly used in mouse (Wakayama et at., 1998), where non-
activating fusion methods are more commonly used although it has been 
used with good results also in cattle (Stice et at., 1996; Cibelli et at., 1998; 
Wells et at., 1998a; 1998b). 
Exposure to low MPF activity, that occurs when pre-activated oocytes or 
zygotes are used as recipients (activation before fusion or ABF system). 
The levels of MPF found in the different systems are associated with 
morphological events with important implications for the ploidy and the 
reprogramming of reconstructed embryos. The morphological changes observed in 
the AF and the FBA system, where there are high levels of MPF, are very similar. As 
described in mouse (Czolowska et at., 1984; Tsunoda et at., 1989), rabbit (Stice and 
Robl 1988; Collas and Robl, 1991), pig (Prather et at., 1990), cattle (Prather et at., 
1987; Kanka et at., 1991) and sheep (Willasden, 1986; Smith and Wilmut, 1989) 
these morphological events are: 1) induction of NEBD, followed by 2) premature 
chromosome condensation (PCC); 3) spindle formation; 4) pseudo-polar body 
exclusion; 5) pseudo-pronuclear formation and nuclear swelling; 6) DNA replication 
and cytokinesis. Among the morphological events taking place after transfer to a Mu 
oocyte (AF and FBA system) NEBD, PCC and, in mouse, extrusion of pseudo-polar 
body, have very important effects on ploidy and chromosomal integrity depending on 
the cell-cycle stage of the donor cell (Campbell et al., 1996b). NEBD, PCC and 
nuclear swelling are also thought to be essential for reprogramming of gene 
expression (Collas et al., 1992a). 
In the absence of MPF activity (ABF system), none of the morphological 
events, previously described, take place. 
1.2.2 Cell cycle stage of donor cells 
The first cell cycle experiments were carried out in the early 90's using 
embryonic donor cells from early cleavage embryos (blastomeres; for review see 
Heynman and Renard, 1996) or blastocyst stage embryos (1CM, ES-cells; Keefer et 
at., 1994; lilmensee and Hoppe, 1981; Smith and Wilmut, 1989; Wakayama et al., 
1999). About 79%-100% of the blastomeres from early cleavage embryos (Barnes et 
at., 1993; Campbell et al., 1993; 1995; Collas et al., 1992b) and 26-64% of inner cell 
mass (1CM) cells or embryonic stem cells (ES-cells), isolated from blastocyst stage 
embryos, are in S-phase (Tsunoda and Kato, 1997; Wakayama et at., 1999; Zhou et 
al., 2001). Embryonic nuclear transfer experiments were carried out with 
asynchronous blastomeres, in S-phase. Alternatively, donor blastomeres were 
synchronized in GI/S, using DNA synthesis inhibitors (e.g. aphidicholine, 
cycloheximide, hydroxyurea), and in G2/M, using inhibitors of tubulin 
polymerisation (e.g. nocodazole or colcemid; Cheong et at., 1993; Kwon and Kono, 
1996; Campbell et al., 1995; Liu et at., 1997). 
Somatic cell nuclear transfer offered new opportunities to investigate the 
effect of cell cycle stage of donor cells on nuclear transfer efficiency. The cell cycle 
of somatic cells differs from the embryonic cell cycle because it is longer (20-24h vs 
9-16h) and has well defined gap-phases. The cell cycle profile of somatic cells is 
characterised by 60-65% GO/GI cells, 10-15% G2/M cells, and 20-25% S-phase 
cells. The percentages of cells in S-phase further decline to 0-1% in quiescent (GO) 
cells, such as terminally differentiated, post-mitotic cells (permanent GO), or mitotic 
cells that are confluent or have been serum-starved (temporary GO). Somatic cells are 
more easily synchronized in a GO/GI and G2/M-phase than blastomeres. 
Furthermore, somatic cells, unlike blastomeres, can be synchronized either in a 
quiescent (GO) as well as a non-quiescent (GI), diploid state. 
1.2.3 Cell cycle coordination: effects on ploidy and chromosomal 
integrity 
The first cell cycle coordination experiments (reviews by Campbell et at., 
1996b; Kono, 1997) were carried out using mouse (Kono et al., 1991, 1992; Kato 
and Tsunoda, 1992; Cheong et at., 1993; Kwon and Kono, 1996; Tsunoda and Kato, 
1997; Otaegui et at., 1994) and rabbit (Collas and Robl, 1990; 1991; Collas et al., 
1992a, 1992b) donor blastomeres that could be easily synchronized in GI/early 5, 
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G2/late S and M. The results of these experiments demonstrated that transfer of GUS 
donor cells to recipient MIT oocytes resulted in higher blastocyst rates (Cheong et al., 
1993; Tsunoda and Kato, 1997; Otaegui et al., 1994), better blastocyst quality (i.e. 
higher cell numbers; Cheong et al., 1993) and higher rates of post-implantation 
development (Tsunoda and Kato, 1997). These data were also confirmed in cattle 
(Campbell et al., 1993) and pig (Verma et al., 1998). 
An explanation for this is that after transfer to an MIT cytoplast, with high 
MPF activity, nuclei re-enter the cell cycle in S-phase, regardless of their stage, in 
response to the NEBD signal. NEBD, induced by MPF nuclear lamin kinase activity, 
acts as a positive signal for DNA replication, regardless of cell cycle stage of donor 
nucleus. Cell fusion experiments showed that heterokaryons produced by fusion of 
vertebrate cells in M-phase and interphase (Gi, 5, G2-phase) display NEBD and 
PCC (Johnson and Rao, 1970b) and induce 5- and G2-nuclei to re-replicate their 
DNA (Johnson and Rao, 1970a). Experiments with Xenopus egg cell-free system 
proved that NEBD acts as a signal for DNA replication regardless of the cell cycle 
stage of the nucleus. In this system G2 nuclei exposed to S-phase extracts would not 
replicate in the presence of an intact nuclear envelope, but would undergo re-
replication after permeabilisation with detergent treatment (Blow and Laskey, 1988; 
Leno et al., 1992) or induction of NEBD and PCC (Hutchinson et al., 1993). These 
data were also confirmed by nuclear transfer experiments in cattle (Campbell et al., 
1993; Barnes et al., 1993) which proved the strict correlation between high MPF 
levels, NEBD and DNA replication and demonstrated that, because of this 
correlation, any nucleus transferred to a MIT oocyte will resume its cycle from 5-
phase regardless of its cell cycle stage. In this experiment NEBD occurred in 100% 
of nuclei transferred to MII oocytes Ohpa, in 50% of nuclei transferred to MI! 
oocytes 5-8 hpa, in 0% of nuclei transferred to S-phase cytoplasts (pre-activated 
oocytes) 9-10hpa. In the same experiment it was demonstrated, using BrdU 
incorporation, that 100% of nuclei, regardless of their cell cycle stage (GI, 5, G21M), 
replicated their DNA after transfer to MIT oocytes. However, in the absence of 
NEBD, after transfer to pre-activated oocytes, 94-100% of Gi and S-phase nuclei 
initiated or completed DNA replication, and 0% of G2IM nuclei duplicated their 
DNA (Campbell et al., 1993). It was concluded that, at least in cattle and rabbit, after 
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transfer to Mll oocytes, only 2N nuclei (GI, early S-phase) will retain diploidy 
whereas transfer of 4N (G2/M) and 2-4N (late S-phase) will result in 
tetraploidisation and aneuploidy (Collas et at., 1992a: 1992b; Campbell et at., 1993; 
Campbell et at., 1996b). 
However, in mouse (Kono et at., 1992), sheep (Liu et at., 1997) and pig (Lai 
et al., 2001) transfer of G2IM nuclei to MIT oocytes is also possible. This occurs 
because, in the absence of cytochalasin B, oocytes from these species extrude a 
pseudo-polar body and, with it, half of their DNA becoming diploid. Pseudo-polar 
body extrusion takes place 3-4hpa, before pseudo-pronuclear formation and DNA 
replication. In mouse it was shown (Kono et at., 1992) that when 2-cell blastomeres 
synchronized in G2/M (4N) were transferred to MIT oocytes and activated in the 
absence of CB, about 78-85% formed a PB (2N) and a PN (2N). Under these 
conditions 81% of the embryos had normal ploidy, 25-26% developed to the 
blastocyst stage and 12.2 % developed to term. However, in the presence of 
cytochalasin B, G2IM nuclei (4N) were unable to extrude half of their genome into a 
polar body, and formed two diploid nuclei (2x2N), that became tetraploid nuclei after 
DNA re-replication, just like observed in cattle and rabbit. The only way transfer of 
G2IM nuclei into MIl oocytes can result in development in mouse, in the presence of 
cytochalasin B, or in cattle and rabbit regardless of the presence of cytochalasin B, is 
by serial nuclear transfer or re-cloning. In this case each of the diploid pronuclei 
resulting from the G2JM donor nucleus are transferred to a recipient zygote for a 
second round of cloning (Kwon and Kono, 1996). Under these conditions the transfer 
of a G2/M (lx 4N) nucleus is transformed into the transfer of two diploid nuclei 
(2x2N) into two recipient cytoplasts. This is technically very demanding and the 
limited results obtained so far do not justify its application. 
In pigs and sheep (Lai et at., 2001; Liu et at., 1997) pseudo polar body 
extrusion occurs spontaneously only after transfer of G2/M nuclei, whereas in mouse 
it occurs spontaneously also after transfer of GuS nuclei to MIT oocytes (Kono et al., 
1992). Therefore, addition of cytochalasin B, in mouse, is essential to prevent 
haploidisation of GUS nuclei after transfer to MIT oocytes (Cheong et at., 1993; 
Wakayama et at., 1998), whereas it can be omitted in pigs and sheep. 
Transfer of donor cells in S-phase to Mll oocytes results in abnormal ploidy 
and reduced NT efficiency in all species. Efficiency of transfer of S-phase donor 
cells to Mll oocytes is also reduced by loss of chromosomal integrity, resulting from 
premature chromosome condensation (PCC). Descriptive studies in mouse have 
shown that, during PCC, GUS (2N) nuclei condense into one or two clumps of 
chromatin that later form one (Cheong et al., 1993) or two (Wakayama et at., 1998) 
pseudo-pronuclei, with an overall diploid DNA content (2N). Donor nuclei in G2/M 
condense into two clumps of chromatin, containing each a diploid content of DNA 
(2x2N; Cheong et at., 1993; Wakayama et at., 1998). As a result of PCC, S-phase 
nuclei condense into a variety of complex structures, usually organised into three or 
more clumps, containing a diploid/tetraploid content of DNA (2-4N Cheong et al., 
1993; Wakayama et al., 1998). Finally, chromatin of GuS and G2JM nuclei 
condenses into individualised, elongated chromosomes respectively with single (2N 
nuclei; Kono et al., 1993; Wakayama et at., 1998) or double-stranded (4N nuclei; 
Kono et al., 1992; Kwon and Kono, 1996) chromatids. Double chromatid 
chromosomes, which can correctly bind to the mitotic spindle, align in a metaphase 
plate (Kwon and Kono, 1996), whereas single chromatid chromosomes fail to form a 
metaphase plate and maintain a random distribution (Wakayama et al., 1998). The 5-
phase chromatin does not form chromosomes and acquires, instead, a pulverised 
appearance (Schwartz et at., 1971) associated with a high incidence of abnormalities 
(Johnson and Rao, 1970b; Collas et at., 1992ab; Campbell etal., 1993). 
When nuclei are transferred to pre-activated oocytes (universal recipient), 
with low MPF activity, all nuclei, regardless of their cell cycle stage, retain normal 
ploidy and chromosomal integrity. The explanation for this is that, in the absence of 
MPF activity, NEBD and PCC donor nuclei resume the cell cycle where they had left 
it. In sheep, cattle and mouse higher rates of pre and post-implantation development 
were obtained when S-phase donor blastomeres were transferred to pre-activated 
oocytes rather than MII oocytes. (Campbell et al. 1995; Barnes et al., 1993; Tsunoda 
and Kato, 1997). 
In conclusion, normal development, after nuclear transfer, can be obtained 
under two experimental conditions: 
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1) 	Transfer to a pre-activated oocyte of all nuclei, regardless of their cell cycle 
stage; 
2) 	Transfer to a MIT oocyte of GUS nuclei, in all species, and G2IM nuclei, in 
mouse, sheep, pigs and cows. 
Although normal development can be obtained with G2IM nuclei, the higher 
efficiency rates obtained with GUS nuclei make them a better option. Studies using 
2-cell blastomeres (Cheong et al., 1993) showed that GUS nuclei, activated in the 
presence of cytochalasin B (97% without polar body, 97% diploid), gave 
significantly higher cleavage rates (97% vs 78%), higher blastocyst rates (78% vs 
21%) and higher blastocyst cell numbers (62 vs 37) than G2IM nuclei, activated in 
the absence of cytochalasin B (67% with PB, 67% diploid). A similar result was 
obtained when mouse foetal fibroblasts, synchronized in M-phase with nocodazole 
where transferred to MIl oocytes and then activated in the absence of cytochalasin B 
(87-91% with PB, 87-91% diploid; Ono et al., 2001a). Under these conditions 37% 
developed to blastocyst but no embryo developed to term. When using serial nuclear 
transfer, that is thought to enhance nuclear reprogramming, about 30% developed to 
blastocyst and 1.8% developed to term, with 60% surviving to adulthood. These 
results are worse than the results obtained using more differentiated, diploid cells 
after transfer to a recipient MIl oocyte, in the presence of CB (Wakayama et al, 
1998; Ogura et al., 2000). In these experiments freshly isolated cumulus cells and 
Sertoli cells or contact-inhibited tail tip cells, were used as nuclear donors and 34-
60% of cloned embryos developed to blastocyst, 2.2-5.7% developed to term and 68-
71% of pups survived to adulthood. In these experiments a single round of nuclear 
transfer was carried out. 
1.2.4 Cell cycle coordination: effects on reprogramming 
There are many reports that support the idea that recipient MIT oocytes have 
a higher reprogramming potential than pre-activated oocytes. In mouse, blastomeres 
from 8-cell embryos failed to develop (McGrath and Softer, 1984) beyond the 4-cell 
stage, after transfer to zygotes, but were able to support development to term after 
transfer to MIT oocytes (Tsunoda et al., 1987). Transfer of cumulus cells to Mu 
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oocytes around the time of activation (AF system) gave higher blastocyst rates than 
cells transferred to oocytes that had been activated lh before fusion or zygotes (ABF 
system; Wakayama et al., 2000b). Similar results were obtained in cattle where 
transfer of embryonic nuclei to zygotes resulted in limited embryo development 
(Robl et al., 1986), while transfer of 8 to 16-cell blastomeres to MIT oocytes resulted 
in development to term (Prather et al., 1987). 
Extended exposure of donor nuclei to MIT oocytes, achieved by delaying the 
time of activation after fusion (FBA system) is also beneficial for reprogramming 
and increases nuclear transfer efficiency. A delay of 1-3h in mouse (Wakayama et 
al., 1998; Wakayama et al., 2000b) and of 4-5h in cattle (Wells et al., 1998b) 
increased blastocyst rates and rates of foetal development compared to simultaneous 
fusion and activation (Stice et al., 1996; Wells et al., 1998a). 
Re-cloning, that extends exposure of the donor nucleus to conditioning 
factors in the recipient ooplasm by serial rounds of cloning also improved 
development of cloned embryos. Previous experiments in amphibians showed that 
embryos reached later stages of development after re-cloning (On et al, 1986). 
Studies in cattle (Zakhartchenko et al., 1999a) demonstrated that blastocyst rates 
significantly increased between the first and second round of cloning (20-39% vs 52-
55%), though this evidence remains controversial (Peura and Trounson, 1998). 
The higher reprogramming potential of MIT oocytes is attributed to the fact 
that their cytoplasm contains reprogramming factors that are present or available 
only for a limited time around the time of activation. The maturation/mitosis/meiosis 
promoting factor (MPF) has been indicated as one of these factors. MPF induces 
morphological events such as nuclear envelope breakdown (NEBD), PCC and 
nuclear swelling thought to enhance the remodelling of donor nucleus. 
NEBD enhances reprogramming by enabling immediate and direct exposure 
of chromatin to epigenetic factors like MPF or lamins, which are present or available 
in the recipient ooplasm for a very short time (2-3h) around activation. Changes in 
chromatin structure are also though to be directly involved in the remodelling 
process (Croston and Kadonaga, 1993; Koide et al., 1994). In mouse (Cheong et al., 
1994), the reprogramming potential of nuclei that underwent PCC (PCC) was 
- 	compared with that of nuclei that did not undergo PCC (NPCC). The conclusion was 
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that only PCC nuclei retained normal ploidy and were able to support development to 
term, whereas NPCC nuclei had all a tetraploid chromosome constitution, and were 
not able to support development to term (Cheong et al., 1994). Nuclear swelling is 
also considered a characteristic of nuclear reprogramming (Gurdon, 1986; Kono et 
al., 1992) and it is likely to arise due to the exchange of cytoplasmic factors between 
the nucleus and the cytoplasm (Prather and First, 1990; Kikyo and Wolffe, 2000). 
Nuclear swelling decreases greatly as fusion and activation become separated 
temporally (Czlowska et al., 1984) and is no longer observed at the pronuclear stage 
(Barnes et al., 1987). In mouse, remodelling of donor thymocytes only took place 
when they were transferred to an oocyte within 3 hours after activation (Szöllosi et 
al., 1988). 
These data suggest that the cytoplasm of MIT oocytes contains "epigenetic 
factors" required for nuclear remodelling (Gurdon, 1986) that are no longer available 
or present in the zygote. One explanation is that some reprogramming factors, 
available in limited supply, are released to the cytoplasm following Germinal 
Vescicle Breakdown (GVBD) and become associated again with the pronuclei 
during their formation (Prather and First, 1990; Aronson and Solter, 1987). Lamins 
might belong to this category of reprogramming factors, since they are usually 
present in the cytoplasm but they move to the nucleus when the nuclear membrane is 
reassembled after mitosis (Gerace and Blobel, 1980). 
Another explanation might be that reprogramming factors have short lives 
(Prather and First, 1990) and are present only around the time of activation (up to 3h 
after activation in mouse; Szollösi et al., 1988). MPF has been indicated as one of the 
main reprogramming factors present in MIT oocytes that disappear after activation. 
In conclusion MIT oocytes, with high MPF levels, have a significantly 
higher reprogramming and developmental potential than pre-activated oocytes 
(activated more than lh before fusion) or zygotes. This is due to the fact that when 
nuclei are fused around the time of activation (AF), as a consequence of NEBD, they 
are immediately exposed to reprogramming factors (lamins, MPF). However when 
nuclei are fused more than an hour after activation, the nuclear envelope remains 
intact and the donor chromatin is not exposed to reprogramming factors, which are 
anyway low (MPF) or not available (lamins), in this system. Finally, a delay in 
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activation of 1-3 h (FBA) significantly increases the developmental potential of 
cloned embryos compared to the AF system, because donor chromatin is exposed to 
reprogramming factors for a longer period (Wakayama et al., 1998; Wakayama et 
al., 2000b). 
These observations, together with previous information acquired about cell 
cycle coordination, indicate that maintenance of correct ploidy and chromosomal 
integrity and maximal reprogramming efficiency can be achieved by transferring 
diploid (GO/G1) cells to Mll oocytes. 
1.3 EFFECT OF QUIESCENCE (GO) OF DONOR 
CELLS ON NUCLEAR TRANSFER EFFICIENCY 
Synchronization of blastomeres in a diploid state (Gi) was difficult and 
transient due to the short length of this phase in the embryonic cell cycle. Nuclear 
transfer (NT) with somatic cells, with a longer cell cycle and longer gap-phases, 
meant that donor cells could be synchronized more efficiently in a diploid state. 
Furthermore, experiments with somatic cells showed that synchronization of donor 
cells in a diploid, quiescent state (GO) might increase nuclear plasticity and enhance 
reprogramming efficiency. In the first experiments using cells isolated from the inner 
cell mass (1CM) or embryonic disk (ED) of blastocyst stage or late stage embryos, 
development to term was obtained in cattle (Keefer et al., 1994; Collas and Barnes, 
1994) and sheep (Smith and Wilmut, 1989; Campbell et al., 1995), but only when 
freshly isolated cells (passage 0) or cells from very early passages (passage<3) were 
used as donors. No development to term was obtained when sheep cells, cultured for 
more than six passages, were used as donors (Campbell et al., 1996a). The decrease 
in nuclear transfer efficiency correlated with the appearance of morphological and 
molecular markers of differentiation (Campbell et al., 1996a). It had been reported 
that 1CM and ED cells, isolated from mammals other than mouse, remained 
undifferentiated and totipotent up to passage 3, but after 2-3 passages in culture, 
unlike mouse ES-cells, they acquired an epithelial or fibroblast-like morphology and 
after passage 6, they expressed the differentiation markers cytokeratin and lamin A/C 
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(Galli et at., 1994). A major breakthrough came when five lambs were successfully 
cloned by fusing differentiating cells isolated from the ED of a late sheep embryo 
(day 9) that had been cultured for 6-13 passages, to MI! oocytes (Campbell et at., 
1996a). Once more the cell cycle proved to play a pivotal role in nuclear transfer 
since the only difference between this experiment and the previous, unsuccessful 
ones was that donor cells had been synchronized in a diploid, quiescent state (GO) by 
serum deprivation (Campbell et al., 1996a). Previous NT studies, using blastomeres 
as nuclear donors, proved that synchronization of donor cells in a diploid, non-
quiescent state (Gi) before transfer to a MIT oocyte was highly beneficial for nuclear 
transfer. Serum deprivation represented an efficient way to synchronize somatic cells 
in a diploid state. However, serum deprivation also induced nuclear quiescence, 
associated with changes in chromatin conformation (Whitfield et at., 1985) that 
might extend the plasticity of the donor nucleus, making it more amenable to 
reprogramming and more capable to support development of cloned embryos. 
The question whether quiescence of donor nuclei is mandatory for 
development to term of reconstructed embryos has still to be answered. 
Most successful cloning experiments, carried out after this groundbreaking 
experiment, have been done using quiescent, donor cells (Table 1.1). The result 
obtained by Campbell et at. (1996a) was confirmed by the birth of more lambs 
cloned using quiescent, epithelial-like (Wells et al., 1997) or fibroblast-like (Wells et 
al., 1998b), embryonic cell lines, isolated from the 1CM of late blastocysts (day 8), 
and cultured for 8-16 passages. Most importantly, the same technique, used to 
reprogram differentiating, embryonic cell lines, was used to produce Dolly, the first 
mammal cloned from adult cells, isolated from the mammary gland of a 6 year old 
ewe, that had been serum-starved before transfer to a recipient MIT oocyte (Wilmut 
et al., 1997). After Dolly's birth, most successful NT experiments, using somatic 
cells of adult or foetal origin, have been done, in a variety of species, using quiescent 
cells (Table 1.1). In some experiments post-mitotic, terminally differentiated cells, 
like cumulus cells or Sertoli cells that are naturally in a quiescent state, were used as 
donors. In other experiments, mitotic somatic cells, that had been cultured and 
induced into quiescence either by serum deprivation or contact inhibition, were used 
as donors and transferred to recipient MIT oocytes. 
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There are many reports suggesting a positive effect of quiescence on nuclear 
transfer. Earlier, nuclear transfer experiments in Amphibian showed that quiescence 
of donor cells improved nuclear transfer efficiency compared to cycling cells. 
Nucleated, frog erythrocytes, that are terminally differentiated and quiescent, were 
able to support development to a later stage (feeding tadpole) than cells which still 
retained replicative potential, such as embryonic myotomes (Gurdon et al., 1984) and 
spleenocytes (Wabi et al., 1975), used in previous experiments (DiBerardino et al., 
1986). Later experiments carried out in cattle (Hill et al., 1998; Zakhartchenko et al., 
1999a) showed that serum-starved quiescent cells gave significantly higher 
blastocyst rates (39% vs 20%) and pregnancy rates at day 30 (78% vs 33%) and day 
90 (63% vs 33%) compared to cycling cells. These observations were confirmed in 
rabbit where quiescence of donor cells (i.e. foetal fibroblasts) significantly improved 
development of cloned embryos (Galat et al., 1998). Recent experiments in cattle 
(Wells, 2002) showed that quiescence of donor nuclei significantly increased 
efficiency of development to term of cloned embryos. 
However, there are also a few reports challenging the theory that quiescence 
might be beneficial for nuclear reprogramming. In some cases, terminally 
differentiated, quiescent cells, such as neurons, have failed to support development to 
term, suggesting that the GO state in itself may not be sufficient to enable complete 
and correct reprogramming of donor nucleus. There have been reports, in cattle, of 
non-quiescent foetal fibroblasts supporting development to term (Cibelli et al., 1998; 
Vignon et al., 1998). However, there are indications that donor cells used in one of 
these experiments (Cibelli et al., 1998) may have not been cycling but, at least 
partially, quiescent: the proportion of cells in S-phase had been overestimated, due to 
fixation artifacts (Campbell, 1998); quiescent cells are also present in populations of 
mitotically active cells, especially in the small-cell population, that is usually 
selected for nuclear transfer (Boquest et al., 1999); the foetal fibroblasts used in this 
experiment, had almost reached confluence, a state which is known to induce 
quiescence in cultured cells. 
Most experiments carried out to assess the effect of quiescence on NT 
efficiency have compared quiescent donor cells with cycling cells (Hill et al., 1998; 
Zakhartchenko et al., 1999a). A more correct approach would be to compare the NT 
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potential of quiescent, diploid cells (GO) with that of non-quiescent, diploid cells 
(Gi), rather than cycling cells. Only with this experimental design it would be 
possible to discriminate between the positive effects exerted on the ploidy and 
chromosomal integrity of cloned embryos by the diploid state, from those produced 
on reprogramming by the quiescence of the donor nucleus. Comparison of the 
developmental potential of GO and GI cells is made difficult by the lack of specific 
markers of cell quiescence, necessary to obtain well-characterised populations of 
donor cells in GO or GI. To date only "putative" GO and GI cells have been 
compared (Kasinatham et al., 2001; Wells, 2002), with contradicting results. An 
American study, carried out in cattle, showed no significant difference in the 
blastocyst rate of putative Gi fibroblasts, obtained by mitotic shake-off and 
replating, and putative GO fibroblasts, synchronized by contact inhibition 
(Kasinatham et al., 2001). However, the same study also showed that putative GI 
cells were able to support development to term more efficiently than putative GO 
cells. These results are in contrast with more recent data, in cattle, where putative GO 
cells, synchronized by serum starvation, gave significantly higher rates of 
development to term than putative GI cells, obtained by shake off and replating 
(Wells, 2002). Other data (Wrenzicky et al., 2001), from the same laboratory in New 
Zealand, showed that embryos derived from putative GI cells had significantly 
higher levels of expression of genes correlated with poor embryo quality, like the 
interferon-tau gene (JEt), than embryos derived from putative GO cells. 
There is also some indirect evidence suggesting that quiescence might be 
beneficial for development of cloned embryos, by creating an epigenetic status more 
amenable to reprogramming. Embryonic cells are totipotent, because they have 
unrestricted genomic potential or unrestricted potential for gene expression. During 
development, as they differentiate into the different somatic tissues, their genomic 
potential becomes restricted through the imposition of epigenetic controls that 
establish tissue specific patterns of gene expression. These repressive chromatin 
structures are difficult to disassemble. There are three main layers of epigenetic 
repression of gene expression, that prevent transcriptional activation in a tissue-
specific manner: 1) methylation of CpG dinucleotides; 2) acetylationldeacetylation of 
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histone H4; 3) changes in chromatin conformation controlled by composition and 
modification status of histone- (Hi, Hl', H2A, H2B, H4, H5) and non-histone 
proteins (Polycomb proteins HMG 1 , HP1). The stable nature of these epigenetic 
changes is the result of the fact that, apart from establishing states of gene repression 
during development, they also have to maintain them in the adult, through cycles of 
DNA replication, chromosome condensation and segregation. During remodelling, 
after transfer of a differentiated nucleus to a recipient oocyte, these chromatin 
repressive structures have to be removed to re-establish totipotency. However, their 
stable nature might impose a formidable obstacle to the development of cloned 
embryos, as suggested by reports showing persistence of epigenetic structures typical 
of differentiated cells in cloned embryos (Kang et al., 2001). There is also evidence 
suggesting that quiescence might help the removal of these repressive structures, 
making quiescent chromatin more amenable to reprogramming. Three issues are 
discussed in this paragraph: how epigenetic patterns are established during embryo 
development and differentiation; how they are successfully or unsuccessfully 
removed during reprogramming; how quiescence might help the remodelling 
process. 
Methylation of CpGs is the main covalent modification found in vertebrate 
embryos (Antequera et al., 1989; Keshet et al., 1986). During pre-implantation 
development, up to the blastocyst stage, genomic DNA is demethylated with 
percentages of methylated genomic DNA ranging from 9% in in vitro derived 
blastocyst, 5% in in vivo derived blastocysts and 3% in parthenogenetic blastocysts 
(Kang et al., 2001). At the time of gastrulation and organogenesis, as embryonic cells 
differentiate into different somatic tissues, de novo methylation takes place mainly 
directed by DNA methyltransferase 3a (Dnmt3a) and Dnmt3b, which recognise both 
demethylated and hemimethylated DNA. Through the activity of these enzymes 
tissue-specific patterns of methylation, monoallelic expression of imprinted genes 
and X chromosome inactivation are established. In adult somatic tissues about 50-
80% of genomic CpGs are methylated and this level is maintained stable through 
cycles of DNA replication by Dnmti, which has a great affinity for hemimethylated 
DNA (Newel-Price et al., 2000). 
17 
After transfer to a recipient oocyte somatic chromatin has to be heavily 
demethylated to reach methylation levels as low as those observed in in vivo or in 
vitro derived embryos (5-9%). Failure to erase tissue specific methylation patterns 
during pre-implantation development may result in establishment of aberrant 
methylation patterns, during post-implantation development. Analysis of the 
methylation status of cloned embryos and foetuses has shown that: cloned blastocyst 
are aberrantly and ectopically hypermethylated compared to control embryos (cattle; 
Kang et al., 2001; Bourc'his et al., 2001); placentas and tissues of cloned foetuses 
have altered levels of expression and levels of methylation of imprinted and non-
imprinted genes (mouse; Humpherys et at., 2001; Ohgane et at., 2001; Inoue et al. 
2002); placentas of cloned foetuses have abnormal methylation patterns of imprinted 
genes (mouse; Humpherys et at., 2001). 
For cloning experiments with mouse ES-cells it has been suggested that 
epigenetic instability of ES-cell lines might have contributed to the problem 
(Humpherys et at., 2001). However placentas from mouse clones derived from more 
stable, somatic cells (e.g. cumulus cells, Sertoli cells) also had significantly lower 
mRNA levels of non-imprinted (Igfbp2, Igfbp6, Vegfr2/Flkl and Esxl) and 
imprinted genes (Pegi/Mest, Megl/GrblO, Meg3/Gt12; Inoue et at., 2002). 
As previously suggested for the Large Offspring Syndrome, (Young et at., 
1998), abnormalities in methylation levels and patterns described in cloned embryos 
and foetuses might also account for some also the foetal and perinatal losses 
observed in nuclear transfer experiments as a result of the "cloned" offspring 
syndrome (Thomson et at., 1995; Holm et at., 1996; Eggan et at., 2001). 
Quiescence of the donor nucleus might help the reprogramming process by 
enhancing the demethylation process. This suggestion is supported by a report (Baqir 
and Smith, 2000) showing that contact inhibition or serum starvation, known to 
induce quiescence in somatic cells, significantly reduced methylation levels and 
expression of the imprinted genes Igf2 and H19. There are no reports to date 
comparing methylation levels and patterns in foetuses cloned from quiescent and 
non-quiescent cells. 
Another important layer of epigenetic control of gene repression is 
deacetylation/acetylation of histone H4 (for review see Newell-Price et al., 2000). 
Acetylated chromatin localises with RNA polymerase II, which suggests that 
acetylation of histone H4 associates with transcriptional activation, whereas histone 
H4 deacetylation is associated with transcriptional repression. Chromatin acetylation 
status results from the balance in the activity of two groups of enzymes: histone 
acetyl-transferases (HATs) and histone deacetylases (HDACs). These enzymes are 
associated with chromatin remodelling complexes, which act in an ATPase-
dependent manner, since structural modification requires energy. HATs usually 
associate with chromatin remodelling complexes (SWIJSNF, NURF, ACF, CHRAC, 
RSC) containing: TATA binding proteins (TBP; e.g. Ada, Spt), that recruit HATs to 
the chromatin template; an ATPase, supplying the energy for the remodelling 
machine (Snf2 for SWJISNF, ISWI for all the others); a transcriptional co-activator 
that might (Gnc5 for SWIISNF) or may not (Ga14.VP16, for all complexes) possess 
intrinsic acetyltransferase activity. As the chromatin template is hyperacetylated 
(tnacetylated, tetracetyalted or more) by HATs, it is also remodelled into a 
decondensed conformation (euchromatin), hypersensitive to DNA-se I digestion and 
accessible to transcriptional activation. On the contrary, HDACs (HDAC 1, HDAC2) 
usually bind to an histone binding protein (Rbac46/48) and associate with chromatin 
remodelling complexes containing: repressor proteins (MeCP2, MBD2a, MBD3), 
with a methylated CpG binding domain (MBD), used to recruit HDACs to sites of 
methylated chromatin, and a transcriptional repressor domain (TRD); an ATPase 
(e.g. Mi213); a co-repressor (MTA-2) which might (Rpd3) or may not (MTA-2, 
Sin3A, SAP30, SAP18) have intrinsic deacetylase activity. As the chromatin 
template, that had previously been methylated, becomes deacetylated (deacetylated, 
monoacetylated, diacetylated), the chromatin is remodelled in a condensed, nuclease 
resistant form (heterochromatin), inaccessible to transcription factors. 
Studies in Xenopus have shown that until the time of ZGA embryonic nuclei 
are transcriptionally inactive, and virtually deacetylated. Xenopus oocytes store large 
quantities of diacetylated histone H4 which, after fertilisation, is incorporated into 
the chromatin of early embryos, and further deacetylated into the mono or 
deacetylated (Dimitrov et al., 1993; Ryan et al., 1999). At this stage active 
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acetylation does not take place and HDACs activity is prevalent. However around the 
time of ZGA, when the embryo becomes transcriptionally active, hyperacetylated H4 
(tri or tetra-acetylated) form becomes predominant and the chromatin is decondensed 
by the SWIJSNF machine (Gelius et al., 1999; Kikyo and Woiffe, 2000). In mouse 
ZGA takes place at the 2-cell stage and it is marked by hyperacetylation of histone 
H4 (Worrad et at., 1995) and H3 (Stein et at., 1997) that takes place at the periphery 
of the pronuclei. This peripheral acetylation pattern is temporally restricted to ZGA 
and disappears after the 4-cell stage, although a diffuse nuclear acetylation pattern is 
present in later stages of development (Worrad et at., 1995; Stein et al., 1997). 
During embryo development acetylationldeacetylation patterns will be established in 
a tissue specific manner. Recent studies showed that parental mono-allelic 
deacetylation of imprinted genes takes place (Feil et at., 1997) and that selective 
deacetylation on imprinted genes and their methylation are linked (Gregory et al., 
2001; 2002). Contribution of acetylation in parental imprinting was confirmed by a 
report showing how trichostatin-A (TSA), an inhibitor of deacetylase activity, 
resulted in hyperacetylation, increased DNase- sensitivity and over expression of the 
maternally imprinted gene U2afl-rs2 in mouse (Gregory et at., 2001; 2002). 
Deacetylation also contributes to X chromosome inactivation (Heard et at., 1997). 
Considering the complementarity of the methylation and deacetylation 
process in gene silencing of somatic cells, it is possible to speculate that, not only 
methylation patterns, but also acetylation patterns, associated with changes in 
chromatin structure, will have to be "reprogrammed", after nuclear transfer, by the 
maternal histone acetylase, accumulated in mature oocytes (Ryan et at., 1999). 
Female gametes accumulate large quantities of remodelling complexes involved in 
chromatin decondensation and acetylation, such as the SWIISNF remodelling 
complex in Drosophila, and BRG1, a SWIJSNF like complex, in Xenopus (Gelius et 
at., 1999). The role of these complexes in normal embryos development is to make 
sure that homeotic genes can be activated at the correct time, when ZGA takes place. 
Nuclear transfer experiments in Xenopus showed that (Kikyo et at., 2000) 
SWIJSNF-like complexes, also play a major role in the in the decondensation of the 
donor chromatin, at the time of nuclear swelling, suggesting that changes in 
chromatin conformation and creation of new patterns of acetylation are an important 
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part of the reprogramming process. Just like observed for methylation, incomplete or 
incorrect erasure of somatic acetylation/deacetylation patterns in donor cells might 
led to incorrect patterns of gene expression. 
Quiescence might facilitate erasure of pre-existing acetylation patterns 
easier, increasing reprogramming efficiency. Terminally differentiated cells, such as 
erythrocytes (Dimitrov et al., 1993) and T-lymphocytes (Pogo et al., 1966), are 
quiescent (0-1% cycling), therefore they are transcriptionally inactive, with more 
than 90% of their histone H4 in an hypoacetylated form. However, to date there are 
no data in the literature comparing acetylation patterns of cloned embryos with those 
of control embryos, and assessing the possible influence of the donor cell cycle on 
these acetylation patterns. 
Chromatin conformation is also determined by composition of histone and 
non-histone, chromatin proteins. Chromatin protein composition changes 
dramatically during development and differentiation, so that chromatin of 
differentiated cells differs greatly from that of embryonic cells. For this reason it not 
surprising that remodelling of the donor chromatin structure is an important element 
of nuclear reprogramming (Kikyo et al., 2000). In the first hours after nuclear 
transfer, after Premature Chromosome Condensation (PCC), the donor nucleus 
doubles in size as the chromatin decondenses. This event, known as nuclear swelling, 
is considered the morphological expression of nuclear reprogramming and is thought 
to be essential for successful cloning (Kikyo and Woiffe, 2000; Kikyo et al., 2000). 
Nuclear swelling results from the exchange of proteins between the nucleus and the 
cytoplasm. During nuclear swelling about 75-80% of proteins, associated with the 
donor chromatin, are removed by molecular chaperons (e.g. nucleoplasmin, N1/N2) 
and are replaced by other proteins contained in the oocyte cytoplasm. These changes 
in the donor chromatin make it, in a way, more similar to the sperm chromatin 
(Dimitrov and Woiffe, 1996; Kikyo and Wolffe, 2000). Sperm contains arginine-rich 
protamines, instead of somatic linker histones (Hi), high levels of core histones H3 
and H4 and low levels of H2A and R2B. During development, N1/N2 and 
nucleoplasmin remove protamines and add H2A and H2B core histones. At later 
stages of development somatic linker-histone Hi is also added. 
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In nuclear transfer experiments, after transfer of erythrocytes to Xenopus 
eggs, the somatic linker histones Hi and Hl' are exchanged for the linker histone B4 
and the chromatin structural protein HMG1, usually abundant in early embryos. No 
changes occur in the composition of somatic core histones, possibly because they are 
tightly bound to the chromatin (H3, H4, H2A, H213). Removal of histone Hi has 
been described also in morula-stage nuclei after transfer to Mll oocytes (Bordignon 
et al., 1999). 
Quiescence affects chromatin structure by modifying histone composition 
(Khochbin and Woiffe, 1994, Dimitrov and Woiffe, 1996). Terminally differentiated 
GO cells, such as erythrocytes, contain the linker histone variant Hi ° (Khochbin and 
Wolffe, 1994), which is arginine-rich, just like sperm protamines, and for this reason 
has a greater affinity for nucleoplasmine and is removed from the chromatin more 
efficiently than histone Hi itself (Dimitrov and Wolffe, 1996). As a result of this, 
during reprogramming, GO cells (e.g. erythrocytes) loose all their histone Hl' and 
only part of their Hi variant. 
The reprogramming process might target other proteins involved in 
heterochromatin-mediated gene silencing. Changes in chromatin structural proteins 
such as Polycomb group (PcG1) and the heterochromatin protein i (HP1), may also 
be required for reprogramming. Studies in Xenopus have shown that these proteins 
are absent in early embryos and appear only after gastrulation, inducing 
heterochromatin-mediated gene silencing in a tissue-specific manner (Strouboulis et 
al., 1999). 
Experiments in mouse have shown persistence of repressive chromatin 
structures in cloned embryos (Moreira et at., 2002). In terminally differentiated 
cumulus cells, the nuclear protein AKAP95 associates with chromatin resistant to 
DNAse-I and NaCl treatment, suggesting a role in differentiation and 
heterochromatin gene silencing (Moreira et at., 2002). In NT embryos AKAP95 
colocalises with patches of heterochromatin and it is not extracted by nuclease 
treatment and NaCl treatment, whereas in ICSI and IVF embryos AKAP95 
associates with euchromatin, therefore it is almost completely extracted by DNAse-I 
and NaCl treatment (Moreira et at., 2002). This suggests that in reconstructed 
embryos proteins such as AKA95 may represent an obstacle to reprogramming by 
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maintaining the donor chromatin template in a more repressive state compared to 
normal IVF or ICSI embryos. Other structural proteins like HMG1 are exchanged for 
histone Hl by nucleoplasmine, at the time of nuclear reprogramming (Dimitrov and 
Woiffe, 1996). 
Quiescence has a great effect on chromatin conformation and on the 
localisation of sub-nuclear distribution of chromatin structural proteins, and this may 
also affect the reprogramming process (Bridger et at., 2000; Juan and 
Darzynkiewicz, 1998). 
1.4 CHARACTERISATION OF DONOR CELLS 
USING GO AND Gi MARKERS 
For NT experiments it would very important to distinguish GO from GI, in 
order to compare the efficiency of these two cell cycle stages for NT. However, there 
is a lack of specific markers of cell quiescence, which makes it difficult to obtain 
well-characterised populations of cells, either in a GO or a Gi stage. For this reason 
donor cells used in most nuclear transfer experiments are defined as being in a 
GO/GI stage, rather than at a GO or GI stage. Conventional methods of cell cycle 
analysis are not sufficient to discriminate between GO and GI cells. Univariate 
analysis of cellular DNA content using DNA specific dyes (Propidium Iodide, DAPI, 
Hoechst, etc) and flow cytometry, can be used to grossly identify cell position in the 
major phases of the cell cycle (GO/GI, S, G2/M). Nevertheless bivariate or 
multivariate analysis, where two or more parameters are measured simultaneously, 
becomes necessary when a more precise discrimination between cell cycle phases is 
required (GO vs Gi or G2 vs M). Quiescent cells are either post-mitotic terminally 
differentiated cells (amphibian nucleated erythrocytes, Sertoli cells, neurons, 
cumulus cells), or mitotic cells made quiescent by serum deprivation or contact 
inhibition. Cells in GO are characterised by a repressive chromatin conformation 
(heterochromatin; Bridger et at., 2000; Juan and Darzynkiewicz, 1998), 
hypoacetylated histones (Pogo et at., 1966) and reduced rates of transcription and 
protein synthesis (Boquest et at., 1998). On the contrary, cells in GI are 
characterised by an open chromatin template, more accessible to transcription 
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factors, prevalence of hyperacetylated histories and higher rates of transcription and 
protein synthesis than GO cells. Besides GO cells express specific cell cycle 
regulators and other quiescence markers that are not present in more activated GI 
cells. In conclusion, although GO and GI have the same DNA content (2N), they can 
be distinguished by considering other discriminating features: 
Transcriptional activity (histone acetylation, chromatin conformation): low 
in GO cell, high in G1 and cycling cells; 
Protein synthesis levels (reran content, protein content, cytoplasmic 
diameter): low in GO cells, high in GI and cycling cells; 
Expression of cell cycle specific regulators: GO cells lack Gi specific 
regulators (cyclin Dl, cyclin E, p21) and express quiescent specific markers 
(p27, p130); 
Cell type specific surface markers (Gas3, CD25, transferrin). 
1.4.1 Cell cycle specific markers 
Cell cycle progression is orchestrated by regulators and each cell cycle stage 
is regulated and characterised by a specific set of regulative molecules. Specific 
regulators of progression through GO and GI can be used to discriminate between 
these cell cycle stages. 
The regulation of GO and Gi, like that of other stages, occurs at different 
levels. The first level is represented by proteins of the retinoblastoma family (pRb 
proteins), which act as negative regulators of cell cycle progression (review by 
Dyson, 1998). This family includes: the retinoblastoma tumour suppressor protein 1 
(pRbl), involved in GI progression (early/late GI transition, GuS transition); p130 
or pRb2, involved in GO/GI progression, and p107, involved in S-phase and G2JM 
progression. These proteins act as negative cell cycle regulators by repressing the 
expression of genes essential for cell cycle progression. Retinoblastoma proteins 
induce an E2F-mediated repression, as demonstrated by the fact that all the genes 
under their control have an E2F consensus-binding site in their promoter (Dyson, 
1998). While pRbl can bind all five E2F factors (E2F1-E2F5), p130 only binds 
E2F4, E2F5 and p107 only binds E2175. Transcriptional repression can occur in two 
different ways: when E2F act as transcription repressors, retinoblastoma proteins act 
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as co-repressors, forming E2F/pRb repression complexes which block the promoter; 
when E2F act as transactivators, they are active when free and inactive when bound 
by retinoblastoma proteins. E2F4 and E2F5, which form complexes with p130, and, 
to a lesser extent, with pRb, repress the transcription of genes important for GO/GI 
transition (E2F1, E2F2, HsOrcl, B-Myb) and are responsible for GO maintenance. 
The important role played by p130 in the maintenance of the quiescent state had 
already been pointed out by Smith et al., (1996) who also understood its potential as 
distinguishing marker between GO and GI. Inimunoprecipitation experiments have 
shown that E2F4 also forms complexes with p107, which inhibits S phase and G2 
phase progression. E2F1, E2F2, E2F3, on the contrary, are transactivators of genes 
important for transition from early to late Gi (cyclin E) and GUS transition (cyclin 
A). These factors are inactivated by pRb binding and activated by pRb 
phosphorylation, that leads to their release. 
All the retinoblastoma proteins can be inactivated, and the blocks they 
represent removed, by phosphorylation. The phosphorylation of these proteins is 
carried out by cyclin-dependent kinases (Cdk), which therefore act as positive 
regulators of cell cycle progression. Cdk activity is periodical and is regulated in a 
cell cycle specific manner (Roberts et al., 1994). Cdk activation requires two things: 
their association with regulatory subunits called cyclins, the levels of which fluctuate 
throughout the cell cycle; phosphorylation of Cdks by the Cdk-activating kinase 
(CAK; Morgan, 1995). Progression through early GI is mitogen-dependent and pRb 
dependent, since it depends on the presence of growth factors and inactivating 
phosphorylation of pRb. The association between mitogenic signals and early GI 
progression is achieved by the cyclin D1/Cdk4 and cyclin D1/Cdk6 complexes 
(Sherr, 1993). As a matter of fact cyclin Dl is short lived (t 1/2  25 mm) and for its 
synthesis it relies on growth signals rather than on intracellular stimuli (E2F factors 
for cyclin E and A). Furthermore, the D1/Cdk4 and D1/Cdk6 complexes are mainly 
responsible for pRb phosphorylation. Progression through late GI is mitogen 
independent and partially pRb-dependent. During this stage the cyclin E/Cdk2 
complex (Resnitzky and Reed, 1995; Ohtsubo et al., 1995) completes pRb 
phosphorylation. The kinase activity of the cyclin A/Cdk2 complex is thought to 
mediate GUS transition possibly by inactivating the p1071E2F4 complex and by de- 
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repressing the transcription of genes important for S-phase progression. The last 
level of regulation is represented by Cdk inhibitors (CKIs; Sherr and Roberts, 1995) 
that, by inhibiting Cdk activity, act as negative regulators of cell cycle progression. 
CKIs bind to cyclin-Cdk complexes and inhibit their catalytic activity either by 
preventing Cdk from binding cyclins or by inhibiting the activating phosphorylation 
of Cdks by CAK. Through Cdk levels remain constant throughout the cell cycle, 
their activity is periodical because of the fluctuations in the levels of cyclins and of 
CMs occurring during the cell cycle. 
CKIs are negative cell cycle regulators (review by Sherr and Roberts, 1995) 
and have been extensively studied by cancer researchers because they can act as 
tumour suppressor genes and their deregulation is implicated in a variety of 
malignancies (Nobori et al., 1994; Guo et al., 1997; Nakazumi et al., 1998). CKIs are 
classified into two families, based on their protein sequence similarities and their 
putative Cdk targets: the INK4 and the CIP/KIP family. CKIs from the INK4 family 
(p15 p16 p 16INK4a 18INK4c p19ARFIINK4d) specifically bind Cdk6 complexes. CKIs 
from the CIP/KIP family (p21C 1/WARF1 27KJP1 p57K1P2) are more promiscuous and 
are able to potently inhibit cyclin D1/Cdk4 and cyclin E/Cdk2 complexes, and, to a 
lesser extent, other complexes containing Cdk2 or Cdc2/Cdkl. CKIs up regulation 
can be induced by a variety of stimuli and leads to cell cycle arrest. Particularly 
important to distinguish between GO and GI are p21 and p27. The protein p27 plays 
a pivotal role in the induction and maintenance of the GO state, as suggested by many 
observations. First of all p27 expression is induced by a variety of antimitogenic 
signals that induce quiescence, such as mitogen (e.g. IL-2, serum) starvation (Nourse 
et al., 1994; Coats et al., 1996; Coats et al., 1999), cell-cell contact (St. Croix et al., 
1998), loss of cell anchorage, TGF-13 (Polyak et al., 1994a) and exposure to 
staurosporine (Kwon et al., 1996). The levels of p27 are high in quiescent cells and 
decrease as cells re-enter the cell cycle in Gi. In serum-starved Baib cI3T3 cells, p27 
levels are undetectable in cycling cells but start increasing 4 hours after serum 
depletion, reaching 60% of the maximum concentration after 12 hours and peaking 
after 24 hours of serum starvation (Coats et al., 1996). Similarly p27 is highly 
expressed in serum-starved human diploid fibroblasts (Nourse et al., 1994) and 
mouse embryo fibroblasts (Coats et al., 1999) but is completely degraded within 24 
26 
hours of serum re-stimulation. Other observations suggest that p27 function may be 
to associate antimitogenic signals with GO arrest. Researchers have demonstrated that 
p27 depleted cells loose their ability to exit the cell cycle and continue to grow for 
several generations in serum free medium (Rivard et at., 1996). Furthermore, p27 
antisense eDNA suppresses quiescence in GO cells (Rivard et at., 1996). The 
mechanism through which p27 induces GO arrest is probably by preventing the 
activation of GI cyclinlCdk complexes. It has been demonstrated that p27 binds 
tightly to cyclin D1/Cdk4 and to cyclin E/Cdk2 complexes and inhibits their activity 
in a stoichiometric manner (Polyak et at., 1994b), either by preventing cyclin Dl and 
cyclin E binding or by preventing them from being phosphorylated and activated by 
CAK. The regulation of p27 expression in response to mitogenic/antimitogenic 
signals occurs on a translational and a post-translational level rather than on a 
transcriptional level. When cells enter quiescence p27 levels increase, as a 
consequence of an increased protein synthesis rate and a decreased proteolysis rate, 
while IURNA levels remain constant. When cells exit quiescence p27 protein levels 
decrease as a result of rate of decreased rate of translation and increased rate of 
degradation. Inactivation and degradation of p27 may involve a different process. 
Sequestering by cyclin D1/Cdk4, Cdk6, during early Gi, and inactivating 
phosphorylation of p27 on Threonine 187 by the cyclin EICdk2 complex, during late 
Gi, are thought to be two of them. It has been demonstrated that although p27 is 
primarily an inhibitor of cyclin E/Cdk2 kinase activity, in the presence of low 
concentrations of ATP (<50uM), when ATP concentrations approach physiological 
levels (>1mM) it becomes also a substrate for cyclin EICdk2 phosphorylating 
activity, resulting in its inactivation (Sheaff et at., 1997). Degradation of p27 also 
occurs through the ubiquitin-proteasome pathway, which takes place in to steps: 1) 
transfer of ubiquitin to the p27, mediated by the ubiquitin—conjugating enzyme 
Cdc34 and a still unknown ubiquitin ligase; 2) proteasome-dependent degradation of 
ubiquitin tagged p27 (Pagano, 1997). The other member of the CIP/KIP family is the 
protein p21. Though it shares a great homology with p27, it has very different 
regulation and function. Unlikely p27 this protein is down regulated in GO cells and 
is up regulated as cells re-enter the cell cycle in GI (Nourse et at., 1994). This 
suggests that while p27 regulates Cdk activity during quiescence, p21 regulates Cdk 
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activity in Gi proliferating cells, without contributing or contributing very little to 
the GO arrest (Coats et at., 1999). Just like p27, also p21 up regulation leads to GI 
arrest, but under different conditions. This protein is in fact the primary mediator of 
the p53-dependent GI arrest that occurs following DNA damage (El Deiry et at., 
1993) and of growth arrest of senescent cells (Noda et at., 1994). Nevertheless p21 
induces growth arrest with the same mechanism as p27, by inhibition of Cdk2/cyclin 
E and Cdk4/cyclin Dl complexes kinase activity. Unlikely p27, p21 regulation 
occurs at a transcriptional level. 
Regulation of the GO arrest by antimitogenic signals is cell type specific. In 
T-lymphocytes p27 is the only mediator of GO arrest (Coats et at., 1999). However, 
in mouse embryo fibroblasts (MEF5) p27 is still the primary regulator of GO arrest 
but it is not the only one. Previous reports have demonstrated that in p27 null MEFs 
p21 is able to induce GO arrest, though to a lesser extent than p27, and that in p27-
p21 null MEFs p130, a member of the retinoblastoma family, is able to compensate, 
inducing complete arrest in GO after serum starvation (Coats et at., 1999). The 
important role played by p130 in the maintenance of the quiescent state had already 
been pointed out by other researchers who also understood its potential as a 
distinguishing marker between GO and Gi (Smith et at., 1996). 
All these markers can be used to distinguish between cell cycle stages using 
either immunocytochemistry or flow cytometry techniques 
1.4.2 Differences in chromatin conformation and acetylation 
Quiescent cells are transcriptionally inactive whereas Gi cells have high 
levels of transcription. Since transcription is affected by chromatin conformation and 
acetylation GO cells will have different acetylation patterns and a different chromatin 
conformation than GI cells. 
Quiescent cells are characterised by very low levels of histone acetylation. 
Terminally differentiated, GO cells like erythrocytes, have such low levels of histone 
acetylation that they are commonly used as a negative control for acetylation since 
90% of their histone H4 is in a mono or deacetylated form, and about 10% is in a 
diacetylated form (Dimitrov et at., 1993). Other terminally differentiated cells, such 
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as T-lymphocytes have very low levels of acetylation, which rise dramatically after 
activation (Pogo et al., 1966). 
Nuclear chromatin conformation is also affected by the cell cycle. 
Chromatin is very condensed during mitosis (M) whereas it is maximally 
decondensed at the time of entrance in S-phase. Chromatin of GO cells presents a 
high level of condensation, even if not as high as cells in M-phase. Changes in 
chromatin condensation are correlated with changes in DNA in situ sensitivity to 
denaturation. These changes can be detected using flow cytometry and staining with 
Acridine Orange (AO), a metachromatic fluorochrome, which differentially stains in 
green non-denatured (double-stranded) DNA and in red denatured (single stranded) 
DNA. Red fluorescence is associated with decondensed chromatin, whereas green 
fluorescence is associated with condensed chromatin (Juan and Darzynkiewicz, 
1998). With this method cells must be treated with RNAse, which would otherwise 
be mistaken as single-stranded (denatured) DNA, and fixed before staining. This 
method has been successfully used to characterise and discriminate quiescent GO T-
lymphocytes from GI and cycling T-lymphocytes (Juan and Darzynkiewicz, 1998). 
1.4.3 Differences in RNA content, protein levels, cell size 
Under different experimental conditions AO can be used to distinguish GO 
and GI cells based on their RNA content. As a matter of fact total RNA content is 
largely composed by ribosomal RNA, and is therefore an estimate of ribosome 
synthesis and ultimately of protein synthesis. At appropriate concentrations and 
stringent ionic conditions, AO intercalation into double stranded DNA results in 
green fluorescence, whereas its binding to single stranded RNA results in red 
fluorescence (Juan and Darzynkiewicz, 1998). With this system neither RNAse 
digestion nor fixation is required, but cells must be permeabilised in order for the dye 
to penetrate the cell membrane and reach the intracellular compartment. The problem 
with both these methods are that they require very stringent conditions (e.g. dye 
concentration) that are difficult to obtain because AO is a very unstable dye that 
tends to attach to plastic ware and then to go back into suspension (Juan and 
Darzynkiewicz, 1998). However, this method has been used successfully in human 
T-lymphocytes to compare DNA and RNA content of: freshly isolated, GO T- 
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lymphocytes; mitogenically stimulated, cycling T-lymphocytes; T-lymphocytes 
synchronized in GI by mitogenic stimulation in the presence of 0/S blocking agents. 
T-cells in 01 had the same DNA content of GO cells but a content of RNA 
(mean=60) intermediate between quiescent (mean=50) and activated T-cells 
(mean=95). 
Simultaneous assessment of cell size and nuclear size can also be used to 
discriminate GO and GI cells (Firpo et al., 1994). Nuclear size is correlated with 
DNA content, whereas cell size is correlated with cytoplasmic protein synthesis. 
Mean nuclear and cytoplasmic diameters can be measured by flow cytometry and 
AO staining for DNA/RNA. For this purpose the fluorescent width (FL-W) will have 
to be considered instead of the fluorescence intensity (FL-H) and green nuclear DNA 
staining (FL1-W), will be used as a measure of the nuclear size, and the red 
cytoplasmic RNA staining, will be used as a measure of cytoplasmic size (FLW-3). 
This method was used to discriminate human T-lymphocytes (Firpo et al., 1994) in 
01 and GO. T-cells in 01 and GO, both diploid had the same mean nuclear size (96 
vs97), but Gi T-cells had a significantly larger cell size (mean=78), intermediate 
between that of GO T-cells (mean=61) and activated T-cells (mean= 100). 
Another way of distinguishing GO and GI cells on the basis of their 
different protein synthesis rates is by measuring simultaneously DNA content and 
total protein content. Using this method, researchers showed that serum-starved pig 
foetal fibroblasts had 87.5% diploid cells (GO/Gi), and 48.3% of cells in GO, while 
contact-inhibited cells had 85.1% diploid cells (00/01) 6% GO cells (Boquest et al., 
1999). The main criticism of this method is that protein content in itself is not only 
correlated with protein synthesis rates but also it is also correlated with cell size. This 
is also suggested by the fact that the percentages of GO cells, with low protein 
content, increased significantly as cell size decreased (Boquest et al., 1999). This 
could have meant that small cells simply had lower amount of proteins than larger 
cells, without any difference in protein synthesis. 
1.4.4 Surface markers 
There are very few surface markers of quiescence and they tend to be cell 
type specific. In T-lymphocytes quiescent cells do not express the high affinity 
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interleukin-2 receptor (IL-2cz or CD25) and the transferrin receptor (Tf-R; Firpo et 
al., 1994). These receptors, however, are up regulated after activation, so that a 
significantly higher number of GI cells and cycling cells will express CD25 and Tf-
R compared to GO cells (Firpo et al., 1994). So CD25 and Tf-R can be used as 
negative markers of T-cell quiescence. To date there is only surface, positive marker 
of cell quiescence. It is a transmembrane protein encoded by the growth arrest-
specific gene 3 (Gas3). The Gas genes were first identified in GO growth arrested 
mouse NIH3T3 cells (Schneider et al., 1988). Among the Gas genes, Gas3 is the 
only gene to encode a transmembrane protein (D'Urso and Muller, 1997). The Gas3 
gene is up regulated in serum-starved or contacted inhibited GO fibroblasts on both a 
transcriptional and translational level (Karisson et al., 1999). At the moment there 
are no antibodies commercially available against the protein encoded by the Gas3 
gene. However specific antibodies recognising this protein could be produced since 
this protein has two hydrophilic extracellular domains. 
1.5 GENERAL AIMS OF THE PROJECT 
Find a suitable mouse cell model which can be used to produce well-
characterised donor cell populations in GO and GI (Chapter 3-5). 
Transfer GO and GI cells to MIT oocytes, and produce nuclear transfer 
mouse embryos (Chapter 6). 
Compare effect of GO and GI on epigenetic changes occurring in the donor 
nuclei before and after nuclear transfer, focussing on events occurring 
around the time of reprogramming (1-4-cell stage: Chapter 6). 




GENERAL MATERIALS AND METHODS 
2.1 MOUSE FOETAL FIBROBLAST ISOLATION 
AND SUB-CULTURE 
Mouse Foetal Fibroblasts (MFF) were generated from 14-day post-coitus 
mouse foetuses, of the 129 inbred strain. A total of 15 foetuses were isolated from 
two female mice. Foetuses were collected in 25m1 tubes containing lOmi Phosphate 
Buffered Saline (PBS; A.1.2), supplemented with 0.2% (v/v) gentamicin 50mg/mi. 
Foetuses were processed individually. The heads and internal organs of the foetuses 
were removed and the carcasses rinsed in PBS supplemented with 0.1mg/mi 
gentamicin. The carcasses were then minced with scissors in a 60mm tissue culture 
dish (Nunclon) containing 0.25% trypsin/0.04% EGTA (w/v) solution (A.1.3), and 
incubated at 37°C for 3-5 mm. After digestion the cells were resuspended in fresh 
medium and centrifuged at 200g for 5 mm. The pellet was then resuspended in 6m1 
of culture medium, containing Dulbecco's Modified Eagle's Medium (DMEM) with 
10% foetal calf serum (FCS; Globepharm), 2mM L-glutamine, 1mM Sodium 
pyruvate, 1% (v/v) Mem-amino acids, 0.05mg/mi gentamicin (A. 1. 1), and plated into 
25cm2 (IWAKI) tissue culture flasks (passage 0). All chemicals used were purchased 
from Gibco, unless otherwise specified. After 24 hours at 37°C with 5% CO 2, the 
medium was changed with fresh, culture medium without gentamicin. Cells reached 
confluence in 24h-72h (maximum time observed 6 days). When 85% confluent, cells 
were trypsinized and either frozen at passage 0 (total 3-4x10 6 cells/flask, 4-5 
vials/flask), or split 1:3 into 75cm 2 tissue culture flasks (IWAKI) and frozen at 
passage 1 (total 9-10x10 6 cells/flask, 16-18 vials/flask). For freezing cells were 
trypsinized, washed once with medium and resuspended in 10% FCS medium at a 
concentration of 1x10 6/ml. The cell suspension was diluted 1:1 with freezing mix, 
containing 1 part FCS, 1 part DMSO (Hybri-max; Sigma D 2650), 2 parts culture 
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medium and dispensed into vials (0.5m1/vial). Vials were stored at —80°C overnight, 
and then at-196°C. 
Freezing reduced cell viability. Viability was checked by diluting lOOul of 
cell suspension 1:2 in 0.5% (w/v) Trypan blue in 0.85% saline solution (Flow 
Laboratories), and live cells were counted (Trypan blue negative cells) using a 
haemocytometer. Average viability in frozen/thawed cells was 83.3±8.7%, ranging 
from 95% to 70%. These values were lower than those found in cultured cells with 
an average viability of 98.3±0.7% and a minimum observed viability of 97%. 
However, cells managed to recover in culture, but their ability to recover appeared to 
be negatively correlated with the time spent in liquid nitrogen. 
Each vial contained enough cells (0.58±0.18x10 6/vial) to plate in a 25cm2 
flask at a concentration of 23±7x10 3/cm2, reaching confluence in about 2 days. At 
confluence cells reached concentrations of 60-80x 1 0 3/cm2 (1 .5-2x 106  cells/25CM2  
flask, 5-6.5x106cells/75cm2flask). Cells were usually seeded at a concentration of 14- 
1 5x 1 03/cm2 (split 1:4; 0.35x 106  cells/25CM2   flask; 1 .05x 106  cells/75CM2   flask), 
reaching confluence in 48 hours (passage 0-2) and 72h (passage 3-5). In some 
experiments cells were also seeded at a concentration 20-25 10 3/cm2 (split 1:3) and 
reached confluence in 48h or at a concentration of 10 4/cm2 (1:6) and reached 
confluence in 96 hours. 
2.2 SELECTION OF MOUSE FOETAL FIBROBLAST 
CELL LINES 
Cell line normality was assessed on the basis of karyotyping results 
(Paragraph 2.3) morphological assessment and life history in culture. Only cell lines 
that had retained a normal chromosome number (n=40) for at least 4-5 passages in 
culture were selected. Mouse embryonic stem cells (ES-cells) are karyotipically very 
stable. The karyotype of a mouse embryonic stem cell line, isolated from the 129 
inbred strain (129 ES-cell), that had reached a population doubling level (PDL) of 27 
(9 passages, split 1:6), was used as a control. Two out of nine MFF cell lines (MFF1, 
MFF2) were excluded from further analysis because at passage 2 they had a 
percentage of normal spreads (46%, 56%) significantly lower than controls (78%, 
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Table 2.1 Karyotype of Mouse Foetal Fibroblast cell lines 
Cell line 
Early 
passage PDL % Normal 
Late 
passage PDL % Normal % Loss/PD 
129 ES p9 27 78.0' - - - - 
MFF1 p2 3 46.0' - - - - 
V1FF2 p2 3 560" - - - - 
4FF3 p2 3 62.5a p4 6.0 58" 0.8 
\4FF4 p2 3 70. Oa p4 6.0 54" 2.6 
VIFF5 p2 3 64. Oa p6 90 53 " 
 1.2 
\4FF6 p2 3 64 .0a p4 6.0  2.3 
VIFF7 p2 3 66 .0a p5 75 _________ 2.1 
V1FF8 p2 3 
74Øa 
p5 7.5 68a 0.8 
vIFF9 p2 3 78 .0a p4 6.0 
71a 1.2 
1ean±SD 1 - - 64.5±9.5 1 	- - - 1.6±0.8 
The karyotype of Mouse Foetal Fibroblast (MFF) was checked by counting 50-100 spreads/8 slides for each cell line and calculating the 
proportion of spreads with a normal chromosome number (n=40; % normal). Es-cell lines are karyotipically very stable. A 129 ES-cell line, 
karyotyped at 27 population doubling level (27 PDL; passage 9, split 1:6) was used here as a control. MFF cell lines were karyotyped at an early 
passage and, if found normal, were also karyotyped at a later passage. PDL indicates the population doubling levels or cumulative population 
doublings, corresponding to each passage. Cell lines that retained normal karyotype (MFF8, MFF9), at least up to passage 4, were selected for 
the following experiments. The percentage of cells that became karyotipically abnormal after each population doubling (%loss/PD) was also 
calculated using the formula: (% Normal at an early passage-% Normal at a late passage)/(PDL at a late passage - PDL at an early passage). 
Cells with different superscripts have significantly different percentages of karyotipically normal cells (two-tailed, Chi-square test, a=0.05). 
p:!~0.001 ; Table 2.1). Two of the remaining seven cell lines, MFF 8 and MFF9, 
retained a normal karyotype respectively till passage 5 (68%, p=0.26) and 4 (71%, 
p=0.36), corresponding to a population doubling level of 7.5 and 6 (Table 2.1). The 
average loss of cells with normal karyotypes at each population doubling was 
1.6±0.8% (mean±SD; Table 2.1). 
Life history of the two selected cell lines, MFF8 and MFF9, was assessed by 
thawing a vial from each cell line at passage 1. At each passage cells were split 1:3, 
and two 25cm2 were kept in the incubator, to reduce contamination risks. At each 
passage cells were counted and viability assessed using the Trypan blue exclusion 
method. It was possible to calculate: 
Percentage of live cells, corresponding to percentage of Trypan blue 
negative cells; 
Population Doublings 	(PDs), 	calculated using 	the 	formula: 
PDs=3.32x(LoglONc-LoglONs), where Ns and Nc correspond respectively 
to cell counts obtained at the time of seeding and confluence (Doyle et al., 
1998); 
Doubling Time (DT), calculated using the formula: DT=days/PDs, where 
days indicate days taken to reach confluence and PDs population doublings 
occurred before confluence (Doyle et al., 1998). 
Changes in cell morphology were also noted. 
The cell line MFF8 (Fig.2.1) was sub-cultured for 45 days, up to passage 7 
(split 1:3, PDL 10.2). The cell line MFF9 (Fig2.1) was sub-cultured for 130 days, up 
to passage 30 (split 1:3, PDL 56). Three phases were identified in the life history of 
these cell lines (Fig.2.1), accordingly to previous reports (Doyle et al., 1998; Todaro 
and Green, 1963): 
Normal, up to passage 3 (PDL:57.2) and with an average doubling time of 
1.96±0.32 days (±SD) for MFF8; up to passage 4 (PDL:58.4), with a 
doubling time of 1.4±0.2 days for MFF9; 
Senescence, between passage 4 and 5 (PDL 7.1-8.6), with a doubling time 
of 3.52±0.78 days (±SD) for MFF8; between passage 5 and 10 (PDL 10.2-
16.8), with a doubling time of 4.7±2.9 days for MFF9; 
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Figure 2.1 Life history of selected Mouse Foetal Fibroblast cell lines 
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Figure 2.1 Cell lines MFF9 and MFF8 were sub-cultured respectively for 130 days 
(30 passages) and 43 days (7 passages). Each pink dot corresponds to a passage. At 
each passage cells were counted and their doubling time (pink line), and cumulative 
population doubling or population doubling level (PDL; blue line) were calculated. 
Based on PDL and doubling time, five cell categories were identified in MFF9: 
normal cells, up to passage 4 (PDL 8.4), with a doubling time of 1.4±0.2 days; 
senescent cells, between passage 5 (10.2 PDL) and 10 (16.8 PDL), with doubling time 
of 4.7±2.9 days; crisis at passage 11(17.8 PDL), with a doubling time of 34 days; 
transforming cells between passage 12 (19.8 PDL) and passage 14 (23.8 PDL), with a 
doubling time of 3.0±1.0 days; transformed cells, beyond passage 15 (25.8 PDL), with 
a doubling time of 1±0. In the MFF8, kept in culture for a shorter period of time, only 
a normal and a senescent-phase were identified. 
Figure 2.2 Brightfield images showing morphological changes in cultured Mouse 
Foetal Fibroblasts. Compared to normal fibroblasts (A), senescent fibroblasts (B) and 
cells at crisis point (C) appeared to be elongated and enlarged. During transformation 
fibroblasts acquired a transient polygonal shape (D) and, finally, a shape resembling 
that of young fibroblasts, small and elongated (E). 
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Crisis, between passage 6 and 7 (PDL 10.0-10.2), with a doubling time of 
12.2±1.1 days (mean±SD) for MFF8; at passage 11 (PDL 17.8), with a 
doubling time of 34 days for MFF9. 
In the case of the cell line MFF9, that was sub-cultured for 130 days, the emergence 
of a transformed cell population was also observed (Fig.2.1). The appearance of two 
cell populations followed the crisis phase: 
Transforming cells, between passage 12 and 14 (PDL 19.8-23.8), with a 
doubling time of 3.0±1.0 days (±SD), shorter than that of senescent cells but 
still longer than that of normal cells; 
Transformed cells, beyond passage 15 (PDL ~!25.8), with a doubling time 
of 1±0. 
Changes observed in doubling time were associated with changes in cell morphology 
(Fig.2.2). Compared to normal fibroblasts (Fig.2.2A), senescent fibroblasts and 
fibroblasts at crisis point appeared flattened out and enlarged (Fig.2.2B-C). During 
transformation, clusters of fibroblasts acquired a transient polygonal shape 
(Fig.2.2D) and, after transformation, a shape resembling that of young fibroblasts, 
small and elongated (Fig.2.2E). 
The 13-galactosidase (3-Gal) staining (Paragraph 2.4) was used as a 
biomarker of senescence, to confirm the senescent state of MFF8 and MFF9. 
Senescent sheep foetal fibroblasts, isolated from Black Welsh foetuses at passage 45 
(split 1:4, PDL=90), were used as a positive control. Senescent MFF, unlike sheep 
foetal fibroblasts, appeared to be 13-Gal negative. This might be due to species 
differences. The 13-galactosidase staining has been effectively used in sheep and 
human foetal fibroblasts, that senesce after 100-50 PDs and then die off, without the 
emergence of immortalized cells. Mouse foetal fibroblasts, however, age very early 
and then transform. This difference associated with the fact that transformed cells are 
13-Gal negative, might explain this discrepancy. 
Based on all these considerations the cell lines MFF8 and MFF9 were 
selected for synchronization experiments and used up to passage 4, beyond which 
they tend to senesce and transform. 
Features observed in the selected MFF cell lines were similar to those 
described in the literature (Todaro and Green, 1963; Doyle et al., 1998): normal 
iB 
features up to 8-10 generations, with a doubling time of 30-60h; senescence and 
crisis at 10-15 PDs, with a doubling time of lOOh or more; transformation at 15-30 
PDs, marked by shortening of the doubling time to 14-24h and emergence of a 
tetraploid population. 
2.3 KARYOTYPING 
Karyotype of mouse foetal fibroblast primary cell lines was assessed at 
passage 2 and passage 4 (Fig.2.3). In contact inhibition experiments karyotype of 
cells that had been kept under contact inhibition for different length of time, at 
passage 3, were passaged and karyotyped at passage 4. 
Cells were plated in 25cm 2 tissue culture flasks and, when 40-50% 
confluent, they were trypsinized, washed once with 10% FCS culture medium, gently 
resuspended in 0.75% (w/v) Na 3citrate 21120 (BDH) hypotonic solution and 
incubated at room temperature for 10mm. After centrifuging 5min at 200g, cells 
were fixed for 5rnin with ice cold, methanol: acetic acid (3:1) solution. After 
centrifuging at 200g, for 5mm, and fixing other two times, cells were smeared onto 
ice cold 76x26mm glass microscope slides (Blue Star, UK) and, once dry, stained 
with 3% (wlv) Giemsa (BDH) for 1 1mm. Slides were read using a lOOx Fluor oil 
objective (Nikon), on a Nikon Microphot-SA microscope, and reading 50-100 
metaphase plates for each cell line (Fig.2.3). 
2.4 13-GALACTOSIDASE STAINING 
The 13-galactosidase (3-gal) staining was performed as previously described 
(Dimri et al., 1995). Cells were washed once with PBS and fixed for 3-4min at room 
temperature with 2% (w/v) formaldehyde and 0.2% (w/v) glutaraldehyde (A.1.4). 
Cells were washed twice with PBS and stained with 1mg/mi X-gal (Promega) 
solution in 40mM Na2HPO4Icitric acid, 5mM Potassium ferrocyanide (Sigma), 5mM 
Potassium ferricyanide (Sigma), 150mM NaCl, 2mM MgC1 2 (A.1.4). Staining was 
carried out at 37°C, for a minimum of 2-4h and a maximum of 12h-16h. 3-gal 
positive cells had blue nuclei and blue cytoplasm in the perinuclear region. 
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Black and white images of Mouse Foetal Fibroblasts with normal (A; n ° chromosomes = 
40) and abnormal (B; n ° chromosomes = 80) karyotype. Cells were processed as 
described in paragraph 2.3 and stained with 3% (wlv) Giemsa. Visual examination was 
carried out with a Nikon Microphot-SA microscope equipped with a 100x oil objective. 
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2.5 SYNCHRONIZATION OF MOUSE FOETAL 
FIBROBLASTS IN GO AND GI 
In serum starvation groups, cells were seeded at a low concentration of 10-
1 1x03/cm2, corresponding to 43x10 3cells/2ml/well, in 12 well plates (3.8cm 2/well; 
IWAKI), for immunocytochemistry, or 0.75x10 6/75cm2 flasks (IWAKI), in flow 
cytometry experiments. Cells were cultured with 10% FCS culture medium, for 48h-
72h, until they were 50-60% confluent, and then serum-starved. For serum starvation 
cells were washed two times with PBS and three times with serum starvation 
medium, and then left incubating in serum starvation medium prepared like culture 
medium, but with 0.5% FCS or 0.1% FCS. Cells in the control groups (cycling), 
were sub-confluent cells that had been cultured in 10% FCS medium for 48h-72h, 
before being fixed and processed. 
In contact inhibition experiments cells were seeded a high density of 
22.5x103/cm2, corresponding to 45x10 3celIs/lml/weIl in 24 well plates (1.9cm 2/well), 
with 1 coverslip/well in PCNA experiments, and 0.55x 106  cells/25cm2 flasks, in flow 
cytometry experiments. Cells were cultured in 10% FCS medium that was changed 
every 48h. Cells in the control groups (cycling), were sub-confluent cells that had 
been cultured in 10% FCS medium for 24h, before being fixed and processed. 
In Gi synchronization experiments, cells were seeded at an average density 
of 14x103/cm2, corresponding to l4xlO4 cell s/0.Sml/slide, placing each slide in a 
55cm2 dish. Slides were incubated for two hours, to allow cells to adhere, before 
adding, to each dish, 12m1 of 10% FCS medium supplemented with the following 
blocking agents (A.1.5): 400uM-800uM mimosine (Sigma); 1mM, 2mM, 4mM 
hydroxyurea (Sigma); 0.1uM, luM, 2uM methotrexate (Sigma); SuM, 15uM, 30uM 
lovastatin (Calbiochem). For flow cytometry, in experiments where hydroxyurea was 
used as synchronizing agent, cells were seeded in 25cm 2 flasks, in 10% FCS culture 
medium and 4mM hydroxyurea was added after 2h. Control, cycling cells, were 
cultured in 10% FCS culture medium, without chemicals, for 24h and 48h. 
Lovastatin stock was diluted in absolute ethanol, so appropriate lovastatin controls 
(A. 1.5), with the same ethanol concentrations but no lovastatin, were also included: 
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0.04u1 ethanol/ml (control for 5uM lovastatin); 0. l2ul ethanol/ml (control for 15uM 
lovastatin); 0.24u1 ethanol/ml (control for 30uM lovastatin). 
2.6 FLOW CYTOMETRY OF MOUSE FOETAL 
FIBROBLASTS 
Each sample for flow cytometry contained O.5-1x10 6/0.5m1. Treatment 
greatly affected the cell yield. A sample for flow cytometry was obtained from half 
of a 25cm2 flask of contact-inhibited cells (2.5x10 6/flask), one 25cm2 flask of cycling 
cells (0.6-1.2x106/flask) and a 75cm 2 flask of serum-starved cells (0.45-
0.89x106/flask, average 0.7x10 6). The limited number of passages available for 
expansion, the high number of cells required for each sample, and the need to include 
appropriate isotype controls, made these experiments difficult to carry out. 
Double staining with Propidium Iodide (P1) and Fluorescein 
isothyocyanate (FITC) was performed using a modified method by Boquest et al. 
(1999). About 0.5-1x106 cells were resuspended in lOOul of cold, "Saline GM", 
(6.1mM D'-glucose, 137mM NaCl, 5.4mM KC1, 1.5mM Na2HPO4 7H20,0.9mM 
KH2PO4, 0.5mM EDTA, in dH20; A.3.1) and fixed by adding, dropwise, while 
vortexing, 4m1 100% methanol (-20°C). After an overnight fixation at —20°C, 
samples were centrifuged at 300g, for 6mm, and washed with 5m1 5mM EDTA in 
Dulbecco's Phosphate Saline (D-PBS; A.3.1). Cells were stained lh, at room 
temperature, with 400u1 in staining solution with 20ug/ml P1 (Sigma), lOOug/ml 
RNAse (Sigma) 0.02ug/ml FITC (Sigma) and 0.1% (w/v) NaN 3 in D-PBS (A.3.4). 
For double staining with P1 and p130 cells were fixed in 100% methanol (-20°C), as 
previously described. For double staining with P1 and p27KIP1  samples were fixed in 
75% ethanol, by resuspending cells in lml cold, "Saline GM" and adding 3ml 100% 
ethanol, dropwise, while vortexing. After an overnight fixation at —20°C, samples 
were centrifuged at 300g for 6mm, and washed with 5m1 D-PBS. Samples were 
gently resuspended in 0.5m1 of 0.25% (v/v) TritonX-100 (Sigma) and 0.1% (w/v) 
Sodium azide (NaN 3 ; Sigma) in D-PBS (permeabilising buffer) and incubated 10mm, 
on ice. Samples were washed once with Sml D-PBS, and incubated 20mm, at room 
temperature in 5m1, D-PBS with 0.1% (w/v) NaN 3 (pH7.3) and 5% goat serum or 2% 
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FCS, for PI/p27 or P1/p130 staining respectively (blocking buffers). After 
centrifuging at 300g for 6mm, cells were incubated 30mm, at 4°C with 3ug/10 6 cells 
FITC-conjugated mouse anti-p27 (Neomarkers; A.4.1). Alternatively samples were 
incubated 60mm, at room temperature, with 2ug/10 6 cells rabbit anti-human p130 
(IgG; Santa Cruz; A.4.1), washed once with D-PBS, and incubated for 60mm, at 
room temperature with 2ug/10 6 FITC-conjugated goat anti-rabbit IgG (Santa Cruz; 
A.4.2). Controls included: unstained samples and samples incubated with the isotype 
controls, 3ug/10 6 FITC-conjugated mouse IgGi (Caltag; A.4.3), and 2ug/10 6 rabbit 
IgG (Santa Cruz; A.4.3). All antibodies were diluted in blocking buffer. All samples 
were washed once with 5mM EDTA and incubated lh, at room temperature, in the 
dark, with 0.4m1 PT solution, with 20ug/ml PT, 100ug/ml RNAse and 0.1% (w/v) 
NaN3 in D-PBS (A.3.15). Data were acquired using a FASCan (Becton Dickinson), 
equipped with an Argon laser line (excitation wavelength 488nm,) and FL3 
(emission wavelength 640nm) and FL1 (emission wavelength 520nm) filter sets, 
respectively for PT (red, peak emission 617nm) and FITC (green, peak emission 
520nm). For each sample 10000 events were acquired. Analysis was performed using 
the CellQuest program (version 3.01, Becton Dickinson). Doublets Discrimination 
Module was used to exclude cell aggregates from the analysis. Propidium Iodide was 
used to analyse the following parameters: percentages of apoptotic cells and 
polyploid cells; percentages of GO/Gi, S and G2/M-phase cells. The percentages of 
FITC, p130 and p27 k cells, as well as mean fluorescence and peak fluorescence 
values were analysed. Expression of markers was evaluated in the whole cell 
population as well as in sub-population of cells, at a specific cell cycle stage. 
2.7 ISOLATION, 	ACTIVATION 	AND 
SYNCHRONIZATION OF T-LYMPHOCYTES 
Lymphocytes were isolated from the spleen, thymus and lymph nodes, of 6 
week old, CBA/Ca female mice (Chapter 4 and 5), killed by cervical dislocation or 
CO2 inhalation, using a modified method previously described (Mishell et at., 1980; 
Fig.2.4). In some experiments lymphocytes were also isolated from the lymph nodes 
of C57BL/6 (Chapter 5 and 6), and (C57BL/6xCBAICa)F1 (Chapter 6). Animals 
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Figure 2.4 Murine lymphoid tissues 
Mishell et al., 1980 
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Sites of collection of murine lymphoid tissues. In the experiments described in this 
project, the following lymphoid tissues were used as a source of T-lymphocytes: thymus; 
spleen; axillary, brachial and superficial inguinal lymph nodes. 
Table 2.2 Proportion of T-lymphocytes in different lymphoid tissues 
Cells/animal (x106) T-cells (%) T-cells/animal (x106) 
Lymph nodes 10.7 ± 34a 90.4 ± 3 . la 9.7 ± 33a 
Spleen 78.5 ± 13.4 42.3 ± 76b 32.7 ± 40b 
Thymus 187.5 ± 65.0" 63.6 ± 19.0" 122.1 ± 65.0c 
Data from three replicates (Chapter 4) are expressed as mean values ± SD. Values within 
columns with different superscripts differ significantly (1-way ANOVA; Statistica, 
Windows, 1995; p<0.05). 
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were placed on their back, the skin was sterilised with 75% ethanol. After making a 
small cut in the pelvic region, the body was stripped of the skin by pulling the two 
flaps of skin in opposite directions. Axillary, brachial and superficial inguinal lymph 
nodes (Fig.2.4), appearing like firm translucent bumps, were exposed, by tearing the 
muscle and fat tissue around them and placed in 20m1 tube containing Dulbecco's 
Phosphate Buffered Saline (D-PBS), without Ca 2' and Mg2 and without 
preservatives (A.2.2). After opening the peritoneal cavity, the spleen (Fig.2.4) was 
lifted with forceps, freed of the vessels and connective tissue around it with curved 
scissors, and placed in a 20m1 tube with D-PBS. To access the thymus (Fig.2.4), the 
diaphragm was removed and the ribcage was opened and folded it black, towards the 
head. The thymus, placed just behind the heart, was lifted with forceps, removed, 
using curved scissors, and placed in a 20m1 tube with D-PBS. Lymphoid tissues 
could be stored at room temperature for a few hours. The tissue samples were 
homogenized, in fresh D-PBS, under laminar flow, using a 5m1 homogeniser 
(Jencon). After allowing clumps to settle for a few minutes, the supernatant was 
transferred to a 15m] tube, and washed once with D-PBS, at 400g. for 10mm, and 
once with culture medium (A.2.1), containing 10% heat inactivated FCS 
(Globepharm), RPMI-1640, 2mM L-glutamine, 1mM Na-pyruvate, Non-essential 
amino acids, 100units/ml penicillin and 0.Olmg/ml streptomycin. In most 
experiments culture medium was also supplemented with 5x10 5M 2-
mercaptoethanol. All reagents for T-cell culture were purchased from Sigma, unless 
otherwise indicated. White blood cell counts were performed by diluting lOOul of 
cell suspension 1:2 with Turk's solution (A.2.5), incubating a few seconds, to 
remove red blood cells, and counting with a haemocytometer or a coulter counter. 
Freshly isolated cells were also stained for CD3, Gri and B220, to assess, 
respectively, the proportion of T-lymphocytes, B-lymphocytes and myeloid cells 
(granulocytes and monocytes) in the different lymphoid tissues. The lymph nodes 
were the lymphoid tissue with the lowest cells yield and the highest percentage of 
CD3 cells (T-lymphocytes; Table 2.2). The different lymphoid tissues also 
contained: 18.2±8.6 % B-lymphocytes and 10.8±8.4% myeloid cells, in the lymph 
nodes; 48.8±5.5% B-lymphocytes and 18.0±5.3% myeloid cells, in the spleen; 
2.0±1.5% B-lymphocytes and 2.4±0.9% myeloid cells, in the thymus. 
ER 
Differences among mouse strains were only observed in the total cell yield 
that was higher from lymph nodes of Fl mice (12.1±0.6x10 6/animal) compared to 
CBAJCa (5.2±2. 6x106/animal) and C57BL/6 (6.6±0.6) inbred strains. The 
percentages of CD3 cells were equally high in lymph nodes from different mice 
strains (>83%). 
Cell concentration was adjusted to 10 7/ml. Cells were seeded in 24 well 
plates at a concentration of 2x10 6/ml/well. Concentrations of 1061m1 or 5x106/ml 
appeared to be sub-optimal. In activation and PHA titration experiments cells were 
cultured with phytohemagglutinin (PHA; Sigma) at concentrations between 0.8ug/ml 
and 16ug/ml (A.2.3), with or without 4nM interleukin-2 (IL-2, Sigma; A.2.4). In 
synchronization experiments with hydroxyurea (HU), 0.5mM or 1mM HU were 
added to the wells 5 hours after onset of activation with 8ug/ml PHA and 4nM IL-2, 
and cells were harvested 24 or 48h after seeding. Proliferation rates in cultured T-
cells were assessed by tritiated thymidine ([ 3H]thymidine) incorporation essay. 
Briefly, cells were cultured in 96 well plates, at a concentration of 
0.2x106/100ul/well. Three wells were assigned to each treatment group. Cells were 
incubated for 18-24h with luCi/well (0.037MBq) [3H]thymidine (A.2.5). Plates were 
then stored at —20°C until analysis by liquid scintillation (Merrill, 1998a). 
2.8 SELECTION OF CD25 CELLS 
Positive selection was performed on cells that had been cultured 24h with 
8ug/ml PHA and 1mM HU, in 24 well plates. Cells were harvested and washed twice 
with 0.1% BSA and 1% NaN 3 in D-PBS (FACS buffer; A.3.1). About 10-15x10 6 
cells were processed each time. Cells were resuspended at a concentration of 
2x107/ml in FACS buffer, and labelled with lug/10 6 cells of R-Phycoerythrin (R-
PE)-conjugated anti-CD25 (Caltag; A.4.1). After incubation for 30min at 4°C, in the 
dark, cells were washed with 20x labelling volume of 0.5% BSA, 1% NaN 3 , 2mM 
EDTA in D-PBS (MACS buffer; A.3.1). Samples were resuspended at a 
concentration of 10 7/80u1 MACS buffer and labelled for 15mm, at 4°C, with 20u1 of 
anti-R-PE or goat anti-rat IgG paramagnetic MicroBeads (Miltenyi Biotec; A.4.3). 
After washing once and resuspending in 500u1 MACS buffer, labelled cells (CD25) 
were enriched on a positive separation column MS (Miltenyi Biotec; A.4.3). In 
some experiments (Chapter 4) CD25 cells were enriched on a second MS column, 
to improve recovery rates. After separation, cells were labelled with 2ug/10 6 cells 
FITC-conjugated anti-CD3 antibody (Caltag; A.4.1) and processed for FACS 
analysis. All steps were performed at 4°C and all centrifugations were carried out at 
400g, for 7mm. 
2.9 FLOW CYTOMETRY OF T-LYMPHOCYTES 
Samples, containing 0.5-1x10 6, were washed once with cold D-PBS with 
0.1% BSA (w/v) and 0.1% NaN 3 (FACS buffer; A.3.1) and resuspended at a 
concentration of 107  /ml. Cells were labelled with lug/10 6 cells FITC-conjugated 
hamster anti-mouse CD3 (Caltag; A.4.1) and 2ug/1 06  R-Phycoerythrin (R-PE)-
conjugated rat anti-mouse interleukin-2 receptor a (IL-2R(x) or CD25 (Caltag; A.4. 1) 
and incubated for 30min at 4°C, in the dark. After two washes, cells were 
resuspended in 0.4ml FACS buffer and analysed. Alternatively cells were labelled 
with FITC-conjugated hamster anti-mouse CD3, washed once with FACS buffer and 
fixed in 300u1 of 50% FCS/FACS buffer and 900u1 of cold 70% ethanol, added 
dropwise. After an overnight fixation at 4°C, samples were washed twice with FACS 
buffer, stained for lh, at room temperature, with 0.4m1 P1 staining solution (A.3.3) 
with 20ug/ml Propidium Iodide (PT) and lOOug/ml ribonuclease A (RNAse A; 
Sigma) in FACS buffer, and analysed. All centrifuging was performed at 400g for 
7mm. For assessment of sub-populations in cells isolated from different lymphoid 
tissues, T-lymphocytes were labelled with FITC-conjugated anti-mouse CD3, as 
before, B-lymphocytes were labelled with 2ug/10 6 FITC-conjugated anti-B220 
antibody (Caltag; A.4.1) and myeloid cells, with lug/1 6 cells R-PE-conjugated anti-
mouse Ly-6G (Gr-1) antibody (Caltag; A.4.1). In some experiments T-cells were 
also stained with PIJp27KIN  Staining and analysis were performed as described for 
Mouse Foetal Fibroblasts. 
Flow cytometry analysis was performed using a FACSCan (Becton 
Dickinson), equipped with an Argon laser line (excitation wavelength 488nm) and 
FL2 and FL1 filter sets, respectively for R-PE (orange, peak emission 575nm) and 
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FITC (green, peak emission 520nm). For each sample 10000 events were acquired. 
Analysis was performed using the CeliQuest program (version 3.01, Becton 
Dickinson). Negative controls included unstained samples, for the CD3/CD25 
staining, and samples stained only with P1, for the CD3lPlstaining. For analysis of 
CD25, the percentages of CD25 cells, as well as mean fluorescence and peak 
channel, used as measures of CD25 level of expression, were evaluated. P1 was used 
to analyse the following parameters: percentages of apoptotic cells and polyploid 
cells; percentages of GO/Gi, S and G2/M-phase cells. All parameters were evaluated 
on the whole cell population and in the CD3 sub-population that included only T-
lymphocytes. 
2.10 FACS ANALYSIS 
2.10.1 FACS analysis of Mouse Foetal Fibroblasts 
P1 staining was used to perform cell cycle analysis and to set gates on specific sub-
populations of cells: 
	
1) 	No gate, all cells included in the analysis (Fig.2.5). Parameters acquired: 
Percentage of hypodiploid cells (<2N; apoptotic cells), considered as 
apoptotic cells; 
Percentage of normoploid cells (2:! ~N<4); 
Percentage of polyploid cells (>4N), including abnormal cells and cell 
aggregates. 
2) 	Live gate, using the Doublets Discrimination Module (DDM) to exclude cell 
aggregates, polyploid (DNA content>4N) and apoptotic (DNA content<2N) 
cells from the analysis (Fig.2.5). Parameters acquired within the live cell 
population were: 
Percentage of cells with diploid content of DNA (2N), considered as 
GO/G1-phase cells; 
Percentage of cells with di/tetraploid content of DNA (2<N<4), 
considered as S-phase cells; 
Percentage of cells with tetraploid content of DNA (4N), considered 
as G2IM-phase cells. 
Figure 2.5 FACS analysis for CD3/PI staining 
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T-cells were stained with anti-CD3-FITC and Propidium Iodide. The following parameters were 
calculated on the whole cell population: percentages of apoptotic cells (hypodiploid or sub-GO/GI 
cells with N<2); normoploid cells (2! ~N!~4); polyploid cells (N ~!4). Doublets Discrimination Module 
(Live gate) was used to exclude doublets and aggregates (D), polyploid cells (P) and apoptotic cells 
(A). Live and CD3 cells gate were used in conjunction to analyse live, T cells only. Cell cycle profile 
of live and liveiT-cells was assessed by gating G0/Gl, S and G2/M cells according to their DNA 
content. Accuracy of gating was confirmed by calculating DNA indexes: 2N=1.0±0; 4N1.95±0.05; 
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3) 	PT staining was also used to gate sub-population of cells at specific cell 
cycle stages: GO/GI, S and G2IM-phase cells. 
In MFF double stained with PT and a specific intracellular marker, expression of the 
specific intracellular marker (p27(IPl,  p130, FITC) was evaluated using the following 
gates and parameters: 
1) 	Live gate (=DDM): expression of a marker in all normoploid, singlets 
(Fig.2.5). Parameters calculated within the gated population: 
Percentage positive cells, relatively to a negative control (unstained 
samples, isotype controls); 
Mean fluorescence: levels of expression of the marker in the cell 
population; 
Peak channel: mode. 
2) 	Gating on GO/GI cells, S cells, G2/M cells: expression of a marker only in 
cells at a specific cell cycle stage. Parameters analysed, within the gated 
population: 
Percentage of positive cells; 
Mean fluorescence; 
Peak channel. 
2.10.2 FACS analysis of T-lymphocytes 
Gates used for FACS analysis, for CD3/CD25 and CD3/PI staining were: 
1) Live cells gate. Dead cells and debris were excluded by using a FSC and 
SSC dot plot, in the CD3/CD25 staining (Fig.2.6), and the DDM module, 
for the CD3/PI staining (Fig.2.5). 
2) 	CD3Vlive cells gate. CD3 receptor was used to gate T-lymphocytes, in the 
live cell population (Fig.2.5-2.6). 
For each of the gated populations, the following parameters of CD25 expression 
were acquired: 
Percentage of CD25 cells; 
Mean fluorescence, used to measure of CD25 level of expression/cell; 
Peak Fluorescence, corresponding to CD25 level of expression/cell 
reached in the majority of the cell population (mode). C5 1 
For each of the two gated populations the same parameters for the P1 staining 
previously described for Mouse Foetal Fibroblasts (Paragraph 2.10.1), were acquired. 
For the P1 staining no gate was used when assessing the percentages of apoptotic 
cells (Paragraph 2.10.1). 
2.11 IMMUNOCYTOCHEMISTRY OF MOUSE 
FOETAL FIBROBLAST AND T-LYMPHOCYTES 
Mouse Foetal Fibroblasts (MFF) were grown on round glass coverslips 
(1.3cm2, BDH, 406/0189/10), placed in 12 or 24 well/plates (1 or 2m1/well), or on 
76x26mm microscope glass slides (10cm 2; Blue Star), placed in 55cm 2 dishes 
(12mlldish). In Gi synchronization experiments cells were resuspended in 0.5m1 of 
culture medium, seeded on 10cm 2 and incubated for 2h, before adding 12m1 medium 
containing the blocking agents. T-lymphocytes, resuspended at a concentration of 
0.5x106/ml in culture medium, were centrifuged on cytospin slides (Thermo 
Shandon; 599 1059), 0.5m1/slide, at 130g, for 5mm, and allowed to dry for a few 
minutes, before processing. 
When staining for Proliferating Cell Nuclear Antigen (PCNA; modified 
method by Kill, 1991) cells were washed twice with PBS, fixed and permeabilised 
for 4 mm, with methanol: acetone (1:1) at —20°C. For cyclin Dl staining, cells were 
fixed and permeabilised for 5mm, with 100% methanol, at —20°C. Cells were then 
washed three times with ice cold PBS, and incubated overnight, at 4°C, in a 
humidified atmosphere, with human anti-serum to PCNA (Immuno Concepts; A.4.1), 
diluted 1:10 in 1% FCS-PBS. Alternatively cells were incubated at 25°C, for 60mm 
with mouse anti-cyclin Dl (Novocastra; A.4.1), diluted at a concentration of 5ug/ml 
in 1% FCS-PBS. After incubation with primary antibodies, slides were washed five 
times with 1% FCS-PBS, and incubated for 60mm, at room temperature, in the dark, 
in a humidified atmosphere, with Texas Red (TXR)—conjugated goat anti-human IgG 
(VectorLaboratories; A.4.2) or fluorescein isothyocyanate (FITC)-conjugated sheep 
anti-mouse IgU (Diagnostic Scotland; A.4.2), diluted 1:100 in 1% FCS-PBS. Finally, 
cells were washed three times with 1% FCS-PBS and mounted. 
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When staining for nuclear antigens, such as PCNA and cyclin Dl, it is 
important to remember that fixation is the most critical step. The use of organic 
solvents (ethanol, methanol, acetone), as opposed to cross-linking reagents 
(paraformaldehyde, glutaraldehyde), is highly recommended for fixing for these 
nuclear antigens because they preserve better antigenicity as opposed to cell structure 
(Harlow and Lane, 1988). Furthermore, the use of 2% paraformaldehyde followed by 
acid treatment, for PCNA staining, can produce artefacts (Campbell, 1998). PCNA is 
expressed in two forms: an insoluble form, which is expressed at low levels in 
quiescent and senescent cells and highly expressed in cycling cells, where it acts as a 
processivity factor for DNA polymerase ö (Celis and Bravo, 1984; Bravo and Bravo, 
1987); a soluble, nucleoplasmic form, which is constitutively expressed during the 
cell cycle. Organic solvents only fix the insoluble form, whereas cross-linking 
reagents destroy the insoluble form and fix the soluble one. 
Staining of T-cells was performed with a modified method by Wreggett et 
at. (1994). Slides were washed twice with PBS, and fixed for 10mm, with 4% (w/v) 
paraformaldehyde (PF). Cells were permeabilised for 12mm, in Tris Buffer Solution 
(TBS; A.3.1) with 0.2% Triton X-100 (permeabilising solution) and blocked for 
20min with 10% (w/v) non-fat milk (Marvel) in permeabilising buffer (blocking 
buffer). For HP1 staining, cells were incubated 60min with lug/ml rat monoclonal 
anti-M31 (AFRC MAC 353; A.4.1), 5ug/ml rat monoclonal anti-M32 (MAC 385; 
A.4.1) or lug/ml purified rabbit anti-serum to mHPla (M235; A.4.1), all diluted in 
blocking buffer. The following primary antibodies recognizing histone H4 
acetylation (H4.Ac; A.4.1) on different lysines were also used: sheep anti-serum to 
H4.Ac.2-4, diluted 1:800; rabbit anti-sera to: H4.Ac5 (R40), diluted 1:800; to 
H4.Ac8 (R232), diluted 1:1500; to H4.Ac12 (RiOl), diluted 1:400; to H4.Ac16 
(R251), diluted 1:1500. The antibodies recognizing mouse HP1 proteins were a gift 
from Dr. Prim Singh; the rabbit anti-sera recognizing acetylated histone H4, except 
the anti-H4.Ac2-4 antibody (a gift from Dr. Prim Singh), were a gift from Prof. 
Bryan Turner. For cyclin D3 staining, cells were stained with mouse anti-human 
cyclin D3 (Novocastra; A.4.1), diluted 1.20. After three washes with permeabilising 
buffer, cells were incubated with the correspondent secondary antibody (see A.4.2): 
FITC-conjugated rabbit anti-rat serum (a gift from Dr. Prim Singh), diluted 1:50; 
53 
FITC-conjugated donkey anti-rabbit IgG (Diagnostic Scotland), diluted 1:100; FITC-
conjugated anti-sheep IgG (a gift from Dr. Prim Singh), diluted 1:400; FITC-
conjugated anti-mouse IgG, diluted 1:50 (Diagnostic Scotland). Cells were finally 
washed three times with permeabilising buffer and mounted. All antibodies were 
diluted in blocking buffer. All steps were carried out at room temperature. 
T-cells were also double stained for M31/CD25 or M31LPCNA. For 
M3 1/CD25, cells were stained with lug/0.5-lx10 6cells R-Phycoerythrin (R-PE) 
conjugated anti-CD25, diluted in FACS buffer, and incubated for 30mm, at 4°C, in 
the dark. After one wash with FACS buffer, the cell suspension was used to prepare 
cytospin slides that were fixed and processed for M31 staining as for MFF. For 
M31IPCNA staining, cytospin slides were fixed in PF4%, permeabilised with 0.2% 
Triton X-100 in TBS (permeabilising buffer) for 12min and blocked in 10% non-fat 
milk in permeabilising buffer (blocking buffer) for 20mm. Slides were stained 
overnight, at 4°C with anti-PCNA antibody, diluted 1:10 in 1% FCS in D-PBS. After 
three washes with permeabilising buffer, cells were stained for 60mm, at room 
temperature with lug/ml AFRC MAC353 antibody. After three washes with 
permeabilising buffer, slides were incubated 60mm, at room temperature, with the 
secondary antibody solution containing both FITC-conjugated rabbit anti-rat serum 
(a gift from Dr. Prim Singh) and TXR-conjugated goat anti-human IgG 
(VectorLaboratories), diluted respectively 1:50 and 1:100 in blocking buffer. Finally, 
slides were washed three times with permeabilising buffer and mounted. 
Isotype controls for cyclin Dl staining were preincubated with 5ug/ml 
mouse IgG2a (Sigma; A.43) before incubating them with the secondary antibody. 
Controls for PCNA and HP1 staining were preincubated with blocking buffer, 
instead of the primary antibody, before incubating them with the secondary antibody. 
All slides were mounted with Vectashield Mounting Medium containing 
1 .Sug/ml 4', 6-diamidino-2-phenylindole (DAPI; VectorLaboratories; A.4.3), and 
were sealed with PANG (Pangus, Hungary). Slides were stored at 4°C, in the dark, 
until visual examination. 
In experiments with MFF, slides were examined with a lOOx Fluor oil 
objective (Nikon), on a Nikon Microphot-SA microscope equipped for 
epifluorescence, and supplied with a mercury lamp (100W, Nikon HB 10101AF) and 
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FITC (Nikon UV-2B; excitation 330-380 nm), TXR (Nikon G-1A; excitation 546-
556 nm) and DAPI (Nikon B-2A; excitation 450-490 nm) selective filter sets. 
Photographs were taken using a photomicrographic attachment (Nikon FX-35DX 
camera and Microflex UFX-DX). 
In T-cell experiments slides were viewed using a Zeiss Axiovert S 100 
photomicroscope equipped with FITC (Zeiss 487709), Texas Red (Zeiss 487714) and 
DAPI (Zeiss 487702) selective filter sets and a 50W mercury arc lamp, using a 40x 
and 63x Plan Neofluar, oil objectives (Nikon). R-PE fluorescence was detectable 
with the FITC filter set. This set-up was also equipped with a Hamamatsu Digital 
camera (C4742-95) and the AQM program (Kinetic Imaging Ltd), for digitalized 
image acquisition and analysis. 
2.12 ANALYSIS OF IMMUNOCYTOCHEMISTRY 
DATA 
A total of 40 cells were acquired, at fixed settings, with a 63x objective, form three 
images obtained from 1-3 slides, preparing 1 slide/experiment for each staining (1 
slide for cyclin D3 and H4.Ac staining; 2 slides for mHPl(x, M32, PCNAJM31, 
CD251M31; 3 slides for M31). A power 40x objective was used only for acquisition 
and analysis of H4.Ac5 and H4.Ac12 staining (Chapter 5). Acquired images were 
then analysed using the AQM program. 
Analysis of chromatin markers (mHPl(x, M31, M32) and histone H4 
acetylation markers (H4.Ac2-4/5/12) was performed in a similar way. The DAPI 
staining was used to gate the nuclear area in each cell and the brightfield image 
(Fig.2.7A) was used to gate the cell area. Three groups of parameters were acquired: 
	




Percentage of nuclear area, calculated as: (nuclear area/cell area)x 100. 






Figure 2.7 Analysis of intracellular proteins by immunofluorescence 
Method used to analyse fluorescence features of intracellular proteins: HPI proteins, cyclin D3, and, in some experiments, PCNA (Chapter 5). 
Brightfield images (A) were used to calculate cell area (pixels). DAPI staining was used to calculate nuclear area (image not shown). Overall 
FITC or TXR fluorescence was calculated by doing a background correction using extracellular fluorescence as background. In the case of M3 1, 
that tends to organise into clusters, clusters of fluorescence were analysed by considering only areas of fluorescence with values higher than 
those found in diffused fluorescence areas. Features of fluorescence acquired using the AQM program (Kinetic Imaging Ltd.) were: integral 
intensity (pixels of fluorescence), area of fluorescence (pixels), mean fluorescence (0-255 on a greyscale), SD of mean fluorescence (0-25 5 on a 
greyscale). 
Percentage of nuclear area with fluorescence, calculated as: (area of 
fluorescence/surface area)x 100; 
Integral intensity; 
Mean intensity, calculated as (integral intensity/area of fluorescence); 
Peak intensity; 
SD of mean fluorescence. 
	
3) 	For M31 staining, clusters of fluorescence features were also acquired 
(Fig.2.7 C): 
Percentage of nuclear area with fluorescent clusters, calculated as 
(area of clusters/surface area) xlOO; 
Integral intensity of fluorescent clusters; 
Mean intensity of clusters, calculated as: (intensity of clusters/area of 
clusters); 
Peak intensity of clusters; 
SD of clusters mean fluorescence; 
Number of clusters/cell. 
Total cell fluorescence features were analysed after subtracting extracellular 
background fluorescence from intracellular fluorescence using the background 
correction module. In cells stained with FITC-anti-M31, clusters were analysed by 
gating only fluorescent areas with FITC fluorescence intensity higher 
(heterochromatin) than that observed in areas with decondensed chromatin 
(euchromatin). 
For PCNA and cyclin D3 staining, one slide was processed for each 
experiment (n=3, for PCNA; n=1, for cyclin D3) and 200 cells were counted from 
three fields/slide. The results were expressed as percentage of PCNA or cyclin D3 
cells. However also morphological features and nuclear fluorescence features were 
also acquired in some experiments (Chapter 5). For cyclin D3 staining, fluorescence 
could have cytoplasmic or nuclear localisation, corresponding to an inactive or active 
form of cyclin D3. The cytoplasmic area could not be gated but cytoplasmic 
parameters could be calculated in the following way: 
1) 	Cytoplasmic area, calculated as: (cell area-nuclear area); 
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2) 	Integral cytoplasmic intensity, corresponding to: (integral cell intensity- 
integral nuclear intensity); 
Percentage of cytoplasmic area with fluorescence, calculated as: (cell 
fluorescent area/nuclear fluorescent area) xlOO; 
Mean cytoplasmic intensity, corresponding to: (integral cytoplasmic 
intensity/cytoplasmic fluorescent area). 
In the absence of a cytoplasmic gate, the cytoplasmic peak could not be 
calculated. 
For M3 1 -FITC/PCNA-TXR/DAPI triple staining the following parameters 
were acquired: morphological features; PCNA fluorescence features (mean 
fluorescence; integral intensity; peak intensity) and the percentages of PCNA cells; 
M31 fluorescence features (mean fluorescence; integral intensity; peak intensity; 
cluster n°). It was also possible to gate PCNA and PCNK cells and to assess their 
chromatin features using the M31 staining. 
For M3 1/CD25-R-PE/DAPI triple staining the following parameters were acquired: 
morphological features; percentage of CD25 cells, confirmed by FACS analysis; 
M31 fluorescence features (mean fluorescence; integral intensity; peak intensity; 
cluster n°). It was also possible to gate CD25' and CD25 cells and to assess their 
chromatin features using the M31 staining. 
Areas and integrative fluorescence were measured in pixels. Mean 
fluorescence, Peak fluorescence and SD of mean fluorescence were calculated on a 
0-255 greyscale. 
2.13 T-CELL NUCLEAR TRANSFER 
2.13.1 Preparation of GO- and Gi- lymphocytes 
For each Nuclear Transfer experiment an average of 7.1±3.1x10 6 
lymphocytes/animal (mean±SD) with 85.8±6.6% CD3 cells (6.1±2.8 x10 6/animal) 
were isolated from the lymph nodes of four to eight, six week old females from the 
following strains: CBA/Ca (5 replicates), C57BL/6 (4 replicates), 
(C57BL/6xCBA/Ca)F1 (2 replicates). Freshly isolated lymphocytes were used 
directly for Nuclear Transfer, as GO donor cells. For synchronization in GI about 22-
48x106 cells/experiment were cultured for 24h in 5% CO2. at 37.5°C, in medium 
supplemented with 1mM hydroxyurea (HU), 8ug/rril phytohemagglutinin (PHA) and 
4nM interleukin-2 (IL-2). At the end of the incubation, GI cells were harvested and 
CD25 cells were positively selected using magnetic cell sorting (G1/CD25; see 
Paragraph 2.8). Donor cells in GO or G1/CD25 were washed once with D-PBS and 
resuspended at a concentration of 1-2x10 6/ml in 10% FCS in RPMI-1640 (A.2.1). 
Cells were used immediately for Nuclear Transfer. Just prior to manipulation, GO 
and G1/CD25 donor cells were washed once in D-PBS (Sigma) and resuspended 
Hepes-CZB (Chatot et al., 1989; A.5.10) with 10% (w/v) polyvinylpyrrolidone 
(PVP, MW 360000; Sigma). The cell cycle profile and the quiescent state of donor 
cells were assessed by FACS analysis and staining for CD3 and CD25, and CD3 and 
Propidium Iodide, as previously described. Quality controls included: cultured 
quiescent cells (GO, cultured), that had been incubated for 24h in medium alone, used 
as a culture control; cycling cells, that had been activated for 24h with 8 ug/mI PHA 
and 4 nM IL-2, used as an activation control; GI cells, that had been activated for 
24h with 8 ug/mI PHA, 4 nM IL-2 and 1 mM HU, used as a synchronization control. 
2.13.2 Enucleation and lymphocyte nucleus injection 
MIT oocytes were collected 14 hours after hCG injection of eCG-primed 
B6D2F1 (C57BL/6 x DBA/2) mice. An average of 23.8±5.3 (mean±SD) and a range 
of 16.7-33.3 oocytes per mouse were collected in 10 nuclear transfer experiments. 
Cumulus cell/Oocyte Complexes (COCs) were collected in Hepes-CZB (A.5. 10) 
medium and cumulus cells were removed by incubating the complexes for 4-5mm, at 
room temperature, with 3001U/ml hyaluronidase (Sigma; A.5.6) in Hepes-CZB. 
Denuded oocytes were rinsed once in Hepes-CZB and placed in CZB medium 
(Chatot et al., 1989; A.5.5), under 5% (v/v) CO 2 in air and at 37.5 °C until 
enucleation. Micromanipulations were performed using a Nikon inverted microscope 
(TE300) equipped with an Eppendorf Transfer Man. Groups of 15 oocytes were 
transferred into a microdrop of Hepes-CZB medium, supplemented with 5ug/ml 
cytochalasin B (Sigma; A.5.12) placed in the operation dish, on the microscope 
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stage. Oocytes were firmly held at the end of the holding pipette while the zona 
pellucida was cored and the oolemma punctured by applying several piezo-pulses to 
an enucleation pipette. The metaphase II oocyte chromosome-spindle complex, 
appearing as a translucent region, was aspirated into the enucleation pipette, trying to 
remove as little volume of ooplasm as possible. The batch of enucleated oocytes was 
then placed into CZB medium, without cytochalasin B, and held there for up to two 
hours under 5% (v/v) CO2 in air and at 37.5 °C. The overall enucleation rate was 
approximately 100 oocytes in 1-2 hours and the survival rates after enucleation were 
90.8±9.9% (mean±SD), comparable to those reported in the literature for the same 
technique (97.9-98.7%; Wakayama et al., 1998). Enucleated oocytes were returned 
to the operating dish immediately before injection. Just before injection lymphocytes, 
resuspended in 10% polyvinylpyrrolidone (PVP, 360 KD, ICN), were stripped of 
their cytoplasm by gently aspirating them in and out of an injection pipette with an 
inner diameter slightly smaller (5um) than the cell diameter (6-8 urn). This procedure 
was particularly difficult considering the smaller diameter of T-lymphocytes 
compared to other somatic cell types, such as cumulus cells (cell diameter= 10- l2um; 
injection pipette inner diameter=5-7 um), previously used in NT experiments 
(Wakayama et al., 1998). After isolation, 4-6 nuclei at a time were aspirated into the 
enucleationlinjection pipette and injected, one at a time, into previously enucleated 
recipient oocytes. In this way each nucleus was immediately injected into an 
enucleated oocyte only minutes of its isolation. The overall reconstruction rate was 
of 50-80 NT embryos/2 hours (100 NT embryos/2 hours for ES cells). The survival 
rate after injection were in the range of 92.9%-94.3%, comparable if not higher than 
those reported in the literature (Wakayama et al., 1998) for similar somatic cell types 
such as cumulus cells (79.1-95.3%). After reconstruction NT embryos were kept in 
CZB medium under 5% (v/v) CO2 in air, at 37.5°C, for 1-3h before activation. 
2.13.3 Oocyte activation 
Following a 1-3 hour delay after nuclear transfer (NT) cloned embryos were 
activated simultaneously by incubating them for 6 hours under 5% (v/v) CO2 in air, 
at 37.5 °C, in Caa2 -free CZB medium (A.5.5) supplemented with 10mM Strontium 
(Sr2 ; Sigma; A.5.8) and 5ug/ml cytochalasin B, to prevent polar body extrusion, as 
previously reported (Wakayama et al., 1998). To assess activation efficiency 10 
oocytes/replicate were parthenogenetically activated. Overall activation rates in T-
cell nuclear transfer experiments (Paragraph 6.3, 8 replicates) were high, with 100% 
(86/86) of control oocytes forming pronuclei, 97.7% (84/86) cleaving, 94.2% (81/86) 
and 86.0% (74/86) reaching respectively the morula and the blastocyst stages. In the 
experiments carried out to assess occurrence of PCC in the first 3 hours after 
reconstruction, embryos were incubated in CZB medium under 5% (v/v) CO2 in air, 
at 37.5 °C, for 3 hours after reconstruction, without being activated. 
2.13.4 Embryo culture or embryo transfer 
For in vitro studies reconstructed or fertilised embryos were cultured in M16 
medium (A.5.4; Whittingham, 1971), under 5% (v/v) CO2 in air, at 37.5°C. CZB 
culture media had also been tested for embryo culture, but M16 gave better 
blastocyst quality (higher cell numbers). 
In in vivo development studies, embryo transfer was performed 
resuspending five to ten embryos, at the 2-cell or morulae/blastocyst stage, in M2 
medium (A.5.3; Fulton and Whittingham, 1978) and by transferring them 
respectively into the oviducts or uteri of Swiss Webster foster mothers, that had been 
mated 0.5 or 2.5 days earlier with vasectomized Swiss Webster males. Caesarian 
section of recipient females was carried out at 19.5 days post coitus (d.p.c), to check 
for signs of implantation and development. 
2.13.5 Control fertilised embryos 
Fertilised embryos were collected from female B6D2F1 (C57BL/6 x 
DBAJ2) mice that had been primed with eCG and mated with B6D2F1 males at the 
time of hCG injection. Fertilisation occurred approximately 10-13 hours after mating 
(5.30-8.30, day 0) and pronuclear formation about 4-5 hours after fertilisation (13.30, 
day 0). Animals were killed by cervical dislocation and embryos (25-30/animal) 
were collected around the time of pronuclear formation, only from females that had a 
vaginal plug. Embryos were collected in Hepes-CZB medium. Cumulus cells and 
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sperm attached to the surface were removed by a 4-5min incubation, at room 
temperature, with 3001U/ml hyaluronidase (Sigma; A.5.6) in Hepes-CZB. Denuded 
oocytes were rinsed once in M2, placed in 30u1 drops (15 embryos/drop) of M16 
medium and cultured under 5% (v/v) CO2 in air, at 37.5°C. 
2.13.6 Control Nuclear Transfer embryos from embryonic stem 
cells 
The HRT-deficiency ES cell line HM-1 was derived from an inbred mouse 
strain 129/01a and was kindly provided by Dr. Ed Gallagher at passage 19. The yield 
of chimeric animals and germ-line transmission had been highly proved by injection 
of HM-1 ES cells into mouse blastocysts. Cells were cultured in GMEM media 
(GIBCO) supplemented with 15% heat-inactivated FCS, 100 units of leukemia 
inhibitory factor/ml, 2mM L-glutamine, 1% MEM non-essential amino acid solution 
(GIBCO) and 1% 2-mercaptoethanol (2-ME). The night before the experiment, the 
serum concentration was reduced to 5%. Nuclear Transfer experiments were 
performed using the same protocol used for T-lymphocytes (Paragraphs 2.13.1-
2.13.3). Only small ES cells, with a diameter of 7-10um were used for NT. Transfer 
of ES-cell derived embryos were only performed at the morula/blastocyst stage into 
the uteri of Swiss Webster foster mothers that had been mated 2.5 days before with 
vasectomized Swiss Webster male mice. 
2.14 IMMUNOCYTOCHEMISTRY OF EMBRYO 
WHOLE MOUNTS 
For double staining, carried out to visualise chromatin and microtubules, 
oocytes and embryos were fixed in paraformaldehyde (4%)/picric acid (0.05%) 
fixative, for lh at 37°C (A.3.2). Specimens were rinsed twice with D-PBS, and 
incubated for 30mm, at 37°C in D-PBS with 0.1% (v/v) Triton X-100 and 0.3% 
(w/v) BSA (permeabilising buffer). Specimens were incubated for 30mm, at 37°C, in 
D-PBS with 0.1M glycine and 0.3%(w/v) BSA (blocking buffer) and washed twice 
in D-PBS with 0.01% (v/v) Triton X-100 and 0.3% (w/v) BSA (washing buffer). 
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Embryos were incubated for 40mm, at 37°C with mouse monoclonal anti-13 tubulin 
(Sigma; A.4.1), diluted 1:300 in blocking buffer, washed three times with washing 
buffer, and incubated for 40mm, at 37°C with FITC-conjugated anti-mouse IgG 
(Sigma; A.4.2), diluted 1:50 in blocking buffer. After washing three times with 
washing buffer, cells were mounted with Vectashield antifade (Vector Laboratories; 
A.4.3) and lOug/mi P1 (Sigma) in D-PBS. 
For triple staining for chromatin, microtubules and microfilaments, 
embryos were fixed at 37°C, for 30n-tin in Complex Fix (modified from Messinger 
and Albertini, 1991) containing 2% formaldehyde and 0.1% Triton X-100 in 
Microtubule Stabilization Buffer (20mM Pipes, 1mM MgC1 2 , 0.5mM EGTA, 1mM 
DTT, Deuterium Oxide; A.3.2). The fixative was removed by washing twice, for 
10mm, with 10% goat serum, 0.02% (w/v) NaN 3 , 0.001% (v/v) Triton X-100 in D-
PBS (10% NGS). Specimens were stained for lh, at 37°C, in the dark, with 
Rhodamine-conjugated anti-phalloidin (Molecular Probes; A.4.1), diluted 1:4000, 
and FITC-conjugated anti-a tubulin (Sigma; A.4.1), diluted 1.500, in D-PBS with 
5% goat serum, 0.02% (w/v) NaN3, and 0.001% (v/v) Triton X-100 (5%NGS). After 
three washes with 10% NGS, embryos were mounted using Vectashield (Vector 
Laboratories) with 1 .5ug/ml DAPI. 
Triple staining for chromatin, M31 and PCNA was carried out on whole 
mounts of MII oocytes, control and NT embryos (modified method by Wregget et 
al., 1994). Specimens, collected at selected time points, were washed twice in PBS 
and fixed in paraformaldehyde (PF) 2% (w/v) overnight at 4 °C (A.3.2). After three 
10min washes, with cold (4 °C) 0.05% (v/v) Tween 20 (Sigma; P1379) in D-PBS, 
specimens were permeabilised in 0.2% (v/v) Triton X-100 D-PBS for 15 mm. After 
three 10min washes, with 0.05% (v/v) Tween 20 in D-PBS, the specimens were 
incubated for lh in 10% FCS (vlv) in PBS (PCNA blocking buffer). Embryos or 
oocytes were placed in a 30ul drop (15 embryos/drop), with anti-PCNA (Immuno 
Concepts) antibody diluted 1:10 in PCNA blocking buffer, and incubated overnight, 
at 4°C, in a humid chamber. After four 15min washes in 0.05% Tween 20 in D-PBS, 
the specimen were permeabilised again by incubation for 15mm, at RT, in 0.2% (v/v) 
Triton X-100, followed by three, 10min washes in 0.05% Tween 20 in D-PBS and a 
lh incubation in 2% BSA (w/v) in D-PBS (M31 blocking buffer). Embryos and 
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oocytes were then incubated lh at RT with rat monoclonal anti-M31 (MAC 353) 
diluted 1:50 in 2% (wlv) BSA in D-PBS. After four, 15 min washes in 0.05% (v/v) 
Tween20 in D-PBS, indirect immunolabelling was performed by incubating 
specimens for lh, at room temperature, in the dark, with Texas red-conjugated anti-
human IgG (Vector Laboratories) and FITC conjugated anti-rat serum (a gift from 
Dr. Prim Singh), diluted, respectively 1:200 and 1:50 in 2% BSA (w/v) in D-PBS. 
Finally embryos and oocytes were mounted using Vectashield with 1 .5ug/ml DAPI. 
For double staining for chromatin and acetylated histone H4 (modified 
method by Worrad et al., 1994) embryos were fixed with 2% PF, overnight, at 4°C. 
After two 15min washes with 0.05% (v/v) Tween 20 in D-PBS, specimens were 
permeabilised with 0.2% (v/v) Triton X-100 in D-PBS. After two 15min washes with 
0.05% (v/v) Tween 20 in D-PBS, embryos were incubated for lh with 2% BSA in D-
PBS. Embryos were then incubated for lh with the same panel of primary antibodies, 
recognizing different acetylated lysines on histone H4, at the following 
concentrations: anti-histone H4 acetylated on lysine 2-4 (anti-H4.Ac2-4, 1:800); 5 
(anti-1­14.Ac5, 1:800), 8 (anti-H4.Ac8, 1:1000), 12 (anti-H4.Ac12, 1:400), 16 (anti-
H4.Ac16, 1:1000). Specimens were rinsed three times, for 15mm, with 0.05% Tween 
20 in D-PBS, and then incubated for lh with the same secondary antibodies, at the 
same dilutions used for somatic cells, except for the donkey anti-rabbit-IgG 
(Diagnostic Scotland), diluted 1:150. After washing three times with 0.05% Tween20 
in D-PBS, embryos were mounted with Vectashield mounting medium with 1 .5ug/ml 
DAPI. 
Triple staining for chromatin, acetylated histone H4 and PCNA was 
performed using the protocol previously described in this paragraph for PCNA, 
followed by the protocol described for immunolabelling of acetylated histone H4. 
Embryos were finally mounted with Vectashield mounting Medium with l.Sug/ml 
DAPI. 
All steps were performed in 30u1 drops, containing a maximum of 15-20 
embryos, placed on a parafilm layer inside a 60mm (IWAKI) or 90mm petri dish 
(Bibby Sterilin). Incubations with primary and secondary antibodies were performed 
in a humid chamber. 
Visual examination of embryos and oocytes stained for chromatin and 
microtubules, Was performed using a confocal microscope (Nikon EFD3), equipped 
with a 100W Mercury lamp, an Argon laser line (Biorad Microscience Division, 
Model 5400) and a 20x Plan Apo objective (Nikon). FITC (green) and P1 (red) 
signals were detected using a 488/515nm and a 546/590 nm excitation/barrier filter 
combination respectively. Images were captured using a digital camera and the 
Confocal AssistantTM  program (Version 4.02; Todd Clark Brelje) and were edited 
with the Adobe-Photoshop program (Windows 2000). 
All the other slides were examined under an inverted Zeiss Axiovert S 100 
photomicroscope, using the DAPI (Zeiss 487702; emission barrier 400nm), FITC 
(Zeiss 487709; emission barrier 515nm) and Rhodamine/TXR (Zeiss 487714; 
emission barrier 573-590nm) selective filter sets and the 40x and 63x oil objectives. 
Images were captured with the Hamamatsu Digital camera, analysed with the AQM 
program (Kinetic Imaging Ltd) and edited with the Adobe-Photoshop program, as 
previously described (Paragraph 2.11). 2-mercaptoethanol 
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CHAPTER 3 
MOUSE FOETAL FIBROBLASTS AS A 
SOURCE OF GO AND Gi KARYOPLASTS 
3.1 INTRODUCTION 
Cells synchronized in GO or Gi are mainly diploid, with significantly lower 
percentages of cells in S-phase, compared to cycling cells. Rates of growth-arrest in 
GO and Gi populations can be assessed by immunostaining for specific proliferation-
associated antigens that include the Proliferating Cell Nuclear Antigen (PCNA), 
Ki67 and bromodeoxyuridine (latropoulos and Williams, 1996, Leonhardt et al., 
2000). Alternatively, Propidium Iodide staining and flow cytometry can be used to 
quantify DNA content in cells and assess percentages of cells in S-phase, 
characterised by a DNA content (2N/4N) intermediate between that of diploid (2N) 
and tetraploid cells (4N). Since low percentages of cells in S-phase are a common 
feature of GO and GI cells, a dual parameter analysis, based on DNA content 
assessment and presence of quiescence markers (for review see Chapter 1), is 
necessary to discriminate GO and GI cells. There are positive and negative markers 
of cell quiescence, depending whether their levels are up regulated or down regulated 
upon exit from the cell cycle. Markers of quiescence include: 
• p27Ml, a cyclin-dependent kinase inhibitor (CKI), highly expressed in GO 
cells (positive GO marker), where it prevents Cdk4 and, to a lesser extent, 
Cdk2 from binding to, and activating cyclin Dl and cyclin E, necessary for 
GO/GI transition (for review see Sherr and Roberts, 1995); 
• p130 or retinoblastoma 2 (pRb2), a nuclear protein, member of the 
retinoblastoma family of proteins, highly expressed in GO cells (positive 
marker), where it binds to, and activates, E21 74 and E2175, repressors of 
early GI gene expression (Smith et al., 1996); 
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• total RNA content (Acridine Orange staining; Juan and Darzynkiewick, 
1998) and total protein content (FITC staining; Boquest et al., 1999), that 
are very low in GO cells (negative GO markers), since quiescent cells have 
low levels of transcription and translation. 
There are also qualitative markers of cell quiescence. Quiescence induces 
changes in chromatin structure. As shown by a modified Acridine Orange staining 
(Juan and Darzynkiewick, 1998), chromatin is condensed in GO cells, but it 
decondenses as cells re-enter the cells cycle. Changes in chromatin status are in line 
with changes in transcription and translation previously described. Changes in 
chromatin status are usually mediated by post-translational modifications of histone 
proteins and changes in sub-nuclear localisation of non-histone proteins (for review 
see Gregory and Hörz, 1998). Proteins of the Heterochromatin Protein 1 (HP1) 
family (for review see Jones et al., 2000) are non-histone proteins that colocalise 
with constitutive, pericentromeric heterochromatin (mouse M3 1/human hHP13; 
mouse mHPlalhuman hHPl(x) and non-constitutive heterochromatin (mouse 
M32/human hHPly). Changes in sub-nuclear localisation of HP1 proteins associate 
with changes in chromatin structure induced by cell quiescence. Furthermore, 
quiescence affects centromere arrangements. Immunostaining of centromeric 
chromatin with anti-centromere antibodies (ACA) showed that centromeric 
chromatin is organised into clusters, localised at the periphery of the nucleus 
(Weimer et al., 1992). Exit from GO is characterised by dissolution of peripheral 
clusters. Through its association with pericentromeric chromatin, mouse M31, 
homologue of human hHP1I3, can be used to monitor these specific chromatin 
changes occurring in quiescent cells and to discriminate between quiescent and non-
quiescent cells. 
Fibroblasts are a good cell model to compare the developmental potential of 
GO and GI karyoplasts. Adult and foetal fibroblasts have been able to support 
development to term in all the species cloned up to date. Furthermore, Mouse Foetal 
Fibroblasts (MFF), together with T-lymphocytes, have been the cell type most 
commonly used to study the effects of quiescence on cultured cells. All the markers, 
previously described, have been used to define the quiescent state in mouse foetal 
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fibroblasts. Several methods to synchronize cultured fibroblasts in GO and GI have 
also been defined. 
Fibroblasts can be synchronized in GO by using one of the following 
antimitogenic signals: serum starvation (Nourse et al., 1994; Coats et at., 1996; 
Coats et al., 1999), cell-cell contact (St. Croix et at., 1998), loss of cell anchorage, 
TGF-13 (Polyak et at., 1994ab), staurosporine (Kwon et al., 1996). 
Synchronization of cultured fibroblasts in GI can be achieved by using one 
of the following methods (for review and protocols see Pagano, 1996): 
Synchronization in GuS, by incubation with the blocking agents 
hydroxyurea and methotrexate; 
Synchronization in early Gi by: 
Incubation with the blocking agent mimosine (Pagano, 1996; Gilbert 
et al., 1995); 
Incubation with the blocking agent lovastatin, that induces G1 arrest 
by increasing the levels of the CDK inhibitors p21CIP1IWARF1  and/or 
p27"''. 
The experiments described in this chapter were aimed at establishing 
synchronization protocols, in GO and Gi, for mouse foetal fibroblasts, by using 
markers previously described, to assess growth-arrest and quiescent state of 
synchronized cells. 
3.2 SYNCHRONIZATION IN GO 
3.2.1 Growth-arrest by contact inhibition and serum starvation 
3.2.1.1 Aims 
Use contact inhibition and serum starvation to synchronize mouse foetal 
fibroblasts (MFF) in GO and compare their status with that of sub-confluent MFF, 
that had been cultured for 24h with 10% FCS (cycling cells), used as a negative 
control for quiescence. 
Consider different experimental conditions: 
1) 	Effect of time (0, 3, 6 days), in contact-inhibited cells; 
T. 
2) 	Effect of different serum concentrations (0.5% FCS, 0.1% FCS) and time 
(0-4 days), for serum-starved cells. 
Select experimental conditions that give: 
Maximal proliferative arrest, assessed using PCNA staining and 
immunocytochemistry; 
Minimal collateral effects: 
Death (Trypan blue staining) or inability to re-enter the cell cycle 
(PCNA staining after serum re-stimulation, morphology) of serum-
starved cells. 
Death (Trypan blue staining) or transformation of contact-inhibited cells 
(morphology, karyotyping, doubling time after sub-culture); 
3.2.1.2 Experimental design 
Serum starvation experiments were set up at passage 4, using the mouse 
foetal fibroblasts (MFF) cell line MFF9 (for selection criteria see Paragraph 2.2). 
PCNA staining was used to assess the effects of serum starvation conditions 
on proliferative arrest and on the ability of cells to re-enter the cell cycle and to start 
replicating their DNA again. 
In a first set of experiments cells, seeded at allow density, were cultured 
72h with 10% FCS till 50% confluent (72h), and then serum-starved, with 0.5% or 
0.1% FCS, from 1 to 4 days. Two coverslips were fixed and stained for PCNA (for 
staining protocol see Paragraph 2.11)48 h after seeding (cycling cells) and every 24h 
after serum starvation. At each time point a total of 100 cells were counted from the 
two coverslips. Experiments were carried out in triplicates. Cells were also assessed 
for morphological changes associated with proliferative arrest such as cell 
enlargement and flattening out. 
In a separate set of experiments, cells that had been serum-starved for 3 
days, with medium containing 0.1% or 0.5% FCS, were stimulated to re-enter the 
cell cycle by adding medium with 20% FCS. Two coverslips were fixed and 
processed for PCNA at Oh, 4h, 8h, 12h and 24h, 36h, 48h, 72h after serum re-
stimulation. Experiments were carried out in three replicates and, for each replicate, 
the proportion of PCNA positive cells was calculated on 100 cells obtained from the 
two coverslips in each treatment group. The percentages of PCNA cells found in 
cycling cells cultured for 48h in 10 % FCS were used as a control of the proliferative 
state. 
Effect of serum starvation on cell viability was assessed by Trypan blue 
staining. Morphological changes occurring in serum-starved and serum re-stimulated 
cells were also evaluated. 
Contact inhibition experiments were set up using the selected mouse foetal 
fibroblast (MFF) cell line MFF8, at passage 3 (for selection criteria see Paragraph 
2.2). 
To assess growth arrest by contact inhibition, using the PCNA staining, 
cells, seeded at an average density, were cultured until confluent (72h). Confluent 
cells were kept under contact inhibition conditions for an additional 7 days. Two 
coverslips were fixed and stained for PCNA, 24 h after seeding (cycling cells); 72h 
after seeding, when they had reached 90-95% confluence (contact inhibition day 0 or 
ci0), and every 24h after they had reached confluence (61-67). Data were collected 
in three separate experiments, and, in each experiment, the proportion of PCNA 
positive cells was calculated on 100 cells, counted from the two coverslips in each 
treatment group. 
The effects of time spent under contact inhibition on replication rates, 
expressed as population doublings/day, on karyotype and on cell morphology were 
also evaluated. 
Three 25cm2 flasks of MFF8 at passage 3, sub-cultured from the same 
passage 1 vial, to avoid variability between one vial and another, were kept under 
contact inhibition for 0 (60), 3 (63) and 6 days (66). Cells from each group were 
then sub-cultured for 3 passages, assessing, at each passage, the population 
doublings/day (for Methods see Paragraph 2.2). For each treatment group, at each 
passage, three 25cm 2 flasks were seeded so that calculations were carried out in 
triplicates. Replication rate can be used as an indication of cell normality, since 
increased growth rates are a feature of transformed cells. 
Viability was also evaluated at each passage using Trypan blue exclusion 
method (for Methods see Paragraph 2.1). 
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At passage 4, a forth 25cm 2 flask from each contact-inhibited group (63, 
66) was karyotyped (for Methods see Paragraph 2.1), and the proportion of normal 
spreads was compared with that sub-confluent cells, of the same cell line, at passage 
4 and at passage 2. 
Cells morphology was also evaluated to detect any signs of transformation. 
In our experience transformation is usually associated with appearance of clusters of 
polygonal cells, from which a population of cells, resembling young-fibroblasts, 
small and elongated, would arise (Paragraph 2.2; Fig.2.1). 
3.2.1.3 Statistical Analysis 
In serum starvation and serum re-stimulation experiments, data were analysed using 
a two-way ANOVA. Variables included: 
Proportion of PCNA cells (dependent variable); 
• 	Serum concentrations during starvation: 0.5% or 0.1% FCS (1st  independent 
variable); 
• 	Time, after serum starvation and re-stimulation (2" independent variable); 
In contact inhibition experiments, data were analysed using a two-way ANOVA. 
Variables included: 
• 	Proportion of PCNA cells or population doublings/day (dependent variable); 
• 	Time, spent under contact inhibition at passage 3 (1St  independent variable); 
• 	Passages, after release from contact inhibition (2"'' independent variable). 
Viability results from serum starvation experiments were analysed with a one-way 
ANOVA: 
Percentage of viable cells (dependent variable); 
Treatment group (cycling, serum-starved for 3 days, contact-inhibited for 3 
days; independent variable). 
Viability results from contact inhibition experiments were analysed with a two-way 
ANOVA: 
• 	Percentage of viable cells (dependent variable); 
• 	Time, spent under contact inhibition at passage 3 and passages after release 
from contact inhibition (independent-variables). 
Karyotyping results were analysed with a Chi-square contingency test. 
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All the ANOVA tests were carried out with the program Statistica 4.5 (Windows 
1995). Chi-square tests were carried out with GenStat 4.21 (Windows 2000). 
3.2.1.4 Results 
PCNA staining showed that reduction of replicating cells (PCNA) observed 
in serum-starved cells is dependent on time elapsed after serum deprivation (time 
effect, p<0.0001). Shifts in the percentages of cycling cells observed during serum 
starvation (serum x time interaction, p=0.71) were similar in cells serum-starved with 
0.1% FCS and 0.5% FCS. The percentages of PCNA cells observed in groups 
serum-starved 24h with 0.5% or 0.1% FCS were significantly lower (p<0.0001) than 
those observed in cycling cells, cultured 24h with 10% FCS (Fig.3.1). At this time 
morphological changes associated with cell quiescence were also observed 
(Fig.3.3B). The percentages of PCNA cells decreased significantly in the 0.1% FCS 
(p<0.02) and the 0.5% FCS (<0.001) groups till 48h after serum deprivation and then 
remained constantly low (p>0.05% for 0.1% FCS; p>0.5% for 0.5% FCS). Overall 
percentages of PCNA cells observed in cells serum-starved with 0.1% FCS 
(3.7±0.9) were lower than those serum-starved with 0.5% FCS (5.7±1.0, p<0.03). 
The lowest percentages of PCNA cells were observed after 72h after serum 
deprivation, with 0.1% FCS (0.6±0.5%). 
Serum re-stimulation experiments showed that average percentages of 
PCNA cells gradually increased after serum re-addition (time effect, p<0.0001; 
Fig.3.2). Overall percentages of PCNA cells, including both data from 0.1% and 
0.5% groups, progressively increased for the first 12h after serum re-stimulation 
(1.2±0.6% at 4h; 0.8±0.5% at 8h; 6.0±2.0% at 12h). At 24h, the percentages of 
PCNA cells reached a peak (25.8±2.9%) that was even higher (p<0.001) than those 
observed in cycling cells that had been cultured for 24h with 10% FCS (19.0±2.3%). 
Cell morphology also changed at this stage (Fig.3.3C). After serum re-stimulation for 
24h, the percentages of PCNA cells started decreasing reaching, at 48h, a level 
(9.3±1.8%) similar to that observed at 12h (p=0.13) and, at 72h, a level (5.6±0.6%), 
similar to that observed in serum-starved cells (2.5±0.7%; p=O.l6). 
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Figure 3.1 Mouse Foetal Fibroblasts were fixed and stained with PCNA 24h before serum starvation (4) and 
at a 24h interval after serum starvation (1-4), with 0.1% or 0.5% FCS. Cells fixed 24h before serum 
starvation had been cultured for 24h in 10% FCS and were considered a control population of cycling cells. 
In Figure 3.2 Mouse Foetal Fibroblasts were serum-starved with 0.5% or 0.1% FCS, and then re-stimulated 
with 20% FCS. Cells were fixed and stained with PCNA at different time points after serum re-stimulation to 
assess cell cycle re-entry. The horizontal line represents levels of PCNA cells in groups cultured with 10% 
FCS (cycling). Only cells at 36h were not significantly different form cycling cells. In Fig.3.I-3.2 data from 3 
experiments are summarised as Mean±SEM (two-way ANOVA, (x=0.05, Statistica 4.5, Windows 1995). 
Figure 3.3 Morphological changes in serum-starved foetal fibroblasts 
fusiform 	 enlarged 4 	 fusiform ' 
'4 
A 	 B 
	
C 
Brightfield photographs of cells cultured with for 24h with 10% FCS (A), serum-starved for 3 days (B), with 
0.1% FCS and then re-stimulated for 24h with 20% FCS (C). Cells were enlarged during serum starvation but 
acquired again a fusiform, fibroblast-like shape after serum re-stimulation. Arrows point at cell nuclei. 
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The average percentages of cycling cells found in 0.1% FCS groups after serum re-
stimulation (9.0±1.8%) were similar (serum effect, p>0.09) tO those observed in 
0.5% FCS groups (7.1±1.7%). Shifts in the percentages of PCNA cells were also 
similar in the two groups (treatment x time interaction, p=046, Fig.3.2). 
Trypan blue staining showed that serum-starved cells had high percentages of 
viable cells (~!94%), similar to those found in cycling cells (~!95%, p=0.35). 
Contact inhibition induced a time-dependent (time effect, p<0.0001) 
reduction of percentages of cells in S-phase (Fig.3.4). The percentages of PCNA 
cells, observed on the day of confluence, were significantly lower than those 
observed in sub-confluent cells (p<0.001). A further decrease in the percentages of 
cells in S-phase was observed after 3 days of contact inhibition (p<0.001). Beyond 
this time point the levels of PCNA cells remained constantly low (p>O. 1). 
Viability of confluent cells kept under contact inhibition for 0, 3 and 6 days, 
was high, regardless of time spent under contact inhibition (98.0±0.5%; 99.0±0.8%; 
98.3±0.3%; p>0.4). Low percentages of apoptotic cells, similar to those found in sub-
confluent cells (95.0±1.1%) were found in samples kept under contact inhibition for 
3 days, and then stained with Propidium Iodide (97±0.9%, p=0.56). However, after 
sub-culture, depending on time spent under contact inhibition (treatment effect, 
p=0.0002) and on passage number (passage x treatment interaction, p<0.04), viability 
was significantly affected. Overall viability of cells kept under contact inhibitions for 
3 days (94.0±1.1%) was significantly lower than viability of cells kept under contact 
inhibition for 0 (98.6±0.2%) and 6 days (97.9±0.5%). The lowest survival rates were 
observed at passage 4 and 5 (93%), after which viability increased to levels 
comparable to those observed in other groups (p>0.8). 
Contact inhibition also affected number of population doublings/day, used 
here as a measure of cell growth rates (Fig.3.5). Cells kept under contact inhibition at 
passage 3, for 3 (ci3p3) and 6 (ci6p3) days, had almost zero population 
doublings/day, whereas cells, that had just reached confluence, had significantly 
higher growth rates (doublings/day, p<0.0001). In control cells, growth rates 
remained unchanged at passage 4 and then decreased significantly at passage 5 and 6 
(p<0.0001), reaching values close to zero. After a temporary decrease in cell 
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Figure 3.4 Mouse Foetal Fibroblasts (MFF) at passage 3 were cultured in 10% FCS 
medium for 10 days. Cells were confluent at day 3 (ciO). Percentages of cells in S-phase 
(PCNA) were calculated in sub-confluent cells (day 1), and cells that had been under 
contact inhibition for a maximum of 7 days (day 10 of culture). Significant reductions in 
percentages of PCNA cells were observed at day 3 (ciO) and day 6 (63), after 3 days 
under contact inhibition. Data are expressed as mean±SEM of three experiments (a=0.05; 
one-way ANOVA; Statistica 4.5, Windows 1995). 
Figure 3.5 Mouse Foetal Fibroblasts (MIFF) that had been kept under contact inhibition, at 
passage 3 (p3), for 0 (ciO), 3 (63) and 6 days (66), were sub-cultured for further 4 
passages. At each passage, population doublings/day were calculated, and used as a 
measure of cell growth rate. Data are expressed as mean±SEM of results of three counts 
carried out on three flasks/group, at each passage (a0.05; 2-way ANOVA; Statistica 4.5, 
Windows 1995). 
Figure 3.6 Mouse Foetal Fibroblasts that had been kept under contact inhibition, at 
passage 3, for 0 (ci0p3), 3 (ci3p3) and 6 (ci6p3) days, were sub-cultured and karyotyped at 
passage 4. Multiple populations of polyploid cells (>4N) were visible after 6 days of 
contact inhibition. 
numbers, observed at passage 4, growth rates of cells, that had been kept under 
contact inhibition for 3 days (ci3p3), started to increase steadily. Growth rates of 
cells, that had been under contact inhibition for 6 days (ci6p3), increased steadily at 
each passage (Fig.3.5). By passage 5, number of population doublings/day in 
contact-inhibited cells was higher than that observed in control cells (p>0.0003; 
Fig.3.5). 
The percentages of cells with normal karyotype found at passage 4 in 
populations that had been under contact inhibition for 3 days (29/50, 58%) were 
comparable to those found in control, sub-confluent cells (34/50, 68%; p=0.30 ; 
Fig.3.6). Cells that had been under contact inhibition for 6 days, at passage 4 had 
significantly lower percentages (22/50, 44%) of cells with normal karyotype than 
controls (p=0.016; Fig.3.6). 
Morphological analysis showed clusters of transforming cells (Fig.2.2D) at 
passage 5 and transformed cells (Fig.2.2E) at passage 6, for cells that had been kept 
under contact inhibition for 3 days at passage 3. Transformed cells were already 
visible at passage 4 in populations that had been kept under contact inhibition for 6 
days, at passage 3. 
3.2.1.5 Discussion 
To induce growth-arrest MFF had to be serum-starved for at least 2 days. 
Serum starvation with 0.1% FCS was more efficient in reducing percentages of cells 
in S-phase than 0.5% FCS. Most efficient growth-arrest was achieved after 3 days of 
serum starvation with 0.1% FCS. 
The gradual increase in PCNA cells observed after serum re-stimulation 
demonstrated that serum starvation did not impair ability of cells to re-enter the cell 
cycle. At 24h, the percentages of PCNA cells were even higher than those found in 
control, cycling cells that had been cultured for 24h with 10% FCS. This effect may 
have resulted from the fact that cells, that had been previously serum-starved, had a 
better level of synchronization in S-phase than asynchronous, control cells. The 
gradual reduction in PCNA cells observed after 24h of serum re-stimulation leading, 
after 72h, to levels comparable to those found in serum-starved cells, indicated that 
cells were reaching confluence. 
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Cells, that had been serum-starved with 0.1% FCS, had the same ability to re-
enter the cell cycle as cells treated with 0.5% FCS, as suggested by the similar 
overall levels of cycling cells found in the two groups. The lag time (24h) before the 
highest DNA replication rate was achieved, was also not affected by the serum 
concentration used to induce proliferative arrest. Trypan blue staining showed that 
serum starvation had no detrimental effect on cell viability. 
Although contact inhibition for three days significantly reduced the 
percentages of cells in S-phase, maximal growth-arrest was achieved after 3 days of 
contact inhibition. Growth-arrest was also confirmed by the low number of 
doublings/day observed in cells that had bee under contact inhibition for 3 or 6 days. 
Contact inhibition did not affect immediately cell viability, but it reduced 
survival rates after sub-culture, at least in cells that had been under contact inhibition 
for 3 days. High death rates were observed in cells kept under contact inhibition for 3 
days, at passage 4 and 5. The high death rates observed at passage 4 might explain 
the drop in population doublings/day observed at this stage. Contact inhibition at 
passage 3, for 6 days (ci6p3) did not affect viability after sub-culture, possibly 
because transformed cells had already replaced suffering cells. The fastest growth 
rates (population doublings/day) observed in this treatment group, compared to cells 
that had been under contact inhibition for 3 days, regardless of the passage 
considered, supports this explanation. The abnormal karyotype found in this 
treatment group, at passage 4, and the appearance of transformed like-cells, at that 
time, also support this idea. 
Control cells, that were passaged immediately after reaching confluence, 
were senescing by passage 5 and 6, as suggested by their growth rates close to zero 
and as previously observed for this cells line (Paragraph 2.2). The lower population 
doublings/day observed at passage 4, in cells that had been kept under contact 
inhibition for 3 and 6 days, suggests the presence of a lag phase following growth-
arrest. The increase in population doublings/day, at passage 5 and 6, at a time when 
control cells are senescing, could be interpreted as a sign of transformation. Other 
two observations support this explanation: appearance of transformed cells at 
passage 4 and 6, respectively in cells that had been kept under contact inhibition for 
6 or 3 days; abnormal karyotype, at passage 4, that had been observed in cells that 
W. 
had been contact-inhibited for 6 days. These observations, together with the 
persistence of a normal karyotype at passage 4, also suggests that transformation of 
cells contact-inhibited for a shorter time (3 days) might occur at a later passage. 
3.2.1.6 Conclusions 
On the basis of these observations, two protocols were selected because of 
their ability to induce growth-arrest, with the least risks of inducing cell death or 
transformation: 
Serum starvation for 72h, with medium containing 0.1% FCS 
Contact inhibition for 72h, in medium containing 10% FCS 
3.2.2 Quiescence by contact inhibition and serum starvation 
3.2.2.1 Aims 
Assess if, under the selected experimental conditions, serum starvation and 
contact inhibition can be used to produce quiescent MFF, characterised by: 
High levels of positive quiescence markers (p27KW1  p130) 
Low levels of negative quiescence markers (FITC staining); 
Changes in chromatin structure (HP1 proteins). 
3.2.2.2 Experimental Design 
Three treatment groups were considered: 
Cycling cells, sub-confluent and cultured in 10% FCS for 24h; 
Serum-starved cells, cultured in 0.1% FCS for 3 days; 
Contact-inhibited cells, cultured in 10% FCS till confluent and kept under 
contact inhibition for three days. 
Bivariate analysis was carried out, with three staining: 
Propidium Iodide and p27 K' pl staining (PIJp27 1 ); 
Propidium Iodide (P1) and p130 staining (P11p130); 
Propidium Iodide (P1) and FITC staining (PIIFITC); 
Propidium Iodide staining (for Methods see Paragraph 2.6-2.10.1) gave 
information about cells cycle profile of growth-arrested cells, based on their DNA 
content (2N=GO/G1; 2/4N=S-phase; 4N=G2IM). It also gave information about 
apoptotic rates (.<2N) and the percentages of polyploid cells (>4N). It was also used 
to gate diploid cells (2N=GO/G1) and assess the percentages of diploid cells, as 
opposed to the percentages of total cells, expressing (GO), or not expressing (Gi), 
quiescence markers. 
The cell line MFF9 was used in all FAGS experiments, within passage 4, 
before the onset of senescence or transformation (see Paragraph 2.2 for selection 
criteria). 
Three replicate experiments were carried out for each group and staining. 
Descriptive studies of HP1 proteins sub-nuclear localisation were carried 
out in serum-starved cells, using indirect immunofluorescence and epifluorescent 
microscopy (for Methods see Paragraph 2.11). 
3.2.2.3 Statistical analysis 
All data were analysed with a one-way ANOVA (Statistica 4.5, Windows 
2000). Variables included: 
Percentages of cells expressing a marker (p27 k , p130, FITC) or with a 
certain DNA content (2N, 2/4N, 4N, >2N, >4N; dependent variable); 
Treatment group, cycling, serum-starved or contact-inhibited (independent 
variable). 
3.2.2.4 Results 
Cell cycle analysis (Fig.3.7A) showed a significant decrease in S-phase cells 
in contact-inhibited and serum-starved cells, compared to cycling cells (p<0.0001). 
The reduction of the percentages of replicating cells observed in synchronized cells, 
was associated with an increase in the percentages of GO/Gi (p>0.05 for serum-
starved cells; p<0.001, for contact-inhibited) and G2JM cells (p<0.0001 for serum-
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Figure 3.7 Cell cycle profile and expression of quiescence markers in serum-starved and contact-inhibited cells 
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Mouse Foetal Fibroblasts, at passage 3, were assigned to three treatment groups: cycling cells, cultured for 24h with 10% FCS; serum-starved cells, cultured 
for 72h with 0.1% FCS; confluent cells, kept under contact inhibition for 3 days. Samples were double stained with Propidium Iodide and 27Kfl,  p130 or 
FITC. Propidium Iodide was used to detect cell cycle profiles (A), whereas p130 and p27 were used as positive GO markers and FITC was used as a negative 
GO marker (B). Data from three replicates are expressed as mean±SEM. Percentages within the same cell cycle category with different superscripts, and 
columns with the same colour and different symbols, differ significantly (one-way ANOVA, a0.05). 
Figure 3.8 Cell cycle distribution of serum-starved quiescent cells 
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Cell cycle distribution of quiescent and non-quiescent cells was assessed in cycling cells, 
used as a non-quiescent control, and serum-starved cells. Cells were stained with 
KIPI PL/p130; PI/FITC. Cells that were p27/pl30/FITC were considered 
quiescent; cells that were p277p1307FITC were considered non-quiescent. Cells were 
gated according to their DNA content: GO/GI (=2N); S (=2N/4N); G2/M (=4N). 
Proportion of cells expressing quiescence markers, was assessed on gated cells. Data are 
expressed as mean percentages of three replicate experiments. 
In serum-starved groups, the percentages of apoptotic cells were 
significantly higher than those found in cycling cells (17.4±2.9% vs 8.7±1.2%, 
p=0.02), whereas in contact-inhibited cells they were significantly lower (3.3±0.6%, 
p<o.000l). 
Serum-starved cells had significantly higher percentages of p27 K1 
(p=0.005) and pl30 cells (p<0.05), and significantly lower percentages of FITC 
cells (<0.01), than cycling cells (Fig.3.713). Cell cycle distribution of quiescent cells 
in the serum-starved population was also investigated (Fig.3.813), and compared to 
that of cycling cells (Fig.3.8A). 
Contact-inhibited cells did not express p27 KIP1  (Fig.3.713), similarly to what 
was observed in cycling cells (p=0.05). The percentages of p130 were significantly 
higher than those found in cycling cells (p<0.05), and comparable to those found in 
serum-starved cells (p=0.82; Fig.3.713). The percentages of FITC cells were 
intermediate between those found in cycling cells (p<0.05) and those observed in 
serum-starved cells (p<0.05; Fig.3.713). 
Immunocytochemistry results showed differences in sub-nuclear distribution 
of HP  proteins in serum-starved and cycling cells (Fig.3.9). 
3.2.2.5 Discussion 
Cell cycle profiles confirmed the growth-arrest state shown by PCNA 
staining. It also showed that 2/3 of the cells were arrested in GO/GI and 1/3 was 
arrested in G2/M. This is not the result of karyotype abnormalities or of cell 
aggregation. It must be therefore correlated with a synchronization effect. Unlike 
progression through early GI (Sherr, 1993; Baldin et al., 1993), that is dependent on 
availability of growth factors (mitogen-dependent), transition through G2/M is 
mitogen-independent, and is regulated by the activity of the cyclin B/p34 2 (Cdkl) 
protein kinase complex, otherwise known as Meiosis/Mitosis Promoting Factor 
(MPF) (for review on Cdks see Pines and Hunter, 1991). Progression through G2IM 
is also regulated by p34 k2 (Cdkl), associated with cyclin A. The Cdk inhibitor 
p27', that is up regulated in GO cells, is a promiscuous inhibitor: it mainly targets 
Cyclin E/Cdk2 and Cyclin D1/Cdk4 complexes, but it is also able to inhibit Cdk2 





mHP1 a/hHP1 a 
Microphotographs of nuclei of Mouse Foetal Fibroblasts, that had been cultured for 24h with 10% FCS (cycling; lA-F), or serum-starved for 72h with 
0.1% FCS (quiescent, 2A-F). Cells were fixed with paraformaldehyde 1% or 4%, processed for indirect immunofluorescence with FITC conjugated 
anti-M32 (IA-B; 2A-B), FITC conjugated anti-M31 (1C-D; 2C-D) or FITC conjugated anti-mHPla (1E-F; 2E-F), recognizing mouse homologues of 
human hHP1'y, hHPIP and h}iPla. Finally cells were stained with the DNA dye DAPI (blue, 1A-2A, 1C-2C, 1E-2E). M32 concentrated around the 
nucleoli in cycling cells (113, arrows) and had a more uniform distribution in GO cells (213); M31 was organized into big clusters (arrows, 2D), 
colocalised with clusters of heterochromatin in GO cells (arrows, 2C) and was both organised into clusters and uniformly diffused in cycling cells 
(ID); mHP 1 a distribution was similar to that of M31, except that clusters (arrows, 2F) were smaller. 
activity, when it is bound to other cyclins, and cyclin p34 cdc2  (Cdkl) activity, when it 
is bound to cyclin B or A (for review on Cdk inhibitors see Shen and Roberts, 1995). 
Therefore, up regulation of 27KIP1  induced by serum starvation, could potentially 
induce arrest in G2IM by inactivation of the cyclin B/Cdkl complex. 
Serum starvation had a negative effect on cell survival, in contrast with what 
previously found with Trypan blue staining, that showed no difference in the 
percentages of live cells between cycling and serum-starved cell populations (94-
95%, p=0.35). P1 might represent a more sensitive method of analysis. 
Contact inhibition had no detrimental effect on cell survival, nor on 
karyotype, as suggested by the low percentages of polyploid cells, similar to the ones 
found in cycling cells. These results confirmed previous findings on cell viability and 
karyotype of cells contact-inhibited for three days at passage 3 (see paragraph 
3.2.1.4). 
According to a broad definition of quiescence, serum-starved cells were 
quiescent because, compared to cycling cells, they had significantly higher 
percentages of p27' and p130 cells, and significantly lower percentages of 
FJTC cells. The existence of a quiescent status in serum-starved cells was also 
confirmed by HP1 immunocytochemistry results, that showed dramatic differences 
in the chromatin status of cycling and serum-starved cells. Particularly important in 
confirming quiescent state of serum-starved cells were changes observed in the sub-
nuclear distribution of M3 1IhHP1 13, with pericentromeric localisation, since changes 
in centromeric chromatin have been described as a landmark of nuclear quiescence. 
However, flow cytometry results also indicated that serum-starved cells 
constitute a variable population of GO cells: 
Not all serum-starved cells were quiescent. Although almost all serum-
starved cells were FITC, only a proportion were p27'" and p130t 
Percentages of quiescent cells varied according to the quiescence marker 
used. This observation suggests that different markers might identify sub-
populations of GO cells with different features. Whether these sub-sets of 
cells overlap could only be proved by simultaneous staining with all three 
markers. 
FIM 
3) 	The high SEM values obtained in serum-starved cells indicated a great 
variability within replicate experiments, carried out under the same 
experimental conditions, but on different populations of cells. 
Cell cycle analysis of serum-starved cells showed that not all quiescent cells 
were diploid and not all diploid cells were quiescent. When considering only diploid 
cells (GO/Gi), the percentages of GO (quiescent) or GI (non-quiescent) cells, 
depending on the marker used, were: with 27KIP1  72.5% in GO and 27.5% in GI; 
with p130,48.2% were in GO, and 5 1.8% were in GI; with FITC, 94.1% were in GO 
and 5.9% were in GI. However, between 81% and 74% of quiescent cells were 
diploid (GO/Gi). The remaining cells were quiescent, but with a tetraploid content of 
DNA, and therefore in G2/M. This implies that, under the experimental conditions 
used in these experiments, quiescence and diploidy were not necessarily associated. 
Contact inhibition results were different from those obtained in serum-
starved cells. Growth-arrest induced by cell-to-cell contact has been usually 
associated with increases in p27"' (St. Croix et al., 1998). However, in these 
experiments very low percentages of contact-inhibited cells expressed p27 KIP1  a 
situation similar to that observed in cycling cells. The percentages of FITC, 
indicative of protein synthesis levels, were also higher than those found in serum-
starved cells, although they remained lower than those observed in non-quiescent 
cells. The only similarity with serum-starved quiescent cells, were the high 
percentages of p130 cells. A possible explanation might be that, although cells still 
appeared to be normoploid under the conditions used in these experiments, they 
might have already been undergoing changes associated with transformation, 
occurring at later passages. The percentages of polyploid cells found in contact-
inhibited cells, at passage 3, were comparable to those found in cycling and serum-
starved cells, and karyotype of contact-inhibited cells was still normal at passage 4. 
However appearance of clusters of transforming cells at passage 6, in association 
with the shortening of the doubling time at passage 5 and 6, suggest that contact 
inhibition might induce transformation at later passages. Subtle changes associated 
with cell transformation occurring at passage 4 could explain loss of immuno-
positivity for quiescence markers. 
3.2.2.6 Conclusions 
Serum starvation appears to be the best method to produce a well-
characterised population of quiescent mouse foetal fibroblasts. However it has two 
main drawbacks: 
• 	It produces a mixed population of diploid and tetraploid cells; 
• 	It produces a mixed population of quiescent and non-quiescent cells. 
Presence of high percentages of diploid and tetraploid cells is not optimal 
for nuclear transfer experiments. Tetraploid cells can be successfully used for mouse 
nuclear transfer, when reconstructed embryos are cultured in the absence of 
cytochalasin B, to enable pseudo-polar body extrusion and depolarisation. However, 
nuclear transfer with diploid cells requires the addition of cytochalasin B, since, 
under these experimental conditions, pseudo-polar body extrusion would induce 
haplodization. 
Serum starvation did not produce a pure population of quiescent cells. The 
levels of purity could not be improved by positive selection of quiescent cells or 
negative selection of non-quiescent cells, given the intracellular nature of the 
quiescence markers in fibroblasts, that makes them accessible only after fixation. 
3.3 SYNCHRONIZATION IN Gi 
3.3.1 Growth-arrest by Gi or GuS blocking agents 
3.3.1.1 Experimental Design 
Mouse Foetal Fibroblasts were synchronized using the GuS blocking agents 
hydroxyurea and methotrexate, and the Gi blocking agent mimosine and lovastatin 
(for Methods see Paragraph 2.5). 
Experimental conditions included: 
• 	Two time points, 24h and 48h; 
• 	Eleven treatment groups, corresponding to four blocking agents used at two 
or three different concentrations: 
Lovastatin: 5uM, l5uM, 30uM; 
Hydroxyurea: 1mM, 2mM, 4mM; 
• Methotrexate: 0.1uM, luM, 2uM; 
• Mimosine: 400uM, 800uM. 
Other four treatment groups were used as controls. Cells cultured in medium 
with 10% FCS, with no chemical added, were used as a culture control. Since 
lovastatin had been reconstituted with ethanol, control cells, cultured in medium with 
10% FCS and similar concentrations of ethanol, but no lovastatin, were also included 
as controls (for Methods see Paragraph 2.5). 
PCNA staining was used to assess growth-arrest under the different 
experimental conditions. Data were collected in three separate experiments. 
3.3.1.2 Statistical analysis 
Data were analysed using a two-way-ANOVA (Statistica 4.5, Windows 
1995). Variables included: 
• 	Percentage of PCNA cells (dependent variable); 
• 	Time and treatment (independent variables). 
Main effects of time or treatment were assessed independently, before 
considering treatment and time interaction. 
Analysis was also broken down in a one-way ANOVA (Statistica 4.5, 
Windows 1995), considering treatment effects only, at a fixed time point, 24h or 48h. 
3.3.1.3 Results 
The percentages of cells in S-phase found at 48h (14.8±1.9%) were 
significantly lower than those found at 24h (8.1±1.1%; time effect, p<0.0001). 
Treatment effect was also significant (p<0.0001). Lovastatin, hydroxyurea and 
mimosine, all significantly reduced the percentages of cells in S-phase compared to 
controls (p<0.0001). The percentages of PCNA cells were similarly low in groups 
treated with lovastatin, hydroxyurea and mimosine (p>0.05). No significant 
difference was observed in the percentages of cells in S-phase found in groups 
treated with different concentrations of lovastatin (p>0.6), hydroxyurea (p>0.3) and 
mimosine (p>0.3). Lovastatin controls were similar to normal controls (p>0.6), 
except for the l5uM control, that had significantly lower percentages of PCNA cells 
(p=0.007). The percentages of cells in S-phase in groups treated with 0. luM and 
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Mouse Foetal Fibroblasts were incubated for 24h or 48h, with 10%FCS alone (Ctr), or 
supplemented with different concentrations of the GI blocking agents lovastatin (Lov 5-3OuM), 
hydroxyurea (FlU 1-4mM), methotrexate (MTX 0.1 uM-2uM), mimosine (MIMO 400-800uM). 
Lovastatin was dissolved in ethanol, so controls, with similar concentrations of ethanol but with 
no lovastatin, were also included in the analysis (Ctr Lov 5-30uM). Cells were fixed and stained 
for PCNA, to assess percentages of cells in S-phase in the different treatment groups. The line 
indicates the level of PCNA' cells in cycling cells, cultured with 10% FCS alone (Ctr level). 
Data from three separate experiments are expressed as mean+SEM. Columns marked by 
symbols had percentages of PCNA+ cells significantly different from controls (Ctr; one-way 
ANOVA; treatment effect at 24h or 48h; (x=0.05; Statistica 4.5, Windows 1995). 
luM methotrexate were similar (p=0.6; p=0.3) to those found in control groups or 
even higher, when methotrexate was used at the highest concentration (2uM; 
P<0.000 1). 
A significant reduction (p<0.0001) in the percentages of cells in S-phase 
was observed when cells were incubated for 24h with lovastatin, hydroxyurea and 
mimosine (Fig.3.10A). The lowest concentrations were as efficient as the highest 
ones in inducing growth-arrest in groups treated with lovastatin (p>O.l), hydroxyurea 
(p>0.2), and mimosine (p>0.3). The lowest percentages of PCNA cells were 
observed in groups incubated for 24h with 800uM mimosine (1.2±0.2). These 
percentages were not significantly different from those observed in groups treated 
with lovastatin, regardless of the concentration, and with 4mM hydroxyurea. The 
percentages of PCNA found in groups treated with 1mM and 2mM hydroxyurea 
(Fig.3. bA), although significantly lower than those observed in the control group 
(p<0.0001), were higher than those found in cells treated with 800uM mimosine 
(p=0.007, p=0.02). 
Cells treated for 24h with methotrexate had levels of cells in S-phase 
similar, in the 0. luM group (p=0.53), or significantly higher, in the luM (p<0.004) 
and 2uM (p<0.0001) groups, than controls. 
Lovastatin control groups were similar to controls, except for the l5uM 
lovastatin control group (p=0.043). 
All treated cells appeared healthy. Signs of suffering were observed only in 
cells treated with lovastatin. 
Cells cultured for 48h, in the absence of blocking agents (control), had 
significantly lower percentages of PCNA cells than cells cultured for 24h (p<0.03). 
Comparison of treatment groups with the control group, at 48h, gave similar results 
to those observed at 24h (Fig.3. lOB). The lowest percentages of PCNA cells were 
observed in cells treated with 800uM mimosine (0.7±0.0), and these were 
comparable to those observed at 24h (p=0.86). Similar percentages were obtained in 
groups incubated for 48h with 5uM (p=0.3) and 30uM (p=0.1) lovastatin and with 
hydroxyurea, regardless of the concentration (p>0.4). Only percentages observed in 
the 15uM lovastatin group were higher than those found in these treatment groups 
(p=0.047). Similarly to what was observed at 24h, the percentages of cells in S-phase 
were similar to controls, in cells treated with 0. 1 u methotrexate (p=0.2), and higher 
than controls, in cells treated with 2uM methotrexate (p=O.Ol). The percentages of 
PCNA cells in the luM methotrexate group were lower than controls (p<0.0001), 
and similar to those found in control groups treated for 48h, with lovastatin (p=0.2), 
hydroxyurea (p=0.4) and mimosine (p=0.4). 
The percentages of PCNA cells found in lovastatin control groups were 
comparable to those found in control groups cultured for 48h (p>0.06). Cells in the 
lovastatin control and lovastatin treatment groups appeared to be suffering. 
3.3.1.4 Conclusions 
Incubation with blocking agents for 24h was as effective as incubation for 
48h in inducing growth-arrest. Overall percentages of PCNA cells were lower in the 
48h groups compared to the 24h groups. However, at 48h, significant reductions in 
the percentages of PCNA cells were observed in the culture control group whereas 
reductions in the percentages of PCNA cells in treatment groups were similar tot 
hose observed at 24h. Time affects culture but not efficiency of growth-arrest. 
Lovastatin, regardless of concentration, hydroxyurea 4mM, and mimosine 
400 and 800uM, were equally effective in inducing growth-arrest. Appearance of 
suffering signs in lovastatin treated group, suggested possible detrimental effect of 
this chemical. This effect was not mediated by the presence of ethanol, used to 
dissolve this drug, since lovastatin controls, containing ethanol but not lovastatin, 
had no signs of suffering. 
The most efficient and less detrimental growth-arrest in Gi was achieved by 
incubating cells with 4mM hydroxyurea or 400uM-800uM mimosine. 
3.3.2 Absence of quiescence in GI arrested cells 
3.3.2.4 Experimental design 
Dual parameter FACS analysis using Propidium Iodide and FITC was 
carried out on Mouse Foetal Fibroblasts, incubated for 24h in 10% FCS medium 
supplemented with 4mM hydroxyurea. Cells cultured for 24h in 10% FCS were used 
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Figure 3.11 Cell cycle and quiescence markers in cells treated with hydroxyurea 
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Figure 3.11 A-B Mouse Foetal Fibroblasts were cultured for 24h in 10% FCS medium 
alone or supplemented with 4mM hydroxyurea. Serum-starved data were obtained in 
previous experiments are shown here for comparison purposes. Samples were double 
stained with Propidium Iodide and FITC. Propidium Iodide was used to detect cell cycle 
profiles (A), whereas FITC was used as a negative GO marker (B). Data from three 
replicates are expressed as mean±SEM. Percentages within the same cell cycle category 
with different superscripts (A), or columns with the same colour with different symbols 
(B), differ significantly (one-way ANOVA, a0.05). 
Figure 3.12 Cells were gated according to their DNA content: GO/G1 (=2N); S 
(=2N/4N); G2IM (=4N). The proportion of non-quiescent cells (FITC) was assessed on 
gated cells. Results of three replicate experiments are expressed as mean percentages. 
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as a control population of cycling cells. Data were also compared with those obtained 
from cells that had been serum-starved for three days with 0.1% FCS. 
Parameters, acquired in three replicate experiments, included: 
Cell cycle profiles, to asses cell cycle distribution of growth-arrested cells; 
Percentages of apoptotic cells; 
Percentages of cells with protein synthesis (FITC). 
Data were analysed using a one-way ANOVA, with percentages as dependent 
variable and treatment as independent variable (Statistica 4.5, Windows 1995). 
3.3.2.2 Results 
Cells treated with hydroxyurea had significantly lower percentages of cells in S-
phase than cycling cells (p<0.02), similarly to what was observed in serum-starved 
cells (p<O.00l; Fig.3. 1 1A). The percentages of cells in S-phase observed in groups 
treated with hydroxyurea were higher than the percentages observed in serum-
starved cells (p<0.02). In cells treated with hydroxyurea, the percentages of GO/G1 
(=2N) and G2IM (=4N) cells were respectively higher (p=0.002) and lower (p<0.03) 
than those observed in cycling cells (Fig.3.1 1A). 
Apoptosis rates found in cells cultured for 24h with 10% FCS and 4mM 
hydroxyurea were higher than those found in cells cultured with 10% FCS medium 
alone (p=0.03) and higher than those found in serum-starved cells (p=0.03). 
The percentages of FITC cells found in the group treated with hydroxyurea 
were 20-fold higher than those observed in serum-starved cells (p<0.0001; 
Fig.3.1 1B). The percentages of FITC cells in the hydroxyurea (p=0.007)  and the 
serum-starved groups (p<0.0001) were both significantly lower than those observed 
in cycling cells (Fig.3. 1 1B). The percentages of FITC cells found in the diploid cell 
population (gate on GO/G1 cells) of the hydroxyurea treated cells (88.1±2.8%), were 
similar to those observed in cycling cells (95.9±1.3%; p=0.13). 
Mean fluorescence of cells treated with hydroxyurea, considered both as a 
whole cell population (337±14) and as a diploid population (302±14), were higher 
than those found in serum-starved cells (168±36; p<O.00S;  129±23; p<0.002) and 
similar to those found in cycling cells (309±7; p=0.5; 256±15; p=0. l8). 
Almost 100% of FITC cells found in the hydroxyurea group, were diploid 
(Fig.3. 12). In the hydroxyurea treatment group, 77±2.2% of the cells were diploid, 
and, of these, 88.1% were FITC (G 1) and 11.9% were FITC (GO). 
3.3.2.3 Discussion 
Cell cycle analysis confirmed the growth-arrest state of cells synchronized 
with hydroxyurea. However, the hydroxyurea block was less effective than serum 
starvation in reducing the percentages of cells in S-phase. In cells treated with 
hydroxyurea, the decrease in the percentages of cells in S-phase was associated with 
a decrease in cells in G2/M, and an increase of cells in GO/Gi-phase. This situation is 
different from the one observed in serum-starved cells, where the decrease in cells in 
S-phase was associated with an increase in cells in G2/M, while the percentages of 
diploid cells remained unchanged. 
The higher apoptosis rates observed in cells incubated with hydroxyurea 
suggested that this treatment was more detrimental than synchronization by serum 
starvation. 
Unlike serum starvation, growth-arrest by hydroxyurea did not significantly 
affect much the state of activity of synchronized cells. The percentages of FITC 
cells in the hydroxyurea groups were 20-fold higher than those found in serum-
starved cells. These percentages were lower (66.9%) than those found in cycling 
cells (84.1%), suggesting that hydroxyurea treatment might be associated, in about 
20% of the cases, with a reduction in cell activity (quiescence). However, the 
percentages of diploid cells with active protein synthesis (GI) were as high as those 
found in cycling cells. The ability of hydroxyurea to induce growth-arrest in the 
absence of quiescence was also confirmed by the fact that the hydroxyurea treatment 
did not affect the levels of protein synthesis/cell (FITC mean fluorescence), unlike 
serum starvation where protein synthesis levels were also reduced. Most of the 
FITC cells found in the HU treatment groups were diploid, possibly as a result of 
the overall increase of diploid cells observed in these groups. 
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3.3.2.4 Conclusions 
The high levels of diploid cells (GO/G1) obtained with hydroxyurea 
treatment, associated with the high percentages of GI cells (88.1 % of GO/GI 
population), make this synchronization method ideal to produce a well-characterised 
GI population of Mouse Foetal Fibroblasts. The only drawback was represented by 
the high rates of apoptosis induced by treatment with 4mM hydroxyurea for 24h. 
More detailed titration assays and improvements in the culture conditions (medium, 
02 tension) might reduce this problem. 
CHAPTER 4 
T-LYMPHOCYTES AS A SOURCE OF Gi 
KARYOPLASTS 
4.1 INTRODUCTION 
Cell models used to compare developmental potential of GO and Gi 
karyoplasts, after transfer to a recipient MIT oocyte, should have two main features: 
1) exist in a well-characterised GO and GI state; 2) have potential for nuclear 
transfer. 
T-lymphocytes possess both these features, therefore they represent a good 
cell candidate for this study. Quiescent blood cells have been previously used for 
nuclear transfer experiments in amphibians, cattle and mouse. In a pioneering work 
carried out in amphibians, transfer to recipient MIT oocytes of frog erythrocytes, that 
are nucleated and arrested in a terminally differentiated GO state, resulted in 
development to a further stage (feeding tadpoles) than that previously reached using 
other types of adult somatic and germ cells (DiBerardino et al., 1986). In mouse it 
was demonstrated that nucleated GO erythrocytes, isolated from 12-day foetuses, 
which have a condensed chromatin and have low levels of transcription, undergo 
chromatin remodelling and resumption of transcription after NT (Szöllosi et al., 
1998). Similar experiments were carried out using mouse thymocytes (Szöllösi et al., 
1986a; 1986b; 1988; Czolowska et al., 1984; 1986). More recently mouse 
lymphocytes, isolated from the thymus, the spleen and the peritoneal cavity, after 
injection into enucleated MIT oocytes, were able to support pre and post-implantation 
development to the foetal stage, though no development to term was reported 
(Wakayama and Yanagimachi, 2001). Development to blastocyst was only 3.1% for 
thymocytes, 21-22% for spleenocytes and 23-31% for cells isolated from the 
peritoneal cavity, identified as macrophages. Implantation rates were 0% for 
thymocytes, 75-91% for spleenocytes, 50-76% for macrophages (Wakayama 
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Yanagimachi, 2001). No development to term was observed with all three cell types. 
Ability of lymphoid cells to support development to term, after transfer to Mu 
oocytes, has been since proved by two separate experiments: an experiment where a 
calf was cloned from peripheral blood pan lymphocytes (Galli et al., 1999); an 
experiment in mouse where development to term was obtained from T and B-
lymphocytes (Hochedlinger and Jaenish, 2002). 
In addition to their potential for nuclear transfer, T-lymphocytes have the 
advantage of existing in a well-defined GO and Gi state. T-cells, are naturally 
quiescent at isolation, but can be induced, by mitogenic stimuli, to leave the GO state 
and re-enter the cell cycle in GI, through a process known as T-cell activation. The 
cell cycle of T-cells, compared to that of other somatic cell types, has three features 
that make them particularly interesting for this study: 1) activation of T-cells is an 
orderly sequence of well known, interdependent events, that can be easily 
manipulated in order to block T-cells in GI; 2) T-cells have a prolonged Gi phase 
(24-30h) compared to that of other somatic cells, which represents a further 
advantage for synchronization in GI; 3) the expression, during T-cell activation, of 
surface markers, that can be used as negative markers of cell quiescence and, 
therefore, to discriminate between GO and G  cells. 
The activation of T-cells takes place in two stages, regulated by different 
stimuli and different signal transduction pathways (Ajchenbhaum et al., 1993): 
A "competence-phase", during which T-cells respond to a primary signal 
(mitogens, e.g. PHA, ConA) undergoing GO/GI transition and becoming 
capable (competent) of responding to a second exogenous signal (IL-2) and 
to proliferate; 
A "the commitment-phase", during which T-cells respond to a second signal 
(lymphokine, e.g. IL-2), undergoing GuS transition and becoming 
committed to progress through DNA replication even in the absence of any 
further stimulation by mitogenic factors. 
These two stages of T-cell activation are characterised by quantitative as well as 
qualitative differences in signal transduction (Ajchenbhaum et al., 1993), in 
particular in patterns of activity of mitogen dependent kinases (MAPK). Stimulation 
of the T cell receptor (TcR) results in induction of the "competent state", that is 
W. 
associated with the following molecular events (Fig.4.2): calcium mobilisation; 
protein kinase C (PKC) dependent internalisation of CD3; translocation of AP- 1 
transcription factors to the nucleus; expression of immediate early genes, within the 
first 3-6h following T-cell activation (c-fun, c-fos, CD25); activation of GI phase 
cyclin-dependent kinases (Cdk4, Cdk6), by increased synthesis of Cdk4 and Cdk6 
and by increased synthesis of cyclin D2, with which they form the cyclin D2/Cdk4 
and cyclin D2/Cdk6 complexes, necessary for G 1 progression. In T-cells cycling Dl 
is not expressed and cyclin D3 is expressed during the commitment-phase, and 
mainly acts as a sink for the sequestration of p27 K1P1 , an inhibitor of Cdk2, the main 
regulator of GuS and S-phase progression (Ajchenbaum etal., 1993). 
Stimulation of the interleukin receptor alpha (IL-2-RA) or CD25 induces a 
cascade of signals, leading T-cells to proliferate (Fig.4.2): sustained translocation of 
AP-1 transcription factors to the nucleus; increased expression of early GI genes (c-
fun, c-fos, CD25) and expression of new genes such as c-myc and IL-2, which further 
increases CD25 expression; activation of GuS and S-phase cyclin-dependent kinases 
(Cdk2), by increased synthesis of GuS (cyclin E, cyclin A) and S-phase (cyclin A) 
cyclins and inactivation of Cdk2 inhibitors, such as p27 KIP1  by ubiquitinization and 
sequestration by cyclin D3 (Ajchenbaum et al., 1993). 
In mature T-cells the primary signal for activation is triggered by antigen 
through the interaction of the T cell receptor and CD3 (TcR.CD3) complex. 
Antigenic stimulation can be mimicked by a variety of compounds including 
mitogenic lectins, such as Concanavalin A (ConA) or phytohemagglutinin (PHA) 
(Kimura and Ersson, 1981), by antibodies directed against components of the 
TcR.CD3 complex (Geppert and Lippsky, 1987) or by a combination of phorbol 12-
myristate 13 acetate (PMA), a protein kinase C activator, and the calcium ionophore 
ionomycin (Truneth et al., 1985). These activating agents will initially stimulate the 
TcR.CD3 complex, leading to GO/G1 transition and CD25 expression (competence-
phase; Fig.4.1), and then induce IL-2 production, which not only drives T-cell 
proliferation but also further increases the levels of CD25 expression (commitment-
phase, Fig.4.1). Stimulation of CD25 by autocrine IL-2 finally triggers GUS 
transition and DNA synthesis completing the transformation of T-lymphocytes from 
resting (GO) cells to cycling cells (for reviews see Erard et al., 1984; Malek and 
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Figure 4.2 T-cell activation: molecular markers 
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Figure 4.1 and 4.2 show cellular and molecular events of T-cell activation. T-cell activation is a two-step process: a competence—phase, triggered 
by mitogens (e.g. PHA, PMA+Ionomycin, ConA, anti-CD3) during which cells re-enter the cell cycle; a commitment-phase, during which cells 
become committed to initiate DNA replication, as a result of IL-2 and IL-2Ra interaction. The competence-phase is characterised by: CD25 
expression, in the absence of DNA replication (Fig.4.1) and molecular events that regulate GO-GI transition (Fig.4.2). The commitment-phase is 
characterised by: reinforced CD25 expression, release of endogenous 1L2, DNA replication (Fig.4. 1) and molecular events that regulate G 1/S 
transition (Fig.4.2). 
Ashwell, 1985; Bismuth et at., 1985). However this cascade of events can be 
manipulated in order to obtain T-cells synchronized in Gi. Two strategies can be 
used to synchronize T-cells in Gi, enabling them to leave their quiescent state (GO) 
without reaching the cycling state: 
Activate T-cells with submitogenic concentrations (e.g. 0.5-0.8ug/mi PHA 
for human T-cells) of activating agents (Modiano et at., 1999; Firpo et at., 
1994; Proust et at., 1991); 
Activate T-cells with mitogenic concentration of growth factors (e.g. 8- 
lOug/mi PHA for human T-cells) in the presence of GUS blocking agents, 
such as hydroxyurea (Adams et at., 1967, Kim et at., 1992; Ajchenbaum et 
at., 1993). 
The first strategy relies on the fact that the intensity of the primary signal 
can determine whether T-cells will re-enter the cell cycle and become arrested in the 
Gi-phase or progress through the restriction point "R", at the GUS transition, and 
undergo DNA replication. Although most of the molecular and cellular events that 
occur following T-cell activation are directly proportional to the concentration of 
ligand as well and the density of ligated receptors, the induction of other key events 
appears to take place in a "all or none" fashion and only when an activating threshold 
is surpassed. Induction of endogenous IL-2, which, by interaction with CD25, 
triggers GUS progression and DNA replication, belongs to the latter group. This 
means that concentrations of activating agents below this threshold (submitogenic 
concentrations) will be enough to induce GO/G1 transition (competence), but not 
enough to induce production of autocrine IL-2, therefore, not enough to induce cell 
cycle progression, unless exogenous IL-2 is added (Modiano et at., 1999). 
The threshold between submitogenic and mitogenic concentrations is 
influenced by many factors and varies with the type of mitogen used, the batch of 
mitogen, the species considered. The mitogenic concentration must be tested under 
each experimental condition, by titrating the activating agent. 
A second method to synchronize T-cells in Gi is to stimulate them with 
mitogenic concentrations of activating agents, in the presence of GUS blocking 
agents, like hydroxyurea (Adams et at., 1967, Kim et at., 1992; Ajchenbaum et at., 
1993). The addition of hydroxyurea (HU) inhibits DNA replication from taking place 
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but it does not interfere with the activation process in itself, which represents the 
mechanism leading to DNA replication. In mouse it has been shown that addition of 
HU does not alter the expression of cell cycle regulators such as cyclin D2, cyclin D3 
and cyclin E, responsible for GI and G/S progression and only marginally reduces 
the synthesis of cyclin A which is responsible for S-phase progression, while 
maintaining the percentages of cells in S-phase below 5% (Ajchenbaum et al., 1993). 
The interleukin-2 receptor alpha (IL-Mc) or CD25 can be used to 
discriminate between GO and GI cells (Fig.4.1). The interleukin-2 receptor (IL-2R) 
is formed by three transmembrane proteins called IL-2Ra, IL-2R13 and IL-2Ry or Yc 
chain (Minami et al., 1993; Waldman, 1989). These subunits combine to give three 
classes of IL-2R (Soldaini et al., 1995): low affinity receptors formed only by the IL-
2Rct chain (p55), devoid of signalling ability; intermediate affinity receptors, that are 
IL-2Ry and IL-2R3 heterodimers (p75), required for signalling transduction; the high 
affinity receptor, formed by a combination of IL-2Rct, IL-2Ry and IL-2R3 chains 
(p55/p75), responsible for the IL-2-driven T-cell proliferation. While the yC chain is 
constitutively expressed in all mature T-cells and their thymic precursors (Cao et al., 
1993), and the IL-2R3 chain is expressed in some resting T-cells (Tanaka et al., 
1991), the IL-2Ra is undetectable in resting T-cells but is efficiently induced upon 
T-cell activation as cells enter the Gi-phase, becoming the key regulator of IL-2 
responsiveness, at the time of GuS transition (Robb et al., 1981; Fig.4.1). For this 
reason the IL-2Ra can be used as a marker to discriminate between GO cells, which 
do not express it, from GI cells, which start expressing it in response to TcR.CD3 
complex stimulation by mitogens. Expression of IL-2Ra or CD25 can be used 
together with DNA content, incorporation of tritiated thymidine ([3H]-thymidine) 
into DNA, the expression of cell cycle specific markers (p27 1 , cyclin D3) to assess 
the cell cycle stage of T-cells. 
4.2 ISOLATION AND ACTIVATION OF T-CELLS 
FROM DIFFERENT LYNPHOID TISSUES 
4.2.1 Aim 
These experiments were aimed at selecting a lymphoid tissue that gave T -
lymphocytes that could be: 
Activated, with mitogenic concentration of activating agents; 
Synchronized in Gi, with sub-mitogenic concentrations of activating agents. 
(Firpo et al., 1994; Modiano et al., 1999). 
Apoptosis rates in different lymphoid tissues were also compared. 
4.2.2 Experimental design 
All data were collected in three separate experiments. 
Lymphocytes were isolated from six-week-old, female, CBAICa inbred 





In each experiment, lymphoid tissues were collected from two animals and pooled 
together, to reduce individual variability. 
Cells were synchronized in GI and activated using the lectin 
Phytohemagglutinin (PHA) and a protocol previously described for human 
lymphocytes (Firpo et al., 1994). Treatment groups included: 
Freshly isolated cells (CtrOh); 
Cells cultured for 48h in 10% FCS culture medium (formulation at A.2.1; 
Ctr48h); 
Cells cultured for 48h in 10% FCS culture medium, supplemented with 
0.8ug/ml, to induce a sub-mitogenic level of activation (P0.8); 
Cells cultured for 48h in 10% FCS culture medium, supplemented with 
8ug/ml PHA and 4nM exogenous IL-2 (P8/IL); 
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5) 	Cells cultured for 48h in 10% FCS culture medium, supplemented with 
16ug/ml PHA, and 4nM exogenous IL-2 (P16/IL); 
Cells in treatment groups 1 and 2 corresponded respectively to fresh and cultured 
quiescent cells. Cells in treatment group 3 represented putative GI cells. Cells in 
treatment groups 4 and 5 represented cycling cells. 
Putative Gi cells were stimulated with sub-mitogenic concentrations of 
PHA (0.8ug/ml), high enough to induce TcR stimulation, resulting in CD25 
expression and GO/G1 transition, but not high enough to induce production of 
endogenous IL-2 and IL-2/CD25 interaction, necessary for GUS transition and DNA 
replication (Firpo et at., 1994). Cycling cell populations were stimulated with 
mitogenic concentrations of PHA (8-16ug/ml), that induce full T-cell activation, 
resulting in CD25 over expression, IL-2 production, and, as a result of CD25 
stimulation by endogenous and/or exogenous IL-2, G1/S transition and DNA 
replication (Firpo et at., 1994). 
For each tissue, about 2-4x10 6 cells were allocated to treatment group 1 
(CTRO), and processed immediately. Cultured cells were seeded at a concentration of 
1x106/ml/well, in 24 well plates, and two wells were allocated to each treatment 
group (2-5). After 48h incubation at 37°C, 5% CO2, cells from 2 wells belonging to 
the same treatment were pooled together, counted, and processed for flow cytometry 
for the following staining (for Methods see paragraph 2.9): 
CD3-FITC/CD25-R-PE 
CD3-FITC/PI 
In these experiments only live cells expressing CD3 (T-lymphocytes) were 
included in the CD25 and P1 analysis (live/CD3 gate; see Paragraph 2.10.2). This 
was done to: prevent apoptotic cells from interfering with the analysis; prevent 
fluctuations in T-cell percentages, among the different lymphoid tissues, from 
interfering with the analysis. 
The following parameters were acquired (see Paragraph 2.10.2): 
1) 	For CD25 staining (live/CD3 gate): 
Percentage of CD25 cells; 
Mean fluorescence levels. 
2) 	For P1 staining: 
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Percentage of apoptotic cells (all cells gated); 
Cell cycle profile (live/CD3 gate), that included: 
Percentage of cells in GO/G1-phase; 
Percentage of cells in S-phase; 
Percentage of cells in G2IM-phase. 
4.2.3 Statistical Analysis 
Data were transformed as follows: percentages (%CD3, %CD25, %G0/Gl, 
%S, %G2/M) by Logit transformation; mean fluorescence data by Log 
transformation (GenStat 4.21, Windows 2000). Treatment and tissue were used as 
independent variables and data were analysed by two-way ANOVA (Statistica 4.5, 
Windows 1995) with an alpha level for critical ranges of 0.05, considering: 
• 	Tissue, as main effect, regardless of treatment; 
• 	Treatment, as main effect, regardless of tissue; 
• 	Treatment and tissue interaction. 
Significant effects were further broken down by using a Least Significant 
Difference (LSD) test or planned comparison (Post-Hoc comparison test), to identify 
the specific source of variance (i.e. specific tissue or specific treatment or specific 
tissue at a given time). Where specified, a one way-ANOVA was used, on selected 
cases, to confirm the LSD results, considering only selected cases for the treatment 
or tissue variable. To discriminate a possible culture effect from the treatment effect, 
for each dependent variable, selected cases were included in the analysis in order to 
assess: 
Culture effect, comparing only treatment group 1 (Ctr0h) and 2 (Ctr48h) in 
the various tissues; 
• 	Effect of treatment on cultured cells, comparing treatment groups 2-5, in the 
various tissues. 
A one-way ANOVA was used to analyse the percentage of T-lymphocytes (CD3) 
found in the different lymphoid tissues. 
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Figure 4.3 Percentages of apoptotic cells were assessed by Propidium Iodide staining and FACS 
analysis. Cells were stained at isolation (Ctr0h) or after culture for 48h with: medium (Ctr48h); 
0.8ug/ml PHA (P0.8); 8ug/ml PHA and 4nM IL-2 (P8/IL); 16ug/ml PHA and 4nM IL-2 (P16/IL). 
The groups Ctr0h and Ctr48h corresponded respectively to fresh and cultured GO cells. Results 
from three replicate experiments are expressed as mean percentages±SEM. Figure 4.4 Apoptosis 
rates were assessed in cells cultured for 48h under the same conditions described in Figure 4.3, but 
in the presence of 2-mercaptoethanol. Data were collected in a single experiment. 
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4.2.4 Results 
Culture for 48h, in the absence of activating agents, dramatically increased 
(time, p<0.001) the percentage of apoptotic cells (Fig.4.3). 
The percentages of apoptotic cells remained equally high, in cultured cells, 
regardless of the treatment conditions (treatment, pz0.86; Fig.4.3). The highest 
apoptosis rates were observed, in all tissues, when cells were stimulated for 48h with 
l6ug/ml PHA in the presence of 4nM IL-2 (group P16/IL). The overall rate of 
apoptosis in culture, under the different conditions, differed among tissues (tissue, 
p=0.03). The death rate observed in thymocytes (range, 76%-83%) was significantly 
higher than that observed in cells isolated from the lymph nodes (range, 59%-65%, 
p<0.005) and the spleen (range, 63% to 70%, p<0.05). The lowest rate of apoptosis 
was observed in cells from lymph nodes (Fig.4.3). 
Apoptosis rates were reduced, in all treatment groups, by addition of the 
anti-oxidant 2- mercaptoethanol (Fig.4.4). 
Culture for 48h (Fig.4.5, A-B), in the absence of activating agents, had no 
effect on the percentage of CD25 cells and the mean fluorescence intensity (time, 
p=0.60 and p=0.18). This applied to all tissues (tissue, p>OA). 
In all the tissues (tissue, p=0.17), the percentages of CD25 cells and values 
of mean fluorescence intensity increased significantly in the presence of activating 
agents (treatment, p<0.001).  Cells treated with 0.8ug/ml PHA (P0.8) had percentages 
of CD25 cells and mean fluorescence intensity similar to those observed in the 
absence of activating agents (Ctr48h), therefore in GO cells (p=0.6 for %CD25; 
p=0.76, for mean fluorescence). Incubation for 48h with 8ug/ml or 16ug/ml PHA and 
4nM IL-2 (P8/IL; P16/IL) increased the percentages of CD25 cells (p<0.001) and 
the mean fluorescence intensity (p<O.00l). No significant difference was observed in 
the level of expression of CD25 in T-lymphocytes stimulated with 8ug/ml or 
l6ug/ml PHA and 4nM IL-2 (CD25%, p=042; mean fluorescence p=76). 
Culture for 48h (Fig.4.6A) reduced the percentages of diploid cells (GO/Gi) 



















Figure 45 Effect of treatment on the expression of CD25 in T-lymphocytes from 










Cells were stained for CD25 and processed for FACS analysis at isolation (CtrOh), or after 
culture for 48h with: medium (Ctr48h); 0.8ug/ml PHA (p0.8); 8ug/ml PHA and 4nM IL-2 
(P8/IL); 16ug/ml PHA and 4nM IL-2 (P16/IL). The groups CtrOh and Ctr48h corresponded 
to fresh or cultured GO cells. Expression of CD25 was assessed as percentage of CD25 
cells (A) and as mean fluorescence intensity of CD25 cells (CD25Icell; B). Data, collected 
in three replicates, are summarised as mean values±SEM. 
109 












ctrOh 	ctr48h  
ln~ 







ctr0h 	ctr48h 	P0.8 	MIL 	P16\IL 
Treatment 
Cell cycle analysis of cells stained with Propidium Iodide (P1) and processed for FACS 
analysis, at isolation (CtrOh) or after culture for 48h with: medium (Ctr48h); 0.8ug/ml PHA 
(p0.8); 8ug/ml PHA and 4nM IL-2 (P8/IL); l6ug/mI PHA and 4nM IL-2 (P16/IL). The 
groups CtrOh and Ctr48h corresponded to fresh or cultured GO cells. Data, collected in three 
replicates, are summarised as mean percentages±SEM. 
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diploid cells was investigated more in detail using the LSD test and a one-way 
ANOVA. The LSD test revealed that the source of variability, detected between Oh 
and 48h, using time as main effect, was the significant difference in the percentage of 
diploid cells observed in the lymph nodes, at time 0, and that found in the spleen 
(p=0.19) and the thymus (p=0.12), at 48h. However no significant difference was 
detected, in each tissue, before and after culture for 48h. A one-way ANOVA, 
considering one tissue at a time and only time as an independent variable, confirmed 
this observation in the lymph nodes (p=0.20) and, to a lesser extent, in the spleen 
(0.054), although it showed a significant decrease in the percentage of diploid cells in 
the thymus (p=0.028). 
Cells isolated from the lymph nodes had percentages of diploid cells higher 
than those found in cells isolated from the thymus and the spleen, both at isolation 
(CtrOh) and after 48h (Ctr48h) in culture (spleen, p=0.02; thymus, p=0.03). 
The decrease observed in the percentage of diploid cells in culture, was 
associated with an increase in the percentage of cells in S-phase (Fig.4.6B) and 
G2IM-phase (Fig.4.6C), but only the latter was significant (time, p=0.033). A more 
detailed one-way ANOVA, restricting the analysis to one tissue at a time and using 
only time as an independent variable, confirmed that the increase in S-phase cells 
was minimal and not significant in the lymph nodes and spleen (p=0.22), and was 
greater and significant in the thymus (p=0.049). The effect of culture on the 
percentages of cells in S-phase was mediated by the tissue of origin (tissue, p=0.04). 
The LSD test, with tissue as a main effect, showed that cells coming from the lymph 
nodes had lower percentage of S-phase cells than cells isolated from the thymus and 
the spleen, both at isolation (p<0.04) and after 48h in culture (p=O.Ol). These data 
were also confirmed by a one-way ANOVA, considering one time point at a time and 
using tissue as an independent variable. 
The percentages of G2/M cells increased in all tissues as a result of culture 
(time, p=0.035; tissue, p=O.l6). When the effect of time was analysed more in detail 
using a one-way ANOVA, considering each tissue separately and time as an 
independent variable, the rate of increase in the percentages of cells in G2IM was 
found to be lowest and not significant in the lymph nodes, higher but still not 
significant in the thymus (p=0.06) and highest and significant in the spleen 
111 
(p<O.00l). T-cells isolated from the lymph nodes had lower percentages of G2IM 
cells at isolation and lower percentages after 48h in culture, compared to the spleen 
and the thymus. 
Treatment (Fig.4.6A) significantly affected the percentage of G0/G1 cells 
(treatment, p<0.001) in a tissue specific manner (tissue, p<0.001). The LSD test, 
considering treatment as a main effect, showed that the percentages of cells in G0/G1 
were not affected by the addition of 0.8ug/ml PHA (P0.8; p=0.93), but were 
significantly reduced by addition of 8ug/ml (P8/IL) or 16ug/ml PHA (P16/IL) and 
4nM IL-2 (p<0.001).  The LSD test, considering tissue as a main effect, showed 
tissue-specific differences (p<O.00l). The percentage of GO/GI cells decreased only 
in the lymph nodes (p<O.00l), while it remained unchanged in the thymus and the 
spleen (p>O.l). 
The effect of treatment on the percentages of T-lymphocytes in G2/M and 
S-phase (Fig.4.6 B-C) was similar to that observed for GO/G1 cells. Both cell cycle 
stages were affected by treatment (p<0.001) and tissue of origin (p<0.001). In the 
lymph nodes the percentages of T-lymphocytes in S and G2/M-phase, were not 
affected by addition of 0.8ug/ml PHA (p=0.8; p= 0.1), but they increased 
significantly after the addition of higher concentrations of PHA (p<0.001). There was 
no significant difference in the percentages of T-cells in S (p=0.55) and G2IM-phase 
(p=0.31) between groups stimulated with 8ug/ml PHA (P8/IL) or l6ug/ml PHA 
(P16/IL), in the presence of IL-2. In T-lymphocytes isolated from spleen and thymus, 
the percentages of T-cells in G2JM and S-phase were not affected by treatment 
(p>0.09), and were as high as those observed in the Ctr48h and P0.8 groups. The 
percentages of cells in G2IM and S-phase in observed in activated cells from the 
thymus and the spleen, were significantly higher than those observed in the lymph 
nodes in the Ctr48h and P/0.8 groups, and similar to those observed in the lymph 
nodes in the P8/IL and P16/IL groups, after activation. 
4.2.5 Conclusions 
High rates of apoptosis were observed in culture, in all tissues, regardless of 
the treatment and the tissue of origin, showing the extreme fragility of murine T- 
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lymphocytes. Addition of 2-mercaptoethanol proved to be essential in reducing death 
rates of mouse T-lymphocytes. 
Shifts in the expression of CD25 were not influenced by culture, in the 
absence of mitogens, but only by culture with activating agents. This observation 
confirmed the strict correlation existing between the expression of this marker and 
the activation state of T-cells. 
The results of these experiments demonstrated that the lymph nodes 
represented the best source of T-lymphocytes to use in this project, because they had 
the following features: 
Consistently lower apoptosis rates, even in the absence of 2-ME; 
Better level of synchronization in GO at isolation, with higher percentages of 
GO/GI cells, and lower percentages of cells in G2IM and S-phase than those 
found in the thymus and the spleen, associated with low levels of CD25 
expression; 
Quiescence of T-lymphocytes was not perturbed by culture, in the absence 
of mitogens, while culture altered the cell cycle profile of T-cells from the 
spleen and the thymus, decreasing the percentages of cells in GO/G1 and 
increasing the percentages of cells in S and G2/M; 
T-lymphocytes isolated from the lymph nodes responded better to 
activation, with a perfect correspondence between the changes observed in 
the cell cycle profile (decrease in GO/Gi cells, increases in S and G2IM 
cells) and the increase observed in the level of expression of CD25. No 
changes were observed in the cell cycle profile of T-cells from the thymus 
and the spleen, during activation, possibly because it was impossible to 
discriminate the effect of culture from the effect of activation. 
Lymph nodes gave a pure population of T-cells (Paragraph 2.7) that did not 
require a further purification step with depletion of CD3 cells. 
Lower concentrations of PHA (0.8ug/ml) were unable to induce GO-Gi 
transition in mouse T-cells, as suggested by the absence of CD25 expression. This 
concentration had been previously used to synchronize human T-cells in GI. 
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However these results indicated that synchronization of mouse T-cells in GI had to 
be achieved with other PHA concentrations or other synchronization methods. 
Culture for 48h with 8ug/ml PHA was able to induce maximal T-cell 
activation, as indicated by the significant increase observed in the expression of 
CD25, in association with a significant reduction in the percentage of GO/G1 cells 
and a significant increase in the percentages of cells in S and G2/M. No further 
increases in the activation state was observed at higher PHA concentrations, 
suggesting that, at this concentration, cells had reached an activation plateau. This 
activation protocol was selected for other experiments, considering that maximal 
apoptosis rates had been consistently observed, in all tissues, when cells were 
stimulated with 16ug/ml PHA. 
4.3 SYNCHRONIZATION OF T-LYMPHOCYTES IN 
Gi BY PHA TITRATION 
4.3.1 Aim 
The previous experiment failed to produce Gi cells by using submitogenic 
concentrations of PHA, 0.8ug/ml, that had been previously used to synchronize 
human T-cells in G  (Modiano et al., 1999; Firpo et al., 1994; Proust et al., 1991). 
The aim of this experiment was to use PHA titration, in the presence or 
absence of IL-2, to find the submitogenic conditions at which mouse T-cells start 
expressing activation markers, in the absence of DNA replication (GO/G1 transition). 
Cells synchronized in GI would be characterised by percentages of CD25 cells and 
levels of CD25 expression significantly higher than those observed in quiescent cells 
and similar to those found in activated cells. They would also have high percentages 
of GO/G1 cells, with a diploid content of DNA (2N), similar to those found in 
quiescent cells and significantly higher than those found in activated, cycling cells. 
They should also have low percentages of cells in S-phase (2/4N) and G2IM phase 
(4N), similar to those found in GO populations, and significantly lower than those 
found in activated cycling cells. Data reported in the literature (Firpo et al., 1994; 
Modiano et al., 1999) have shown that human T-cells, stimulated with submitogenic 
concentrations of PHA (0.5-0.8ug/ml) have 96% of the cells in GO/Gi, only 1-3% of 
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the cells in S and G2/M, and 12-15% of the cells expressing CD25 (CD25). These 
cells can be considered in GI because they have the same cell cycle profile as 
quiescent cells, cultured in medium alone, with similar high percentages of GO/Gi 
cells (97%) and low percentages of cells in S (3%) and G2IM-phase (0%). They also 
have percentages of CD25 cells (12-15%) higher than those found in cultured 
quiescent cells (<3%), though lower than those observed in fully activated T-cells 
(80%-90%). 
4.3.2 Experimental design 
Data were collected in three separate experiments. 
For each replicate, cells were isolated from the lymph nodes of four, 
CBA/Ca, 6 week old, female mice. For each experiment cells from each animal were 
pooled together, counted and assigned to various treatment groups. For each 
treatment group three sets of data were collected: data from the FACS analysis; data 
from the [ 3H]thymidine incorporation assay; cell counts. For each replicate 4x10 6 
freshly isolated cells, were resuspended in medium containing only 10% FCS, 
processed and stained immediately for FACS analysis. This was considered as 
treatment group 1), containing freshly isolated quiescent cells (GO). The remaining 
cells were seeded at a concentration of 2x10 6/well in 24 well plates, assigning 1 
well/treatment group for the FACS analysis and the cell counts, or O.2x10 6/well in 96 
well plates, assigning 3 wells/treatment group for the [3H]incorporation  assay. All the 
cells were cultured for 48h, at 37°C, 5% CO2 in air, under the following treatment 
conditions: 
Medium with 10 % FCS, considered as cultured quiescent cells (P0); 
Medium with 10 % FCS, lug/ml PHA (P1); 
Medium with 10 % FCS, 2ug/ml PHA (P2); 
Medium with 10 % FCS, 4ug/ml PHA (P4); 
Medium with 10 % FCS, 8ug/ml PHA (P8); 
Medium with 10 % FCS, l6ug/ml PHA (P16); 
Medium with 10 % FCS, Oug/ml PHA and 4nM IL-2 (P0/IL); 
Medium with 10 % FCS, lug/mi PHA and 4nM IL-2 (P1/IL); 
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Medium with 10 % FCS, 2ug/ml PHA and 4nM IL-2 (P2/IL); 
Medium with 10 % FCS, 4ug/ml PHA and 4nM IL-2 (P4/IL); 
Medium with 10 % FCS, 8ug/mI PHA and 4nM IL-2 (P8/IL); 
Medium with 10 % FCS, l6ug/ml PHA and 4nM IL-2 (P16/IL). 
For detailed Media composition see A.2.1, A.2.3, A.2.4. At the end of the 
incubation period, cells from each treatment group that had been cultured in the 24 
well plates, were harvested, counted, divided into samples for FACS analysis (for 
Methods see Paragraph 2.9) and stained for: 
• 	CD3-FITC/CD25-R-PE 
• 	CD3-FITC/PI 
Gates and parameters acquired were as described at paragraph 4.2.1. 
For the [3H]thymidine  incorporation assay cells were frozen at —20°C and 
processed by liquid scintillation (for Methods see Paragraph 2.7). 
4.3.3 Statistical Analysis 
Data, categorised in the different dependent variables were transformed as 
follows: percentages (%CD25 cells, %G0/G1-phase cells, %S-phase cells, %G2/M-
phase cells) by Logit transformation; mean fluorescence data and counts per minute 
(cpm) by Log transformation (GenStat 4.21, Windows 2000). Data from FACS 
analysis (%CD25 cells, %G0/G1-phase cells, %S-phase cells, %G2/M-phase cells, 
mean fluorescence) were analysed using the program Statistica 4.5 for Windows 
1995, with an alpha level for critical ranges of 0.05, to perform a one-way and a two-
way ANOVA, on selected groups. 
The two-way ANOVA was carried out on groups 2-13, considering PHA 
and IL-2 as independent variables and analysing: 
PHA concentration as main effect, regardless of IL-2 presence or absence 
• 	IL-2, presence or absence, as main effect, regardless of PHA concentration 
• 	PHA x IL-2 interaction, to assess a possible synergic effect of these two 
factors 
Significant effects were further broken down by using a LSD test or planned 
comparison (Post-Hoc comparison test) to identify the specific source of variance 
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(e.g. specific PHA concentration, presence or absence of IL-2, specific concentration 
of PHA with or without IL-2). 
A one-way ANOVA and a LSD test were used on groups 1-13, considering 
only treatment group as an independent variable to compare the quiescent state of 
freshly isolated cells (group 1, GO) with that of: 
Quiescent cells cultured for 48h without mitogens (group 2, P0), to confirm 
that culture in itself did not affect the quiescent state and that P0 cells could 
be used as a good control of cell quiescence with which to compare 
activation state of cultured groups; 
All the other treatment groups (groups 3-13), the ones containing GI cells in 
particular, to see how their activation state differed from that of freshly 
isolated quiescent cells and to identify the specific source of variance (e.g. 
specific treatment). 
Data from the [ 3H]thymidine incorporation assay were analysed using a 
Nested Analysis of Variance (GenStat 4.21, Windows 2000), using the following 
structure: 
	
1) 	Block Structure: block/wells/IL-2/PHA, where: 
Blocks, corresponded to experiments 1-3; 
Wells, corresponded to wells 1-3; 
IL-2, corresponded to groups with or without IL-2; 
PHA, referred to PHA concentrations 0-l6ug/ml. 
2) 	Treatment structure (IL-2 x PHA), considering: 
IL-2 as main effect, regardless of PHA; 
PHA concentration as main effect, regardless of IL-2 presence; 
IL-2 and PHA interaction. 
At each level of analysis, differences between specific groups of interest were 
assessed using a Student's T-test for the difference in means, with an alpha level of 
0.05: 
t =(meanl-mean2)/SE (mean l-mean2) 
using the means values and the standard error of the difference in means (SED), 




An average of 7.3x106 total cells/animal were collected, of which about 
86.5±7.4%, corresponding to 6.3±1.8x 106  cells/animal, were CD3, T-lymphocytes. 
Comparison of GO cells (group 1) with cells cultured for 48h in the absence 
of mitogens (P0, group2) showed that these treatment groups had similar percentages 
of CD25 cells (p=0.91) and mean fluorescence (p=0.78; Fig.4.8 A-B). The cell cycle 
profiles of the two groups were also similar (Fig.4.9 A-B), with high percentages of 
GO/GI cells (p=0.18) and low percentages of cells in S-phase (p=0.82) in both 
groups. Cells in the P0 group only had significantly higher percentages of cells in 
G2IM (p=0.04; Fig.4.9C). A similar increase in G2/M cells as a result of culture had 
been observed in the previous experiment, in particular in T-cells derived from the 
spleen. The percentages of apoptotic cells observed in the treatment group P0 
(Fig.4.7) were higher than those observed in the group GO (p=O.Ol). These data 
suggested that cells cultured in the absence of mitogens represented the best control 
of cell quiescence with which to compare the level activation of cultured cells, since 
they were as quiescent as freshly isolated GO cells, but with rates of apoptosis, that 
can interfere with the analysis, comparable to those of other cultured cells. 
The overall rate of apoptosis in culture (Fig.4.7) was 30±4.5%, comparable 
to that previously observed for cells cultured with the anti-oxidant 2-mercaptoethanol 
(37.1±4.6%), and it remained constant regardless of treatment. The rate of apoptosis 
in culture was not affected by PHA concentration (p=0.54) nor by IL-2 (p=0.54), 
although the absence of IL-2 slightly increased the death rates from 27.7±6.0% to 
32.3±6.6%. The interaction of PHA and IL-2 was also not significant (p=0.92), 
suggesting that there was no synergic effect of these two factors on apoptosis. 
The expression of CD25, expressed both as percentage of CD25 cells and 
mean fluorescence, was affected by treatment in culture. The percentage of CD25 
cells (Fig.4.8A) was affected by PHA concentration (p<O.00l). There was a positive 
correlation between PHA concentration and the percentage of CD25 cells that rose 
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Percentages of apoptotic cells were assessed by Propidium Iodide staining and FACS 
analysis on cells treated for 48h, with increasing concentrations of PHA (0-1 6ug/ml), in the 
presence or absence of 4nM IL-2. Freshly isolated cells (Ctr0h) were also included as 
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Cell were stained for CD25 and processed for FACS analysis at isolation (CtrOh), or after 
culture for 48h with increasing concentrations of PHA (0-16ug/ml), in the presence or 
absence of 4nM IL-2. The groups CtrOh and Ctr48h corresponded to fresh or cultured GO 
cells. Expression of CD25 was assessed as percentage of CD25 cells (A) and as mean 
fluorescence intensity (CD25/cell; B). Data collected in three replicates are summarised as 
mean values±SEM. 
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Cell cycle analysis of cells stained with P1 and processed for FACS analysis, at isolation (CtrOh), or 
after culture for 48h with increasing concentrations of PHA (0-16ug/ml), in the presence or absence 
of 4nM IL-2. The groups CtrOh and Ctr48h corresponded to fresh or cultured GO cells. Data from 
three experiments are expressed as mean percentages±SEM of GO/GI (A), S (B) and G2/M (C) 
cells. 
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from 7.5±0.5%, in the absence of PHA, to 11.5±2.3%, at lug/ml, 21.5±7.5%, at 
2ug/ml, 42.4±7.5%, at 4ug/ml, 52.5±8.3%, at 8ug/ml and, finally, 56.4±6.5% at 
16ug/ml. The percentages of CD25 cells found in cells stimulated with 2ug/ml PHA 
or more, regardless of the presence of IL-2, was significantly higher than that found 
in quiescent cells, cultured without PHA (P0, p<O.00l). Cells stimulated with 4ug/ml 
PHA had percentages of CD25 comparable to those found in cycling cells 
stimulated with 8ug/ml (p>0.12), but significantly lower than the maximal levels 
reached in cycling cells stimulated with 16ug/ml (p<0.04). The percentage of CD25 
cells observed in the two cycling groups, stimulated with 8ug/ml and l6ug/ml PHA, 
were similar (p=0.52). 
The presence of IL-2 also affected CD25 expression. The overall percentage 
of CD25 cells was significantly higher (p<O.00l) in groups activated in the presence 
of IL-2 (41.9±6.2%), than in cells stimulated without-IL-2 (22.1±3.8%). 
When considering specific treatment groups (Fig.4.8A), the percentages of 
CD25 cells rose significantly (p<0.03) above the levels observed in cultured, 
quiescent cells, when cells were stimulated with lug/ml PHA or more, in the 
presence of IL-2, or with 2ug/ml PHA or more, in the absence of IL-2. Cells 
stimulated with 4ug/ml PHA, in the presence of IL-2, had percentages of CD25 cells 
similar (p>0.19) to those observed in cycling cells stimulated with 8ug/ml or 
l6ug/ml PHA and 4nM IL-2. Cells stimulated in the absence of IL-2 never reached 
(p<0.008) levels of CD25 expression similar to those of cycling cells, not even when 
stimulated with 16ug/ml PHA (42.3±5.2%). 
Mean fluorescence intensity (Fig.4.8B), used as a measure of the levels of 
CD25 expression/cell, was also greatly affected by PHA concentration (p<0.001). 
Mean fluorescence was positively correlated with PHA concentration, and it 
gradually increased from 239±79, in the absence of PHA, to 485±103, at lug/ml, 
511±131, at 2ug/ml, 774±187, at 4ug/ml, 1148±393, at 8ug/ml, and 1182±435 at 
16ug/mI PHA. Mean fluorescence was significantly higher (p<0.008) than that of 
quiescent cells, cultured in the absence of PHA, when cells were stimulated with 
lug/ml or more PHA. Cells stimulated with 4ug/ml PHA or more had mean 
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fluorescence levels similar to those of cycling cells, stimulated with 8 or 16ug/ml 
PHA (p>.0.3). 
Mean fluorescence was also significantly affected by IL-2 (p<O.00l). Cells 
cultured in the presence of IL-2 had significantly higher levels of mean fluorescence 
(1125±200) than cells cultured without IL-2 (322±36). 
Specific treatments also influenced the level of expression of CD25 
(Fig.4.813). Mean fluorescence increased significantly from the levels observed in 
cultured quiescent cells, when cells were stimulated with lug/ml or more PHA, in the 
presence of IL-2 (p<0.001), and 4ug/ml PHA or more, in the absence of IL-2 
(p<0.036). Mean fluorescence values were comparable (p>0.05) to those observed in 
cycling cells, stimulated with 8ug/ml or 16ug/ml PHA and 4nM IL-2, in groups 
cultured with lug/ml PHA or more, in the presence of IL-2. However the levels of 
mean fluorescence observed in cycling cells appeared to be much closer to those 
detected in cells stimulated with 4ug/ml PHA and IL-2 (p=0A6-0.50), rather than to 
those seen in cells stimulated with 4nM IL-2 and lug/ml (p=0.064-0.071) or 2ug/ml 
PHA (p=0.050-0.053). In the absence of IL-2, the levels of expression of CD25 never 
rose above those observed in cultured quiescent cells (p>0.5), not even after maximal 
stimulation with l6ug/ml PHA, and remained significantly lower than those observed 
(p<0.006) in cycling cells stimulated with 8ug/ml or l6ug/ml, in the presence of 4nM 
IL-2. 
The percentage of cells GO/G1-phase was affected by PHA concentrations 
(p<0.001) and it gradually decreased as PHA concentrations increased. The 
percentages of GO/G1 cells were as high as 90.2±1.8% and 90.7±0.6%, in groups 
cultured without PHA or with lug/ml PHA, but gradually decreased to 88.4±1.9%, at 
2ug/ml, 80.3±3.2%, at 4ug/ml, 74.6±3.5%, at 8ug/ml and 71.4±2.9%, at 16ug/nil 
PHA. Cells stimulated with 2ug/ml or less PHA, retained percentages of diploid cells 
similar to those found in cultured quiescent cells (p>0.4). Cells stimulated with 
4ug/ml PHA had percentages of diploid cells similar to those of cycling cells 
stimulated with 8ug/ml PHA (p=0.13), but significantly higher than those of cycling 
cells stimulated with 16ug/ml PHA (p=0.02). The percentages of diploid cells 
observed in cycling groups stimulated with 8ug/ml or l6ug/ml were similar (p=0.42). 
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The presence of IL-2 also influenced the percentages of diploid cells, that 
were significantly lower (p<0.002) in groups containing IL-2 (78.8±2.6) compared to 
groups that did not contain it (86.4±1.5). 
The percentage of GO/GI cells in culture was affected by specific treatments 
(Fig.4.9A). The percentage of diploid cells remained similar to that observed in 
cultured, quiescent cells in groups where cells were stimulated with 2ug/ml PHA or 
less, in the presence of IL-2 (p=0.20), or with 4ug/ml or less, in the absence of IL-2 
(p=0.27). Cells stimulated with 4ug/ml PHA in the presence of IL-2 had low 
percentages of GO/GI cells, comparable (p>0.29) to those found in cycling cells 
stimulated with 8ug/mI or l6ug/ml PHA and 4nM IL-2. Cells stimulated with 
l6ug/ml PHA, in the absence of IL-2, also had low percentages of diploid cells, 
comparable to those observed in cycling cells stimulated with 8ug/ml or 16ug/ml 
PHA and 4nM IL-2 (p>O.l7). 
Treatment in culture also affected the percentages of cells in S-phase. PHA 
had a significant effect on the percentages of cells in S-phase (p<0.001). These 
percentages were positively correlated with PHA concentrations, starting at 
5.6±1.9% and 3.1±0.4%, at 0 and lug/ml PHA, and then increasing steadily at 
6.9±1.7%, at 2ug/ml, 11.2±2.3%, at 4ug/ml, 16.5±2.7%, at 8ug/ml, and finally 
18.7±2.4%, at l6ug/ml. Groups stimulated with 2ug/ml or less PHA, still retained 
low percentages of cells in S-phase, comparable to those observed in groups cultured 
without PHA (p>0.4). Cells stimulated with 4ug/ml PHA or more had percentages of 
cells in S-phase as high as those observed in cycling cells stimulated with 8ug/ml or 
l6ug/ml PHA (p>O.OS). 
The percentage of replicating cells found in the T-cell population was also 
influenced by IL-2 (p<0.006). The overall percentages of cells in S-phase were 
13.5±2.0%, in groups containing IL-2, and 7.2±1.1%, in groups with no IL-2. 
When considering specific treatment effects (Fig.4.9 B), it was observed 
that the percentages of cells in S-phase remained (p>.0.24) as low as the ones found 
in cultured quiescent cells in groups stimulated with 2ug/ml PHA or less, in the 
presence of IL-2 (p=0.24), or 8ug/mi PHA or less, in the absence of IL-2 (p=0.14). 
Cells stimulated with 4ug/mI PHA, in the presence of IL-2 (p>0A7), and cells 
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stimulated with l6ug/ml PHA, in the absence of 1L-2 (p>0.28), had percentages of 
cells in S-phase comparable to those found in cycling cells stimulated with 8ug/ml or 
l6ug/ml PHA, and 4nM IL-2. 
The percentages of cells in G2/M were affected by PHA concentrations 
(p<O.00l). For concentrations of PHA between 0 and 2ug/ml, the percentages of cells 
in G2IM ranged from 4.2±0.3% to 6.2±0.4%. They then increased progressively to 
8.5±1.3%, at 4ug/ml, 8.9±1.0%, at 8ug/ml and 9.9±0.7% at l6ug/ml PHA. The 
percentages of G2JM were similar to those observed in cultured, quiescent cells in 
groups stimulated with 2ug/ml or less PHA (p>0.5). Cells stimulated with 4ug/ml 
PHA or more had percentages of G2/M cells comparable to those of cycling cells, 
stimulated with 8ug/ml or l6ug/ml (p>0.  18). 
Addition of IL-2 also increased the percentage of G2/M from 6.4±0.5% to 
7.6±0.8%, although this difference was not significant (p=0.09). 
Comparison of specific treatment groups (Fig.4.9C) showed that 
percentages of G2/M cells remain similar (p>0.8) to those observed in cultured, 
quiescent cells, when cells were stimulated with 2ug/ml PHA, both with and without 
IL-2. The percentages of G2IM cells found in groups that had been stimulated with 
4ug/ml PHA, with or without IL-2, were as high (p>0.7) as those observed in cycling 
cells, stimulated with 8ug/ml or 16ug/ml PHA and 4nM IL-2. 
The [3H]thymidine incorporation assay confirmed that cells cultured with 
lug/nil (9764±3269) or 2ug/ml PHA (23924±5951cpm), in the presence of 4nM IL-
2, had higher (p<0.001) rates of incorporation, than quiescent cells, cultured in 
medium alone (448±124cpm). However these levels of incorporation remained lower 
(p<0.001) than the maximal levels observed in cycling cells cultured with 4ug/ml 
PHA or more (>46664±10624cpm), in the presence of IL-2, or with l6ug/ml PHA, in 
the absence of IL-2 (37250±13122cpm). 
Cell counts failed to give a clear indication of the replication rates of 
cultured cells. A possible explanation might be that differences in cell numbers 
among treatment groups might have been masked by the overall apoptosis rates in 
culture, which were uniformly high in all treatment groups (average 30.0±4.5%). 
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4.3.5 Conclusions 
Cells stimulated with 2ug/ml PHA and 4nM IL-2 represented the best GI 
model obtained by means of PHA titration (Table 4.1). Cells in this treatment group 
had higher percentages of CD25 cells and higher mean fluorescence levels than 
those found in cultured quiescent cells, but similar, high percentages of diploid cells 
(Table 4.1). The percentages of cells in S-phase and G2/M-phase were also as low as 
those observed in cultured, quiescent cells (Table 4.1). 
Although it was possible to use submitogenic concentrations of PHA and 
IL-2, identified by PHA titration, to synchronize cells in GI, this method turned out 
to be sub-optimal. The ideal Gi population should have 100 percent of the cells 
expressing CD25, at high levels, while remaining in a diploid state, without 
undergoing DNA replication. Signs of activation, at submitogenic concentrations of 
PHA, low enough not to trigger G1-S transition and DNA replication, are very weak. 
The percentages of CD25 cells and mean fluorescence levels observed in cells 
stimulated with 2ug/ml and IL-2 (Table 4.1) were lower than those observed in 
cycling cells, stimulated with 4ug/ml or more PHA and 4nM IL-2. 
Cells stimulated with lug/ml PHA and IL-2, also had cell cycle and CD25 
expression features similar to those of Gi cells. However the fact that their levels of 
CD25 expression were even lower than those found in cells stimulated with 2ug/ml 
PHA and IL-2 and the fact that their percentages of cells in G2IM were significantly 
higher than those found in cultured, quiescent cells (P0), made them a less suitable 
G  candidate than cells stimulated with 2ug/ml PHA and IL-2. 
Cells stimulated with 1 and 2ug/ml PHA and IL-2, had rates of thymidine 
incorporation higher than those of found in quiescent cells. This is in contrast with 
what observed using PT staining that showed that percentages of cells in S-phase 
were not increased by PHA concentrations as low as 2ug/ml, even in the presence of 
IL-2. This difference might depend on the greater sensitivity of the thymidine 
incorporation assay, and suggests that it might not be possible to completely 
uncouple T-cell activation from S-phase progression, by means of mere PHA 
titration. 
These findings suggested that it might be necessary to find an alternative 
method to PHA titration to produce G  cells with higher percentages of CD25 cells 
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Table 4.1 Summary of PHA titration results 







GO - 6 .6±0.4a 158±34a 90 .5±1 .7a,b 5.5±1.8a 402b 448±124a 
Gi P2/IL 27.6±6.5 b 753±l68' 861±28b 93±23a 4606b 23924±5951c 
Cycling P4/IL 57.9±4.9 C  1216±95c 740±27C 1626b 9.8±2.2 C 48632±l3353' 
Comparison of the activation state of T-cells from three treatment groups: 1) freshly isolated quiescent cells (GO); 2) cells activated for 
48h with 4ug/ml PHA and 4nM IL-2 (cycling); 3) cells activated for 48h with submitogenic concentrations of PHA, 2ugIml, and 4nM 
IL-2 (G 1). The optimal submitogenic concentration of PHA was assessed by PHA titration. The activation state of T-cells was assessed 
considering their cell cycle profile (%GO/G 1, %S and %G2/M cells), expression of CD25 (%CD25 cells; mean fluorescence) and 
[3H]thymidine incorporation rates, expressed as counts per minute (cpm). Data were collected in three replicates and are summarised 
as means±SEM. Data in the same columns with different superscripts are significantly different (p<0.05). 
and higher mean fluorescence levels, associated with lower rates of thymidine 
incorporation. 
Conclusions, regarding the activation protocol, were also drawn. When 
added to PHA, IL-2 increased the state of activation of T-lymphocytes (4.3.3 
Results), as indicated by the reduction observed in the percentages of GO/G1 cells, 
and the increase observed in the percentages of cells in S and G2/M-phase, 
associated with the increase in CD25 expression (percentages of CD25 cells, mean 
fluorescence). However, no significant difference was observed in the activation 
state of cells stimulated with IL-2 alone, in the absence of PHA, and that of quiescent 
cells, both cultured (P0) or freshly isolated (GO). 
PHA alone, in the absence of IL-2, was also unable to fully activate T-
lymphocytes: 1) percentages of CD25 cells and mean fluorescence levels, in the 
absence of IL-2, never reached levels observed in cycling cells, stimulated with 
4ug/ml or more PHA and IL-2, not even when stimulated with maximal 
concentrations of PHA; 2) cell cycle profiles and rates of thymidine incorporation 
similar to those observed in cycling cells, were observed only when cells were 
stimulated with maximal levels of PHA (16ug/ml). 
These results indicated that PHA and IL-2 were both necessary to induce T-
lymphocyte activation. In the presence of IL-2 and PHA, a plateau of activation, 
beyond which no further significant increase was observed in the activation state of 
T-cells, measured as levels of CD25 expression, cell cycle profile and rates of 
thymidine incorporation, was reached when cells were stimulated with 4ug/ml or 
more PHA (Table 4.1). However maximal levels of activation were reached when 
cells were stimulated with 8 or 16ug/ml PHA and 4nM IL-2. 
4.4 SYNCHRONIZATION OF T-LYMPHOCYTES IN 
Gi BY HYDROXYUREA BLOCK 
4.4.1 Aim 
In the previous experiment PHA titration was successfully used to identify 
the submitogenic concentration of PHA to use for synchronization in Gi of mouse T-
cells. However it also suggested that other methods should be used to produce Gi 
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cells, with higher percentages of CD25 cells and higher mean fluorescence levels, 
while retaining a quiescent cell cycle profile. Activation in the presence of GuS 
blocking agents, like hydroxyurea, was tested for synchronization in Gi (Adams et 
al., 1967, Kim et al., 1992). 
4.4.2 Experimental design 
The design of this experiment was divided into two parts: 
Identification of optimal synchronization conditions; 
Assessment of cytotoxic effects of the blocking conditions. 
Experiments to find optimal blocking conditions were carried out in three replicates. 
For each replicate cells from the lymph nodes of eight, 6 week old, CBAICa, female 
mice, were isolated, pooled together, counted and assigned to a specific treatment 
group. Cells were cultured in culture medium containing 2-mercaptoethanol, 10% 
FCS (legend=M; composition A.2.1), in the presence or absence of 8ug/ml and 4nM 
IL-2 (legend=A; composition A.2.4-A.2.5), that induce maximal activation, as shown 
in previous experiments. Cells were also cultured in the absence or presence of 
hydroxyurea (Kim et al, 1992; Paragraph 2.7) at two different concentrations: 
0.5mM (legend=B 1) or 1mM (legend=B2). Treatment groups are summarised below: 
Culture in medium with 10% FCS (M); 
Culture in medium with 10% FCS, 0.5mM HU (M+B1); 
Culture in medium with 10% FCS, 1mM HU (M+B2); 
Culture in medium with 10% FCS, PHA and IL-2 (M+A); 
Culture in medium with 10% FCS, PHA, IL-2, and 0.5mM HU (M+A+B1); 
Culture in medium with 10% FCS, PHA, IL-2, 1mM HU (M+A+B2); 
Previous experiments (Paragraph 4.2-4.3) had shown that culture in itself, in the 
absence of activating agents, did not alter the quiescent state of T-lymphocytes, 
isolated from the lymph nodes. Therefore, only cultured cells were used as a 
quiescence control (groupi) in this analysis, while freshly isolated, quiescent cells 
were omitted. Cells, in each treatment group, were cultured for 24h or 48h. 




3) 	Cell counts. 
Cells were seeded in two, 24 well plates, at a concentration of 
2x106/well/ml, assigning 1 well/treatment group. Cells cultured for 24h were seeded 
in one plate and cells cultured 48h were seeded in the other plate. Cells were also 
seeded in two 96 well plates, at a concentration of 0.2x10 6/welll100ul, assigning 3 
wells/treatment group. Cells cultured for 24h were seeded in one plate and cells 
cultured for 48h were seeded in the other plate. At the end of the incubation period, 
24h or 48h after seeding, cells in the 24 well plates were harvested, counted and 
processed for FACS analysis (Paragraph 2.7). At the end of the incubation period, 
cells in the 96 well plates were frozen at —20°C and processed together to detect rates 
of [ 3H]thymidine incorporation (Paragraph 2.9). 
To further confirm that the selected protocol for synchronization in GI had 
no detrimental effect, cells, that had been treated for 24h with the highest 
concentration of hydroxyurea (HU), were activated for another 24h with 8ug/ml 
PHA and 4nM IL-2, to assess their ability to re-enter the cell cycle. The state of 
activation of T-cells was assessed by FACS analysis, [ 3H]thymidine incorporation, 
and cell counts. Experiments were set up by culturing cells, for 24h, in 24h well 
plates, at a concentration of 2x10 6 cell/well/ml, for FACS analysis and cell counts, 
assigning 1 well/sample. Alternatively cells were cultured in 96 well plates, at a 
concentration of 0.2x10 6/well/100ul, for [3H]thymidine incorporation, assigning 3 
wells/sample. Cells were cultured in triplicate samples, and each of the three 
samples, belonging to the same treatment group, was placed on a separate plate. All 
samples were cultured, for 24h, under the following treatment conditions: 
Medium alone (M); 
Medium with hydroxyurea 1mM (M+B2); 
Medium with activating agents (M+A); 
Medium with activating agents and hydroxyurea 1mM (M+A+B2). 
After 24h, one plate, containing a sample from each of the four treatment 
groups, was left in culture and incubated, under the same conditions for further 24h, 
and harvested at 48h. A second plate was harvested at 24h. Samples on the third 
plate, from all treatment groups, were harvested, washed twice in PBS and once with 
medium, and replated, at the same concentration, with activating agents, regardless 
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of the previous treatment condition, and incubated for further 24h. At harvest, each 
plate was processed for FACS analysis and cell counts, or frozen at —20°C and 
processed for [3H]thymidine incorporation. 
Samples processed for FACS analysis were stained with anti-CD3-
FITC/anti-CD25-R-PE and anti-CD3-FITC/PI (for Methods see Paragraph 2.9). 
Although these studies are mainly focused on T-lymphocytes, previous 
experiments (Paragraphs 4.2-4.3) had confirmed that cells from the lymph nodes 
were mainly CD3 (i.e. T-lymphocytes). This level of purity in the lymph nodes is 
such that no further purification steps, to deplete unwanted CD3 cells, would be 
required in future NT experiments, and the cell population isolated from the lymph 
nodes could be used as a whole. Therefore, although it would have been possible to 
restrict the analysis to T-lymphocytes, gating cells which were both live and CD3 
(1ive/CD3 gate), only live cells were included in the CD25 and P1 analysis (live 
gate; see Paragraph 2.10.2), omitting the CD3 gating for T-lymphocytes. 
The following parameters were acquired (see Paragraph 2.10.2): 
	
1) 	For CD25 staining (live gate): 
Percentage of CD25 cells; 
Mean fluorescence levels. 
2) 	For PT staining: 
Percentage of apoptotic cells (all cells gated); 
Cell cycle profile (live gate), that included: 
Percentage of cells in GO/G1-phase; 
Percentage of cells in S-phase; 
Percentage of cells in G2IM-phase; 
The [3H]thymidine incorporation assay was performed as previously described (for 
Methods see Paragraph 2.7). 
4.4.3 Statistical Analysis 
Data, categorised in the usual dependent variable categories, were 
transformed as follows for analysis (GenStat 4.21, Windows 2000): percentages 
(%CD25 cells, percentages of cells in GO/Gi, S and G2/M) with the Logit 
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transformation; continuous numerical values (mean fluorescence, cpm) with the Log 
transformation. 
Data were analysed using a Nested Analysis of Variance and a one-way 
ANOVA. 
The Nested Analysis of Variance, with an alpha level for critical ranges of 
0.05, was used on the different treatment groups, to assess variance in the quiescence 
state deriving from different culture treatments, containing activating and/or blocking 
agents. In this case variance was considered only relatively to a cultured control of 
cells quiescence: cells cultured in the absence of activating agents, with or without 
blocking agents (M, M+B 1, M+B2). The analysis was carried out on two levels: 
	
1) 	General level, considering individual treatment groups: 
Block Structure: block/time/condition, with: 
• Block, including replicate 1, replicate 2, replicate 3; 
• Time, including 24h or 48h; 
• Condition including M, M+B1, M+B2, M+A, M+A+B1, M+A+B2; 
Treatment structure: time x condition, with: 
• Time, as main effect; 
• Condition, as main effect; 
• Time and condition interaction; 
2) 	Detailed level, braking variation into variation depending on activating 
agents (A) and variation depending on blocking agents (B). Furthermore, 
two levels were assigned to factor A, corresponding to culture medium with 
(Al) or without (A0) 8ug/ml PHA and 4nM IL-2. Three levels were 
assigned to factor B corresponding, respectively to 0mM (BO), 0.5mM (B 1) 
and 1mM hydroxyurea (132). 
Block Structure: block/time/condition (A x B), with: 
• Block, including replicate 1, replicate 2, replicate 3; 
• Time, including 24h or 48h; 
• Condition, including all the possible combinations of A and B: 
AOBO (M), AOB1 (M+Bl), A0132 (M+B2), A1BO (A), A1B1 
(A+B1), A1B2 (A+B2); 
Treatment structure: (time x A x B), with: 
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• Time, as main effect; 
as main effect, regardless of B; 
as main effect, regardless of A; 
• A and time interaction, regardless of B; 
• B and time interaction, regardless of A; 
• A and B and time interaction; 
In the experiments assessing the detrimental effects of hydroxyurea, the 
block structure used for the Nested Analysis of Variance included also variance 
between wells, because a great variability among wells was observed: 
block/well/time/condition or block/well/time/condition (A x B). 
At each level of analysis, differences between specific groups of interest 
were assessed using a Student's T-test for difference in means, with an alpha level of 
0.05: t=(meanl-mean2)/SE (meanl-mean2). Means and SED (Standard Error of 
Difference in Means) were obtained from the tables of the Nested Analysis of 
Variance (GenStat 4.21, Windows 2000). 
A one-way ANOVA, considering treatment as independent variable, 
(Statistica 4.5, Windows 1995) was also carried out on all groups, including cultured 
groups and freshly isolated cells (GO), with an alpha level for critical ranges of 0.05. 
This was done to compare variance of the quiescent state found in cultured treatment 
groups, not only relatively to cultured quiescent cells, but also relatively to the 
quiescent state of T-cells at isolation (GO). 
4.4.4 Results 
An average of 6.2±3.2x 106  total cells were isolated from the lymph nodes of 
each animal. About 89.7±1.7 % of total cells, corresponding to 5.5±'2.8x10 6/animal, 
were CD3 (i.e. T-lymphocytes). 
Time in culture affected apoptosis (time, p=0.044). Overall apoptosis rates 
in culture, considering all culture conditions, were 4-fold higher at 48h (23.9±2.9) 
than they were at 24h (5.6±1.9). 
Cells that had been cultured for 48h in medium alone, in the absence of 
activating and/or blocking agents (M), had higher rates of apoptosis than cells that 
had been cultured for 24h under the same conditions (O.Ol<p<O.OS; Fig.4.10). Cells 
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M 	M+B1 	M+B2 	M+A 	M+A+B1 M+A+B2 
Cells were assessed for apoptosis by P1 staining and FACS analysis, at isolation, or after culture for 24h or 48h in: 10% FCS medium 
(M); M supplemented with the activating agents PHA 8ug/ml and IL-2 4nM (M+A); M or M+A supplemented with the blocking agent 
hydroxyurea (B) at two different concentrations, 0.5mM (B 1) or 1mM (132). Cells in the group M were a quiescence, culture control, 
cells in group M+A were cycling cells; cells in M+A+B were "putative G  cells". Data were collected in three replicates and are 
summarised as mean±SEM. 
that had been cultured for 24h in M had very low death rates (Fig.4.10), though they 
were significantly higher than those observed in freshly isolated GO cells (p<0.001). 
Treatment conditions in culture (condition, p=0.005) influenced rates of 
cells death, adding their effect to the effects of time, rather than synergizing with it 
(time x condition, p=0.147). Apoptosis in culture could be affected by three factors: 
1) presence of activating agents (A); 2) presence of blocking agents (B); 3) 
interaction of activating and blocking agents (A x B). 
Activating agents, with or without B, increased apoptosis (A, p<0.001), but 
this effect appeared to be mediated by time (time x A, p=0.027). Compared to M, 
incubation with A for 24h, in the presence or absence of B, did not increase cell 
death rates (0.1<p<0.5), but it increased apoptosis at 48h (p<0.001). Similarly 
incubation with A, in the absence of blocking agents (B), did not increase apoptosis 
at 24h (p>0.5), but it did at 48h (O.00l<p<O.Ol). 
Blocking agents, in the presence or absence of activating agents, had no 
effect on cell survival in culture (B, p=0.05), at least at the concentrations used in 
these experiments. Their effect was independent from time in culture (time x B, 
p=0.626). In the absence of activating agents, incubation with blocking agents, at 
both concentrations, for 24h (BI at 24h, 0.1<p<0.5; B2 at 24h, O.l<p<0.5) and 48h 
(Bi at 48h, p>0.5; B2 at 48h, p>0.5) did not increase apoptosis rates, compared to 
controls, cultured in medium alone (Fig.4. 10). Rates of apoptosis observed in groups 
containing BI were higher at 48h than at 24h (0.05<p<0.1), and significantly higher 
at 48h that at 24h in groups containing B2 (0.01<p<0.05). However, a comparable 
increase in death rates was observed as a result of culture in medium alone (M) for 
24h and 48h (0.01<p<0.05). 
Interaction of activating and blocking agents did not increase apoptosis (A x 
B, p=0.55), at both time points (time x A x B, p=0.289). However the effect of their 
interaction depended on the concentration of hydroxyurea (Fig.4.10): activation in 
the presence of lower concentrations of hydroxyurea (A+B1), did not increase 
apoptosis, at 24h (p>0.5) and 48h (0.1<p<0.5); activation in the presence of higher 
concentrations of hydroxyurea (A+B2), increased apoptosis at 24h in a marginal way 
(0.01<p<0.05). Activation in the presence of higher concentrations of hydroxyurea 
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Figure 4.11 Synchronization with hydroxyurea: effect on the cell cycle profile 
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cells in group M+A were cycling cells; cells in M+A+B were "putative GI cells". Data were 
collected in three replicates and are summarised as mean±SEM. (*) Significantly different. 
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(A+B2) did not increase apoptosis at 48h (0.1<p<0.5), possibly masked by the 
culture effect (M at 24h vs M at 48h, 0.01<p<0.05). 
The percentages of GO/GI cells were influenced by time in culture (GO/Ui, 
p=0.048). The overall percentages of GO/G1 cells, considering all treatment 
conditions, were higher at 24h (97.7±0.8) than at 48h (88.6±2.2). The percentages of 
GO/GI cells found in groups that had been cultured for 24h in medium alone (M) 
remained as high as those found in freshly isolated, quiescent cells (p=0.78; 
Fig.4.1 1A). Culture for 48h in medium alone, decreased the percentages of GO/GI 
cells, compared to cultured and freshly isolated quiescent cells (p<0.001; Fig. 4.11 
A). 
Treatment affected the percentages of GO/G1 cells (condition, p<0.001) and 
their effect was mediated by time (time x condition, p<0.031). Activating agents (A, 
p<O.00l), in the presence or absence of blocking agents, affected the percentages of 
GO/G1 cells, regardless of time (timex A, p=O.11). Incubation with activating agents 
alone (A; Fig.4.11A), for 24h and 48h, decreased the percentages of GO/GI cells 
(p<0.001) compared to quiescent cells cultured for 24h and 48h in medium alone. 
The percentages of GO/GI cells observed in cells that had been activated for 
48h were lower than those obtained after activation for 24h (p<O.00l). 
Presence of blocking agents during culture altered the effect of activation on 
the percentages of GO/GI cells (A x B, p<0.001) in a time-dependent manner (time x 
A x B, p<O.00l). The percentages of GO/G1 cells found in groups activated 24h in 
the presence of both concentrations of hydroxyurea, were higher than those observed 
in activated cells (p<0.001; for B! and 132; Fig.4.11 A), and similar to those found in 
quiescent cells, that had been cultured in medium alone for 24h (p>0.5, for A+B 1 
and A+132) and to freshly isolated quiescent cells (p=0.16, for A+B1; p=0.23, for 
A+B2). At 24h, the percentages of GO/GI cells, found in the two groups activated 
with the lower and higher concentrations of hydroxyurea were also mutually similar 
(p>0.5). The percentages of GO/GI cells found in groups that had been activated for 
48h, in the presence of both concentrations of hydroxyurea, were higher than those 
observed in activated cells (p<0.001, for A+B 1 and A+B2), and comparable to those 
found in quiescent cells, cultured in medium alone for 48h (0.1<p<0.5, for A+B1 and 
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A+132), though not as high as those found in freshly isolated, GO cells (p=0.024, for 
A+B 1; p=0.042 for A+132). However the percentages of GO/G1 cells found in cells 
activated for 48h, in the presence of both concentrations of hydroxyurea, apart from 
being mutually similar (p>0.5), were also similar to those found at 24h, in the same 
treatment groups (0. 1 <p<O.5). 
Time in itself had no significant effect on the percentages of cells in S-phase 
(p=0.076). The overall percentages of replicating cells found at 24h, regardless of 
treatment conditions, were similar to those found at 48h (p>0.5; Fig.4.11B). Cells 
cultured in medium alone, in the absence of any treatment, had low percentages of 
cells in S-phase, both at 24h and 48h of culture (0.1<p<0.5), similar to those found in 
freshly isolated quiescent cells (p=0.89, at 24h; p=0.139, at 48h). 
The treatment condition had a significant effect on the percentages of cells 
in S-phase (condition, p<0.001) and this effect was mediated by time (time x 
condition, p=0.012). The presence of activating agents, regardless of the presence of 
blocking agents, influenced the percentages of replicating cells (A, p<0.001) in a 
time-dependent manner (A x time, p<O.00l). Incubation with activating agents, in the 
absence of blocking agents, for 24h and 48h, increased the percentages of cells in 5-
phase (p<O.00l), compared to culture controls. The percentages of S-phase cells, 
after activation for 48h, were higher than those found at 24h (0.01<p<0.001). 
Hydroxyurea altered the effect of activating agents on the percentages of 
cells in S-phase (A x B, p<0.001). The effect of blocking agents was mediated by the 
length of the activation period. 
The percentages of cells in S-phase found in groups activated for 24h in the 
presence of both concentrations of hydroxyurea were lower than those found in 
activated cells (p<0.001,  for A+Bl or 132). At 24h (Fig.4.11B), the percentages of 
replicating cells found in the groups activated with blocking agents, regardless of the 
concentration, remained as low as those found in cultured (p>0.5, for A+B 1 or B2) 
and freshly isolated, quiescent cells (p=0.93, for A+B1; p=0.94, for A+B2). At 48h 
(Fig.4. 11 B),  the percentages of replicating cells found in the groups activated in the 
presence of blocking agents, were higher than those observed in the culture control, 
though to a lesser extent in groups incubated with 1mM hydroxyurea (0.01<p<0.05) 
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rather than with 0.5mM hydroxyurea (0.001<p<0.01). These percentages were also 
higher than those found in GO cells (p=0.004, for A+B1; p=0.015; for A+132). 
However, the overall percentages of replicating cells found at 48h, in groups 
activated in the presence of blocking agents, were, anyway, very low (2.7-3.5%). 
The percentages of cells in S-phase observed in groups activated in the 
presence of blocking agents, at both concentrations, were mutually similar at 24h 
(p>0.5) and at 48h (p>0.5). However, groups with the same concentrations of 
blocking agents, at different time points, differed significantly (O.Ol<p<O.00l). 
The percentages of cells in G2/M, considering all treatment groups, were 
not influenced by time (time, p=0.079) and were similar at 24h (3.3±0.4%) and at 
48h (5.8±0.6%). However, the percentages of G2JM cells were affected by treatment. 
Cells cultured 24h had percentages of G2IM cells similar to those found, at isolation, 
in GO cells (p=0.92). However, cells cultured in medium alone, for 48h had higher 
(p=0.002) percentages of G2/N4 cells than those observed in cultured and freshly 
isolated, GO cells (Fig.4.1 1C). At 48h, the percentages of G2IM cells were higher 
those observed in cells cultured for 24h, even in groups where cells were incubated 
with medium and blocking agents (OO.l<p<O.Ol for M+B1; p<0.001, for M+B2). 
These percentages were similar to those observed in cells cultured 48h, in medium 
alone (p>.0.5). 
The percentages of G2JM cells were affected by the treatment condition 
(condition, p=0.007) in a time-dependent manner (condition x time, p<0.001). 
Incubation for 24h with activating agents, in the absence of blocking agents, 
increased the percentages of G2/M cells compared to the culture control 
(0.001<p<0.01) and to freshly isolated quiescent cells (p=0.016). Incubation for 48h, 
with activating agents, in the absence of blocking agents, increased the percentages 
of G2IM cells, compared to those found in GO cells, at isolation (p=0.002). However 
the increase induced by activation was similar to that observed at 48h as a result of 
culture alone (0.1<p<0.5) in the absence of activating agents. The culture effect 
might have masked a possible activation effect. The percentages of G2IM cells 
observed in cells activated for 48h were significantly higher than those observed at 
24h (0.01<p<0.05). 
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Blocking agents inhibited the increase in the percentages of G2IM cells 
induced by activation (A x B, p=0.009). 
Activation for 48h in the presence of hydroxyurea, regardless of 
concentration, reduced the percentages of G2IM cells to levels lower than those 
obtained in activated cells (p<0.001; Fig.4. 1 1C). Furthermore, these percentages 
were even lower than those observed in cells cultured in medium alone (p<0.001), 
and similar to those observed in freshly isolated, GO cells (p=0.25 for A+B 1; p=0.54 
for A+B2). 
Activation in the presence of hydroxyurea, for 24h, reduced the percentages 
of G2JM cells from 5.4% to 3.8-3.9%, though this decrease was not significant 
(0.1<p<0.5, Fig.4.11C). The percentages of G2IM cells found in cells that had been 
incubated for 24h with activating and blocking agents, also remained very low 
(3.8%-3.9%), though they appeared to be significantly different (0.001<p<0.01, 
A+B1; O.Ol<p<O.OS, A+B2; t-test) from those observed in the culture control (2.1%). 
However, a one-way ANOVA showed no significant difference with freshly 
(p=0.07-0.1 1) and cultured quiescent cells (p=0.06-0.09). 
The percentages of G2IM cells found in groups activated for the same time 
but with different concentrations of hydroxyurea, were mutually similar (p>0.05). 
Groups activated with the same concentration of HU, but for different times were 
also similar (for Bi, 0.001<p<0.01; for B2, p<0.001). 
The percentages of CD25 cells (Fig.4. 12A), increased slightly, as an effect 
of culture, from 5.4±0.3%, observed in freshly isolated cells (GO), to 10.8±1.1% and 
11.8±0.3%, for cells cultured respectively for 24h and for 48h. However this increase 
was not significant (p=0.06) and it was not affected by time in culture (10.8±1.1 vs 
11.8±0.3, p>0.5). 
The different treatment conditions in culture had a significant effect on 
CD25 expression (condition, p<O.00l), in a time-dependent manner (condition x 
time, p<0.001), at least for some treatments. Incubation with activating agents, for 
24h and 48h, in the absence of blocking agents, increased the percentages of CD25 
cells compared to the culture control (p<0.001) and freshly isolated, quiescent cells 
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Figure 4.12 Effect of hydroxyurea on CD25 expression 
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Cell were stained for CD25 and processed for FACS analysis at isolation (GO), or after 
culture for 24h 48h with: medium (M); M with the activating agents PHA, 8ug/ml, and IL-2, 
4nM, (M+A); M or M+A supplemented with the blocking agent hydroxyurea (B) at two different 
concentrations, 0.5mM (B 1) or 1mM (B2). Cells in the group M were a quiescence, culture control, 
cells in group M+A were cycling cells; cells in M+A+B were "putative GI cells". Expression of 
CD25 was assessed as percentage of CD25 cells (A) and as mean fluorescence intensity 
(CD25/cell; B). Data, collected in three replicates, are summarised as mean values ± SEM. 
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(p<0.0001). The percentages of CD25 cells were higher after activation for 24h than 
for 48h (73.3% vs 56.3%), although this difference not significant (0.1<p<0.5). 
The presence of blocking agents did not affect the percentage of CD25, 
both in the presence or absence of activating agents (p=O.11l). In the absence of 
activating agents, the proportion of CD25 cells remained as low as those found in 
the culture controls, where only medium was added, regardless of the concentration 
and of the length of the culture period (p>0.5, at 24h; 0.l>p>0.5, at 48h with Bi, and 
p>0.5 with B2). The percentages of CD25 cells found in groups incubated with the 
same concentration of hydroxyurea, but for a different length of time, were similar 
(p>0.5). Groups incubated with different concentrations of hydroxyurea but for the 
same length of time, were also similar. 
The percentages of CD25 cells found in all groups incubated with 
hydroxyurea, without activating agents, regardless of time, were comparable to those 
found in GO cells (p>0.05), the only exception being cells cultured for 48h with 1mM 
HU (p<0.04). 
Blocking agents had no significant effect on the expression of CD25 during 
activation (A xB, p=0.219), but this was depended upon the time spent in culture. 
The percentages of CD25 cells observed in groups activated for 24h in the 
presence of hydroxyurea, were higher than those found in cultured (p<0.001) and 
freshly isolated quiescent cells (p<0.001) and remained as high as those found in 
groups activated without hydroxyurea (p>0.5, Fig.4.12 A). 
The percentages of CD25 cells, observed in groups activated for 48h in the 
presence of hydroxyurea, were higher than those found in cultured (p<0.001) and 
freshly isolated, quiescent cells (p<0.001), but they were also lower than those found 
in groups activated without hydroxyurea (p<0.001, Fig.4.1 1 A). The percentages of 
CD25 cells found in groups activated for 48h with hydroxyurea were also lower 
than those observed in cells activated for 24h in the presence of the same 
concentration of hydroxyurea (p<0.001). 
Cells cultured for 24h or 48h, in medium alone, had the same levels of mean 
fluorescence (p>O.S) and these levels were also similar to those observed in freshly 
isolated, quiescent cells (p=0.84, Fig.4. 12B). 
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The different treatment conditions in culture had a significant effect on mean 
fluorescence expression (condition, p<0.001). Incubation with activating agents (A, 
p<O.00l), regardless of the presence or absence of blocking agents (A x B, p=0.338), 
dramatically increased mean fluorescence levels. Activation, for 24h and 48h, in the 
absence of blocking agents, increased mean fluorescence levels, compared to culture 
controls (p<0.001; Fig.4. 12 B) and to freshly isolated, quiescent cells (p<0.003, at 
24h; p<0.0001, at 48h). The increase in mean fluorescence levels observed after 
activation for 48h was greater than that observed after activation for 24h 
(0.01<p<0.05; Fig.4.12B). 
The addition of blocking agents did not affect the expression of CD25 
(p=0471), both in the presence or absence of activating agents. During incubation 
with blocking agents, in the absence of activating agents, the levels of mean 
fluorescence remained as low as those found in the culture controls, where only 
medium was added, regardless of the concentration of hydroxyurea and of the length 
of the culture period (p>0.5, for all groups). The levels of mean fluorescence, 
observed under these experimental conditions, were also similar to those found in 
freshly isolated GO cells (p>.0.8). The levels of mean fluorescence found in groups 
incubated with the same concentration of hydroxyurea, but for a different length of 
time were similar (p>0.5). Groups incubated with different concentrations of 
hydroxyurea but for the same length of time were also similar (p>0.5). 
The presence of blocking agents did not interfere with the expression of 
CD25 during activation (A x B, p=0L338). However the outcome was affected by the 
length of the incubation period. Cells activated for 24h, in the presence of 
hydroxyurea, regardless of the concentration, had mean fluorescence levels higher 
than those found in freshly isolated (p<0.001) and cultured quiescent cells 
(0.01<p<0.001). The levels of mean fluorescence, at both concentrations of 
hydroxyurea, were also as high as those found in activated cells (p>0.5; Fig.4.12B). 
Cells activated for 48h in the presence of hydroxyurea, regardless of the 
concentration, had mean fluorescence levels higher than those found in freshly 
isolated (p<0.001)  and cultured quiescent cells (p<0.001; Fig.4. 1 2B). However, their 
levels of mean fluorescence, at both concentrations of hydroxyurea, were not as high 
those found in cells activated for 48h (0.05<p<0.01,  for A+B1 and A+B2), though 
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comparable to those found after activation for 24h, in the presence or absence of 
hydroxyurea (p>0.5, Fig.4. 12 B). 
Results of the [ 3H]thymidine incorporation assay, expressed as counts per 
minute±SEM, confirmed that incubation with activating agents increased 
dramatically thymidine incorporation rates, both at 24h (16163±5887cpm, p<0.0001 
and at 48h (56575±13668cpm; p<0.0001), compared to culture controls 
(390±143cpm, at 24h; 519±150cpm, at 48h). Replication rates at 48h were 
significantly higher than those observed at 24h (p<O.00l). The addition of 
hydroxyurea was able to maintain replication levels as low as those observed in 
cultured, quiescent cells (390±143) only when added at the higher concentration of 
1mM and when the cells were activated for no longer than 24h (318±112, p>0.5). 
Cell counts results, expressed as population doublings±SEM, showed that, 
apart from cells cultured in the presence of activating agents for 24h (1.13±0.17, 
PDs) and 48h (1.34±0.5, PDs), that had higher cell numbers than controls (0.8±0.11, 
at 24h; 0.61±0.12, p<0.049) all the other groups, including cells activated with 
hydroxyurea (0.71±0.09, at 24h; 0.80±0.8, at 48h), had replication rates similar to 
controls (p>0.5) and appeared to be in a growth arrest state. 
Cytotoxicity experiments showed that, after replating the percentages of 
cells in GO/Gi, found in cells that had been previously activated in the presence of 
hydroxyurea, decreased from 97.7% to 77.9%, and the percentages of cells in S-
phase and G2/N4-phase increased from 0.5% to 13.7% and from 1.8% to 8.4%. This 
cells cycle profile was similar to that observed, after replating, in cells, that had been 
previously activated for 24h, without hydroxyurea, and to that of cells that had been 
continuously activated for 48h (Table 4.2). The percentages of CD25 cells remained 
at high levels (78.3%), comparable to the maximal levels found in cells that had been 
activated for 24h (81.3%). The levels of mean fluorescence were slightly lower than 
those observed in cells activated for 48h, but higher than the levels reached after 
activation for 24h. 
Rates of [3H]thymidine incorporation in cells rescued from the hydroxyurea 
block (153 l64cpm, for 1mM HU; 180323cpm, for 0.5mM HU) were comparable to 
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those of cells that had been activated for 24h, before being replated and activated for 
other 24h (166276cpm). These rates were also higher than those observed in cells 
that had been activated for 24h (38875) or 48h (113863). 
Results of cell counts showed that cells that had been activated for 24h in 
the presence of 0.5mM or imIVI HU and then replated and activated for additional 
24h had higher population doublings (1.38-1.48 PDs) than cells in the control groups, 
that had been cultured for 24h,in medium with (0.62-0.84 PDs) or without (0.73 PDs) 
hydroxyurea, before they were replated. These population doublings were also higher 
than those observed in cells that had been activated for 24h (1.08) or 48h (0.97). 
4.4.5 Discussion 
Due to the fragility of mouse lymphocytes in culture, selection of treatment 
conditions with minimal effects on apoptosis is crucial. Culture increased apoptosis, 
in a marginal way at 24h, and dramatically, at 48h. Activation did not increase 
apoptosis at 24h, but increased death rates at 48h, although this might have been a 
result of the culture effect. 
Blocking agents, in the absence of activating agents, did not increase 
apoptosis, at both concentrations, compared to culture controls. Higher death rates 
were observed at 48h, in the presence of blocking agents, especially at higher 
concentrations, however this was a result of culture: increases in death rates had been 
observed also in absence of blocking agents; death rates observed at 48h, with or 
without blocking agents, were the same. Activation in the presence of blocking 
agents had a marginal effect at 24h, when the highest concentration of hydroxyurea 
was used. This concentration might have been detrimental also at 48h, but it was 
masked by the culture effect. 
Taking all these considerations into account, the most successful treatment 
to reduce apoptosis of mouse T-cells would be to activate them with hydroxyurea for 
no longer than 24h. 
Culture for 24h did not alter the quiescent state of cells. However culture for 
48h, in medium alone, decreased the percentage of GO/GI and increased the 
percentage of G2IM cells. The former effect had not been observed in previous 
experiments (Paragraph 4.2-4.3). This difference may have resulted from the fact that 
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in previous experiments cell cycle analysis had been restricted to T-lymphocytes. 
Analysis carried out on T-lymphocytes (CD3Vlive, gate), confirmed this suggestion: 
no difference was observed in the percentages of GO/G 1 cells observed in CD3 cells 
cultured for 24h or 48h in medium alone (M, pO.l<p<0.05). However, the 
percentages of GO/Gi, at 48h, were higher than those found in freshly isolated, 
quiescent cells (p<O.Ol), whereas they remained similar, at 24h (p=0.2). 
Activation for 24h and 48h reduced the percentage of GO/G1 cells. The 
effect observed at 48h was stronger, but might have been a result of the culture 
effect. 
Analysis of the effects of activation and blocking agents on the percentages 
of GO/Gi cells showed that hydroxyurea, at whatever concentration, was able to 
maintain high levels of diploid cells during activation, under all experimental 
conditions. The only difference observed was that, at 48h, the percentages of diploid 
cells were not as high as those found in freshly isolated cells. However, this might 
have been a result of the culture effect, more intense at 48h than at 24h (M at 48h vs 
M at 24h, p<0.001), on which hydroxyurea had no effect (24h M vs 48h M+B1 or 
B2, 0.01<p<0.001; 48h M vs 48h M+B1 or B2, 0.1<p<0.5; 48h M vs 24h M, 
p<o.001). 
Activation increased the percentages of replicating cells. This effect was 
more accentuated at 48h than at 24h. Hydroxyurea was more effective in containing 
increases in the percentages of replicating cells in cells activated for 24h. At 48h 
hydroxyurea was less effective, although percentages always remained quite low 
(3.5%-2.7%). 
Activation increased the percentages of G2IM cells, both at 24h and 48h. 
Activation for 24h or 48h in the presence of hydroxyurea, maintained the percentages 
of G2/M cells at acceptable levels, since percentages never rose above 3.9%, even if 
the levels found in cultured or freshly isolated quiescent cells were even lower. 
Increases in the percentages of CD25 cells and in CD25 mean fluorescence 
were observed only as a result of activation, and not of culture, confirming that 
CD25 expression cannot be triggered by aspecific stimuli, but only as part of the T-
cell activation pathway. Maximal percentages of CD25 cells were found in cells 
activated for 24h, both in the presence or absence of hydroxyurea, since addition of 
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blocking agents did not interfere with the activation status of T-cells. The situation 
after activation for 48h was less favourable since the percentages of CD25 cells, in 
the absence of hydroxyurea were lower than those found at 24h, and became even 
lower after addition of hydroxyurea. This may have been the result of higher rates of 
apoptosis observed in cells activated for 48h (24.7±5.1%), especially in the presence 
of 0.5mM (39.8±2.6%) and 1mM (35.6±1.0%) HU. 
Activation increased dramatically mean fluorescence levels, at 24h and 48h, 
with a stronger effect observed at the latter time point. Hydroxyurea did not alter the 
level of mean fluorescence of cells activated for 24h, confirming that it did not 
interfere with the activation process. Though maximal levels of mean fluorescence 
were found in cells activated for 48h, after addition of hydroxyurea, these levels 
remained comparable to those found in cells activated, with or without hydroxyurea, 
for 24h. However these results might have been affected by the high death rates 
observed under those experimental conditions 
Cytotoxicity experiments confirmed that the effect of hydroxyurea was completely 
reversible. 
4.4.6 Conclusions 
Activation in the presence of hydroxyurea represented the best method to 
produce GI karyoplasts from T-lymphocytes: the addition of hydroxyurea during 
activation blocked the undesired cell cycle effects of activation, keeping the 
percentages of GO/GI cells at high levels and inducing replicative arrest, but without 
interfering with the activation state of T-cells (Table 4.2). 
Activation with HU for 24h and 48h produced GI cells with similar cell 
cycle profiles: the percentages of GO/G1 cells were equally high at 24h (95%) and at 
48h (94%); the percentages of cells in S-phase and G2IM-phase were low at 24h and 
at 48h, though the percentages of cells in S-phase were significantly lower at 24h 
(0.8% vs 2.7-3.5%) and the percentages of cells in G2IM were significantly lower at 
48h (3.8-3.9% vs 2.9-3.3%). However when using [3H]thymidine incorporation to 
assess replication rates, effective growth arrest was observed only when cells were 
activated for 24h in the presence of 1mM HU. 
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Table 4.2 Summary of synchronization in Cl by hydroxyurea 
Cycling 	 Gi 	 GO 
(24h) 	 (24h) 	 (24h) 
Apoptosis 3.1±0.3 a 15.4±0.3 I 0.4±0.1 ci 
[3 H]-Tdr (SI) 47.76±8.76 a 	0.93±0.05 c 1±0c 
GO/GI 87.8±1.7 a 	95.3±1.0 C 96.8±0.4 C 
S 6 .9±0 .4a 	0 . 8±0 . 3c 1 .0±0 .4C 
G2/M 5.4±1.4 a 	3.9±0.9 C 2.1±0.1 c 
CD25 73 . 3±6 . 0a 71.6±6 .0a 
Fluorescence 322±39a 302±75a 1I6±16d 
Results from three replicates are expressed as mean percentages±SEM, except for 
Fluorescence, where data are expressed as mean fluorescence intensity (Mean FL2-H) 
±SEM and [3H]-Thymidine incorporation, where data are expressed as mean stimulation 
index (SI) ± SEM, obtained by dividing counts per minute (cpm) found in treatment groups 
by those found in control group. All data were analysed with a Nested Analysis of Variance 
and a one-way ANOVA (paragraph 4.4.3). Data in the same row with different superscripts 
are significantly different (p<0.05). Cells with border of same colour contain similar 
results. 
148 
Activation for 24h, even in the presence of HU, was enough to induce high activation 
levels, in terms of CD25 expression, in the GI population. This was the result of two 
factors: 1) T-cells achieved very high levels of activation, already at 24h; 2) the 
activation state of T-cells was not affected by the presence of hydroxyurea. The 
effects of activating agents, on the cell cycle, were stronger at 48h than at 24h, since, 
after activation for 48h, lower percentages of GO/G1 cells, and significantly higher 
percentages of S and G2IM cells were observed. However, the effects of activating 
agents on CD25 expression were similar at 24h and 48h. The percentages of CD25 
cells and the levels of expression of CD25/cell were very high at 24h and 48h, 
though the percentages of CD25 cells were higher at 24h, and mean fluorescence 
was significantly higher at 48h. The presence of hydroxyurea did not alter at all the 
activation state of cells activated for 24h, whereas in cells activated for 48h with HU 
the percentages of CD25 cells decreased to levels lower than those obtained at 24h 
and mean fluorescence decreased to levels comparable to those observed at 24h. The 
concentration of hydroxyurea did not affect at all the activation state of T-cells, at 
both time points. 
Finally, apoptosis rates were lower at 24h, ranging from 2.9% to 15%, than 
at 48h where it ranged from 13% to 39.8%. At 48h cell death rates increased as a 
result of culture (13.0%), as a result of activation (24.7%) and as a result of 
activation in the presence of blocking agents (35.6-39.8%), though blocking agents 
did not have a significant effect. 
The outcome of this experiment (Table 4.2) was that activation for 24h, with 
8ug/ml PHA and 4nM IL-2, in the presence of 1mM HU, was identified as the 
optimal method to produce cells in GI, because, though they had slightly higher 
apoptosis rates than cells activated for 24h with 0.5mM HU, they were the only ones 
that had the same thymidine incorporation rates (0.93±0.05, SI) and the same cell 
cycle profile (95.3±1.0, %G0/G1) as cultured quiescent cells. The cells in this 
treatment group also had percentages of CD25 (71.6±6.0%) as high as those found 
in cells that had been activated for 24h (73.3±6.0%) and even higher than those of 
cells that had been activated for 48h (56.3±4.7%). These putative GI cells also had 
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levels of mean fluorescence (302±75) as high as those of cells activated for 24h 
(322±39) and of cells activated for 48h with hydroxyurea (330±54), though lower 
than that of cells that had been activated for 48h without hydroxyurea (600±60). 
Cells that had been activated for 24h with 0.5mIvI hydroxyurea, had similar features 
as cells activated 24h with 1mM HU: a cell cycle profile similar to that of quiescent 
cells; high percentages of CD25 cells (72.7±5.9); high levels of mean fluorescence 
(313±43). Their apoptosis rates were even lower than those of cells activated with 
1mM hydroxyurea (3.7% vs 15%), however their main disadvantage was that they 
had a high stimulation index (1.56±0.20 SI) indicating that hydroxyurea 0.5mM was 
not enough to contain completely DNA replication, and that higher concentrations of 
HU were required. Cells activated for 48h with hydroxyurea, cannot be used as GI 
cells mainly for three reasons: their extremely high levels of apoptosis, at both 
concentrations of hydroxyurea (35.6%-39.8%); their low percentages of CD25 cells 
(35.5%); their high replication rates 2.56-fold higher than those observed in cultured 
quiescent cells. 
Finally, the cytotoxicity assay showed that T-lymphocytes stimulated with 
1mM hydroxyurea, for 24h, were able to resume the cell cycle without any side 
effects. In conclusion, hydroxyurea did not impair the ability of T-cells to undergo 
normal DNA replication and cell cycle progression, as clearly demonstrated by their 
high rates of [3H]thymidine  incorporation, even higher than those seen in cells 
activated for 24h or 48h without HU, and by their cell cycle profile, typical of 
actively replicating cells. 
4.5 PURIFICATION OF Gi CELLS BY POSITIVE 
SELECTION OF CD25 CELLS 
4.5.1 Aim 
It was decided to further purify GI cells, produced by HU block, expressing 
CD25 (G1/CD25). This experiment had two aims: 1) use magnetic activated cell 
sorting (MACS) to positively select cells expressing CD25; 2) check that the 
separation procedure did not trigger S-phase progression in T-cells. 
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4.5.2 Experimental Design 
Three experiments were set up to compare three different separation 
protocols. In each experiment 22x 106  cells isolated from the lymph nodes of 8 
female CBAICa, 6 week old mice, seeded at a concentration of 2x10 6/well in 24 well 
plates, for 24h, with 8ug/ml PHA and 1mM hydroxyurea, were harvested, labelled 
with PE-conjugated rat anti-mouse CD25 antibody (IgG) and separated using three 
different protocols (for Methods see Paragraph 2.8): 
Incubation with anti-Rat IgG magnetic microbeads, separation with one 
positive selection column (MS) and elution of C1325 cells; 
Incubation with anti-Rat IgG magnetic microbeads and separation with two 
positive selection columns (MS) as follows: separation on a first column 
and elution of the first fraction of CD25 cells; separation of the CD25 
cells on a second column and elution of a second fraction of CD25 cells; 
The two fractions of C1325 cells were then pooled together. 
Incubation with anti-PE magnetic microbeads, separation with one positive 
selection column (MS) and elution of CD25 cells 
The following cell samples from each experiment were counted and processed for 
FACS analysis: 
Freshly isolated, GO cells; 
Activated cells, cultured with 8ug/ml PHA and 4nM IL-2; 
Total Gi cells, cultured with 8ug/ml PHA, 4nM IL-2 and 1mM HU; 
Total GI cells, after labelling and before separation; 
G1ICD25 cells, after separation; 
G11CD25 cells, after separation. 
Samples from each treatment group were stained with CD3-FITC/CD25-R-
PE or C133-FITC/ P1 (for Methods see Paragraph 2.9). Gates and parameters 
acquired were the same as previously described (Paragraph 4.4.2). 
4.5.3 Results 
All results are summarised in Table 4.3. and Table 4.4. 
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Anti-Rat-IgG/ 1 column 22 (63.6) (75.0) (88.6) (8.6) 0.80 (3.6)* 
Anti-Rat-IgG/ 2 columns 22 (59.1) (84.6) (66.7) (8.2) 0.77 (3.5)* 
Anti-PE/ 1 column 22 (47.3) (75.2) (72.8) (52.8) 2.40 (10.9)* 
Cells were synchronized in Gi, by activation for 24h with 8ug/ml PHA and 4nM IL-2, in the presence of 1mM hydroxyurea. Cells in 
GI were labelled with anti-CD25-PE antibody, and G 1 /CD25 cells were positively selected using anti-Rat IG or anti-PE microbeads 
and one or two positive selection columns. Data, collected in a single experiment, are expressed as cells xl 0 or as percentages. 
(-'I 
Table 4.4 Features of G1/CD25 cells obtained with different selection methods 
CD3 (%) CD25 (%) Fluorescence Apoptosis (%) GO/G1 (%) 
Anti-Rat IgG/1 column 
GI/All 94.55 67.26 294 3.77 92.48 
G1/CD25 98.64 96.83 1288 4.56 97.11 
G1/CD25 98.25 78.54 292 3.56 94.03 
Anti-Rat IgGI2 columns 
GI/All 91.16 66.59 381 9.63 89.59 
G1/CD25 83.12 93.81 1144 11.5 97.07 
G1/CD25 96.94 54.60 226 5.15 93.53 
Anti-PE/1 column 
GI/All 92.14 62.51 428 22.11 95.10 
G1/CD25 98.23 90.20 823 10.5 93.40 
G1/CD25 95.89 61.50 430 8.13 96.28 
Analysis of apoptosis rates, proportion of T-cells (CD3), cell cycle distribution and CD25 expression (% CD25 cells, mean 
fluorescence) of cells synchronized in GI by activation for 24h with 8ug/ml PHA and 4nM IL-2, 1mM hydroxyurea (GI/All), 
and positively selected using anti-Rat IgG or anti-PE microbeads and one or two positive selection columns (G1/CD25). 
Features of cells in the negative fractions were also assessed (G1/CD25). Data, collected in a single experiment are expressed 
as percentages or as mean fluorescence intensity (Mean FL2-H). 
4.5.4 Discussion 
Cell yield decreased as a result of culture, processing and MACS separation 
(Table 4.3). About 56.7±6.9% of seeded cells were recovered after culture, 
78.3±4.5% of harvested cells were recovered after cell processing and 76.0±6.2% of 
processed cells, including both positive and negative fractions, were recovered after 
separation on MS columns. Although the separation protocol did not influence the 
total cell yield, ranging from 66.7% to 88.6%, separation with anti-FE microbeads 
gave a greater yield of G1/CD25 cells than separation using anti-Rat IgG 
microbeads, that was 10.9% of seeded cells (2.4x10 6/22x106 ; Table 4.4). 
All separation protocols gave G1/CD25 fractions with high percentages of 
CD25 cells and high levels of expression of CD25/cell (Fluorescence), higher than 
those observed in GI cells before separation (GI/All; Table 4.4). The only difference 
was that G1/CD25 cells, isolated with anti-PE beads, expressed CD25 
(Fluorescence) at a slightly lower level than G1ICD25 cells isolated with anti-Rat 
beads (Table 4.4). This suggests that anti-PE microbeads had a greater affinity for 
cells expressing CD25, selecting also T-cells that expressed CD25 at very low levels 
(i.e. low mean fluorescence). This would also explain the greater yield obtained with 
the anti-PE beads compared to anti-Rat IgG beads. 
4.5.5 Conclusions 
A highly pure G1/CD25 population was isolated, regardless of the 
separation technique used (Table 4.5). The percentages of CD25 cells and of diploid 
cells (2N) found in the G1/CD25 population were always >90% and >93%. The 
levels of expression of CD25 (823-1288) were not only higher than those observed in 
GO cells (137) but also higher than those observed in total G1 cells (294-428), 
suggesting that only cells expressing a certain amount of CD25 on their surface were 
positively selected. The G1/CD25 fraction also represented an almost pure 
population of T-lymphocytes (>90% CD3 cells). Rates of apoptosis remained low 
and ranging between 4.56% and 11.50% of total cells. 
Although the cell cycle features (Table 4.4) of positively selected G1/CD25 cells 
were similar, regardless of the separation method used, the yield was different (Table 
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Table 4.5 Summary of synchronization in Gi by hydroxyurea block and selection of 









Apoptosis 11.4±2.3 11.8±9.4 10.5 12.4±7.2 
CD3 83.5±7.2 92.6±1.7 98.2 89.2±4.2 
GO/G1 95.2±1.9 92.4±2.8 93.4 81.2±3.4 
CD25 11.8±3.5 65.5±2.6 90.2 63.9±10.3 
Fluorescence 121±39 368±69 823 447±96 
Cells isolated from the lymph nodes were cultured for 24h in: 10% FCS culture medium 
(GO); 10% FCS culture medium with 8ugIml PHA and 4nM IL-2 (Cycling); activated in the 
presence of 1mM hydroxyurea (GI); synchronized in GI and then purified by CD25 cell 
selection with anti-PE microbeads and one positive selection column. Data from three 
experiments are expressed as Mean±SEM. Some data (*) were obtained from a single 
experiment. Parameters include: percentages of CD3 cells (T-cells); percentages of diploid 
cells (GO/Gi); percentages of CD25 cells and CD25 mean fluorescence (CD25 
expression/cell). 
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4.3). Separation with anti-FE beads gave a greater yield of CD25' cells compared to 
anti-Rat IgG beads, considered both as total cell numbers (2.4x10 6 vs 0.8x106) and as 
percentage of seeded cells (10.9% vs 3.5-3.6%). Anti-FE beads were selected for 
future experiments, because they gave a G1/CD25 population of similar purity than 
anti-Rat IgG microbeads, but with greater efficiency. 
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CHAPTER 5 
T-LYMPHOCYTES AS A SOURCE OF GO 
KARYOPLASTS 
5.1 INTRODUCTION 
During differentiation epigenetic changes of the genome restrict the 
potential for gene expression, in a cell type specific manner. During reprogramming 
the cell type specific epigenetic patterns established during differentiation must be 
erased in order for the genome to acquire totipotency. Recent evidence suggests that 
low nuclear transfer efficiency might result from incomplete or incorrect removal of 
these epigenetic patterns during reprogramming (Kang et al., 2001; Humpherys et 
al., 2001; Inoue et al., 2002). Quiescence greatly affects the epigenetic status of 
chromatin with possible consequences on the reprogramming process. 
Up to now only abnormal DNA methylation patterns have been studied in 
cloned embryos foetuses and placentas. Cloned pre-implantation cattle embryos 
displayed insufficient (Kang et al., 2001) and ectopic demethylation of genomic 
DNA, with most of the abnormalities localised in the trophectoderm (Kang et al., 
2002). Mice cloned using ES cells and their placentas had significantly higher 
weights than controls and abnormal levels of expression of imprinted genes, mostly 
lower than controls (H19, Pegi/Mest, Megl/GrblO; Humpherys et al., 2001). 
Abnormal patterns of expression of parental imprinted genes (Igf2, H19) were 
observed in placentas from cloned pups (Humpherys et al., 2001). Foetuses cloned 
using Sertoli and cumulus somatic cells, retained normal weights and had normal 
patterns and levels of expression of imprinted genes (Inoue et al., 2002). However, 
their placentas where abnormally enlarged and, though retaining normal patterns of 
expression of imprinted genes, foetal tissues had lower levels of expression of some 
imprinted (Pegi/Mest, Megl/GrblO, Meg3/Gt12) and non-imprinted genes (Igfbp2, 
Igfbp6, Vegfr2fFlkl, Esxl) compared to controls (Inoue et al., 2002). 
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There is contradictory evidence whether quiescence might affect 
methylation patterns of gene expression. Serum-starved human normal fibroblasts 
(NHF) had significantly higher levels of methylation (50% vs 0-15%) of CpG in the 
0-6-methylguanine-DNA methyltransferase (MGTMT) gene than non-quiescent 
cells (Pieper et at., 1999). Furthermore, serum starvation and contact inhibition, 
conditions known to induce cell quiescence in somatic cells, resulted in reduced 
methylation levels and increased transcription levels of the imprinted genes H19 and 
Igf2, in ES cells (Baqir and Smith, 2000). However, other evidence in cattle suggests 
that there is no difference in the overall methylation level of genomic DNA of 
serum-starved and cycling foetal fibroblasts (50-100% CpG methylated in the Boy-B 
gene; Kang et at., 2001). 
This chapter focused on investigating other epigenetic changes, that play an 
important role in the regulation of gene expression both during development and 
quiescence, that have not been investigated yet in relation to nuclear transfer: 
chromatin remodelling and acetylation. 
Nuclear chromatin condensation and spatial organisation changes during the 
cell cycle (Juan and Darzynkiewicz, 1998; Bridger et al., 2000). Chromatin appears 
to be very condensed during mitosis whereas it is maximally decondensed at the time 
of entrance in S-phase. Chromatin of GO cells presents a high level of condensation, 
even if not as high as cells in M-phase. Quiescence-related changes in chromatin 
condensation are particularly dramatic in T-cells, the cell model of choice of these 
experiments, as demonstrated directly by Acridine Orange staining and indirectly by 
changes in T-cell nuclear size and composition. Changes in chromatin condensation 
correlate with changes in DNA in situ sensitivity to denaturation and have been 
detected in T-cells using Acridine Orange (AO), a metachromatic fluorochrome, 
which differentially stains in green non-denatured (double-stranded) DNA, with a 
higher level of condensation, and in red denatured (single stranded) DNA, with a 
lower level of condensation (Juan and Darzynkiewicz, 1998). This assay has shown 
that quiescent T-cells have significantly higher levels of red fluorescence, associated 
with decondensed chromatin, and significantly higher levels of green fluorescence, 
associated with condensed chromatin than activated T-cells (Juan and 
Darzynkiewicz, 1998). 
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These differences in chromatin condensation associate with changes in the 
transcriptional activity, as detected under the same experimental conditions using a 
modified AO staining and flow cytometry. Under different experimental conditions 
AO can be used to distinguish GO and GI cells based on their RNA content. Total 
RNA content is largely composed of ribosomal RNA, and is therefore an estimate of 
ribosome synthesis and ultimately of protein synthesis. At appropriate concentrations 
and stringent ionic conditions AO intercalation into double stranded DNA results in 
green fluorescence, whereas it results in red fluorescence when it intercalates to 
single stranded RNA (Juan and Darzynkiewicz, 1998). 
Quiescent lymphocytes, upon activation, also undergo dramatic changes in 
their nuclear size and morphology, also associated with changes in the rate of DNA 
replication and/or transcription. Two separate studies clearly show the correlation 
existing between state of activation and nuclear size (Setterfield et at., 1983) and 
state of activation and chromatin conformation (Pompidou et at., 1984). In these two 
studies human peripheral blood lymphocytes (99% T-cells, <1% monocytes, <1% B-
cells) were stimulated with Concanavalin A (Con A) or phytohemagglutinin (5ug/mI) 
over a chase period of 48h-72h. Nuclear volume (Setterfield et at., 1983) was 
measured, whereas chromatin condensation (Pompidou et at., 1984) was evaluated 
using nuclear refringency (image intensity analysis: quantifies the shift in chromatin 
condensation in the cell population) and electron microscopy (semi-quantitative 
ultrastructural analysis: percentage of cells with condensed or decondensed 
chromatin). These studies identified three nuclear morphotypes on the basis of 
activation state, nuclear size and chromatin conformation: I) unstimulated (resting T-
cells); II) partially activated (competent T-cells); III) fully activated (lymphoblastic 
cells) nuclei. Resting cells (morphotype I) have a small nucleus that constitutes 
nearly all the cell volume. Semi-quantitative ultrastructural analysis >60% GO cells 
display a condensed chromatin conformation characterised by dense masses 
(compact chromatin bodies), that in rat have been shown to correspond to a haploid 
number of chromosomes (Lopez-Velazquez et al., 1996). Most bodies are localised 
at the periphery, in contact with the nuclear envelope. The largest body always 
contains the nucleolus-associated chromatin and is positioned around the nucleolus. 
There is a certain level of variability in the distribution pattern of compact chromatin 
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bodies among GO lymphocytes, but interestingly lymphocytes may share identical 
distribution patterns with different cell types of individuals of the same species 
(Lopez-Velazquez et al., 1996). Resting lymphocytes usually have one, large 
nucleolus displaying a ring-like figure (Pompidou et al., 1984). 
Upon T-lymphocyte activation cellular and nuclear size increase 
dramatically and chromatin becomes gradually dispersed (Setterfield et al., 1983). 
During early activation (<24h, morphotype II) the nucleus starts enlarging, reaching 
a 6-fold increase by the late activation stage (24h-72h, morphotype III). The increase 
in nuclear volume mainly results from a 10-fold increase in the volume of the 
proteinaceous intechromatinic region, and, to a lesser extent, from the 1.5-fold 
increase in volume and spatial dispersion of chromatin (Setterfield et al., 1983). 
Cycloheximide and alpha-amanitin block nuclear structural and functional activation 
by preventing matrix expansion showing the strict association existing between these 
events. During early activation (morphotype II), within 30 min of mitogenic 
stimulation, chromatin partially and transiently disperses, as chromatin bodies begin 
to disaggregate. This event is marked by a 6.7% reduction in nuclear refringency 
index (NRI) and 16% cells condensed. Within 60 min this situation is reversed: NRI 
goes back to control levels, and by the acquisition by >60% of the cells of a 
condensed chromatin structure. During late activation (morphotype III) complete and 
prolonged chromatin decondensation takes place, marked by a 11% reduction in NRI 
with 15% of the cells displaying a condensed chromatin structure, and a 33% 
reduction in NRI with 7% of the cells displaying a condensed chromatin structure by 
48h (Setterfield et al., 1983). 
Early nuclear structural activation events are temporarily coupled with 
transcriptional activation but not DNA replication events (Setterfield et al., 1983). 
The appearance of morphotype II is associated with a 55% increase in [3H]uridine 
incorporation. Late nuclear structural activation events are temporarily coupled with 
initiation of DNA replication. The appearance of morphotype III is associated with a 
7-13-fold increase in [ 3H]thymidine incorporation. Pre-treatment with lug/ml 
actinomycinD (actD), which binds DNA preventing transcription, blocks chromatin 
dispersion. These data support the association between chromatin conformation and 
DNA transcription and/or replication, without proving any causal-effect relationship. 
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The mechanisms behind cell cycle regulated chromatin changes are largely 
unknown. However there is some evidence that non-histone proteins might mediate 
heterochromatin repression during quiescence. Proteins belonging to the Polycomb 
group (e.g. BMI1) and zinc finger proteins (e.g. Ikaros, Eos, Pegasus, Ailos), mainly 
expressed in T-lymphocytes, are cell cycle regulated (Voncken et al., 1999; Avitahi 
et al., 1999; Georgopoulos, 2002). Furthermore, quiescent cells also contain larger 
amounts of histone Hi° instead of histone Hi. The reprogramming factor 
nucleoplasmin has a greater affinity for histone Hl' and this might also represent an 
advantage for reprogramming (Kikyo and Wolffe, 2000). Histone post-translational 
modifications, such as histone H4 acetylation (Pogo et al., 1966) and histone H3 
phosphorylation (Patskan and Baxter, 1985) are also associated with exit of 1-cells 
from quiescence. 
Chromatin conformation is one of the regulatory mechanisms involved in 
the restriction of genomic potential during differentiation (Leitch, 2000). These 
epigenetic restrictions have to be removed to re-establish totipotency. Experiments 
carried out in Xenopus showed that chromatin remodelling complexes play an 
important role in reprogramming the patterns of gene repression of somatic nuclei 
after transfer to recipient oocytes (Dimitrov and Wolffe, 1996; Kikyo and Wolffe, 
2000; Kikyo et al., 2000). The reprogramming process involves the appearance of a 
more open and transcriptionally active chromatin structure mediated by the activity 
of remodelling complexes and by the removal of repressive chromatin structures 
established during differentiation. Particularly important seems to be the activity of 
complexes that create a more open and transcriptionally active chromatin structure, 
such as the complexes of the SNF/SWI family containing the ATP-ase ISWI, often 
coupled to acetyltransferases. On the contrary, complexes inducing closed chromatin 
structure, deacetylation and CpG-methylation (e.g. MeCP2/Rdb3/Sin3) do not seem 
to be involved in the reprogramming process (Kikyo and Woiffe, 2000). Removal of 
proteins that accumulate during differentiation is also important for the 
reprogramming of cloned embryos. Histone Hi is removed during reprogramming 
(Bordignon et al., 1999; 2001). However removal of other proteins, associated with 
differentiation, may also be important. These include the Polycomb-group (Pc-G) of 
proteins (Kikyo and Woiffe, 2000), that sustain developmentally regulated 
161 
expression (e.g. homeotic genes, Drosophila; Hox gene clusters, mammals) and the 
zinc-finger proteins (e.g. Ikaros, Eos, Pegasus, Ailos) that mediate lineage 
commitment and differentiation of haematopoietic stem cells into lymphocytes 
(Georgopoulos, 2002). 
Post-translational modifications of histones, which are affected by 
quiescence, also contribute to the restriction of gene expression during embryo 
development and differentiation, and might play an important role in nuclear 
reprogramming. In particular, dramatic changes in the acetylation status of histone 
H4 (Adenot et at., 1997; Worrad et at., 1995), at lysines 5, 8, and 12 (H4.Ac5; 
H4.Ac8; H4.Ac12), histone H3 (Stein et at., 1997), at lysines 9 and/or 18 
(H3.Ac9/1 8) and histone H2A (H4.Ac5), take place in the mouse embryo around the 
time of zygotic gene activation and during differentiation (Ma et at., 2001; 
Wiekowski et al., 1997). These changes have been mapped in detail in mouse and 
will be described in detail in the next chapter. However acetylation patterns have yet 
to be described in cloned embryos. 
Experiments in this chapter focused on the effects of quiescence on the 
expression and sub-nuclear localisation of proteins belonging to the heterochromatin 
protein 1 (HP1) group, and on the acetylation status of histone H4. HP1 proteins 
were selected because they belong to the same family as the Pc-G proteins (Jones et 
al., 2000), which are both cell cycle regulated (Voncken et at., 1999) and 
developmentally regulated. The regulation of HP1 proteins in relation to quiescence 
and embryo development is still unknown and so is its possible involvement in 
nuclear reprogramming. A single form of HP1 was first isolated in Drosophila 
melanogaster (James and Elgin, 1986). However screening with CD probes has 
revealed multiple variants in higher eukaryotes (Singh et al., 1991). Mammalian HP  
comprises three distinct isotypes termed hHPla, hHP1I3, hHPly in humans and 
mHPlct, M31, M32 in mice. The different isotypes are structurally very similar but 
are distributed in different regions of the nucleus (Jones et at., 2000). Descriptive 
studies using specific antibodies showed that HP1a and HP1I3 are predominantly 
found in pericentromeric constitutive heterochromatin, suggesting they might play a 
role in centromere function as previously described in HP1-like proteins in fission 
yeast and Drosophila. On the contrary, HP1y is distributed in a fine-grain pattern 
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throughout the nucleoplasm, which suggested its possible association with 
heterochromatin complexes within euchromatin and its exclusion from constitutive 
heterochromatin. The effect of T-cell quiescence on histone H4 acetylation has 
partially been investigated (Pogo, 1966; Knosp et al., 1991). However the aim, of the 
experiments in this chapter was to use specific antibodies, developed to investigate 
changes in histone H4 acetylation during early embryo development, in mouse 
(Worrad et al., 1995), to correlate specific changes in acetylation induced by cell 
quiescence with changes observed during reprogramming, after nuclear transfer. 
Changes observed in HP1 proteins and histone H4 acetylation, were also correlated 
with specific activation markers. 
Markers of T-cell activation included: 
CD25 or IL-2Rc4 negative marker of quiescence, that is not expressed in GO 
T-lymphocytes but is expressed upon activation (see Chapter 4; Soldaini et 
al., 1995); 
Proliferating cell nuclear antigen (PCNA), negative marker of quiescence, 
that is maximally expressed during the S—phase of the cell cycle and has 
been described in activated T-cells (Kurki et al., 1987); 
Cyclin D3, negative marker of quiescence, that is not expressed in GO T- 
lymphocytes but it is up regulated after activation as shown using Western-
blots (Ajchenbaum et al., 1993); 
p27", that is down regulated as GO T-lymphocytes become activated 
(Polyak et al., 1994b). The protein p27"' is also over expressed in serum-
starved mouse fibroblasts (Rivard et al., 1996; Chapter 3). This protein is 
the only known positive marker of cell quiescence in T-lymphocytes, since 
p130, of the retinoblastoma family, is only found in serum-starved mouse 
fibroblasts (Coats et al., 1999; Paragraph 1.4.1). 
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5.2 EFFECT OF QUIESCENCE ON CHROMATIN 
CONFORMATION 
5.2.1 Aims 
Use specific antibodies to describe qualitative (sub-nuclear localisation) and 
quantitative (levels of expression) differences in mouse HP1 proteins (mHPl(t, M31, 
M32) between quiescent and non-quiescent cells. Correlate changes observed in 
chromatin conformation during activation with specific activation markers: p27 1 , 
CD25, PCNA and cyclin D3. 
5.2.2 Experimental design 
Experiments were carried out in three replicates, unless stated otherwise For 
each replicate T-cells were isolated from the lymph nodes of eight, six week old, 
female mice of the inbred strain C57BL/6, pooled together and counted (6.7±0.4 
X106 cells/animal; 73.4±12.4% CD3 cells). A total of 21-30x10 6 cells were used in 
each experiment, of which 5-8x 106  cells were used fresh (fresh GO cells), and 16-22 
x106 were cultured in 24 well plates, at a concentration of 2x10 6/well. Three 
treatment conditions were considered: 
Fresh quiescent cells (GO fresh); 
Quiescent cells, cultured for 24h in 10% FCS medium (A.2.1; GO cultured) 
cells; 
Cells activated for 24h with 10% FCS medium, supplemented with 8ug/ml 
PHA (A.2.3) and 4nM IL-2 (A.2.4; Cycling). 
Cells from each treatment group were assigned to different staining groups (Table 
5.1) and processed for FACS analysis (Paragraph 2.9 and 2.10.2) or for 
immunocytochemistry (Paragraph 2.11). Number of replicates varied among staining 
conditions (Table 5.2). In cells processed for mHP1aIDAPI, M31JDAPI, M32IDAPI 
parameters defining morphological and total fluorescence features were acquired 
(Paragraph 5.12). Parameters defining features of clusters of fluorescence were also 
acquired for M3 1/DAPI staining, since this protein colocalises with pericentromeric 
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Table 5.1 Experimental design for chromatin experiments: staining/treatment 
group 





Activation markers FACS CD25, PT X X X 
FACS p27'/PI X - X 
IF PCNAIDAPI X X X 
IF D3/DAPI X - X 
Chromatin markers IF mHP1-cdDAPI X - X 
IF M31IDAPI X X X 
IF M32IDAPI X - X 
Chromatin/Activation IF M31/PCNA/DAPI X - X 
FACS/IF M31/CD25/DAPI X X X 
Table 5.2 Experimental design for chromatin experiments: staining/replicate 
Experiment Analysis Staining Replicate 
1 2 3 4 
Activation markers FACS CD25 +  , PT X X X - 
FACS p7KIPlfpJ x - - 
IF PCNAIDAPI X X X - 
IF D3/DAPI X - - 
Chromatin markers IF mHP1-a/DAPI X X(?) X X(?) 
IF M31IDAPI X X X X 
IF M32/DAPI X X(?) X X(?) 
Chromatin/Activation IF M31IPCNA/DAPI - - - 
FACS/IF M31/CD25IDAPI - - - 
Table 5.1 Cells were assigned to three treatment groups: freshly, isolated, quiescent 
cells (GO fresh); quiescent cells cultured for 24h in 10% FCS medium (GO cultured); 
cells activated for 24h with 8ug/mI PHA and 4nM IL-2 (Cycling). In some cases only 
one quiescent group was included in the analysis. 
Table 5.2 Staining were performed in 1-4 experiments. In some replicates gave 
inconsistent results (?), and were excluded from the analysis. 
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heterochromatin, and concentrates into clusters. The mHPla protein should also be 
organised in clusters, similarly to what observed for M31 (Kourmouli et al., 2000). 
However, in these experiments mHPla clusters were not as clear as the ones 
observed with M31 staining, maybe due to a background problem. M32 associates 
with non-constitutive heterochromatin and is evenly distributed throughout the 
nucleus, in a fine grain distribution (for review on HP! proteins see Paragraph 5.1). 
When analysing both total nuclear fluorescence and clusters of fluorescence, 
mean fluorescence and peak fluorescence were used as positive markers of chromatin 
condensation and SD of mean fluorescence was used as a negative marker of 
chromatin condensation. Fluorescence intensity was considered a measure of the 
level of expression of HP1 proteins. The area of fluorescence was a measure of the 
level of expression and the level of condensation of HP1 proteins. The number of 
clusters was used as measure of the tendency of M31 to concentrate in the 
pericentromeric regions. Cluster numbers :! ~ 1 indicated a dispersed nuclear 
distribution. 
The results of the M31 staining obtained in three replicates, were always 
very consistent. On the contrary staining for M32 and mHPla appeared to be less 
consistent, and in one replicate, no data were collected. When repeated for a fourth 
time M31 gave results consistent with previous experiments whereas M32 and 
mHPla still gave inconsistent results for inexplicable reasons. As a consequence of 
this results from M31 were collected in four replicates and results from M32 and 
mHPl(x staining, could be collected only in two replicates. 
In the first replicate different markers of T-cell activation were tested, trying 
to identify markers which gave us the clearest result and could be used in following 
experiments in combination with the chromatin staining. 
Staining for activation markers were performed as follows: 
Staining for CD25 and Propidium Iodide (P1; for Methods see Paragraph 
2.9), for FACS analysis; 
Double staining for p27KIP1/pj  (Methods Paragraph 2.9), for FACS analysis; 
Double staining for cyclin D3/DAPI (for Methods see Paragraph 2.11), for 
immunocytochemistry; 
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4) 	Double staining PCNAIDAPI (Methods Paragraph 2.11), for 
immunocytochemistry. 
CD25-R-PE and P1 staining were performed only on live cells, using gates 
(live gate; Paragraph 2.10.2) and parameters as in previous experiments (see 
Paragraph 4.4). 
For 27KIPl1pj  double staining parameters acquired included: 
Percentages of p27 k cells, calculated in the whole population of live cells 
(live gate; Paragraph 2.10.2); 
Percentages of p27 k cells, calculated only in diploid cells (GO/Gi cells gate; 
see Paragraph 2.10.2). 
Double staining with P1 made it possible to calculate the percentages of diploid, 
quiescent (p27 k) cells (GO) and diploid, non-quiescent (p2T) cells (Gi). 
For cyclin D3 and PCNA (Methods see Paragraph 2.11), analysis was performed 
using parameters and gates described elsewhere (Paragraph 2.12). 
Only the activation markers that gave us the best results in the first replicate 
would be used in the following two replicates as activation controls and would be 
correlated with the chromatin changes observed during activation. 
In the last replicate, the two activation markers selected in previous 
experiments were correlated with changes observed in the M31 staining. In view of 
the inconsistency of earlier results, M32 and mHPla were not correlated with 
activation markers. 
Staining included (for Methods see Paragraph 2.11): 
• 	M3 1 -FITC/PCNA-TXRJDAPI 
• 	M3 1 -FITC/CD25-PEIDAPI 
For each staining, three images and a total of 40 cells were acquired from 
two slides. Analysis was carried out using the parameters and gates described 
elsewhere (Paragraph 2.12). 
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5.2.3 Statistical analysis 
All data were transformed using a log transformation (mean fluorescence, 
peak, integral intensity), except data expressed as percentages, which were 
transformed using a Logit transformation. Choice between non-transformed and 
transformed data was made by comparing the normality of their distributions using 
residual fit plots (GenStat 4.21, Windows 2000). Treatment groups were compared 
using Student-t test for independent samples (Statistica 4.5, Windows 1995). A Chi-
square test was used to compare proportion of cells expressing p27 Pl 
5.2.4 Results 
Morphological features T-cells changed dramatically according to their 
activation state (Fig.5. 1). Quiescent cells, either fresh or cultured, were significantly 
smaller than cycling cells, activated for 48h. Since most of the cell area of T-cells is 
occupied by the nucleus, changes in cell size mainly reflected changes in the size of 
the nucleus. The percentage of cell area occupied by the nucleus was very high in all 
groups, ranging from 70.8%, in activated cells, to 81.4% and 82.8%, respectively in 
cultured and freshly isolated, quiescent cells. Similarly cell: nuclear ratios were very 
low ranging from 1.23 an 1.26, respectively in fresh and cultured quiescent cells, to 
1.44 in cycling cells. As a result of this, not only the cell size, but also the nuclear 
size of quiescent T-cells, either fresh or cultured, was significantly smaller than that 
of cycling cells. Culture of T-cells in the absence of mitogens also increased their 
cell size and nuclear size, however this increase was of a significantly lower 
magnitude than that triggered by mitogenic activation. Finally, although the increase 
in cell size induced by T-cell activation was associated with a significant increase in 
nuclear size, it was also the result of an increase in cytoplasm volume, as shown by 
the increase in the cell: nuclear ratio (1.44) significantly higher than that of quiescent 
cells (1.23-1.26). This might have resulted from the increase in cytoplasmic (protein 
synthesis) as well as nuclear activities (replication/transcription) associated with T-
cell activation. 
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Figure 5.1 Cell morphology of quiescent (GO) and cycling lymphocytes 
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GO (fresh) 	GO (cultured) 	Cycling (activated) + + + 
Nuclear area (%) 82.8±1.6' 81.4±1.8 k' 
Cell/Nucleus 1.23±0.03 a 1.26±0.03a 1.44±0.03b 
Nuclear area 3962±55a 4472±1 00' 7054±280c 
Cell area 4864±75k' 5565±143 b 10022±386c 
Brightfield images comparing freshly isolated T-cells (GO fresh), quiescent T-cells that had 
been cultured for 48h in 10% FCS medium (GO cultured), and T-cells that had been activated 
for 48h with 8ug/ml PHA and 4nM IL-2 (Cycling). Data were obtained analysing 40 cells from 
3 images collected in three experiments and are expressed as mean±SEM (t-test for independent 
samples). Data within rows with different superscripts differ significantly (p<0.05). 
Immunostaining for M31 (Fig.5.2), the mouse homologue of human HP13, showed 
that the nucleus of quiescent cells, either cultured or freshly isolated, contained 
clusters of M31, colocalised with patches of condensed chromatin (DAPI). On the 
contrary both M31 and the chromatin (DAPI) were dispersed in the nucleus of 
activated cells. This observation was confirmed by image analysis (for Methods see 
Paragraph 2.11). Analysis of total nuclear fluorescence showed that quiescent cells 
had significantly lower fluorescence intensity, therefore less M31 content, than 
activated cells (Fig. 5.2). This was probably a result of the smaller size of their 
nucleus (Fig. 5.1). However, M31 appeared to be more concentrated in quiescent 
cells, as confirmed by their significantly higher values of mean fluorescence, SD and 
peak fluorescence compared to activated cells (Fig. 5.2). Cultured quiescent cells 
contained the same quantity of M31 as freshly isolated quiescent cells (Fig.5.2) but 
in a larger nucleus (Fig. 5.1). This explains why the mean intensity and peak 
intensity of cultured quiescent cells was intermediate between that of freshly isolated 
and activated cells and their SD was lower (Fig.5.2). These data suggest that culture 
in itself might have a marginal effect on chromatin condensation, though not as high 
as that induced by activation. Cluster analysis confirmed the tendency of chromatin 
and M31 to condense into clusters in quiescent cells and be dispersed in activated 
cells (Fig. 5.2). Data showed that quiescent cells contained an average of 3.2-4.0 
clusters of M31, whereas activated cells only contained a diffused form of M31 
(cluster n° :~ 1). The intensity of the fluorescence of clusters of M31 was similar in all 
groups, but concentrated over a significantly smaller area in quiescent cells (30.3%-
34.5%) compared to activated cells (40.9%; Fig.5.2). As a consequence of this M31 
clusters found in quiescent cells had a higher mean fluorescence and peak 
fluorescence compared to activated cells (Fig.5.2). Cultured quiescent cells had a 
peak cluster intensity intermediate between that of freshly isolated and activated cells 
and a lower SD, suggesting, once more, a possible effect of culture on chromatin 
condensation. In conclusion the analysis of the clusters of M31 confirmed what 
observed when considering total nuclear fluorescence. 
The protein mHPla, mouse homologue of human hHPla, also appeared to 
be more concentrated in quiescent cells and dispersed in activated cells (Fig.5.3). In 
contrast to earlier reports (Kourmouli et al., 2000), mHPla appeared to be only 
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Figure 5.2 Chromatin conformation of T-cells: immunostaining for M31 





Merge I E 
Nuclear GO 	I ruli) (M (cultured) 	Cycling - 
Fluorescence 1 2 	 3 1 vs 3 2 vs 3 	1 vs 2 
%area FL 100.00±0.00 100.00±0.01 100.00±0.00 p>0 . 5 p>0 . 5 p>0 . 5 
Mean 93.2±5.1 83.6±3.6 79.5±3.8 n p0.498 pO.12O 
SD 39.2±1.8 19.6±1.3 33.1±1.8 p H 
Intensity 367814±19350 372969±19974 545615±28894 '0.0001 p 	h 	J00 p0.590 
Peak 240.3±4.8 216.2±5.5 181.6±6.3 p 	0.0001 pH0.0001 H 13 
Cluster 
Fluorescence  
Cluster n' 3.2± 0.2 4.0±0.3 0.1±0.1 p pO.' p0.034 
% area Fl 34.5±4.1 30.3±3.1 40.9±3.9 p'0.271 p=0.040 p=0.415 
Mean 152±2 132±3 80±7 p0.696 p0.333 p=0.485 
SD 39.2±1.8 19.6±1.3 33.1±1.8 I I' ____ 
Intensity 213574±24632 1 189902±22429 230368±34368 p0.881 p=0 .980 p 0 . 088 
Peak 240±5 1220±5 153±8 1 p 	H 
Epifluorescent images of T-cells double stained with FITC-conjugated anti-M31 antibody 
(ctM3l-FITC) and DAPI, represented with a pseudo colour red. M31 was condensed into large 
clusters (pericentromenc heterochromatin) in freshly isolated GO cells and dispersed in cycling 
T-cells, activated with 8ug/ml PHA and 4nM IL-2. T-cells cultured for 48h in medium alone 
(GO cultured) were included as controls. Data summarised in the table were obtained from 40 
cells (x63 objective) acquired from 3 images (for Methods see Paragraphs 2.11-2.12, Fig.2.7). 
Data, collected in three experiments, are expressed as mean±SEM (t-test for independent 
samples; a=0.05; GenStat 4.5, Windows 1995). 
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partially organised in large clusters, colocalised with areas of heterochromatin 
(DAPI), and partially organised in smaller clusters, scattered throughout the nucleus. 
For this reason cluster analysis was omitted. Analysis of nuclear fluorescence 
confirmed the tendency of mHPla to be more condensed in quiescent cells 
compared to activated cells. Quiescent cells had a significantly lower intensity, 
therefore mHPlct content, than activated cells, possibly as a result of their smaller 
nuclear size (Fig.5.3). However quiescent cells had significantly higher peak 
fluorescence and a higher mean fluorescence and SD compared to activated cells 
(Fig.5.3). These data suggested the tendency of mHPlct to exist in a concentrated 
form in quiescent cells and in a dispersed form in non-quiescent cells. 
Immunostaining for M32 (Fig. 5.4), the mouse homologue of human hHPly, 
showed that M32 had the tendency to organise in small clusters, with the appearance 
of speckles, scattered throughout the nucleus. These speckles were very clear in 
quiescent cells, where the chromatin and M32 were more condensed, but disappeared 
in activated cells, where the chromatin and M32 were more dispersed. Image 
analysis showed that quiescent cells had significantly lower fluorescence intensity, 
therefore M32 content, than activated cells (Fig. 5.4). This may be due to the lower 
nuclear size of quiescent cells compared to activated cells (Fig. 5.1). However M32 
appeared to be more concentrated in quiescent cells as demonstrated by the 
significantly higher mean fluorescence, peak fluorescence and SD values, found in 
GO cells compared to activated cells. 
The analysis of activation markers confirmed efficiency of CD25 and 
Propidium Iodide (P1) staining (Chapter 4) as T-cell activation controls. Freshly 
isolated and cultured quiescent cells had significantly higher percentages of GO/GI 
cells than activated cells and significantly lower percentages of cells in S-phase 
compared to activated cells (Table 5.3). The percentages of G2IM cells found in 
freshly isolated cells, were also significantly lower than those found in activated cells 
and similar to those observed in cultured quiescent cells (Table 5.3). In quiescent 
cells, both freshly isolated and cultured, the percentages of CD25 cells and CD25 
mean fluorescence were significantly lower than those found in activated cells, 
indicating a very good level of activation in this set of experiments (Table 5.3). 
There was no significant difference in the percentage of CD25 cells and mean 
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Figure 5.3 Chromatin conformation of lymphocytes: immunostaining for mllPla 
GO (fresh) 	 Cv cling (Activated) 
DAPI r lIjuii7 
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p- 0.000 I 
 -0.0121 
 h(10 1 
Cell morphology 	GO (fresh) 	 Cycling 	 p 
Nuclear Area 44502±143 7811±364 
Cell Area 	 5607±171 	 10495±478 
p 
Nucleus (%) 78.5±0.6 74.8±1.2 p 
Cell/Nucleus 1.28±0.01 1.35±0.03 p ftL 
Nuclear 
Fluorescence 
Intensity 267374±28032 431243±29171 
 
Epifluorescent images of T-cells double stained with FITC conjugated anti-mHPlcx-
antibody (amHPlcx-FITC), and DAPI represented with a pseudo colour red. mFIPla is 
condensed in large clusters (pericentromeric heterochromatin) and small speckles in ) in 
freshly isolated GO cells and dispersed in cycling T-cells, activated with 8ug/ml PHA and 
4nM IL-2. Data summarised in the table were obtained from 40 cells (x63 objective) 
acquired from 3 images (for Methods see Paragraphs 2.11-2.12, Fig.2.7). Data, collected 
in three experiments, are expressed as mean±SEM (t-test for independent samples; 
(t=0.05; GenStat 4.5, Windows 1995). 
Mean Intensity 59±4 56±3 p=O.77 
SD 21.0±1.5 17.5±1.3 pO.O89 
Peak 181±8 129±7  
Area 
Fluorescence 
100.0±0.0 100.0±0.0 p>0. 5 
173 
Figure 5.4 Chromatin conformation of lymphocytes: immunostaining for M32 







_ p - 
Merge 
Cell morphology 	GO (fresh) 	 Cycling 	 p 
Nuclear Area 	 4199±153 7413±281 p 
Cell Area 5396±291 	 12432±488  
Nucleus (%) 	 79.1±0.9 61.3±2.1 	1)<0.000I 
Cell/Nucleus 1.27±0.02 	 1.72±0.07 p<O.00() I 
Nuclear Fluorescence  
Intensity 	 122138±6260 	311981±59147 	p<0 . 0001 
Mean Intensity 	 62.7±3.4 17.0±1.1 V0.0001 
SD 	 21.3±1.5 	 5.5±0.8 	p< 0 . 000 I 
Peak 166.6±8.9 53.0±7.1 P<- 0. 0001 
Paragraphs 2.11-2.12, Fig.2.7). Data, collected in three experi ments, are expressed as 
mean±SEM (t-test for independent samples; a=0.05; GenStat 4.5, Windows 1995). 
Epifluorescent images of T-cells double with FITC conjugated anti-M32 antibody 
(aM32-FITC) and DAPI, represented with a pseudo colour red. M32 is condensed into 
speckles (facultative heterochromatin) in freshly isolated GO cells and dispersed in 
cycling T-cells, activated with 8ug/ml PHA and 4nM IL-2. Data summarised in the table 
were obtained from 40 cells (x63 objective) acquired from 3 images (for Methods see 
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% area fluorescence 99.9±0.3 100.0±0.0 p>0. 5 
fluorescence between freshly isolated and cultured quiescent cells, although they 
seemed to have higher percentages of G2IM and S-phase cells, and lower 
percentages of GO/G1 cells (Table 5.3). 
Results of the double staining with anti-p27'/PI showed that the 
percentages of p27 k cells were significantly higher in freshly isolated, quiescent cells 
than in activated cells (Table 5.4). This difference was even greater when 
considering only the diploid cell population (GO/Gi; Table 5.4). In this case 88.9% 
of diploid, quiescent cells (GO/G 1) were in GO (p27 k) and 11.1% appeared to be in 
GI (p27 -). Of the diploid cells (GO/Gi), in the activated cell population, 40.5±% 
were in GO (p27k) and 59.5% were in GI (p27 -). The p27 staining showed a 
reduction of quiescent cells after activation. However, the percentages of p27 k 
(65.2%) found in activated cells appeared to be exceedingly high, especially when 
compared to the percentage of CD25 cells found in the same cell population 
(11.1%). This might result from the fact that intracellular staining is not ideal for 
FACS analysis because of high background problems leading to false positives. 
PCNA appeared to be a very reliable marker of T-cell activation (non-
quiescence): quiescent cells, both fresh and cultured, had significantly lower 
percentages of PCNA cells compared to cycling cells (Fig.5.5). There was no 
difference in the percentage of PCNA cells found in cultured and freshly isolated, 
quiescent cells (Fig.5.5). 
The percentages of D3 cells were significantly lower in cultured quiescent 
cells compared to activated cells (Fig.5.5). Quiescent cells also had significantly 
lower values of intensity associated with lower values of mean fluorescence, and 
peak fluorescence suggesting that GO cells contained less cyclin D3 than activated 
cells (Fig.5.5). Analysis of cyclin D3 nuclear and cytoplasmic fluorescence, showed 
that GO cells contained less cyclin D3 in the nucleus, where the cyclin is present in 
an active form, while maintaining similar levels of cyclin D3 in the cytoplasm, where 
the protein is not active (Fig.5.5). This observation together with the high 
percentages of D3 cells found in the GO cell population, suggests that, when using 
cyclin D3 as a negative marker of quiescence, discriminating between D3 and D3 
cells may not be enough and may require further discrimination of D3 cells with or 
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3 1vs3 Ivs2 2vs3 
CD25+ (%) 3.7±0.5 11.4±4.1 88.8±3.4 ft =0.14 
Fluorescence 62.9±10.5 65.7±14.8 290.4±6.7 <0.00W =0.87 0,()001 
G0/G1 (%) 93.7±0.3 82.8±2.2 57.9±1.9 <0.0001 <0.000 
S(%) 0.7±0.1 5.6±0.9 28.8±1.6 0.0001 0W4 
G2/M (%) 5.6±0.3 11.5±1.3 13.3±0.3 <0.005 (040 =0.26 
Apoptosis 1.1±0.6 31.5±5.7 18.3±0.2 () 000  01Ui1)1 =0.28 
Results from three replicate experiments (10000 events/replicate). Data are expressed as 
Mean±SEM (t-test for independent samples, a=0.05). 






p27+ (% Total cells) 87.6 65.2 p<:0.0(.)1 
p27+ (% GO/GI cells) 88.9 40.5 p<O.I)Ol 
GO/GI (%) 90.2 65.3 p- 0.00I 
S(%) 1.1 22.0 p<00fl 
G2/M (%) 8.7 12.7 p>0.05 
Results from a single experiment (10000 events). Data are expressed as Mean±SEM 
(Chi-square test, cx=0.05). 
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Figure 5.5 Activation control for chromatin experiments: PCNA and cyclin D3 




GO (cultured) 	Cycling (activated) 	 p 
D3+(%) 	24.0±2.4 	38.8±1.9 	 pUJ)2 
Cell 	Intensity 	145464±20256 	493291±52024 	p<0Ut) I 
Mean 48.5±6.2 	87.7±6.5 	 P<O• 001 
SD 	26.2±2.7 38.2±3.1 P<0 • 005 
Peak 164.1±13.5 	208.3±9.1 	 P 
%Area Fl 	94.6±2.5 100.0±0.0 P 0 .053 
Nucleus 	Intensity 92422±13280 	394272±43834 	 11. 
Mean 	47.1±6.0 	104.2±7.6 	 pOO() I 
SD 17.1±2.4 30.5±2.3 p 
Peak 	132.8±14.1 	205.7±9.6 	 P 
%AreaFl 	98.0±1.3 100.0±0.0 P 038 
Cytoplasm 	Intensity 53042±7709 	99019±11504 	 p 
Mean 	52.1±6.8 56.2±5.7 	 P=O. 109 
%Area Fl 90.1±4.0 	97.1±2.5  





1 vs 3 
p 
1 vs 2 
p 
2 vs 3 
PCNA+(%) 0.6± 0.1 2.5± 0.6 40.7± 2.1 =0.13 
 I slide/replicate. 
T-cells double stained with FITC conjugated anti-cyclin D3 ((x-D3-FITC) antibody or Texas red 
conjugated anti-PCNA ((x-PCNA-TXR) and DAPI. Quiescent cells are PCNA, with cyclin D3 only 
in the cytoplasm (Cy). Activated cells are PCNA, with cyclin D3 in the nucleus (Nu) or in the 
whole cell. Data summarised in the tables are expressed as mean±SEM (1-way ANOVA, for 
%PCNA* and %D3; t-test for independent samples, for others; (x=0.05). Fluorescence values were 
acquired on 40 cells taken from 3 images obtained in 1 (D3) or 3 experiments (PCNA). Percentages 
of PCNA+ and cyclin D3+ cells were calculated on 200 counts! 3 fields/slide, with 
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without nuclear staining. For these reasons PCNA appeared to be a more direct and 
less subjective marker of T-cell activation. 
The activation markers CD25 and PCNA were selected and were correlated 
with the chromatin marker M31 that had given the most consistent results. 
Results of the FACS analysis of cells double stained with M31 and CD25 
(Fig.5.6) confirmed that quiescent cells, both fresh and cultured, had lower 
percentages of CD25 cells, and lower levels of CD25 expression/cell (mean 
fluorescence), than activated cells (Fig.5.6A). Microscopic evaluation (Fig.5.613) of 
CD25 expression also confirmed that GO cells had lower percentages of CD25 cells 
(4/40, 10%) than activated cells (21/40, 52.5%). Discrepancies between the 
percentages of CD25 cells obtained by FACS analysis and by microscopic 
evaluation, especially in the activated group (78.9% vs 52.5%), may be due to 
damage of the CD25 surface marker during fixation of samples for FACS analysis. 
Changes in CD25 expression were associated with changes in chromatin status 
(Fig.5.6B and Table 5.5A). Quiescent cells were mostly CD25 and, at the same time, 
were characterised by patches of condensed chromatin and clusters of M31 (high 
intensity/small nuclear area; high mean fluorescence, peak fluorescence and SD; high 
cluster number). Activated cells were mainly CD25 and characterised by dispersed 
chromatin and dispersed M31 distribution (high intensity/large nuclear area; low 
mean fluorescence, peak fluorescence and SD; no clusters). To further prove the 
correlation between CD25 expression and chromatin status, chromatin features of 
CD25 and CD25 cells, were compared (Table 5.5B). Results showed that CD25 
cells had a chromatin status (condensed) and a nuclear distribution of M31 similar to 
that of GO cells (high intensity/small nuclear area; high mean fluorescence, peak and 
SD; high cluster number). Results also showed that CD25 cells had a chromatin 
status (dispersed) similar to that found in activated cells (high intensity/large nuclear 
area; low mean fluorescence, peak fluorescence and SD; no clusters). 
Results of the double staining with M31 and PCNA confirmed the good 
level of activation in this experiment (Fig.5.7-Table 5.6). Only 5% of freshly isolated 
quiescent cells were PCNA, while 60% of activated cells were PCNA (Table 5.6A). 
All the fluorescence parameters of the PCNA-TXR staining (intensity, mean, peak, 
SD) were also significantly lower in quiescent cells than in activated cells (Table 
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Figure 5.6A CD25 expression assessed by FACS analysis. 
Figure 5.613 Triple staining for FITC conjugated anti-M31 antibody (aM3 l-FITC), PE-
conjugated anti-CD25 (aCD25-PE) antibody and DAPI, represented here with a 
pseudo-colour red. GO cells do not express CD25 and have M31 condensed in large 
clusters (pericentromeric heterochromatin). Activated cells express CD25 and dispersed 
M3 1. 
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3 1 vs 3 2 vs 3 1 vs 2 
Nuclear Area 4363±111 4603±154 9511±549 ftI))1  0.435 
Cell Area 5645±126 6456±148 13320±710 0()l H 	H 1L()l 
Nucleus (%) 77.3±0.8 70.8±1.3 71.8±1.4 =0.471 10002 
Cell/Nucleus 1.30±0.01 1.43±0.03 1.41±0.03 0.002 =0.615 0.0003 
Nuclear 
fluorescence  
FITC-Intensity 422389±14199 383921±19231 431358±42339 0.21 0.16 0.88 
FITC-Mean 97.9±3.2 
Intensity  
86.5±4.5 46.3±3.4 I 	I 0.060 
FITC-SD 40.5±1.4 38.9±1.5 18.7±1.5 0001 0.0001 =0.0455 
FITC-Peak 235±3.8 216±5.5 131±9.9 ftOl <0.0001 =0.210 
Clusters (n°) 3.30±0.30 2.80±0.20 0.20±0.02 0.0001 I <0.123 




CD25 CD25 p 
Nuclear Area 6066±377 8854±865 
Cell Area 8256±559 12182±1132  
Nucleus (%) 75.3±1.0 72.9±1.5 =0.203 
Cell/Nucleus 1.34±0.02 1.39±0.03 =0.249 
Nuclear 
Fluorescence  
FITC-Intensity 407222±18199 470108±58276 =0.196 
FITC-Mean Intensity 78.0±4.5 59.0±6.0 =0.0 179 
FITC-SD 32.7±1.9 22.7±2.2 H 
FITC-Peak 193.2±9.1 159.7±14.1 =0.0488 
Clusters (n°) 2.49±0.29 0.39±0.03 
Table 5.5A-Table 5.513 Results of triple staining with uM3 I -FITC, cxCD25-PE and 
DAPI. Data were obtained from 40 cells acquired from 3 images (x630) collected in 
one replicate experiment. Data are expressed as mean±SEM, and were analysed using 
a t-test for independent samples (ct=0.05). 
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5.6A). Results (Table 5.6A) showed that fresh, quiescent cells were mainly PCNK 
and, at the same time, were characterised by patches of heterochromatin (DAPI) 
associated with clusters of M31-FITC. as indicated by the nuclear fluorescence 
parameters (high intensity/small nucleus, high mean fluorescence, peak, SD and 
number of clusters). Activated cells (Table 5.6A) were mostly PCNA and 
characterised by dispersed chromatin and dispersed M3 1 -FITC distribution as 
indicated by the nuclear fluorescence parameters (high intensity/large nucleus, low 
mean fluorescence, peak and SD, absence of clusters). To further prove the 
correlation between PCNA expression and chromatin status, chromatin features of 
PCNA and PCNK cells, were compared (Table 5.613). PCNA cells coupled low 
PCNA-TXR expression levels (low intensity, mean, peak, SD) with a condensed 
M3 1 -FITC distribution, similar to that of GO cells (low intensity/small nuclear area; 
high mean Iluorescence, peak and SD: high cluster number). PCNA cells coupled 
high PCNA-TXR expression levels (high intensity, mean, peak, and SD) with a 
dispersed M31 distribution, similar to that found in activated cells (high 
intensity/large nuclear area; low mean fluorescence, peak fluorescence and SD; no 
clusters). 
5.2.5 Conclusions 
Previous nuclear transfer experiments suggested that smaller cells might 
have a greater potential for NT than larger ones (development to term 2.2% vs 0.7%; 
Wakayama et al., 1999). These experiments confirmed that cell size, at least in the 
lymphocyte model, depends on the nuclear size that is greatly affected by the 
activation state. Quiescent cells had a smaller nucleus, and therefore a smaller cell 
size, than activated cells. This is due to the fact that nuclear size is affected by 
ploidy: diploid cells (G07G1) have a smaller nucleus than cycling cells (S, G2/M). 
Quiescent cells are mainly diploid while activated cells have high percentages of 
cells in G2/M and S-phase. Nuclear size might also be affected by the dramatic 
differences in chromatin conformation observed in quiescent and activated cells. 
Immunostaining with anti-HPI antibodies (anti-mHPlcx, anti-M31, anti-




a-M3 1 -FITC 




Cells triple stained with FITC conjugated anti-M31 antibody (uM31-FITC), TXR-
conjugated anti-PCNA ((xPCNA-TXR) antibody and DAPI. GO cells are PCNA- and 
with M31 condensed in large clusters (pericentromenc heterochromatin). Activated 
cells are PCNA and with dispersed 31. 






Nuclear Area 4022±145 7283±501 ().000l 
Cell Area 5303±212 10015±682 0.00()1 
Nucleus (%) 76.6±1.2 72.8±0.9 0.0I)5') 
Cell/Nucleus 1.32±0.03 1.38±0.02 0.052 
M31 fluorescence  
Intensity 310918±20317 317177±22929 0.649 
Mean Intensity 77.8±4.2 49.2±4.2 0.0(101 
SD 32.9±1.7 23.4±2.3 00002 
Peak 199.4±6.4 136.3±9.7 1 0.0001 
Clusters (n°) 2.92±0.29 0.17±0.09 0.00W 
PCNA fluorescence  
Intensity 62671±38720 342767±45655 <.().0001 
Mean Intensity 11.2±4.6 42.5±4.1 0,0001 
SD 4.9±1.3 13.0±1.2 0.000I 
Peak 29.6±7.5 90.5±7.2 <0 fl()1)l 
PCNA+ (%) 5% 60% - 
Table 5.6B Results of M31/PCNA staining: comparison of PCNAand PCNAcells 
Cell 
morphology  
PCNK PCNA p 
Nuclear Area 4314±248 8433±502 <0.0001 
Cell Area 5772±345 11578±689 <0.0001 
Nucleus (%) 75.4±0.9 73.1±1.2 0.128 
Cell!Nucleus 1.34±0.02 1.38±0.02 0.246 
M31 fluorescence  
Intensity 293306±17742 357126±27548 0.0462 
Mean Intensity 73.3±4.3 42.9±2.5  
SD 32.5±1.9 19.0±1.6 I 
Peak 188.7±7.9 124.4±7.9 --0.000 1 
Clusters (n°) 2.24±0.29 0.12±0.08 0.0001 
PCNA fluorescence  
Intensity 32800±6899 555628±59170 <0.0001 
Mean Intensity 11.2±4.6 42.2±4.1 <()0001 
SD 4.9±1.3 13.0±1.2 
Peak 29.6±7.5  90.5±7.9 
Table 5.6 A-B show data acquired from cells triple stained with aM31-FITC, 
aPCNA-TXR and DAPI. Data were obtained from 40 cells acquired from 3 images 
(x630) collected in one replicate experiment. Data are expressed as mean±SEM, and 
were analysed using a t-test for independent samples ((0.05). 
proteins in GO cells compared to activated cells. However, as confirmed by 
image analysis, quiescence induced dramatic changes in the distribution patterns of 
these proteins. In GO cells, HP1 proteins had a tendency to concentrate in clusters, 
whereas in activated cells they have a dispersed distribution. These studies showed 
that the nucleus of quiescent cells is characterised by large clusters of M31 and 
mHPlcx proteins, colocalised with patches of pericentromeric, constitutive 
heterochromatin, and smaller clusters (speckles) of M32, colocalised with areas of 
non-constitutive heterochromatin. After activation, as nuclear size increased and 
chromatin decondensed, M31, mHPl(x and M32 also acquired a dispersed 
distribution. The differences in chromatin status observed in quiescent and non-
quiescent cells are likely to be one of the regulatory mechanisms involved in gene 
silencing during quiescence. 
Staining with the four activation markers of choice, three positive markers 
of activation led to the following conclusions: 
All markers showed a significant difference between quiescent and non-
quiescent cells, confirming the good activation level achieved in these 
experiments; 
Percentages of cells expressing positive markers of activation (CD25, cyclin 
D3, PCNA) and their levels of expression were significantly lower in 
quiescent cells than in activated cells; 
Percentages of cells expressing the negative marker of activation (p271"IP1) 
was significantly higher in quiescent cells compared to activated cells and 
this difference was even greater when only diploid cells (2N) were included 
in the analysis; 
CD25 and PCNA were considered as the most reliable markers of activation 
and were correlated with markers of chromatin status; 
The shifts observed in the activation markers during exit from quiescence and re-
entry into the cell cycle were associated with changes in chromatin status. 
Quiescent cells contained smaller quantities of HP 1 proteins (M3 1, MEP 1 a, 
M32) compared to activated cells but in a more condensed form, which tended to 
associate with areas of condensed chromatin (DAPI). 
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Quiescent cells, fresh and/or cultured, were characterised by clusters of M31 
and in some cases mHPlct, colocalised with patches of pericentromeric, constitutive 
heterochromatin (DAPI). The nucleus of quiescent cells also contained small clusters 
of M32, with speckled appearance, possibly colocalised with areas of non-
constitutive heterochromatin (DAPI). 
Activated cells were characterised by a dispersed chromatin status of 
pericentromeric, constitutive heterochromatin and non-constitutive heterochromatin. 
Changes in chromatin status were associated with dispersion of all three HP1 
proteins (M31, mHPl(x, M32). 
Results of the triple staining for M31/CD25/DAPI and M31IPCNAJDAPI 
showed a negative correlation between activation and chromatin condensation and 
confirmed the strict correlation existing between the state of activation of 
lymphocytes and the chromatin status. Quiescent cells could be characterised as 
being CD257 M3 1condensed  and PCNA7M3 1condensed  whereas activated cells could be 
characterised as being CD25IM3 1dispersed  and PCNA4JM3 1dispersed  This correlation 
was otherwise confirmed by selecting PCNA and CD25 cells or PCNA and CD25 
cells and checking the M31 distribution. This confirmed once more the association 
CD257PCNA7M3 1condensed  and the association CD25/PCNA/M3 1dispersed 
These experiments highlighted the potential of M31 to act as a marker of the 
chromatin changes induced by quiescence. M31 was therefore selected to assess the 
impact of these changes on nuclear transfer. 
5.3 EFFECT OF QUIESCENCE ON HISTONE H4 
ACETYLATION 
5.3.1 Aim 
Assess the effect of quiescence on acetylation status of histone H4 on 
specific lysines (K5, K12), using specific antibodies (anti-H4.A6, anti-H4.Ac12) 
that are able to detect changes in acetylation associated with zygote gene activation 
in mouse embryos. The antibody H4.Ac2-4, that recognizes acetylation of lysines 2-4 
and had not been previously described in the literature, was also used in these 
lull 
experiments. Changes in acetylation were correlated with changes observed in the 
activation markers, CD25 and PCNA. 
5.3.2 Experimental design 
Experiments were carried out in three replicates. For each replicate T-cells 
were isolated from the lymph nodes of 4-8, six week old female mice of the inbred 
strain C57BL/6 (5.9±0.5 x106 cells /animal; CD3, 77.8±14.6%). 
A total of 19-21x10 6 cells were used in each replicate, of which 2.5-4.5 x106 
cells were used fresh (fresh, quiescent cells) and 16x 106  were cultured in 24 well 
plates, at a concentration of 2x10 6/well. Treatment groups included (Table 5.7): 
Fresh, quiescent cells (GO fresh); 
Quiescent cells, cultured 24h in 10% FCS medium (A.2.1; GO cultured) 
cells; cells activated 24h with 10% FCS medium, supplemented with 8ug/ml 
PHA (A.2.4) and 4nM IL-2 (A.2.5; Cycling). 
For some staining only one quiescent group was included (Table 5.7). 
For H4.Ac2-4, H4.Ac5, H4.Ac12 staining (Methods see Paragraph 2.11), 
nuclear area and features of nuclear fluorescence were analysed (Analysis see 
Paragraph 2.12). 
Only two activation markers were used in these experiments: PCNA 
staining (Methods see Paragraph 2.11); CD25 and P1 staining (Methods see 
Paragraph 2.12). Gates and parameters used for analysis were as previously 
described (Paragraphs 2.10-2.11). For CD25 and P1 analysis was carried out on total 
live cells (live gate) omitting CD3 gating (see Paragraph 4.4). 
An attempt was made to assess cells for activation and acetylation 
simultaneously by double staining them with PCNAIH4.Ac5 or H4.Ac12 or H4.Ac2-
4 and counter staining with DAPI. However, it was not possible to stain cells in this 
way. Negative interactions between anti-acetylated H4 and antibodies for 
functionally correlated molecules (RNA polymerase II; Worrad et at., 1995) have 
been described before. Acetylation is highly dependent on DNA replication, and is 
reduced by inhibitors of DNA synthesis (Worrad et at., 1995). DNA replication and 
pD1Sj 
Table 5.7 Experimental design for acetylation experiments: 
staining/treatment groups 
Experiment Analysis Staining GO GO Cycling 
(fresh) (cultured) 
Activation control FACS CD25 and PT X X X 
IF PCNA/DAPI X X X 
H4 Acetylation IF H4.Ac2-4 - X X 
IF H4.Ac5 - X X 
IF H4.Ac12 - X X 
Cells from were assigned to three treatment groups: freshly isolated, quiescent cells (GO 
fresh); quiescent cells, that had been cultured for 24h, in 10% FCS medium (GO 
cultured); cells that had been activated for 24h with 8ug/ml PHA and 4nM IL-2 
(Cycling). Samples were processed either for Immunocytochemistry (IF) or FACS 
analysis (See Paragraph 2.9-2.11 for Methods). 
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acetylation sites are also spatially correlated. In these experiments a similar nuclear 
distribution at the periphery of the nucleus (ring-like) has been observed in PCNA 
cells (Fig. 5.7, cycling cells) and cells stained for acetylation, especially H4.Ac2-4 
and H4.Ac12 (Fig.5.8). These observations suggest that negative interaction might be 
possible. No attempt was made to correlate CD25 and H4 acetylation markers. 
5.3.3 Statistical analysis 
All data were transformed using a log transformation (mean fluorescence, 
peak, integral intensity), except data expressed as percentages, which were 
transformed using a Logit transformation. Choice between non-transformed and 
transformed data was made by comparing the normality of their distributions using 
residual fit plots (GenStat 4.21, Windows 2000). Treatment groups were compared 
using Student-t test for independent samples (Statistica 4.5, Windows 1995; (x=0.05). 
5.3.4 Results 
Activation controls showed that T-cells responded very well to the 
activation protocol (Table 5.8; Table 5.9). Quiescent cells, fresh or cultured, was had 
lower percentages of CD25 cells, lower levels of CD25 expression and higher 
percentages of diploid cells (GO/Gi), than activated cells. Culture increased cell 
death rates regardless of the culture conditions (Table 5.8). However the percentages 
of apoptotic cells in culture were similar to those observed in previous experiments, 
if not lower (Fig. 4.9). 
PCNA staining also confirmed that quiescent cells, either fresh or cultured, 
were only occasionally PCNA (0.5-0.0%), while high percentages of activated cells 
were PCNA (Table 5.9). 
There was a dramatic difference in the acetylation level of histone H4, 
between quiescent and activated cells (Fig.5.8). Immunostaining with FITC 
conjugated antibodies recognizing acetylated histone H4 (H4.Ac2-4, H4.Ac5, 
H4.Ac12) resulted in a dull, green fluorescence staining in quiescent cells and a very 
bright, green fluorescence in activated cells. A peripheral nuclear distribution, similar 
to that described in mammalian embryos (Worrad et al., 1995) at the time of zygote 















Apoptosis 1.1±0.6 19.8±2.1 17±2  =0.75 
CD25 (%) 4.5±0.9 9.0±1.0 64±13 <0.005 =0.42  
Fluorescence 95.2±4.7 82.1±5.5 595±120 0.0005 0.57 <OJ0003 
Gi (%) 95.5±0.6 89.8±3.9 68.2±3.9 ()2 =0.14 <0.001 
S (%) 0.9±0.1 2.8±1.6 22.0±2.5 (1)01 =0.29 (I 	H11 
G2/M (%) 3.3±0.7 7.4±2.4 9.7±1.4 003 =0.12 =0.37 
Data were obtained analysing 10000 events/replicate in three replicate experiments. 
Data are expressed as Mean±SEM ( t-test for independent samples, a=0.05). 





Cycling 1 vs 3 1 vs 2 2 vs 3 
PCNA+(%) 0.5±0.0 0.0±0.0 35.7±0.6 <<<i 0.52 
Data were obtained analysing 200 cells/3 fields/replicate in three replicate 









Figure 5.8 Staining for histone H4 acetylation in T-lymphocytes 
Staining Parameter GO (cultured) Cycling p 
H4.AC2-4 Nuclear area (pixels) 4579±99 8815±384 I 
Intensity 43630±4590 961768±60717  
Mean 9.5±0.9 110.4±5.4  
SD 3.1±0.1 32.4±1.6 H 
Peak 28.2±4.9 206.0±7.0 '-0.001  
Area Fluorescence (%) 92.1±1.7 100.0±0.0 
H4.AC5 Nuclear area (pixels) 4219±220 4119±304 =0.431 
Intensity 36500±5632 122347±14503 
Mean 9.5±1.2 26.8±2.5 
SD 4.9±0.3 3.4±0.3  
Peak 32.7±5.3 50.0±4.4 
Area Fluorescence (%) 8 1.5±5.0 99.7±0.3  
H4.Ac12 Nuclear area (pixels) 3829±195 3863±184 =0.901 
Intensity 21535±3840 100003±8391  
Mean 5.3±0.8 25.6±1.6 <0.001 
SD (Mean I) 3.0±0.4 5.9±0.3 
Peak 23.9±3.9 62.1±3.9 O.00l 
Area Fluorescence (%) 72.2±5.7 99.±0.3 -()J)03 
Figure 5.8 shows cells double stained with FITC conjugated a114.Ac2-4, aH4.Ac5, and 
ctH4.Ac12 and DAPI (merge). GO cells are deacetylated and activated cells are 
hyperacetylated. Data in the table are expressed as mean±SEM (t-test for independent 
samples, a=0.05) and were obtained from 40 cells acquired from 3 images (x400), collected 
in three replicate experiment. 
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gene activation, was observed in activated cells (Fig. 5.8). This pattern was 
particularly clear when cells were stained with anti-H4.Ac2-4 and anti H4.Ac12 
antibodies. Histone acetylation is associated with transcriptional activation, therefore 
the observation that GO cells are deacetylated whereas activated cells are 
hyperacetylated complies with the observation that quiescent cells are 
transriptionally comparatively inert whereas cycling cells are transriptionally active. 
In all three staining (H4.Ac2-4, H4.Ac5, H4.Ac12), all the fluorescence parameters 
(intensity, mean, peak, SD of mean) considered were significantly lower in quiescent 
cells compared to activated cells (Fig.5.8). 
5.3.5 Conclusions 
Changes in the activation status of lymphocytes are associated with changes 
in the acetylation status of histone H4 on lysines K2-4, KS, K12. Quiescent cells are 
CD257PCNA and deacetylated, whereas activated cells are CD25/PCNA and 
hyperacetylated. Some of the antibodies used in this set of experiments (H4.Ac5/12) 
have been used to detect changes in acetylation patterns occurring in mouse embryos 
at the time of zygote gene activation (ZGA). Therefore they can be used to 
investigate the impact of quiescence-induced changes in H4 acetylation on the time 
of ZGA in cloned embryos. 
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CHAPTER 6 
EFFECT OF QUIESCENCE ON NUCLEAR 
TRANSFER 
6.1 INTRODUCTION 
The main aim of the experiments described in this chapter was to investigate 
if and how quiescence of donor cells might affect development of cloned embryos. 
There have been suggestions that quiescence of donor nuclei might improve 
development of cloned embryos. The first mammals cloned from somatic cells were 
produced using serum-starved, quiescent cells (Campbell et al., 1995; 1996b; Wilmut 
et al., 1997). Most successful somatic cell nuclear transfer experiments, in a variety 
of mammalian species, have been performed carried out using cultured or freshly 
isolated quiescent cells (Chapter 1, Table 1.1). However, up to date, there is still no 
conclusive evidence proving a direct link between quiescence and nuclear transfer 
efficiency. 
In the experiments described in this chapter donor T-cells synchronized in 
GO and Gi were used to investigate the effects of quiescence on the pre- and post-
implantation development of cloned embryos. The effect of quiescence on timing of 
Premature Chromosome Condensation (PCC) was also included in these 
developmental studies. 
PCC refers to the condensation of donor chromatin into chromosomes, 
within 2-3h after reconstruction, followed by chromatin decondensation, nuclear 
swelling and pronuclear (PN) formation. Earlier experiments in rabbits and mouse 
showed that PCC is a morphological expression of nuclear reprogramming and is 
strictly correlated with the developmental potential of cloned embryos (Collas et al., 
1992a, 1992b; Collas and Rob!, 1991; Cheong et al., 1994). Mouse nuclear transfer 
(NT) experiments with donor b!astomeres at the 2-cell stage showed that both PCC 
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and non-PCC embryos were able to support development to blastocyst but only PCC 
embryos were able to support development to term in 12.5% of cloned embryos 
(Cheong et al., 1994). Other studies in rabbits indicated that cell cycle stage of donor 
cells influenced FCC (Collas et al., 1992a) and that a strict correlation existed 
between cell cycle-mediated abnormalities observed during PCC and low 
developmental potential of transplants (Collas et al., 1992a, 1992b; Collas and Robl, 
1991). GI transplants had significantly higher rates of development to blastocyst 
(71%) and normal PCC morphology, with metaphase plates characterised by normal 
spindle morphology and chromosomes aligned at the equator of the spindle. On the 
contrary, S transplants had low developmental potential (15%) and abnormal PCC 
morphology with chromosomes located outside the spindle, adjacent to the front 
poles, and abnormal spindle morphology. The most common spindle abnormalities 
included microtubules radiating from the poles and/or the sides and multiple spindles 
(2-3). These studies suggested that donor cell cycle has a significant effect on very 
early stages of development of cloned embryos, such as PCC. These effects can 
result in chromosome and spindle abnormalities in transplant embryos that are 
responsible for impaired development during later stages of development (Collas and 
Robl, 1991). Abnormal features of PCC have also been described in cloned mouse 
embryos reconstructed using cumulus cell (Wakayama et al., 1998). In this case 
some of the embryos were unable to form a regular metaphase plate, correctly 
aligned at the equator, and single, condensed chromatids appeared to be attached to a 
single pole of the spindle. 
There is also some indirect evidence suggesting that quiescence might affect 
nuclear transfer efficiency by altering epigenetic status and gene expression in cloned 
embryos. Cloned embryos derived from quiescent cells have lower levels of 
expression of interferon Tau (IF-'r) gene, correlated with poor embryo quality 
(Wrenzicky et al., 2001). Furthermore, contact inhibition, a condition known to 
induce quiescence in cultured cells, reduced the methylation levels of imprinted 
genes (Baqir and Smith, 2000), often abnormally hypermethylated in cloned embryos 
(Inoue et al., 2002; Humpherys et al., 2001). 
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The experiments described in this chapter focused on histone H4 acetylation 
and chromatin conformation, and addressed the question whether epigenetic changes 
induced by quiescence in donor cells (Chapter 5) affected the epigenetic status of 
cloned embryos, after nuclear transfer, with potential effects on embryo 
development. 
Changes in chromatin conformation contribute in establishing epigenetic 
constraints during embryo development and differentiation (Leitch, 2000). Before 
fertilisation maternal chromatin is condensed in chromosomes with a nucleosomal 
structure and sperm chromatin, where most or all histones are replaced by 
protamines, appears as a highly compacted structure. At this stage maternal and 
paternal genomes are also transcriptionally inactive. After fertilisation, as a result of 
exposure to the ooplasm of Mll oocytes and gradual replacement of protamines with 
histones, the sperm chromatin decondenses (Perreault, 1992). After a transient re-
condensation and female pronucleus formation, the male pronucleus is formed. A 
phase of pronuclear swelling is followed by condensation into chromosomes at 
syngamy and, finally, karyo and cytokinesis (Adenot et al., 1991). 
Heterochromatin gene silencing also plays a pivotal role in cell type specific 
restriction of gene expression, as embryonic cells differentiate into somatic cells. 
Chromatin changes taking place during early embryo development and 
differentiation are mediated by remodelling networks, involving histone and non-
histone silencing proteins. In early embryos sperm protamines and the embryonic 
linker histone B4 are exchanged with core histones H2A and H2B and the somatic 
linker histone Hi (Clarke et al., 1998), mediated by the remodelling factor 
nucleoplasmin (Hiyoshi et al., 1991). As shown in Xenopus, eggs store large 
amounts of SWIISNF-like complex containing a BRG 1-like remodelling factor 
(Gelius et al., 1999). Early mouse embryos contain large amounts of SWIJSNF-like 
complexes containing BRM (SNF2 alpha) and BRG1 (SNF2 beta) remodelling 
factors (Dauvillier et al., 2001), mainly involved in vasculogenesis. Changes in 
chromatin non-histone silencing proteins play an important role in differentiation. In 
Xenopus embryos Polycomb proteins (xPcGl), involved in heterochromatin gene 
repression, accumulate as cells differentiate. There is a negative correlation between 
accumulation of xPcGi and cell totipotency, expressed as their ability to produce 
swimming tadpoles after nuclear transfer (Kikyo and Wolffe, 2000). Other 
transcription factors are involved in the differentiation of specific tissues specific 
manner. The activity of some zinc-finger proteins (e.g. Maros, Eos, Pegasus, Ailos) 
is, for example, restricted to chromatin changes that mediate lineage commitment 
and differentiation of haematopoietic stem cells into lymphocytes (Georgopoulos, 
2002). 
During reprogramming epigenetic restrictions to gene expression established 
during differentiation, including heterochromatin repression, have to be erased. 
There is increasing evidence supporting the central role played by remodelling 
networks in nuclear reprogramming (Kikyo and Woiffe, 2000; Renard, 1998; 
Cheong et al., 1994). Recent data demonstrated that nuclear swelling is the 
morphological expression of an exchange between cytoplasm and donor nucleus of 
molecules with chromatin remodelling properties (Kikyo and Wolffe, 2000). At the 
time of nuclear swelling about 85% of the proteins contained in the donor nucleus 
are lost and replaced by proteins coming from the recipient oocyte cytoplasm (Kikyo 
et al., 2000). When Xenopus epithelial cells are transferred to recipient oocytes Hi 
and Hl' linker histories are replaced by B4 embryonic linker histone and by the 
chromatin structural protein HMG1 (Dimitrov and Wolffe, 1996). Loss of 
immunoreactivity to Hi has been described also in cattle and it has been suggested as 
a marker of reprogramming (Bordignon et al., 1999; 2001). Removal of Hi and its 
replacement with B4IHMG1 is mediated by nucleoplasmin, in a reverse manner to 
what is observed during normal embryo development. The ATP-ase ISWI, contained 
in several SNF/S WI-like remodelling complexes, is also incorporated, as Hi is lost. 
On the contrary the MeCP2IRdb3/Sin3 that targets deacetylation and 
heterochromatin silencing to regions of methylated DNA, does not seem to be 
involved in nuclear reprogramming (Kikyo et al., 2000). 
Post-translational modifications of histones, that are affected by quiescence, 
also contribute to the restriction of gene expression during development and 
differentiation and might play an important role in nuclear reprogramming. 
In mouse, both maternal and paternal mature gametes are hypoacetylated 
(histone H4<3 acetylated lysines). However during early embryo development 
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(Adenot et al, 1997), before zygote gene activation (ZGA), paternal and maternal 
chromatin are differentially acetylated. The oocyte stores large quantities of 
diacetylated histone H4, which are preferentially incorporated into the sperm after 
fertilisation. Therefore, during Gi of the first cell cycle, the male pronucleus is 
hyperacetylated and transcriptionally more active than the female pronucleus, as 
confirmed by the fact that reporter genes are preferentially expressed when injected 
into the male pronucleus (Ram and Shultz, 1993). Differences in acetylation reflect 
differences in chromatin structure previously described in this paragraph. At the end 
of Gi of the first cell cycle, female and male pronuclei exhibit equivalent acetylation 
and chromatin structure. In the mouse, the time of zygote gene activation, which 
starts at the G2/S of the 1-cell stage (Latham et al., 1992) and is maximal at the 2-
cell stage (Schultz, 1993), is marked by the appearance of a typical acetylation 
pattern at the periphery of the nuclei. This peripheral staining pattern was observed 
when embryos were assessed for acetylation of H4 at lysines 8, 5, 12 (H4.Ac5/8/12; 
Worrad et al.,. 1995) and acetylation of histone H3 (Stein et al., 1997) on at lysines 9 
and/or 18 (H3.Ac9/18). However it was not observed when embryos were assessed 
for acetylation of histone H4 at lysine 16 (H4.Ac16; Wonad et al., 1995), suggesting 
different histone isoforms may play different roles during embryo development. 
Apart from this correlation between histone acetylation and transcriptional activation 
(ZGA), histone H4 deacetylation is often found in association with CpG methylation 
(Newell-Price et al., 2000), suggesting a possible implication in cell differentiation, 
genomic imprinting and X chromosome inactivation. Some imprinted genes, such as 
the U2afl-rsl in mouse, appear to be both methylated and deacetylated (Gregory et 
al., 2001; 2002). Furthermore, the level of acetylation of the inactive X chromosome 
is lower than the active X chromosome (Jeppesen and Turner, 1993). These data 
suggest that erasure of patterns of acetylationldeacetylation should also be a 
prerequisite of nuclear reprogramming. 
In conclusion the general aim of the experiments described in this chapter 
was to investigate the possible effect of quiescence on the epigenetic status of donor 
cells and its possible implications on nuclear reprogranmiing. The main focus was on 
the possible effect of quiescence on the expression and sub-nuclear localisation of 
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the chromodomain proteins belonging to the heterochromatin 1 (HP1) group, and on 
the acetylation status of histone H4. The HP1 proteins are very similar to the 
Polycomb group of proteins (Jones et al., 2000), which are both cell cycle regulated 
(Voncken et al, 1999) and developmentally regulated. The regulation of HP1 
proteins in relation to quiescence and embryo development is still unknown and so is 
its possible involvement in nuclear reprogramming. Effect of quiescence on histone 
acetylation has partially been investigated using electrophoresis (Pogo et al., 1966). 
However the present aim is to use specific antibodies, developed to investigate 
changes in histone H4 acetylation during early embryo development in mouse 
(Worrad et al., 1995) to correlate more specific changes in acetylation induced by 
cell quiescence with changes observed during reprogranmîing, after nuclear transfer. 
6.2 METHODS 
Donor T-cells in GO and Gi were produced using a protocol optimised in 
previous experiments (Paragraphs 4.4-4.5; Methods Paragraph 2.13.1). Cell yield, 
cell cycle and activation features of GO and G1/CD25 donor cells were assessed in 
the first three Nuclear Transfer experiments. Cell counts (mean±SEM) showed that 
in each NT experiment, an average of 34.7±13.0 x10 6 cells were seeded, 16.8±7.4 
X106 cells were harvested; 10.0±12.1 x10 6 were processed and 5.5±6.7 x106 (54.5%) 
were selected and used as G1/CD25 donor cells. FACS analysis confirmed 
quiescent state of GO donor cells, and non-quiescent state of G1/CD25 donor cells 
(Fig.6.1; Table 6.1). 
Donor T-cells were injected into enucleated M11 oocytes (for Methods see 
Paragraph 2.13.2). Reconstructed embryos were cultured in M16 medium for 72h, till 
the morulalblastocyst stage, and assessed for in vitro development (8 replicates; 
Methods see Paragraph 2.13.4) or fixed, at selected time points, and processed for 
immunocytochemistry (5-6 replicates; Methods see Paragraph 2.14). 
Double staining for chromatin (DAPI) and microtubules (FITC-anti--
tubulin, Methods see Paragraph 2.14), was used to assess timing of Premature 
Chromosome Condensation and spindle morphology. 
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Figure 6.1 Preparation of donor T-cells 
T- cells 
(Oh) 	 PHA+IL+HU (24h) 
I . 
CD25+ 	GO/G1 	 L CD 5+ L 	 GO/G1 
GO 	 Selection of 	G1/CD25+ 
CD25 by MACS 
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Table 6.1 Cell cycle features of GO and GI lymphocytes used in NT experiments 
Parameter GO G1/CD254 p 
CD3+ 85 . 7±2 . 6a 97.4±0 .9b <0.05 
CD25 (%) 17 .6±4 . la 93.3±l.&' <0.0001 
CD25 Mean FL 97±24a 474±151" 0.03 
GO/GI (%) 98 . 4±0 . 2a 94.8±1.4"  
S(%) 0 . 5±0. 2a 0 . 7±0 . 2a 0.55 
G2/M (%) 1 . 2±0 . 2a 4 .4±1 . 2 at 0.077 
Apoptosis 1 . 1±1 . la 8.0±1.1" 0.04 
Figure 6.1 GO donor cells were freshly isolated lymphocytes (GO, fresh). GI donor cells, were 
isolated from cultured 24h in medium supplemented with 1mM hydroxyurea (HU), 8ug/ml 
phytohemagglutinin (PHA) and 4nM interleukin 2 (IL-2). At the end of the incubation period GI 
cells were harvested and CD25 cells were positively selected using magnetic cell sorting 
(G I /CD25). 
Table 6.1 FACS analysis of donor cells stained with Propidium Iodide (cell cycle analyses) and 
anti-CD25 antibody. Results from three replicates experiments expressed as Mean±SEM. Data 
were transformed using a log (Mean Fluorescence) or logit transformation (%) and analysed using 
a T-test for independent samples ((x=0.05). 
To assess changes in histone H4 acetylation, in epigenetic studies, control fertilised 
embryos, cloned embryos and M11 oocytes were double stained for chromatin and 
histone H4 acetylation (DAPI/anti-H4.Ac double staining; Methods see Paragraph 
2.14), using a panel of polyclonal antibodies recognizing different acetylated 
isoforms of histone H4: anti-histone H4 acetylated on lysine 5 (anti-H4.Ac5), lysine 
8 (anti-H4.Ac8), lysine 12 (anti-H4.Ac12), lysine 16 (anti-H4.Ac16). Patterns of 
expression of these antibodies had been previously described in detail in cells 
(Thorne et al., 1990; Turner and Fellows 1989, Turner et al., 1989) as well as mouse 
embryos (Adenot et al., 1997; Worrad et al., 1995; Ma et al., 2001; Wiekowski et al., 
1997), but never in NT embryos. Sheep anti-serum to histone H4 acetylated on lysine 
2-4 (anti-H4.Ac 2-4), the patterns of expression of which had never been described 
before, was also used. Samples were then incubated with the corresponding FITC-
conjugated secondary antibodies and mounted using Vectashield antifade containing 
DAPI (Methods see Paragraph 2.14). 
Triple staining for chromatin, H4 acetylation and DNA replication 
(DAPI/anti-H4.Ac/PCNA triple staining) was also carried out on control, fertilised 
embryos collected and fixed at selected time points, but with very limited results 
(Methods see Paragraph 2.14). 
Changes in chromatin conformation mediated by HP1 proteins, in 
epigenetic studies, were assessed by triple staining for chromatin, M31 and DNA 
replication (DAPI/M3 1/PCNA, triple staining), carried out on whole mounts of Mu 
oocytes, control, fertilised embryos and NT embryos (Methods see Paragraph 2.14). 
For in vivo developmental studies (2 replicates), 2-cell embryos or 
morulalblastocyst stage embryos were transferred respectively to the oviducts or 
uterus of Swiss Webster foster mothers (Methods see Paragraph 2.13.4). Caesarean 
section of recipient females was carried out 19.5 days post coitus, to look for signs of 
implantation and foetal development. 
Nuclear transfer experiments with mouse embryonic stem cells were carried 
out in three replicates, in the same weeks in which T-cell nuclear transfer 
experiments were performed (Methods see Paragraph 2.13.6). The data from these 
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experiments were included to show efficiency rates of the nuclear transfer system 
used in our laboratory, in terms of rates of in vitro and in vivo development after 
reconstruction. 
Fertilised B6D2F1 embryos were used, in four experiments, as a control for 
epigenetic changes occurring during normal embryo development. Fertilised 
embryos, collected around the time of pronuclear formation (10-13 h.p.c.), were 
fixed and processed for immunostaining at selected time points (Methods see 
Paragraph 2.13.5-2.14). 
MIT oocytes were also included as activation controls (Methods see 
Paragraph 2.13.3) and immunostaining controls. 
6.3 EFFECT OF QUIESCENCE ON PREMATURE 
CHROMOSOME CONDENSATION 
6.3.1 Aim 
Investigate if quiescence has an effect on the timing of premature chromatin 
condensation (PCC) and on the morphology of the chromosomes and the spindle at 
the time of PCC. 
6.3.2 Experimental Design 
Experiments were carried out in two replicates. In each replicate embryos 
were reconstructed by injecting GO and G1/CD25 lymphocytes (2 treatment groups) 
derived from the lymph nodes of C57BL/6 mice, into MIT oocytes of B6D2F1 
(C57BL/6 x DBAI2) mice. In each replicate 30 embryos belonging to each of the two 
treatment groups, derived from GO or Gi-cells, were placed in culture in microdrops 
(15 embryos/30u1 drop) of complete M16 medium immediately after reconstruction. 
In each replicate, 3 embryos per treatment group were collected at 10mm, 30mm, lh, 
2h, 3h after reconstruction. Embryos were fixed and double stained with FITC 
conjugated anti-tubulin antibody (3-tubu1in-FITC), which stains in green the 
microtubules in the mitotic spindle, and Propidium Iodide (P1), that stains in red the 
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DNA. Embryonic chromatin was classified as being: condensed; organised in a 
metaphase plate; organised in individualized chromosomes. Furthermore, 
chromosomes could have a normal or abnormal appearance. Embryos could either 
have a spindle or not, and the spindle could have normal or abnormal features. In 
general early embryo development progressed through three stages: 1) condensed 
chromatin with asters but no spindle; 2) metaphase plate, associated with a mitotic 
spindle; 3) chromosomes migrating to the two poles of the mitotic spindle. 
Digitalized images were acquired using a confocal microscope (Nikon EFD3), a x 20 
objective, and the Confocal AssistantTM  program (Version 4.02; Todd Clark Brelje) 
and were edited using Adobe Photoshop program (Windows 2000). 
6.3.3 Results 
Results of double staining for 13-tubulin-FITCIPI suggest that events 
associated with early embryo development occur at an earlier time in GI-derived 
rather than GO-derived NT embryos (Fig.6.2-6.3). After 10mm (Fig.6.2/113) from 
reconstruction GI-derived embryos already had multiple asters, and by 30 mm 
(Fig.6.2/2B) microtubules started organizing in a mitotic spindle, even if the 
chromatin was still condensed. In GO-derived embryos multiple asters were visible 
30min after reconstruction (Fig.6.2/2A) and microtubules only appeared in 
association with the metaphase plate, lh after reconstruction (Fig.6.2/3A). At lh after 
reconstruction the situation was similar in both groups, with the 50% (3/6) of the 
embryos still with condensed chromatin, 33.3% (2/6) with metaphase plates and only 
16.7% (1/6) with individualized chromosomes (Fig.6.3). However, 2h after 
reconstruction, in the Gi-derived embryos, individualized chromosomes, migrating 
to the opposite poles of the mitotic spindle, were the predominant feature (4/6, 
66.6%) and the only feature (6/6, 100%) at 3h after reconstruction (Fig.6.3). On the 
contrary, in the GO-derived embryos, 50% (3/6) of the embryos were still at the 
metaphase plate stage at 2h after reconstruction, and chromosomes became the most 
represented feature (3/6, 50%) only 3h after reconstruction (Fig.6.3). Approximately 
1/3 of GO-derived embryos still had a condensed nucleus, that had not undergone 
PCC yet, 3 hours after reconstruction (Fig.6.3). In the Gi-group all embryos 
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Figure 6.2 Double staining with anti-tubulin-FITC and Propidium Iodide in GO- and Gi- derived NT embryos 
GO- (A) and Gl- (B) derived NT embryos stained with anti-tubulin-FITC (green) and Propidium Iodide (red) to assess chromatin con lbrmation 
and spindle morphology. Embryos were fixed and processed after 10 mm, 30 mm, 1 hour, 2hours and 3 hours after transfer to an enucleated Mu 
oocyte. Chromatin (red) could be condensed (1 A/B, 2A/B), organised in a metaphase plate (3A/B, 4A) or in individualised chromosomes (413, 
5A/B). Chromosomes usually looked abnormal, with their chromatids laying outside the mitotic spindle in a disorganised way. The first sign of 
spindle formation was the appearance of the asters (A). The Spindle (green) could have a normal (3A/B, 4A/B) or abnormal (5AIB) appearance. 
Images were taken using a confocal microscope and a x20 objective. 
Figure 6.3 Premature Chromosome Condensation (PCC) in GO and GI-derived NT embryos 
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At each time point 6 embryos (replicates=2), embryos fixed and were double stained with DAM (DNA staining) and FITC-anti-tubulin (spindle) 
antibodies at selected time point after reconstruction. Based on DNA staining, chromatin organisation levels: I) condensed; 2) organised in a 
metaphase plate, with individualised chromosomes just about visible. 
underwent full PCC by 3 hours after reconstruction. Finally 100% of individualized 
chromosomes (Fig.6.2/4B, Fig.6.2/5A-5B), regardless of the cell cycle stage of the 
donor cells, had abnormal features and were usually associated with abnormal 
spindles (double spindle, Fig.6.2/5A-5B). 
6.3.4 Conclusions 
This study showed that quiescence affected the timing of early embryonic 
events after NT, with regard to PCC. A longer delay ( ~!3h) between reconstruction 
and activation might be required if the cells are in a quiescent state, whereas a shorter 
delay (2h) should be enough for completion of PCC in GI -derived embryos. 
In this experiment failure to undergo PCC in 33.3% of GO-derived embryos, 
even at 3h after reconstruction might be associated with cell membrane retention. 
Failure to break the membrane of donor cells before injection is more likely to occur 
with GO cells as opposed to Gi cells because their smaller size makes it technically 
more demanding. 
Finally, abnormalities in chromosome and spindle morphology, both in GO 
and Gi-derived embryos, may account for some of the abnormalities in nuclear/cell 
segregation observed (abnormal karyokinesis and cytokinesis) observed in later 
stages of development (see Appendix B.1). 
6.4 EFFECT OF QUIESCENCE ON THE 
DEVELOPMENT OF CLONED EMBRYOS 
6.4.1 Aims 
Compare: 
In vitro developmental potential of GO and GI-derived NT-embryos 
(activation, cleavage, 4-cell, morulalblastocyst rates); 
In vivo developmental potential of GO- and Gi- NT embryos performing 2-
cell stage and blastocyst stage embryo transfers. 
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6.4.2 Experimental Design 
A total of 8 replicate Nuclear Transfer experiments were performed using 
GO or G1/CD25 donor cells derived from the lymph nodes of CBA/Ca (5 
replicates), C57BL16 (1 replicate) or (C57BL/6xCBA) Fl (2 replicates). Donor T-
cells were injected into Mll oocytes of B6D2F1 (C57BL/6 x DBA/2) mice. Embryos 
were cultured in M16 to assess in vitro development. When possible, blastocysts 
were fixed and stained with DAPI to assess cell numbers. 
In three replicate experiments, using GO-donor cells, and 4 replicate 
experiments, using Gl- donor cells, NT embryos at the 2 and blastocyst stage were 
transferred to Swiss Webster recipient females to check for implantation sites and 
development to term. 
6.4.3 Statistical analysis 
In vitro development data were analysed using the Chi-square test and a 
Fisher's exact test for 2x2 contingency, in groups where expected frequencies were 
less than 5. A one-tailed test was performed since, during development, percentages 
were only expected to decrease (GenStat 4.21, Windows 2000; (x=0.05). 
6.4.4 Results 
In vitro developmental studies (Table 6.2) showed that survival rates after 
injection were similarly very high in GO and Gi- derived embryos (p>0.05). 
Embryos reconstructed with GO and Gl-lymphocytes also had similar activation 
rates (p=0.26) and similar rates of development to the 4-cell (p=0.57), morula 
(p=0.17) and blastocyst stages (p=0.065; Table 6.2). The only difference was that 
Gi-derived embryos had significantly higher cleavage rates than GO-derived 
embryos (p<0.0001). Survival rates after injection were significantly lower than 
those obtained with ES-cells, at least when using donor T-cells in GO (p=O.Ol). 
Unlike ES-derived embryos (p=O.l), activation rates of T-lymphocyte derived NT 
embryos were lower than those observed in parthenogenetic and fertilised control 
embryos, at least when using GO-derived NT embryos (p<0.0001). Activation rates 
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Table 6.2 In vitro development of GO- and Gi- derived NT embryos 












Lymphocytes (GO) 436 405(92.9)' 342(84.4)' 249(72.8)' 43/243 (17 . 7)a 12/243 (4•9)a 1/243 (0•4)a 
Lymphocytes (Gi) 618 583 (94.3)ab 507 (870)ab 430 (84 . 8)1 65/348 (18 .7)a 27/348 (7 . 8)a 8/348 (2.3)a 
Controls 
(parthenogenetic) 
86 - 86 (100)c 84(97.7) C - 81/86 (94•2)b 74/86 (86.0)" 
ES (HM-1) 471 455 (966)b 441 (96 .9)c 238 
(53•9)e 
- 143/441 (324)d - 
Thymocytes' - 176 168 (95.5) - - 5/168 (3.0) - 
Spleenocytes' - 80 49(57.5) - - 11(13.7) - 
Macrophages' - 308 187 (60.7) - - 58 (31.0) - 
Results from 8 replicate experiments with GO- and Gi-lymphocytes isolated from the lymph nodes of (C57BL/6xCBA) Fl, C57BL6 and 
CBA/Ca female mice (-50-80 embryos/replicate). In the table are also included: data of parthenogenetically activated oocytes of B6D2F1 mice 
(-10/replicate); data from fertilised embryos (4 replicates); data from NT experiments carried out in the same period with HM-1 ES cells (100 
embryos/replicate; 4 replicates); data regarding NT experiments carried out in other laboratories using lymphoid cells isolated from the thymus 
the spleen and the peritoneal cavity of B6D2F1 females ('Wakayama et al., 2001). Of the NT blastocysts we obtained 1/1 GO-derived blastocyst 
and 5/8 Gi -derived blastocyst were fixed to assess cell numbers and 3/8 of GI-derived blastocysts were transferred to the uteri of recipient 
females for in vivo development (see tab. 6.7). Values within columns with different superscripts differ significantly. Chi-square test or Fischer's 
exact test for 2x2 contingency (one-tailed), where expected frequencies were less than 5 (a=0.05). Only data acquired in our laboratories were 
included in the analysis. 
Table 6.3 In vivo developmental potential of NT embryos 













Lymphocyte (GO) 52 44 (84.6) 42 (95.4) 25 (59.5) - 25 (l) - 0 
Lymphocyte (GO) 40 35 (87.5) 35 (87.5) 12 (34.3) - 12(l) - 0 
Lymphocyte (GO) 103 80 (77.7). 79 (98.7) 62 (78.5 - 62 (3) 0** 0 
Lymphocyte (Gi) 62 58 (93.6) 50 (92.6)* 44(88.0 6(12.0) 3(l)  0 
Lymphocyte (Gi) 103 81(78.6) 81(100) 62 (76.5) - 26(l) - 0 
Lymphocyte (GI) 149 116 (77.8) 114 (98.3) 103 (90.3) - 29(1) - 0 
Lymphocyte (GI) 57 53 (93.0) 43 (81.1) 37 (86.0) - 37(l) - 0 
ES 387 374 364 194 110 102(6) 0 0 
Thymocytes' NA 176 168 (95.5) NA 5/168 (3.0) 0 - 0 
Spleenocytes' NA 80 49 (57.5) NA 11/80 (13.7) 11(2) 10 (90.9) 0 
Macrophages' NA 308 187 (60.7) NA 58/308 (31.0) 52 (5) 26 (50.0) 0 
Results of embryo transfer experiments with GO-derived (3 replicates) and GI -derived (4 replicates) NT embryos. Experiments with ES cells 
(HMI) are the result of three replicate experiments. 
*Calculated 50/54, instead of 50/58 because 4 were lost. 
** Female sacrificed on day 11. Uterus red and oedematous but no implantation signs. 
Female sacrificed on day 21, but no implantation signs. 
§ Implantation and development to term from HM-1 and RI ES-cell lines were obtained one month after these experiments (Gao et al., 2002). 
'Wakayama etal., 2001. 
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of T-lymphocyte NT embryos were also significantly lower than those observed in 
ES-derived embryos (p<z0.0001). Cleavage rates of T-lymphocyte derived embryos 
were lower than those observed in parthenogenetic (p<0.001) and fertilised control 
embryos, but higher than those obtained with ES-derived NT embryos (p<O.00l). 
Rates of development beyond the 2-cell stage were lower than those observed both in 
control embryos and NT embryos derived from ES-cells (p<0.0001). The rates of 
development to morula/blastocyst obtained when using T-lymphocytes were higher 
that those obtained in previous studies (Wakayama and Yanagimachi, 2001), with 
similar cell types (e.g. thymocytes). However rates of development to 
morula/blastocyst obtained with spleenocytes and macrophages were higher than the 
ones obtained in these experiments with T-cells isolated from the lymph nodes 
(Table 6.2). 
Blastocyst cell numbers appeared to be lower in NT Gi- (n=5; 29.0±5.6) 
and GO-derived (n=1; 34) embryos than in parthenogenetically activated control 
embryos (n=29; 38.4±9.6). 
No development to term or implantation was obtained under any condition, 
using GO and G1-T-lymphocytes (Table 6.3). Although neither implantation nor 
development to term was obtained using ES-cells, in experiments carried out at the 
time of T-cell nuclear Transfer, pups were obtained from HM- 1 cells just one month 
later. 
6.4.5 Discussion 
Quiescence did not affect the in vitro developmental potential of nuclear 
transfer embryos. Only cleavage rates of GO-derived NT embryos were significantly 
lower than those of GI-derived NT embryos. This difference might be due to the fact 
that the plasma membrane of GO cells, due to their smaller size, is more difficult to 
disrupt at the time of injection. Disruption of the donor cell membrane and direct 
exposure of the donor chromatin to the ooplasm is thought to be crucial for a 
successful reprogramming (Galli et al., 1999). Previous NT experiments using cattle 
lymphocytes have linked membrane retention to developmental failure of cloned 
(Galli et al., 1999). The previous observation that 33% of GO-derived embryos failed 
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to undergo PCC and retained a condensed chromatin conformation even 3h after 
reconstruction, while 100% of Gi-derived embryos undergoes PCC within 3h from 
reconstruction (Paragraph 6.3.1), also suggests that technical problems leading to 
plasma membrane retention may result in lower cleavage rates of GO-NT embryos. 
The overall developmental potential of T-lymphocytes, regardless of their 
cell cycle stage, was low. The high efficiency rates of the enucleation, injection and 
activation protocols (see Methods 2.13 and Table 6.2) used in these experiments 
suggests that the choice of donor cell, rather than technical problems, was entirely 
accountable for the developmental failures observed. Furthermore the in vitro 
development rates obtained with T-lymphocyte derived NT embryos were 
comparable or even higher those reported in the literature for similar cell types 
(Wakayama and Yanagimachi, 2001). In particular thymocytes, the majority of 
which are T-lymphocytes, gave higher activation percentages but lower rates of 
development to blastocyst stage than the T-lymphocytes isolated from lymph nodes, 
used in these experiments. This might be due to the fact that thymocytes are in a 
cycling state, with high percentages of S-phase cells, whereas the cells used in these 
experiments were synchronized in a GO or GI diploid state, therefore less likely to 
undergo DNA damage after transfer to MII oocytes with high MPF levels. Better 
developmental rates than the ones obtained in these experiments were achieved only 
with haematopoietic cell types. Spleenocytes and macrophages, both gave lower 
activation rates and higher rates of development to the morulalblastocyst stage than 
the cells isolated from the lymph nodes, used in these experiments. The different 
nature of the cells used in these experiments might account for the differences 
observed in the developmental potential of cloned embryos. Cells isolated from the 
lymph nodes are mostly T-lymphocytes while the spleen contains both T-
lymphocytes and B-lymphocytes. As for macrophages, they do not even share the 
same lineage as lymphocytes, and they belong to the myeloid lineage. Therefore the 
greater developmental potential observed in these experiments might be due to the 
presence of B-cells and macrophages. 
Comparison of NT embryos derived from T-lymphocytes and ES-cell 
highlighted some interesting differences. Survival rates after injection were 
significantly higher for ES-cell derived embryos than for T-lymphocyte embryos. 
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Rates of pronuclear (PN) formation observed in ES-derived NT embryos were 
comparable to those of those found in activation controls and higher than those 
obtained from T-cells. The larger size (- l5um) of ES-cells compared to that of T-
lymphocytes (-.6-8um) might be accountable for this difference, resulting in a lower 
incidence of membrane retention. Interestingly, T-lymphocytes had very high 
cleavage rates, significantly higher than those observed in ES-cell derived embryos. 
The situation was reversed at later stages of development when ES-cell derived NT 
embryos gave significantly higher rates of development to the morula/blastocyst 
stages. 
Due to the low rates of in vitro development and low blastocyst yield, only a 
limited number of transfers with cloned embryos, mostly at the 2-cell stage, were 
performed. Regardless of the cell cycle stage, T-lymphocytes isolated from the 
lymph nodes, used in these experiments, were not able to support development to 
term. Later reports also confirmed the inability of T-lymphocytes, isolated from the 
thymus, T and B-cells and macrophages to support development to term (Wakayama 
and Yanagimachi, 2001). However the question whether haematopoietic cells are 
able to support development to term still remains controversial. Cattle lymphocytes, 
isolated from peripheral blood, were able to support development to term of cloned 
embryos (Galli et at., 1999). Furthermore, recent reports showed that mouse T- and 
B-lymphocytes were able to support development to term of cloned embryos 
(Hochedlinger and Jaenisch, 2002). However, pups were only obtained using a 
complex technique that coupled nuclear transfer and tetraploid aggregation. In this 
specific experiment ES-cells isolated from the inner cell mass of lymphocyte-derived 
cloned embryos were injected into tetraploid blastocysts and the resulting embryos 
were then transferred to recipient females. This suggests that, although possible, 
reprogramming of haematopoietic cells might require extreme technical solutions, 
able to enhance their otherwise limited plasticity. 
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6.5 EFFECT OF QUIESCENCE ON EPIGENETIC 
STATUS OF CLONED EMBRYOS 
6.5.1 Epigenetic status of control, fertilised embryos 
6.5.1.1 Experimental design 
Control fertilised embryos were collected in four separate experiments 
(Methods see Paragraph 2.13.5), assessed for in vitro development (Table 6.4) and 
fixed at selected time points (Table 6.5). The time points were chosen around the 
time of zygotic gene activation, when major changes in transcriptional activation and 
gene expression are associated with dramatic changes in patterns of histone H4 
acetylation (Adenot et al., 1997; Wonad et al., 1995) and chromatin conformation 
(Adenot et al., 1991; Perreault, 1992). Triple labelling with anti-M31 antibody 
(MAC 353), anti-PCNA antibody and DAPI was used to assess changes in chromatin 
conformation (DAPI) mediated by the non-histone protein M31, the mouse 
homologue of the human hHP1 13 protein, and onset of DNA replication activity 
(PCNA) in mouse fertilised embryos. Double staining for chromatin (DAPI) and 
histone H4 acetylation, on lysines 2-4/5/8/12, was used to detect shifts in histone H4 
acetylation patterns. The antibody MAC 353 had never been used before to study 
chromatin changes taking place during embryo development. The antibodies anti-
H4.Ac5/8/12 had been previously used in mouse fertilised embryos (Worrad et al., 
1995) and are able to mark the time of zygote gene activation with the appearance of 
a typical staining pattern at the periphery of the nucleus, as opposed to uniform 
nuclear staining. The antibody anti-H4.Ac16 had also been used previously in mouse 
fertilised embryos (Worrad et al., 1995) but unlike the other antibodies it retains a 
uniform distribution throughout embryo development. The antibody anti-H4.Ac2-4 
had never been used before in developmental studies. 
Control embryos were used to: establish immunolabelling protocols on 
whole embryo mounts (M31iPCNA; H4.Ac2-4/5/8/12/16); study changes in 
chromatin (M3 1/PCNA) and histone acetylation (H4.Ac2-4) occurring during 
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Total 506/562 (90.0) 313/349 (89.7) 214/226 (94.7) 128/129 (99.2) 98/98(100) 
Fixed 157 87 85 30 40 








Stage Chromatin staining Acetylation staining 
Day 0, 12.30-13.30 5 17/18 0 PN (early) M31/PCNA Ac2-4, Ac5, Ac8, Ac 12, Ac 16 
Day 0, 20.30 11-12 25 6/7 PN(late) M31/PCNA Ac2-4, Ac5, Ac8, Ac 12, Ac 16 
Day 1, 16.30 32-33 45 28 2-cell M31/PCNA Ac2-4, Ac5, Ac8, A62, Ac16 
Day 2, 10.00 51 63 46 4-cell M31/PCNA Ac2-4, Ac5, Ac8, A62, Ac16 
Day 3, 10.00 65 87 70. M M31IPCNA Ac2-4, Ac5, Ac8, Ac 12, Ac 16 
Day 4, 10.00 89 111 94 BL - - 
Unfertilised eggs - - - Mil M31/PCNA Ac2-4, Ac5, Ac8, Ac 12, Ac 16, 
Tables 6.4-6.5 Results of four replicate experiments. Animals were injected with hCG and mated at 19.30. Fertilisation takes place 10-13 hours 
post hCG/mating, so around 5.30-8.30 (day 0). Embryos were collected around the time of pronuclear formation, 4-5 hours after fertilisation, 
approximately at 13.0-13.30 (day 0) and then cultured in vitro. Only in one instance embryos were collected earlier, at 10-10.30 (day 0). As a 
result of this a lot of embryos were not fertilised (*). Cultured control embryos were assessed for development (Tab. 6.8) and fixed and processed 
for immunostaining at selected time points (Tab. 6.9). In the table we have omitted that a total of 7 embryos, 6 at the two cell stage and 1 at the 4-
cell stage, were used as staining controls and were incubated with the secondary antibodies in the absence primary antibodies: GAR-FITC (n=2); 
GAR-TXR (n=2); TXR/FITC-anti-rat (n=2); GAS-FITC (n=1). 
development, that had never been described before; select antibodies and protocols to 
use efficiently on nuclear transfer embryos. 
6.5.1.2 Statistical Analysis 
Data were analysed using a Pearson Chi-square test. In groups where 
expected frequencies were less than 5, data were analysed using a Fisher's exact test 
for 2x2 contingency (GenStat 4.21, Windows 2000). In particular a modified, non-
randomised version of this test, namely the mid-P-value test (Hirji et al., 1991), was 
used, since it is considered less conservative and with an actual level of significance 
closer to the nominal value, as compared with the classical test. Furthermore, 
because the percentage of embryos positive for a specific marker was expected to 
either increase or decrease, a two-tailed test was performed. 
6.5.1.3 Results 
Shifts in the percentages of PCNA and M31 cells occurred simultaneously 
(Fig.6.4-6.6). Before fertilisation, 100% (12/12) M11 oocytes were M317PCNK 
(Fig.6.4 F-M). After fertilisation, at the early pronuclear stage, 16h after hCG, 66.6% 
(8/12) of the embryos was M31 47PCNA (Fig.6.4 G-N). The percentage of 
M31VPCNA increased significantly (16/16, p=0.024) by the late pronuclear stage, 
24h post hCG (Fig.6.4 11-0), and then remained constantly high, at the 2 (12/12), 4 
(14/14) and morula (515) stages. Similarly to what previously seen in quiescent and 
non-quiescent T-cells (Paragraph 5.2), M31 had two different distribution patterns: a 
"diffused" nuclear distribution, where M31 was uniformly spread throughout the 
nucleus; a "condensed" distribution, where M31 was organised in clusters, 
colocalised with patches of condensed chromatin (DAPI). The "condensed" M31 
distribution resembled the distribution patterns observed in quiescent T-cells 
(Fig.6.5), previously described (Paragraph 5.2). Apart from quantitative changes in 
the percentages of M3 1 cells, occurring around the time of zygote gene activation, 
qualitative changes in the distribution patterns of M31 were also observed (Fig.6.6). 
At the early and late pronuclear stages only the "diffused" distribution was observed 
(8/8; 16/16). The only difference between the early and late pronuclear stages was 
that the proportion of "diffused" M31 cells (8/12 vs 
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Figure 6.4 In1muhIu(ainuII2 for \ll 	 PI in ciiiiuI cmhro 
11111111  
A-E DAPI staining F-F anti M3 I -FITC staining; M-Q PC\1\ staining; A, I. NI, Nih ooc te B. ;. N 1-cell stage 16h post-hC( ) ( , 1!, 0, 1-
cell stage (24h post-hCG); D, 1, P, 2-cell stage (45h post-hCG); E, L, Q, 4-cell stage (64h post-hCG). Conclusions: M31 staining becomes clear 
at the onset of zygotic gene activation (ZGA). After ZGA, at the 4-cell stage, nuclear distribution of M31 looks like that of quiescent chromatin. 
Arrows indicate appearance of clusters of M31 at the 4-cell stage, showed in more detail in Fig.6.5. 
Figure 6.5 After ZGA, 4-cell embryo nuclei look like nuclei of quiescent cells 
A-C, nuclei of 4-cell embryo; D-F nuclei of GO 1-cells. A, D, DAPI staining in red pseudo 
colour; B, E anti-HP1 beta —FITC staining; C, F merged images of DAPI/HPI-beta 
staining. Conclusion: after ZGA, HPI-beta colocalises again with patches of condensed 
chromatin (arrows). 
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Figure 6.6 Results of M31IPCNA immunostaining in control embryos 
Results of triple staining of control fertilised embryos with DAPIIanti-M3 1IPCNA (4 
experiments). Embryos were classified according to the presence (M3 1) or absence (M3 U 
) of M31 staining. M31 + embryos were also classified according to the sub-nuclear as 
distribution of M31: "condensed", with M31 organised in clusters, colocalised with 
pericentromeric heterochromatin; "diffused", with M31 uniformly diffused in the nucleus. 
Results of PCNA staining are presented elsewhere (Paragraph 6.5.1). 
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16/16) was significantly higher in the latter (p=0.024). The main changes in M31 
distribution were observed at the 2 and 4-cell stages, around the time of zygote gene 
activation. The overall proportion of M31 remained constant between the late PN 
stage and the 2-cell stage, remained constant (16/16 vs 12/12). However, a 
significant decrease in the proportion of M31' cells with "diffused" distribution 
(16/16 vs 8/12, p=0.024) and the appearance M31 cells with "condensed" 
distribution (4/12) were observed at this stage. This trend was maintained at the 4-
cell stage where a further decrease in the proportion of M31 cells with "diffused" 
distribution (8/12 vs 0/14, p<0.001) and a further increase in the percentage of M31 
cells with "condensed" distribution (4/12 vs 14/14, 33.4 vs 100%, p<O.00l) occurred. 
The appearance of clusters of M31 was restricted to the 2 and 4-cell stages, since it 
was no longer detectable at the morula stage (0/5). Changes in the distribution 
patterns were also observed for the PCNA staining, but these were not quantified. 
Briefly PCNA appeared to concentrate at the periphery of the nucleus, with a ring-
like structure, at the PN, 2-cell stage and in some of the nuclei at the 4-cell stage, 
whereas it had a uniformly diffused distribution in at the morula stage and in some of 
the nuclei at the 4-cell stage. 
Staining for acetylation on lysines 8 and 16 (anti-H4.Ac8/16) gave 
inconsistent results that were excluded from the statistical analysis (data not shown). 
Immunolabelling of mouse fertilised embryos with anti-H4Ac.5 and anti-H4Ac. 12 
(Fig.6.7) gave similar results to those previously described (Worrad et al., 1995). For 
each of these antibodies changes in the proportion of cells positive for acetylation 
staining (total Ac), as well as qualitative changes observed in the distribution 
patterns of these antibodies, were assessed (Fig.6.8). Staining of Ac cells could be 
classified according to two different distribution patterns (Worrad et al., 1995): a 
"diffused" distribution pattern, when the staining was uniformly distributed in the 
nucleoplasm; a "peripheral" distribution pattern, when the staining was restricted to 
the nuclear periphery (Fig.6.7 4C-5C, 313-513). Results (Fig.6.8) obtained with anti-
H4Ac.5 and anti- H4Ac.12 were very similar. Before fertilisation, M11 oocytes 
appeared to be deacetylated on lysines 5 (0/6) and 12 (0/6). After fertilisation, at the 
early PN stage, the proportion of Ac5 and Ac12 cells increased, though not 
significantly (p=0.27), to 4/14 (28.6%) and 3/12 (25%). Between the 
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Figure 6.7 Immunostaining for histone 114 acetvlation in control embryos 





1B 	 2 BI 	 3B 
I 3A1 	4A 	 5A J 
DAPI staining (A); anti-H4 (Ac 2-4)-FITC staining (B); anti H4 (Ac5)-TXR staining (C); 
anti H4 (Ac 12)-TXR (D). 1) Mll oocytes; 2) 1-cell embryos at an early PN stage 16h after 
hCG); 3)1-cell embryos 7-8h after PN formation (24h after hCG); 4) 2-cell stage (after 
45h after hCG); 5) 4-cell stage (64h after hCG). Peripheral nuclear staining was observed 
for H4.Ac5 (4C-5C) and H4.Ac12 (413), at the 2 and 4-cell stages (Ac5), and H4.Ac2-4, at 
the pronuclear stage (2B-313). These data confirmed that patterns of acetylation of histone 
H4 on lysines 5 and 12 could be used as markers of zygote gene transcriptional activation. 
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Control, fertilised embryos were fixed and double stained with DAPI and antibodies recognising histone H4 acetylated on lysines 2-4 (H4.Ac2-4), 5 (H4.Ac5) 
and 12 (H4.Ac 12). Embryos were classified according to the presence (Ac') or absence (Ac) of acetylation staining. AC embryos were also classified 
according to the sub-nuclear acetylation patterns: "peripheral", with acetylation staining concentrated at the periphery of the nucleus, in a ring-like structure; 
"diffused", with acetylation staining uniformly diffused in the nucleus. Appearance of peripheral acetylation staining for Ac5 and Ac 12 has been correlated with 
onset of Zygote Gene Activation. 
early and late PN stages the proportion of Ac5 and Ac12 cells increased 
significantly (p<0.001) to 11/11(100%) and 8/11(72.7%). Acetylation on lysine 12 
reached a plateau (100% AC12) at the 2-cell stage, at a slightly later stage than 
acetylation on lysine 5 (late PN stage). At the 4-cell and morula stages, the 
percentages of Ac5 and Ac12 embryos remained high (14/14; 5/5). 
MIT oocytes were negative for acetylation staining on lysine 5 and lysine 12. 
Early PN stage was characterised by very low percentages of "peripheral" and 
"diffused" Ac5 (3/12; 0/12) and Ac12 cells (2/14; 2/14). The late PN stage was 
characterised by an overall increase in the percentages of Ac5 and Ac12 cells, 
mainly resulting from a significant increase in the proportion of "diffused" Ac5 
(0/12 vs 8/11; p=0.040) and Ac12 (2/14 vs 6/11; p=0.048), while the proportion of 
"peripheral" Ac5 (3/12 vs 3/11; p=0.91) and Ac12 (2/14 vs 2/11; p=0.81), cells 
remained unchanged. At the 2 and 4-cell stages the trend was inverted: the 
proportion of "peripheral" Ac5 and Ac12 (13/15, 15/15; p=0.002; p<0.001) at the 2 
and 4-cell stages (12/14; 14/14, p=0.005, p<0.001) were significantly higher than 
those observed at the late PN stage while the proportion of "diffused" Ac5 and 
Ac12 at the 2 (2/15; 0/15; p=0.004, p=0.002) and 4-cell stages (2/14, 0/14; p=0.003, 
p=O.00S) were significantly lower than those observed at the late PN stage. At the 
morula stage, though all of the embryos were acetylated, they only displayed the 
"diffused" distribution (5/5) while the "peripheral" distribution was no observed at 
this stage (015). 
Results of the staining with the anti-H4.Ac2-4 antibody (Fig.6.7-6.8), 
suggested a possible involvement of acetylation on lysines 2-4 at an earlier stage of 
development, than acetylation on lysines 5 and 12. Similarly to what was observed 
with anti-H4.Ac5 and anti-H4.Ac12 antibodies, changes in the proportion of Ac(2-
4) embryos and qualitative changes observed in the distribution patterns of this 
antibody were observed. Also for this antibody a "diffused" distribution pattern 
(Fig.6.7 4B-5B), characterised by a uniform nuclear staining, and a "peripheral" 
distribution pattern, with staining restricted to the nuclear periphery (Fig.6.7 2B-3B), 
were observed. The proportion of Ac(2-4) cells increased significantly between the 
M11 stage, before fertilisation, and the early PN stage (0/6 vs 8/12, p=O.Ol 1), 
reaching a peak at the late PN stage (11/11). These data were similar to what 
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observed with anti-H4.Ac12/Ac5 antibodies. The proportion of Ac(2-4) cells 
decreased slightly at the 2 cell stage (12/13, p=0.542) and, by the 4-cell (8/14, 
p=0.017) and morula stages (2/5, p=0.18), reached levels significantly lower than 
those observed at the late PN stage and comparable to those observed at the early PN 
(p=0.648; p=0.374) stage. This trend was different from what observed with anti-
H4.Ac5 and anti-H4.Ac12, where acetylation levels never decreased after reaching a 
plateau, respectively at the late PN and 2-cell stages. 
When considering distribution patterns of the anti-H4.Ac(2-4) staining 
(Fig.6.8), it was observed that the proportion of cells displaying the "peripheral" 
pattern increased significantly between the MIT stage (0/6), before fertilisation, and 
the early PN stage (4/12, p=0.01 1), reaching maximal levels at the late PN stage 
(8/11). However, at later stages of development, the "peripheral" distribution pattern 
was no longer observed (0/13; 0/14; 0/5). On the contrary the "diffused" distribution 
pattern was present in a low proportion of cells at the early and late PN stages (4/12-
3/11) and reached a peak (12/13) at the 2-cell stage. At the 4-cell (8/14) and morula 
stages (2/5) the proportion of "diffused" Ac(2-4) embryos gradually decreased to 
levels comparable to those observed at the early (p=0.26; p=0.81) and late PN stages 
(p=16; p=65) and significantly lower than the ones observed at the 2-cell stage, at 
least at the morula stage (p=0.046). 
6.5.1.4 Conclusions 
These experiments showed that important changes occur in the chromatin 
status and the acetylation status of fertilised mouse embryos, around the time of 
zygote gene activation (late-PN/2-cell stage). Results of the M31 staining in fertilised 
embryos showed that transition between early and late PN stages is characterised by 
a significant increase in the percentages of "diffused "M31 cells. At the 2 and 4-cell 
stages, the diffused distribution pattern gradually decreased, while the condensed 
pattern appeared. Clusters of M31 seemed to be temporally restricted to the 2 and 4-
cell stages. Appearance of these clusters might be correlated with the establishment 
of gene silencing patterns associated with differentiation. There are no reports in the 
literature showing changes in non-histone proteins during early development in the 
mouse, so these data represent the first ones of this kind. 
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PCNA staining suggested that DNA replication started at the early PN stage 
(5h post-fertilisation, 17/18h post-hCG, Oh post-PN formation) and by the late PN 
stage all of the cells were PCNA and remained so in all the following stages 
analysed. However, these results are inconclusive since the cross-linking reagents 
used in these experiments fix the soluble form of PCNA, constitutively expressed 
throughout the cell cycle (see Paragraph 2.11). 
Staining for acetylation of histone H4 on lysines 5 and 12 gave very similar 
results, and different from the ones obtained when assessing acetylation on lysine 4. 
The acetylation staining with anti-H4.Ac5 and anti-H4.Ac12 showed that the late PN 
stage is characterised by an overall increase of H4 acetylation on lysines 5 and 12, 
mainly due to a significant increase in the percentage of cells with a "diffused" Ac.5 
and Ac. 12 staining pattern. Though the overall levels of histone H4 acetylation on 
lysines 5 and 12 remained unchanged at the 2-cell stage, an inversion in the 
distribution patterns, with a significant increase in H4.Ac5 and H4.Ac12 peripheral 
staining, and a significant decrease in "diffused" staining pattern were observed. The 
situation at the 4-cell stage was comparable to the one observed at the 2-cell stage 
with similar, high percentages of Ac5 and Ac12 cells with "peripheral" staining 
pattern and similar, low percentages of cells with "diffused" staining pattern. Beyond 
the 4-cell stage only high percentages of H4.Ac5' and H4.Ac12 cells with 
"diffused" distribution patterns, similar to those observed at the late PN stage were 
detected. These data suggest that acetylation of histone H4 on lysines 5 and 12 at the 
periphery of the nucleus, though present also at earlier stages, is a main feature of the 
2-cell stage. This is not surprising considering that appearance of peripheral staining 
after immunolabelling for H4.Ac5/12 has been correlated with transcriptional 
activation (Worrad et al, 1995), occurring in mouse at the late PN/2-cell stage. 
However previous reports also indicated that this staining pattern disappeared by the 
4-cell stage while the data of these experiments suggest its persistence till the 4-cell 
stage. This discrepancy might arise from the fact that at the 4-cell stage only some 
nuclei (1/4, 2/4) appear to be acetylated on lysines 5 and 12, at the periphery of the 
nucleus. This discrepancy might stem from subjective differences on the 
classification of these partially stained embryos. 
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The anti-H4.Ac2-4 staining gave different results from those obtained with 
anti-H4.Ac5 and anti-H4.Ac12 staining. Overall acetylation on lysines 2-4 reached a 
peak at the late PN stage, remained high at the 2-cell stage and then decreased. 
Acetylation on lysines 5 and 12 reached a peak at the later, 2-cell stage and then 
remained high, at least till morula stage. Similar staining patterns to those observed 
on lysines 5 and 12, a peripheral and a diffused pattern, were also observed but with 
different shifts in distribution patterns. High percentages of cells with peripheral 
distribution of H4.Ac2-4 staining were restricted to the early and late PN stages, 
instead of the 2 and 4-cell stages. The increase in this pattern was more evident at the 
late PN stage, when percentages reached a peak. The 2-cell stage was characterised 
by high percentages of Ac(2-4) cells with a "diffused" distribution pattern 
significantly higher then the ones observed at earlier stages of development. Beyond 
the 2-cell stage these percentages decreased to levels similar to the ones observed at 
the PN stages. 
Observations regarding acetylation of histone H4 at lysines 2-4 (H4.Ac2-4) 
have never been described before. Only changes in histone H3 acetylation (Stein et 
al., 1997) at lysines 9 and/or 18 (H3.Ac9/18) and histone H4 acetylation (Adenot et 
al., 1997; Worrad et al., 1995) at lysines 5, 8, 12 (H4.Ac5/8112) had been described 
during mouse embryo development. These findings suggest that acetylation Ac2-4 
can be used as a marker of early ZGA events (late PN), Ac5/12 marker of late 
activation events (2-cell stage). One of the aims of these experiments was to select 
appropriate acetylation markers, associated with transcriptional activation, to use in 
conjunction with M3 1IPCNA to study epigenetic reprogramming in lymphocyte-
derived nuclear transfer embryos. Considering the limited availability of material 
from nuclear transfer experiments, it was decided to use only the anti-H4.Ac5/12 
antibodies. The main reason for this was that dramatic chromatin changes, 
highlighted by changes in M31 sub-nuclear distribution, mainly occurred at the 2 and 
4-cell stages when changes in Ac5 and 12 also occur. 
223 
Table 6.6 In vitro development of NT embryos processed for immunostaining for chromatin and acetylation status 










GO Total (%) 195 61/176 (34.7) 49/61 (80.3) 12/33 (36.4) - - 
GO Fixed 19 - 16 12 - - 
Gi Total (%) 183 133/161 (82.6) 114/133 (85.7) 24/89 (27.0) - 
Gi Fixed 22 - 25 24 - - 
Control Total (%) 1 41 40/41 (97.5) 40/40 (100) 40/40(100) 40/40 (100) 40/40 (100) 
Table 6.7 Developmental stages at which NT embryos were processed for immunostaining for chromatin and acetylation status 




Day 0, 10.00-10.30 Condensed -3/2.5 15/15.5 - 7.5/8 M31IPCNA - 
Day 0, 11.00-13.00 1-cell (M) -2/0 16/19 -5/7 M3IIPCNA - 
Day 0, 18.00 PN (early) 5 22.5 0 - - 
Day 0/1, 00.00-1.00 PN(late) 11-12 29 6/7 - - 
Day 1, 22.00 2-cell 33 50.5 28 M31/PCNA H4.Ac5, H4.Ac12 
Day 2, 16.00 4-cell 151 68.5 46 M31IPCNA H4.Ac5, H4.Ac12 
Tables 6.6-6.7 Experiments were carried out in two replicates using donor oocytes and C57BL/6 donor lymphocytes. Animals were 
injected with hCG at 19.30. The next day embryos were reconstructed around 10.00-12.00 (day 0) and activated 1-3 hours after 
reconstruction (13.00, day 0) by culture in Sr2+ for 5 hours (13.00-18.00). Pronuclei were visible towards the end of the activation 
period (18.00, day 0). Embryos were assessed for development (Tab. 6.6) and fixed and processed for immunostaining (Tab. 6.7). 
Developmental potential of NT embryos was not assessed beyond the 4-cell stage in this experiment because all the developing embryos 
were fixed earlier stages of development. Embryos were stained at two time points before activation, between 0 and 3 hours after 
reconstruction (10.00-13.00, day 0), and at two time points after activation (2-cell, 4-cell). 
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6.5.2 Immunostaining of nuclear transfer embryos 
6.5.2.1 Experimental design 
Embryos reconstructed from GO and GI cells (Methods see Paragraph 2.13; 
Table 6.6), in two separate experiments, were fixed at selected time points and 
processed for immunolabelling (Methods see Paragraph 2.14; Table 6.7) at two time 
points shortly after reconstruction, to assess changes in M31 distribution and histone 
H4 acetylation immediately after transfer (1-cell/condensed, 0-30' after 
reconstruction; 1-cell,PCC, 1-3h after reconstruction) and detect immediate 
chromatin remodelling events after NT. Embryos were also stained at the 2-cell and 
4-cell stage (Table 6.7), to assess chromatin-remodelling events taking place around 
the time of ZGA. Results obtained at the 2- and 4-cell stages were compared with 
those obtained at similar stages in fertilised, control embryos. 
6.5.2.2 Statistical Analysis 
Because sample sizes were very small and in most cases expected 
frequencies were less than 5, they were analysed using a Fisher's exact test for 2x2 
contingency (GenStat 4.21, Windows 2000). In particular, the mid-P-value test was 
performed since it is less conservative and with an actual level of significance closer 
to the nominal value than the classical test (Hirji et al., 1991). Furthermore, because 
the percentages of embryos positive for a specific marker were expected to either 
increase or decrease, a two-tailed test was used. 
6.5.2.3 Results 
Results of triple staining for M31/PCNAIDAPI of GO and G1-NT embryos, 
showed that between O-3h min after reconstruction and at the 2-and 4-cell stages are 
shown respectively in (Fig.6.9A-6.9B). During the first 0-30 min after reconstruction 
Gi-derived embryos (Fig.6.9A, 3A-3C) still appeared to be M31 (4/5), with a 
diffused distribution pattern, while none (015) of GO-derived embryos (Fig.6.9A, 1A-
1C) were M31 +. Between 1-3h after reconstruction, when embryos are reaching PCC 
stage, and chromatin is organised in individualized chromosomes, both GO 
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Figure 6.9A Immunostaining for M31/PCNAJDAPI in NT embryos: 0- 3h after 
reconstruction 
NT-GO 	 NT-G1 
NT embryos were triple stained with DAPI (blue, A), M31-FITC (green, B) and TXR-
PCNA (red, C) to assess respectively chromatin structure, M31 sub-nuclear localisation 
and presence of DNA replication. GO (1-2) and GI (3-4) NT embryos were fixed 0-30mm 
(1, 3) after reconstruction, when chromatin is still condensed, and 2-3h (2, 4) after 
reconstruction, at the PCC stage. 
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Figure 6.9B Immunostaining for M31IPCNAIDAPI in NT embryos: 2 and 4-cell 
stages 
2-cell stage 	 NT-GO 	NT-G1 
I 
D LJ 
4-cell stage 	 NT-GO 	NT-G1 
P 
Lai  
GO and (il-NT embryos were fixed at the 2- and 4-cell stage and triple stained with DAPI (blue, 
A), M31-FITC (green, B) and TXR-PCNA (red. D). Figure C shows a merged image ofFITC-M31 
(green) and DAPI, represented in this picture with a pseudo-colour red. The yellow colour 
corresponds to areas of colocalisation of M31 and heterochromatin. Arrows point to M31 clusters. 
Figure 6.10 Comparison of M31IPCNA immunostaining in control and NT embryos 
Control 	 GO-NT 	 G1-NT 
	
120 	 120 	 120 •M31+ condensed 
LI M31+ diffused 
N=12 N=14 	 N=7 	N=6 	 N=7 	N=8 
80 	 80 - 1 80 
40 	 40 
	
40 
0 	 0 ____________ 	0  
2-cell 4-cell 	2-cell 4-cell 	2-cell 4-cell 
Data from two nuclear transfer experiments were compared with the results obtained with 
fertilised embryos. Classification was similar to that described for Figure 6.6. 
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(Fig.6.9A, 2A-2C; 6/6) and Gi-derived (Fig.6.9A, 4A-4C; 6/6) NT embryos were 
M31 (Fig.6.10). Embryos in all groups were, as expected, PCNA since DNA 
replication only begins at later stages of development. 
At the 2-cell stage (Fig.6.9B-Fig.6.10), when ZGA is expected, both GO-
derived (7/7) and GI-derived (7/7) embryos were M31/PCNAt In a percentage of 
GO (3/7, 42.8%) and G1-NT embryos (2/7 28.5%) M31 was organised in clusters, 
localised at the periphery of the nucleus. These clusters resembled closely the 
"condensed" M31 distribution observed at the 2-cell stage in fertilised embryos 
(4/12, 33.3%, p=0.708 with GO-NT; p=0.806 with GI-NT). The remaining GO (4/7, 
57.2%) and G1-NT (5/7, 71.6%) embryos were characterised by a "diffused" sub-
nuclear distribution for M31, again similar to the one observed in fertilised embryos 
(8/12, 66.6%, p=0.708 with GO-NT; p=O.8O6 with G1-NT). 
At the 4-cell stage M31 distribution patterns observed in NT embryos, 
regardless of their cell-cycle stage, were very different than those observed in 
fertilised control embryos. Fertilised embryos at the 4-cell stage were characterised 
by a "condensed" M31 distribution pattern (14/14, 100%). Both GO (2/6, 33.3%, 
p=0.003) and 01-derived NT embryos (0/8, 0%, p<0.001) had significantly lower 
percentages of 4-cell embryos with a "condensed" distribution pattern. The 
percentages of "condensed" M31 distribution found in GO- derived embryos (2/6, 
33.3%), though significantly lower than the ones found in fertilised embryos, were 
higher the those found in Gi-derived embryos where this patterns was not observed 
(0/8, 0%, p=0.07). The percentages of PCNA embryos at the 2 and 4-cell stages 
were equally high in GO (7/7; 5/6), GI-derived NT embryos (7/7; 8/8) and fertilised 
embryos (12/12; 14/14). 
Results of double staining for DAPI and for histone 114 acetylation on 
lysines 5 (H4.Ac5) or 12 (H4.Ac12) showed that (Fig.6.11A-6.1113) during the first 
0-30 min after reconstruction both GO (Fig.6.11A, 1A-1B; 5/5) and GI-derived 
embryos (Fig.6.11A, 3A-3B; 5/5) appeared to be intensively acetylated on lysines 5 
and 12. At the PCC stage the situation remained unchanged, with hyperacetylated 
chromosomes forming the metaphase plates of GO (Fig.6.11A, 2A-2B; 515) and Gi-
derived embryos (Fig.6.11A, 4A-413; 5/5). These data were surprising considering 
that quiescent and non-quiescent T-cells had different acetylation states at the time of 
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transfer: the former being transcriptionally inactive and deacetylated, and the latter 
being hyperacetylated and transcriptionally active. 
At the 2-cell stage and at the 4-cell stage (Fig.6.1113-Fig.6.12), the overall 
percentages of GO (5/5; 3/3) and G1-NT embryos (9/9; 9/9) hyperacetylated on 
lysines 5 and 12 of histone H4 were comparable to those of fertilised embryos 
(15/15; 14/14) However distribution patterns observed in H4.Ac5 and H4.Ac12 
were dramatically different between GO-NT, G1-NT and fertilised embryos. At the 2-
cell stage all GI-derived NT embryos had a "peripheral" (9/9) and H4.Ac12 (9/9) 
staining pattern for H4.Ac5 (9/9) and H4.Ac12 (9/9), similarly to what observed in 
control embryos (13/15, 86.7%, p=0.380; 15/15, p=l). GO-derived NT embryos had 
percentages H4.Ac5 (015) and H4.Ac12 (0/5) with "peripheral" staining 
significantly lower than the ones observed in fertilised (p=0.001 for AcS; p<0.001 for 
Ac 12) and Gi-derived embryos (p<0.001 for Ac5 and Ac 12). At the 4-cell stage the 
situation was inverted: all GO-derived embryos had a "peripheral" staining pattern for 
H4.Ac5 (3/3) and H4.Ac12 (3/3), comparable to what observed in fertilised embryos 
(12/14 for H4.Ac5, p=0.669; 14/14 for H4.Ac12, p=l); GI-derived embryos had 
percentages of embryos with "peripheral" staining patterns for H4.Ac5 (3/9, 33.3%) 
and H4.Ac12 (1/6, 16.7%) significantly lower than those observed in fertilised 
(p=0.018 H4.Ac5; p<0.001 for H4.Ac12) and GO-derived embryos (p=0.091 for 
H4.Ac5; p=0.048 for H4.Ac12). 
6.5.2.4 Conclusions 
The results of these experiments showed that quiescence affected both 
chromatin status and histone H4 acetylation status of cloned embryos. Differences in 
the non-histone protein M31 were observed between GO-NT and G1-NT embryos in 
the first 30min after reconstruction, when G1-NT embryos are M31 and GO-NT 
embryos are M31. At PCC stage, 1-3h after reconstruction, both GO-NT and G1-NT 
embryos were M31 as expected since M31 is usually not associated with DNA 
during the M phase. At the 2- cell stage the situation was similar in GO-NT, G1-NT 
and controls. This stage was characterised in all groups, by the majority of embryos 
displaying a "diffused" M31 pattern and by the appearance of clusters of M3 .1 
("condensed" pattern) at the periphery of the nucleus, 
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Nuclear Transfer embryos reconstructed using GO (1-2) or G  T-lymphocytes (2-3) were fixed after 0-30 minutes after reconstruction 
(1, 3), when nuclei were still condensed, and 1-3h after reconstruction (2, 4), when chromatin was organised in chromosomes (PCC-
stage). Embryos were stained with the DNA staining DAPI (blue, A) and FITC anti-H4.Ac5 to detect acetylation on lysines 5 of histone 
H4. These images show that regardless of their acetylation status before transfer (deacetylated for GO, hyperacetylated for GI) GO and 
G  cells become immediately acetylated after transfer to a recipient MII oocyte. 
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Figure 6.11B Immunostaining for histone 114 acetylation of NT embryos: 2-and 4-cell stages 
GO-(1-2) and Gi- (3-4) derived embryos were fixed at the 2-cell (1-3) and 4-cell (2-4) stages. Images "A" show brightfield images. 
Images "B" show nuclei of embryos stained with FITC conjugated anti-H4.AC5 or antiH4. Ac12 antibodies, represented here in grey. 
GO-derived embryos had a uniformly "diffused" (D) sub-nuclear distribution at the 2-cell stage and a "peripheral" (P) staining 
distribution at the 4-cell stage. On the contrary GI-derived embryos had a peripheral" staining distribution at the 2-cell stage and a 
"diffused" sub-nuclear distribution at the 4-cell stage. 
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Figure 6.12 Comparison of immunostaining for histone 114 acetylation in control and NT embryos 
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Control fertilised and GO and Gi-derived NT embryos were double stained with DAPI and antibodies recognising histone H4 acetylated 
on lysines 5 or 12. Percentages of embryos characterised by peripheral acetylation staining, correlated with transcriptional activation, 




where histone acetylation and transcription also take place. Dramatic differences 
between NT embryos, regardless of their cell cycle stage, and fertilised embryos 
were observed at the 4-cell stage. All controls, at the 4-cell stage, were characterised 
by the M31 "condensed" distribution pattern. A similar distribution pattern was 
observed only in a limited number of GO-NT embryos (2/6, 33.3%) and was not 
observed in G1-NT embryos (0/8). The results of PCNA staining suggested that this 
difference in chromatin status did not correlate with differences in replicative 
potential since equally high percentages of PCNA embryos were observed in all 
groups. However the fixation method used in these experiments was not ideal to 
carry out this investigation: organic solvents would have been more appropriate than 
cross-linking reagents to fix the insoluble form of PCNA expressed in a cell cycle-
dependent manner (see Paragraph 2.11). 
During the first 3h after reconstruction the acetylation status of histone H4 
appeared to be similar in GO and GI-derived embryos. Regardless of their cell cycle 
stage and their acetylation status before transfer, both GO and G1-nuclei became 
hyperacetylated on lysines 5 and 12 of histone H4. This observation is in contrast 
with the differences observed in cultured cells (Chapter 4) where quiescent cells 
were deacetylated and activated cells were hyperacetylated (Chapter 5) on histone 
H4. 
At the 2 and 4- cell stages the situation of GO- derived and GI-derived NT 
embryos appeared to be dramatically different. When diploid, non-quiescent cells 
were transferred to recipient Mll oocytes (GI), appearance of the "peripheral" 
distribution pattern for the anti-H4.Ac5/12 staining, was synchronous with that 
observed in control fertilised embryos and occurred at the 2-cell stage. On the 
contrary, when quiescent, diploid nuclei (GO), used as donor cells, appearance of this 
"peripheral" distribution pattern was delayed to the 4-cell stage. Appearance of the 
"peripheral" staining patterns after staining with anti-H4.Ac5 and anti-H4.Ac12 in 
fertilised mouse embryos had been associated with transcriptional activation (Worrad 
et al., 1995). The results of the experiments in this chapter suggest that quiescence 
delays timing of ZGA in NT embryos while in the absence of quiescence, timing of 





Since the first mammal was cloned using quiescent somatic cells (Wilmut et 
al., 1997), there have been strong suggestions that quiescence plays an essential role 
in Nuclear Transfer (NT). Quiescent, somatic cells, either freshly isolated or made 
quiescent by serum starvation or contact inhibition, have been used to clone mice 
(Wakayama et al, 1998; Wakayama and Yanagimachi, 1999; Ogura et al., 2000), 
goat (Baguisi et al., 1999), muflon (Loi et al., 2001) and cow (Kato et al., 1998; 
Wells et al., 1998a; Wells et al., 1999; Zakhartchenko et al., 1999b; Galli et al., 
1999; Kubota et al., 2000). Nuclear transfer is still very inefficient technique, being 
low post-implantation development one of the limiting factors. Recent evidence in 
cattle shows that quiescence improves development to term of cloned embryos 
(Wells, 2002). Mechanisms on how quiescence might affect quality of cloned 
embryos and their potential to support development to term are still unknown. A 
possible explanation is that quiescence affects gene expression in cloned embryos, 
down-regulating expression of genes related to poor embryos quality (Wrenzicky et 
al., 2001). Regulation of gene expression by quiescence could occur by altering the 
epigenetic status of donor cells and cloned embryos. The hypothesis sustained in this 
thesis is that quiescence affects the epigenetic status of donor cells and of cloned 
embryos, with consequences on embryo development. 
Production of well characterised quiescent and a non-quiescent cell 
population was an essential step in proving this theory. Up to now quiescence of 
donor cells used for NT had never been confirmed, and "presumptive GO" cells 
(Wrenzycki et al., 2001) had been used as donors. In these experiments specific 
markers, previously identified by Northern and Western blot analysis were used to 
confirm quiescence of donor cells. FACS analysis and immunoforescence were the 
techniques of choice because they offered the unique possibility, compared to 
molecular biology tools previously used, to assess expression of specific markers on 
single cells within a population, rather than in cell extracts. The first cell model used 
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to produce donor cells synchronized inGO and Gi were Mouse Foetal Fibroblasts. 
Two synchronization methods were used to synchronize cells in GO and several 
nuclear markers (p130, p27KIP1, cyclin Dl) and FACS analysis were used to 
confirm level of synchronization in a diploid quiescent state. Results of these 
experiments showed that serum starvation induces reversible growth arrest in 
cultured cells, associated with up regulation of positive markers of quiescence 
(p27 1 , p130) and down regulation of negative marker of quiescence, like the 
protein synthesis marker FITC. The opposite situation was observed in cycling cells, 
used as negative control of quiescence. FACS analysis showed that serum starvation 
alters the percentages of cells expressing quiescence markers, rather than the levels 
of expression/cell. However not all serum-starved cells expressed quiescence 
markers and high SEM values also suggested a certain degree of variability within 
experimental population of cells, belonging to the same cell line and treated with the 
same protocol. Serum starvation can be used to synchronize cells in GO but this level 
of synchronization varies depending on the marker used for assessment (97% FITC, 
64% 27KIP1+  40% p130). 
Another observation was that serum starvation-induced growth arrest, was 
associated with a significant increase in the percentage of G2/M cells (-30%) while 
the percentages of diploid cells remained unchanged (-65%). This result could not be 
due to presence of cell aggregates, excluded from the analysis by DDM, nor of cells 
with abnormal karyotype, as confirmed by karyotyping results. Expression of 
markers of quiescence was observed in a high percentage of GO/G1 (48-96% GO) as 
well as in G2IM cells (0-50%). About 74-100% of quiescent cells were in GO/G1 and 
0-26% of them was in G2/M. It was concluded that serum starvation produces a 
diploid/tetraploid population of quiescent cells. Contact inhibition has been 
previously used to induce a "presumptive" quiescence in cultured cells. PCNA 
staining cell cycle analysis confirmed growth arrest under contact inhibition 
conditions. However only expression of p130 was comparable to that of serum-
starved cells, whereas FITC and p27'"' expression, was similar to that observed in 
cycling cells, and FITC expression intermediate between that of cycling and serum-
starved cells. Changes in morphology, replication time and karyotype observed in 
cells kept under contact inhibition for different length of time, suggest that this 
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synchronization method carries, at least in mouse fibroblasts, a high risk of genotypic 
instability (transformation). Partially abnormal patterns of expression of quiescence 
markers might be part of the transformation process. Previous reports (Rhodes et al., 
1994) had shown that serum starvation of v-mos transformed NIH 3T3 fibroblasts 
induced growth arrest, as confirmed by reduction in bromodeoxyuridine and 
[3H]thymidine incorporation, and cell cycle profile. However transformed NIH 3T3, 
unlike wild NIH 3T3 fibroblasts, were unable to express quiescence markers (e.g. 
gas I), and arrested in a G  stage (Rhodes et al., 1994) rather than a GO stage. 
Gi can be defined as a diploid, but non-quiescent cell cycle stage. Various 
methods were used to synchronize Mouse Foetal Fibroblasts in GI. The most 
effective methods, in inducing growth arrest, were incubation, for 24h, with 800uM 
Mimosine or 4niM hydroxyurea. More detailed analysis showed that growth arrest 
by hydroxyurea, induced reductions not only in the percentages of cells in S-phase, 
but also of cells in G2/M, while the percentages of diploid cells (-77%, GO/Gi) 
increased. FITC staining also confirmed that most diploid cells, were in a non-
quiescent state (GI, (-88%). 
These results offer the first insight into the level of synchronization 
achieved in fibroblasts, commonly used as donors in nuclear transfer experiments, 
using custom synchronization methods. It also shows that serum starvation may not 
be optimal for synchronization in GO, because the variable level of synchronization 
in GO and the high percentages of cells in G2/M. Because markers of quiescence 
available for fibroblasts are all intracellular, and can be detected only in fixed and 
permeabilised cells, they cannot be used to improve level of synchronization in GO. 
The only possible approach would be to produce cell lines transgenic for p27 or p130 
and Green Fluorescent Protein (GFP). 
Finally, although tetraploid cells can be used for NT, the protocol is 
different from that used for diploid cells: NT with GO/GI cells requires presence of 
cytochalasin B, to inhibit pseudo-polar body extrusion and haploidisation; NT with 
G2IM cells does not require cytochalasin B, since diploidy can only be achieved 
through pseudo-polar body extrusion. This suggests that presence of a 
diploidltetraploid population in serum-starved cells may not represent an optimal 
experimental condition for Nuclear Transfer (NT): 
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T-lymphocytes were also used as a second cell model to produce well-
characterised cells in GO and Gi. This cell type was chosen for the unique possibility 
it offered of using surface, negative markers of quiescence (interleukin-Receptor (x or 
CD25; Transfemn receptor y), alongside intracellular markers observed in other cell 
types. T-lymphocytes, that are quiescent at isolation, also display dramatic changes 
in chromatin status and histone post-translational modifications, associated with exit 
from quiescence (activation). Growth arrest of freshly isolated of T-cells was 
confirmed by low percentages of cells in S-phase, associated with very high the 
percentages of diploid cells (GO/Gi, —90%). Quiescence status was confirmed by the 
low percentages of cells expressing CD25 (-96% CD25) and the relatively high 
percentages of cells expressing p27 1 (-88% p27"'+).Detailed analysis of one of 
these markers, p27'' pl , also confirmed that, almost all diploid cells were quiescent 
(-90% GO) and almost all of the quiescent cells were diploid (-91%). In this cell 
model, quiescence and diploidy appeared to be strictly associated. 
T-lymphocytes were also used to investigate effects of quiescence on the 
epigenetic status of somatic cells. Previous studies, using general markers of 
chromatin condensation (e.g. Acridine Orange, Juan and Darkinzinkiewicz, 1998), 
had shown that chromatin is highly condensed in human peripheral T-lymphocytes, 
that are in GO, and decondenses upon activation. In the present study the mouse 
homologues of human HP! proteins, were used as specific landmarks of chromatin 
conformation. More precisely, M31 and mHPla, respectively mouse homologues of 
human hHP1I3 and hHPla, were used to investigate changes affecting constitutive, 
pericentromeric heterochromatin; M32, the mouse homologue of human hHPly, was 
used to investigate changes affecting non-constitutive heterochromatin. 
Immunofluorescence and previously characterised antibodies (AFRC MAC 353; 
M235; MAC 385) were used to investigate changes the sub-nuclear localisation and 
in the levels of expression of HP! homologues, induced by T-cell activation. 
Changes in HP1 proteins correlated with cell quiescence had never been investigated 
before. The results obtained showed that in quiescent, T-lymphocytes M31 and 
mHPla, was organised in large clusters, colocalised with areas of condensed 
chromatin (putative pericentromeric chromatin), whereas M32 was condensed into 
smaller aggregates, appearing like fluorescent speckles (putative non-constitutive 
heterochromatin). Smaller aggregates were also visible in quiescent cells stained for 
mHPla. Fluorescence was used to quantify level of HP1 condensation and overall 
level of protein expression. Tendency of mouse HP1 proteins to concentrate in GO 
cells, correlating with tendency of chromatin to condense, was confirmed by the high 
levels of mean fluorescence, and peak fluorescence observed GO cells. The high 
levels of SD of mean fluorescence also indicated high levels of condensation, by 
indicating a non-uniform HP1 nuclear distribution, ranging from a very dispersed 
form to a very condensed one. After activation, as cells re-entered the cell cycle, 
chromatin became dispersed and so did all three HP1 isoforms, as indicated by the 
lower mean fluorescence, peak fluorescence and SD of mean fluorescence observed 
in non-quiescent cells. Results showing negative correlation between CD25 or PCNA 
expression and condensation of M31 further confirmed the HP1-mediated effect of 
quiescence on chromatin conformation, in particular pericentromeric chromatin 
conformation. 
Quiescence also induces histone post-translational modifications, such as 
histone acetylation (Pogo et al., 1966; Knosp et al., 1991) and phosphorylation 
(Patskan and Baxter, 1985). Quiescence-mediated changes in histone acetylation 
were of particular interest to this project, for two reasons: 1) they are strictly 
correlated with chromatin changes; 2) they play a pivotal role during early embryo 
development. Models correlating chromatin changes and changes in overall histone 
acetylation have been previously described (Newell-Price et al., 2000). This 
correlation has been also confirmed by experiments showing how Trichostatin A, 
and inhibitor of histone deacetylases, increases the levels of histone acetylation as 
well as inducing chromatin decondensation (Maison et al., 2002). This correlation is 
evident in quiescent cells, such as T-lymphocytes or serum-starved fibroblasts, where 
chromatin is very condensed (Juan and Darkinzinkiewicz, 1998; Bridger et al., 2000) 
and level of acetylation are low (Pogo et al., 1966; Knosp et al., 1991). Changes in 
the levels of histone H4 acetylation in quiescent and non-quiescent cells were 
detected using a panel of antibodies that are also able to map changes in histone H4 
acetylation patterns occurring at the time of zygote gene activation. The levels of 
acetylation on all the lysines residues considered on histone H4 (K2-4, K5, K12) 
appeared to be hypoacetylated in quiescent cells and hyperacetylated in non- 
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quiescent cells. These changes were observed under the same conditions used to 
study changes in chromatin conformation. 
Activation of T-lymphocytes in the presence of hydroxyurea, followed by 
positive selection of CD25 cells, produced a well-characterised population of GI 
cells, with very high percentages (>93% in nuclear transfer experiments) of diploid 
and non-quiescent cells. 
T-lymphocytes, either in GO or GI were used as donor cells in Nuclear 
Transfer experiments, to assess effect of quiescence on epigenetic status and 
developmental potential of cloned embryos. Results showed that quiescence did not 
affect in vitro developmental potential of cloned embryos. However quiescence 
affected epigenetic status of cloned embryos. As shown by M31 staining, both GO 
and G1-NT embryos had the same chromatin patterns as control embryos at the 2-
cells stage. However, at the 4-cell stage, between 0%-33% of NT embryos had 
chromatin patterns (M31 clusters in perinucleolar localisation), similar to control 
embryos. These percentages were higher in GO-NT embryos (33%) than in G1-NT 
embryos (0%), suggesting that condensed, GO might be more favourable to 
chromatin remodelling than G1. Quiescence also delayed 
Regardless of their acetylation status before NT, both quiescent and non-
quiescent nuclei became hyperacetylated immediately after NT. Differences in 
histone H4 acetylation were observed at the 2 and 4-cell stage, when the majority of 
NT embryos reconstructed using T-lymphocytes as donor cells failed to display the 
typical peripheral acetylation pattern associated with transcriptional activation. 
Regardless of their cell cycle stage, between 0-33% of NT-embryos had H4.Ac5 
acetylation patterns similar to controls and between 0-17% of NT-embryos had 
H4.Ac12 acetylation patterns similar to controls. Differences in abnormal acetylation 
patterns were observed between GO-NT and G1-NT embryos: presence of GO nuclei 
delayed appearance of the peripheral staining pattern at the 4-cell stage, in 100% of 
NT embryos; presence of GI nuclei induced early disappearance at the 4-cell stage, 
of peripheral acetylation pattern in 67-83%. These results suggest that quiescence 
might delay the time of transcriptional activation in cloned embryos. Histone H4 
acetylation is strictly dependent on DNA replication (Worrad et al., 1994; 1995). 
Abnormal spatial and temporal regulation of histone acetylation may underline 
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abnormalities in DNA replication (Worrad et al., 1994; 1995). However, it was not 
possible to assess this correlation. Fixation with cross-linking reagents used in these 
experiments, was optimal for immunostaining of the other nuclear proteins studied, 
but only preserved the soluble form of PCNA, constitutively expressed in cells, in a 
cell cycle-independent manner (see pages 53, 222, 234). 
The low percentages of NT-embryos, derived from T-lymphocytes, with 
normal chromatin status and acetylation patterns similar to controls suggests a poor 
potential for nuclear transfer of this particular cell type. The poor rates of 
development to blastocyst obtained in experiments using T-cells, regardless of the 
cell cycle stage, supports this idea (Wakayama and Yanagimachi, 2001). Recent 
reports have shown that, T and B-lymphocytes can also be reprogrammed to support 
development to term (Hochedlinger and Janenisch, 2002). However, also in this case, 
efficiency was extremely low, and development to term, using T and B-lymphocytes, 
was achieved only by combining the nuclear transfer and the tetraploid aggregation 
technique. The abnormalities observed in acetylation and chromatin status of 
embryos cloned from T-cells in these experiments might be an early indication of 
this poor attitude for reprogramming of this particular cell type. 
The present study shows that quiescence does affect epigenetic status of 
cloned embryos with no immediate effect on pre-implantation development, but 
possible effects on post-implantation development. 
It also suggests that further investigation in cloned embryos, of histone post-
translational modifications, such as H3/H4 acetylation, histone H3 phosphorylation 
and methylation, and changes in chromatin conformation, mediated by histone as 
well as non histone proteins, is needed to give us a better understanding of the 
mechanisms undermining development of cloned embryos. 
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APPENDIX A 
MEDIA AND STOCK SOLUTIONS 
A.1 MEDIA AND STOCKS FOR T-MOUSE FOETAL 
FIBROBLASTS 
A.1.1 Culture Medium: 10% FCS DMEM 
Component ml/500m1 Product 
L-glutamine 200mM 5 Life Technologies 25030-024 
Foetal Calf Serum (FCS) 50 Globepharm 
Na-pyruvate Mem 100mM 5 Life Technologies 11360-039 
Mem non-essential amino acids 5 Life Technologies 1140-035 
DMEM 
(Dulbecco's Modified Eagle's Medium) 
435 Gibco 1965-039 
Medium was filtered with 0.22uM disposable filters. It was stored at 4°C, for up to a 
week. Medium was warmed at 37°C, in waterbath, each time, before use. Medium 
used for first 24h after cell isolation, was also supplemented with 0.2% (v/v) of 
50mg/mi gentamicin (Gibco, 15750-037). Serum starvation media, with 0.1% and 
0.5% FCS were prepared as 10% FCS medium, only adding respectively 500u1 or 
2.5m1FCS. 
A.1.2 Phosphate Buffer Saline (PBS) 
Phosphate Buffer Saline (PBS), with Ca 2 and Mg2 , was prepared by dissolving five 
OXOID tablets (BR14a; OXOID Ltd., Basingstoke, UK) in ddH 20, and autoclaving 
at 115°C, for 20mm. PBS was stored at room temperature. 
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A.1.3 0.25% Trypsin/0.04 % EGTA 
Component g/lt Product 
NaCl 6.3 BDH 102414J 
Na2HPO4 21-120 0.12 BDH 103834G 
KH2PO4 0.216 BDH 102032W 
KC1 0.333 BDH 101983K 
D+-glucose 0.9 BDH 101174Y 
Tris 2.7 BDH 103154M 
Trypsin 2.5% (w/v) lOx 2.5 (lOOml) Life Technologies 25090-028 
Ethylene Glycol-bis 
Tetraacetyc Acid (EGTA) lOx 
0.4 Sigma E4378 
Polyvinyl Alcohol (PVA) 0.1 Sigma P8136 
ddH20 Up to lit - 
All components, except Trypsin, EGTA and PVA, were dissolved in 800m1 
ddH20. Then, Trypsyn, EGTA and PVA were added and pH was adjusted to 7.6, 
using IN HC1. Volume was finally adjusted to ilt. Solution was autoclaved, 
dispensed in 5m1 aliquots and stored at-20°C, for several moths. After thawing, 
solution was stored at 4°C, and it was stable for a couple of weeks. For use, 
trypsinlEGTA solution was warned up at 37°C, in waterbath. A 3min incubation was 
usually enough to lift cells. 
A.1.4 -ga1actosidase staining 
Fixative 
Stock ml Final concentration (w/v) Product 
Formaldehyde 40% (wlv) 2.5mm 2% BDH 101134A 
Glutaraldehyde 25% (wlv) 0.4 0.2% Aldrich G4004 
ddH20 47.1 - - 
Glutaraldehyde was stored at 4°C. Formaldehyde was stored at room temperature. 
Fixatives were prepared under chemical hood, on day of experiment. 
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Stocks for 3-gatactosidase staining 
Stock Component MW Product 
X-gal 50mg/mi lOOmgX-gal - 
in 2m1 Dimethylformamide 
Promega V394A 
 
Na2HPO4 21120 1M 88.99g Na2HPO4 177.99 BDH 103834G 
in 500m1 ddH20 
Citric acid H20 3M 315.21g Citric acid 210.14 BDH 444452P 
In 500m1 ddH20 
Potassium ferrocyanide 0.5M 105.6g Potassium ferrocyanide 3H 20 422.4 Sigma, PQ387 
in 500m1 ddH20 
Potassium ferricyanide 0.5M 329.2 Sigma, P8131 
82.30g Potassium ferricyanide 
in 500m1 ddH20 
NaC11M 29.22gNaCl 58.44 BDH1O2414J 
in 500m1 ddH20 
203.3 Sigma M8266 
MgC12 1M 101.65g MgC12 
in 500m1 ddH20 
All stock solutions were filtered with 0.22 disposable filters, and stored at room 
temperature. Potassium ferricyanide and Potassium ferrocyanide, are light sensitive, 
so they were always kept in the dark. 
3-ga1actosidase staining 
Stock ml Final concentration 
X-gal 50mg/mi 0.2 lmg/ml 
Na2llPO4lcitrate acid 1M (pH6)* 0.4 40mM 
Potassium ferrocyanide 0.5M 
0.1 5mM 
Potassium ferricyanide 0.5M 0.1 5mM 






*The 3M citric acid stock was used to adjust the pH of the Na 2HPO4 1M stock to 6. 
Staining solution was prepared on day of experiment. Initially 7.5m1 ddH20 were 
added. After adjusting pH of staining solution to 6, volume was brought up to lOml. 
A.1.5 Chemicals and controls for synchronization in GI 
Hydroxyurea (Sigma H8627): 0.1M stock solution was prepared by 
diluting 76.05mg/lOmI PBS and, then, filtering. Stock was prepared on day of 
experiment. Working dilutions were obtained by diluting the stock in the medium as 
follows: lOul/ml (1mM), 20u1/ml (2mM), 40u1/ml (4mM). 
Mimosine (Sigma, M0253): a 10mM stock solution prepared dissolving 
25mg/12.6m1 PBS. Mimosine is insoluble in aqueous solutions. Dissolved first in 9 
ml PBS, add HC1 IN, until dissolved (-1.2m1). Then ad IN NaOH until pH is 7.36. 
Add PBS to 12.6m1 volume. Filter and store at 4°C for up to a month. Working 
dilutions of 400uM and 800uM obtained diluting exactly 40u1/ml (use 960u1 
medium), 80u1/m1 in medium (use 920u1 medium). 
Lovastatin (Calbiochem, 438195): a 5mM stock solution was prepared by 
dissolving 25mg/12.5 ml. Dissolve in 0.5m1 ethanol 100%, at 55°C. Add 391u1 
NaOH IN. Leave at room temperature, to dissolve, for 30-50min.Add 9-10ml PBS, 
and adjust pH to 7.2 using HCL IN (--0.54ml). Add PBS to reach 12.5m1 volume. 
Filter, aliquot and store at-20°C. Lovastatin is light sensitive. Working dilutions of 
5uM, 15uM, 30uM obtained diluting lul/ml, 3u1/ml, 6u1/ml in medium. 
Lovastatin controls: a stock was prepared by diluting 500u1 ethanol/12.5m1 
PBS. The stock was then diluted, in medium, at the following working 
concentrations: lul/mi (control 5uM lovastatin), 3u1/ml (control 15uM lovastatin), 
6ul (control 30uM lovastatin). 
Methotrexate (Sigma, M8407): a 50uM stock was prepared by diluting 
10mg/4.4m1 PBS. The 10mg of methotrexate had to be first dissolved in 300u1 NaOH 
IN (pH 12.5). After adding 3.5m1 PBS, pH was adjusted to 7.2 using HCl IN (-P200- 
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240u1). Finally PBS was added to a final volume of 4.4m1. Stock was aliquotted and 
stored at —20°C. For working dilutions, 50uM stock was diluted as follows: 2uIJml 
(f.c. 0.1uM or 10 7M); 20u1/ml (f.c. luM or 10 6M); 40uIIml (f.c. 2uM or 2x 10-6M). 
A.2 MEDIA AND STOCKS FOR T-LYMPHOCYTES 
A.2.1 Culture Media: 10% FCS RPMI-1640 
Component Volume Product Final concentration 
'FCS lOmi Globepharm 10% 
L-glutamine 200mM imi Sigma G7513 2mM 
Sodium Pyruvate 100mM imI Sigma S8636 1mM 
Penicillin 10000units/ml 
Streptomycin 10mg/mi 
imI Sigma P0781 100units/ml 
0.01mg/mi 
Non-essential amino acids (lOx) imi Sigma M7145 lx 
22-mercaptoethanol 5x10 2 M 0.1ml Stock 5x10 5 M 
RPMI-1640 lOOm! Sigma R7509 - 
A.2.2 Dulbecco's Phosphate Buffered Saline (D-PBS) 
Component gIlt MW mm Product 
KC1 0.200 74.55 2.68 BDH 102032W 
NaCl 8.000 58.44 136.89 BDH 102414J 
Na2HPO4 2H20 1.441 177.99 8.09 BDH 103834G 
KH2PO4 0.200 135.55 1.47 BDH 101983K 
ddH20 Up to lit - - - 
Adjust pH 7.3-7.4. Osmolarity 280-283 mOsm. Autoclave. Formula taken from 
Gibco 14190, but without preservatives, which are detrimental for T-lymphocytes. 
For Mouse Foetal Fibroblasts D-PBS was purchased from Sigma (B 6758). 
'Foetal Calf serum was inactivated by incubating for 30mm, at 56°C, in waterbath. 
2  2-mercaptoethanol was added in most but not all experiments with T-lymphocytes (Chapter 4). 
FZFGI 
A.2.3 Phytoemagglutinin Stocks 
Phytohemagglutinin, lectin from Phaseolus vulgaris (PHA), 5mg lyophilized 
powder to reconstitute with 2m1, 0.22uM-filtered, D-PBS (Sigma, L9132). Aliquots 
containing 80ug/32u1 were prepared and stored at —20°C, for 12-18 months. On day 
of experiment, the following (2x) stocks were prepared, and filtered with 0.22uM 
disposable, syringe filters: 
32ug/ml stock: 80ug/32u1 in 2.5 ml culture medium; 
16ug/ml stock: 80ug/32u1 in 5m1 culture medium; 
8ug/ml stock: 1:2 dilution of l6ug/ml stock in culture medium; 
4ug/ml stock: 1.4 dilution of 8ug/ml stock in culture medium; 
2ug/ml stock: 1:8 dilution of 8ug/ml stock in culture medium; 
1 .6ug/ml stock: 1:10 dilution of 8ug/ml stock in culture medium; 
These stocks were stable for up to a week, at 4°C. The (2x) stocks were finally 
diluted 1.2, so that each well, of 24 well plates, would have 500u1 cell suspension, in 
culture medium, and 500u1 (2x) PHA stocks. Final PHA concentrations were: 
l6ug/ml, 8ug/ml; 4ug/ml; 2ug/ml; lug/nil; 0.8ug/ml. 
A.2.4 Interleukin-2 Stock 
Lyophilized mouse recombinant interleukin-2 (IL-2; Sigma 10523), was 
reconstituted with lml of 0.22 urn-filtered D-PBS, pH 7.4, containing 0.1% (w/v) 
bovine serum albumin (BSA, Sigma A6003), to a concentration of 20ug/ml. Stored at 
—20°C, for several months. On day of experiments 2ul of the 20ug/ml IL-2 stock 
were added directly to each well, containing 2x10 6 cells/imi culture medium (4nM). 
Alternatively, when IL-2 was added together with PHA, 4u1 of 20ug/ml IL-2 stock 
were added for each ml of PHA (2x) stock. Finally 500u1 of (2x) PHA and IL-2 
stock, were added to 500u1 cell suspension, in culture medium, to a final 
concentration of 4nM (0.04ug/ml) IL-2 and 0.8ug/ml- l6ug/ml, PHA. 
A..2.5 Other reagents 
2-inercaptoethanol 5x10 2 Stock 
Prepare under chemical hood. Make a 1M solution of 2-mercaptoethanol 
(ME) by diluting 0.5m1 2-ME (Sigma, M7522) into 6.6nil sterile double-distilled 
p 
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water. Dilute 2.5m1 of the 1M stock into 47.5m1 of sterile ddH 20 to give a 
concentration of 5x 10-2M.  Store at 4°C. This solution has to be made fresh each 
week. 
[3H]thymidine stock 
Stock prepared by diluting lmCi (37MBq)/ml solution (TRA 306) 1:20, in 
3m1 sterile D-PBS. This stock solution can be stored at 4°C for 2-3dàys. Add to 96 
well plates, at a concentration of luCi/well/0.2x 106  cells. 
Turk's Solution 
Prepared by dissolving 0.01% (wlv) gentian violet (Sigma C3886) in 3% 
(w/v) acetic acid (Sigma 27,931-5) in ddH 20. 
A.3 IMMUNOCYTOCHEMISTRY AND -FACS 
REAGENTS 
A.3.1 Buffers and Saline Solutions 
Tris Buffer Solution (TBS) 
Component g/lt MM Product 
NaCl 6.640 200 BDH 102414J 
Tris-HC1 pH 7.4 11.688 50 Sigma T4003 
ddH20 up to lit - - 
Adjust pH 7.3-7.4. Autoclave. 
FACS Buffer 
Component gI500ml (w/v) Product 
BSA 0.5 0.1% Sigma A-6003 
NaN3 0.5 0.1% Sigma S-2002 
D-PBS Up to 500m1 - - 
KM 
Buffer used to wash and resuspend samples processed for Fluorescence Activated 
Cell Sorter (FACS) analysis. Buffer was filtered and stored at 4°C for months. Stable 
also at room temperature. 
MACS Buffer 
Component g/500m1 Final concentration 
BSA 2.5000 0.5% (w/v) Sigma A6003 
EDTA 0.2922 2mM Sigma E6758 
D-PBS up to 500m1 - - 
Buffer used to wash and resuspend Magnetic Cell Sorting (MACS) samples. Buffer 
was filtered and stored at 4°C for a few months. Try and avoid bubbles as much as 
possible because they interfere with MACS. 
"Saline GM" 
Component g/lOOml MW mm Product 
D+-glucose 0.1100 180.16 6.1 BDH 10117 
NaCl 0.8000 58.44 137 BDH 10241 
KC1 0.0400 74.55 5.4 BDH 10198 
Na2HPO4 71120 0.0402 268.10 1.5 Sigma S9390 
KH2PO4 0.0122 135.55 0.9 BDH 10203 
EDTA 0.0146 292.20 0.5 Sigma E6758 
ddH20 up to lOOml - - - 
D-PBSJEDTA 
Component g/500m1 MW mM Product 
EDTA 0.7305 292.20 5mM Sigma E-6758 
D-PBS Up to 500m1 - - - 
D-PBS was either prepared (A.2.2), for T-lymphocytes, or purchased from Sigma (E 
6758) for Mouse Foetal Fibroblasts. 
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Buffers for DNA/microtubules staining 
Component Permeabilising Blocking Washing Product 
D-PBS lOmi 10m] 50m1 Sigma E-6758 
BSA 30mg 30mg 30mg Sigma A-6003 
TritonX-100 SOul lOu! 50u1 Sigma T 8787 
Glycine - 75mg - Sigma G-7126 
Adjust pH of all solutions at 7.2, filter and store at 4°C. 
Buffers for DNA/microtubules/microfilaments staining 
Component 5% NGS 10% NGS Product 
Goat Serum 25m1 (5%) 50rnl (10%) Diagnostic Scotland S028-220 
Triton X-100 0.5ml (0.1%) 0.5m1 (0.1%) Sigma T 8787 
NaN3 0.lg (0.02%) 0.lg (0.02%) Sigma S-2002 
D-PBS Up to 500m1 Up to 500m1 Sigma E-6758 
Normal Goat Serum (NGS) solutions can be stored at 4°C, for up to a month. 
A.3.2 Fixatives 
Paraformaldehyde 8% (w/v) 
Prepared by dissolving 4g paraformaldehyde (Sigma, P-6148) in 50m1 in D-PBS, and 
heating at 60°C, for a few hours. A few drops of NaOH iN (Sigma 5 2770), were 
added, to help dissolving. Filtered with 0.22uM disposable filters, to remove non-
dissolved powder. Aliquots, containing 25m1 or 6.25m1 PF 8% (wlv), were stored at 
—20°C, for up to 1 month. On day of experiment, aliquots were thawed in hot water, 
and diluted 1.2 (PF4%) or 1:8 (PF1%) with D-PBS. Diluted PF was stable at 4°C, for 
MM 
Paraformaldehyde/picric acid fixative 
3.7g paraformaldehyde (Sigma P-6148) were dissolved in 60m1 D-PBS (pH 
7.4), by heating gradually at 60°C, stirring and adding NaOH until clear. The 
solution was then removed from heat, and brought at room temperature. After 
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adjusting pH to 7.4 with 6N HC1, 4.2m1 saturated picric acid (Sigma 92540) were 
added and volume was brought up to lOOm!. 
Complex Fix 
SB stock (5X) 
Component g/50m1 mm Product 
PIPES 7.55 0.1M Sigma P 6757 
MgC12 0.25 5mM Sigma M 8266 
EGTA 0.235 2.5mM Sigma E 4378 
ddH20 Up to 50m1 - - 
pH was adjusted to 6.1-7-5, to allow PIPES (Piperazine -N,N' -bis[2-ethanesulfonic 
acid]) to go into solution. Store at 4°C, for a maximum of 1 year. 
Microtubule Stabilization Buffer (MTSB) stock 
Component mIJlOml ml! 5m1 Product 
SB stock (5X) 2 1 - 
DTT (1M) 0.010 0.005 Sigma D 5545 
Deuterium Oxide (D 20) 5 2.5 Aldrich 26979-4 
ddH20 3 1.5 - 
Cleland's reagent or DL-Dithiothreitol (DTT; MW 154.2) stock was dissolved in 
ddH20, dispensed in 20u1 aliquots, and stored at —20° C. D 20 was stored at room 
temperature. MTSB was prepared on day of use, and warmed up at 37°C, for 30mm, 
in waterbath, to allow components to dissolve before preparing complex fix. 
Complex Fix 
Component mIJlOml ml! 5m1 Product 
MTSB 2 1 - 
Triton X-100 0.010 0.005 Sigma T 8787 
Formaldehyde (37%) 5 2.5 Sigma F 1268 
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A.3.3 Propidium Iodide (P1) staining 
P1 stock 
Propidium Iodide (PT) powder (Sigma P4170), was diluted at a 
concentration of lOmg/lOml in 0.22um-filtered D-PBS supplemented with 0.1% 
(w/v) NaN3 . Stored at 4°C, in the dark, is stable for 2 years. 
RNAse stock 
Ribonuclease (RNAse) type hA, from Bovine Pancreas (100mg, Sigma 
R5000), was diluted at a concentration of lmg/ml in 0.22um-filtered D-PBS. 
Aliquots containing lml stock were prepared and stored at —20°C. Stable for 2 years. 
Component ul ug/mi 
RNAse (1mg/mi) 1000 100 
P1(1mg/mi) 200 20 
FACS Buffer 8800 - 
This staining solution was used when samples were double stained with PT 
and 27KLP1  and p130. It was 0.22um-filtered. Stored at 4°C in the dark it was stable 
for a few weeks. 
A.3.4 PIJFITC staining solution 
FITC stock 
Fluorescein isothyocyanate (FITC) powder was stored at 4°C (50mg, Sigma F4274). 
On day of use, about 5-10mg FITC were diluted at a concentration of 1mg/mi 100% 
ethanol. This stock was further diluted 1:100, with 100% ethanol (lOug/ml FITC 
stock). 
Component ul ug/mi 
RNAse (lmg/ml) 1000 100 
Ph (1mg/mi) 200 20 
FITC (lOug/ml) 20 0.02 
FACS Buffer 8780 - 
252 
This solution was prepared on the day of experiment. Kept at 4°C. This staining 
solution was stable only for a short time because FITC is degraded by aqueous 
solutions. 
A.4 ANTIBODIES 
A.4.1 Primary Antibodies 
All diluted antibodies were stored at 4°C, for maximal 3 days, and were 
centrifuged 30sec, at 13000 rpm, each time, before use. 
Human anti-Human Proliferating Cell Nuclear Antigen (PCNA). 
Human anti-serum to human PCNAIcyclin (0.5m1; Immuno Concepts, 2037). It 
recognizes sheep, pig and mouse PCNA. Stored at 4°C, it is stable for 12 months. 
Used for immunocytochemistry, diluted 1:10 in 1% FCS-PBS. Secondary used: 
TXR—conjugated goat anti-human IgG (Vector Laboratories). 
Mouse anti-Human cyclin Dl. Mouse monoclonal antibody (Sug/lOOul; 
clone DCS-6, subclass IgG2a; Novocastra, NCL-Cyclin Dl), raised against human 
recombinant full-length cyclin Dl as immunogen. It also recognises mouse cyclin 
Dl, expressed in primary mouse embryo fibroblasts (Lukas et al., 1995), and can be 
as a blocking-antibody in inimuno-knockout experiments (Baldin et al., 1993; Lukas 
et al., 1995). It recognises cyclin Dl, that is positive regulator of early Gi-phase, and 
is expressed at very low levels in GO cells. Cyclin Dl is present in fibroblasts but not 
T-cells. Lyophilised antibody was reconstituted at a concentration of Sug/ml in 
sterile ddH20. Stored at 4°C, reconstituted antibody was stable for 2 months, at 4°C, 
and for 12months, at-20°C. Used for immunocytochemistry, diluted 1:10 in 1% FCS-
PBS. Secondary antibody used: FITC-conjugated sheep anti-mouse IgG (Diagnostic 
Scotland). 
Mouse anti-Human cyclin D3. Mouse monoclonal antibody (Sug/lOOul; 
clone DCS-22, subclass IgGi; Novocastra, NCL-Cyclin D3), produced using human 
recombinant full-length cyclin D3 as immunogen. It does not cross react with cycling 
Dl and D2. It recognises cyclin D3, that is a regulator of late Gi progression, and it 
is not expressed in GO cells. Cyclin D3 is present in fibroblasts and T-cells. 
Lyophilised antibody was reconstituted at a concentration of 5ug/ml in sterile 
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ddH20. Stored at 4°C, reconstituted antibody was stable for 2 months, at 4°C, and for 
12months, at-20°C. Used for immunocytochemistry, diluted 1:20 in in TBS with 
0.2% TritonX-100. Secondary antibody used: FITC-conjugated sheep anti-mouse 
IgG (Diagnostic Scotland). 
Antibodies to mouse HP1 proteins. 
AFRC MAC 353 (Wregget et al., 1994). Purified, rat-monoclonal antibody 
(IgG; SOugIml), raised against M31, the mouse homologue of human hHP1I3. Used 
for immunocytochemistry at a concentration of lug/ml (1:50) in 10% milk powder in 
TBS with 0.25% Triton X-100. Secondary antibody used: FITC-rabbit anti-rat serum 
(a gift from Dr. Prim Singh). 
MAC 385 (Horsley et al., 1996). Purified, rat monoclonal antibody (1gM; 
50ug/ml), raised against M32, the mouse homologue of human hHPly. Used for 
immunocytochemistry at a concentration of 5ug/ml (1:10) in 10% milk powder in 
TBS with 0.25% Triton X-100. Secondary antibody used: FITC-rabbit anti-rat serum 
(a gift from Dr. Prim Singh). 
M235 (Kourmouli et al., 2000). Purified, rabbit anti-serum (50ug/ml) raised 
against mHPlct, the mouse homologue of human hHPlu. Used for 
immunocytochemistry at a concentration of lug/ml (1:50), in 10% milk powder in 
TBS with 0.25% Triton X-100. Secondary used: FITC conjugated donkey anti-rabbit 
IgG (Diagnostic Scotland). 
All the antibodies reognizing HP1 proteins were a gift from Dr. Prim Singh. 
Acetylated histone H4 antibodies. Various antibodies recognizing histone 
H4 acetylation on different lysine residues were used for immunocytochemistry of 
cells and embryos: 
lysines 2-4, sheep anti-serum (anti-H4.Ac2-4), diluted 1:800; 
lysine 5, rabbit anti-serum (R40; anti-H4.Ac5), diluted 1:800; 
lysine 8, rabbit anti-serum (R232; anti-H4.Ac8), diluted 1:1500; 
lysine 12, rabbit anti-serum (RiOl, anti-H4.Ac12), diluted 1:400; 
lysine 16, rabbit anti-serum (R251, anti-H4.Ac16), diluted 1:1500. 
All antibodies recognizing acetylated histone H4 were a gift from Prof. Bryan 
Turner, except the anti-H4.Ac2-4 that was a gift from Dr. Prim Singh. 
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Antibodies anti-H4.Ac5, 8, 12, 16 had been previously characterised in detail 
(Turner and Fellows 1989, Turner et al., 1989), and had been used to detect changes 
in histone acetylation in somatic cells (Thorne et al., 1990; Turner and Fellows 1989, 
Turner et at., 1989) and embryos (Adenot et al., 1997; Worrad et al., 1995; Ma et al., 
2001; Wiekowski et al., 1997). All these antibodies were stable for at least lyear at - 
20°C. 
Rabbit anti-Human p130 (Santa Cruz, Sc-317; 200ug/ml). Purified, rabbit 
polyclonal antibody (IgG), raised against peptide mapping carboxy terminus of 
human p130. Reacts with rat, human and mouse p130. Used for flow cytometry at a 
concentration of 2ug/10 6 cells (1:100) in 1.5% goat serum in D-PBS. Stored at 4°C. 
Stable for 18 months. Secondary used: FITC-conjugated goat anti-rabbit (Santa 
Cruz). 
Mouse anti-Rat 13  tubulin (Sigma T-4026). Mouse monoclonal antibody 
raised against rat 13 tubulin (IgGi; clone TUB 2.1). Recognizes 13 tubulin in a variety 
of species including human, mouse, bovine, chicken. Antibody provided in solution. 
Stored at -20°C it is stable for at least 1 year. Secondary antibody used: FITC-
conjugated anti-mouse IgG. 
FITC-conjugated Mouse anti-Mouse p27'"1 (Neomarkers, MS256-F0; 
200ug/ml). Purified, mouse monoclonal antibody (IgGi; clone DCS-72.176) raised 
against mouse recombinant p27', negative regulator of Gi progression. Reacts 
with human, mouse and rat p27KW1  Aliquotted and stored at-20°C. It is stable for 1 
year. Used for flow cytometry, diluted 2ug/10 6 cells, in 1% FCS in D-PBS. 
R-PE-conjugated Rat anti-Mouse CD25 (Caltag RM 6004; 50ug/0.5m1). 
Rat monoclonal antibody (IgGi; clone PC61 5.3) that recognizes the c chain of the 
IL-2 receptor (IL-2R(t) or CD25, expressed in activated B and T-cells. Stored at 4°C, 
for at least 1 year. Light sensitive. Used for flow cytometry and MACS separation at 
a final dilution of 1-2ug/10 6 cells, in FACS buffer. 
FITC-Hamster anti-Mouse CD3 (Caltag HM3401; lOOug/ml). Hamster 
monoclonal antibody (IgGi; clone 500A2) that recognizes mouse CD3, expressed in 
mature T-cells. Stored at 4°C, for at least 1 year. Light sensitive. Used for flow 
cytometry at a final dilution of 2ug/10 6 cells, in FACS buffer. 
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R-PE-Rat anti Mouse Ly-6G (Gr-1; Caltag RM3004; 50ug/0.5m1). Rat 
monoclonal antibody (IgG2a; clone RB6-8G5) that reacts with Ly-6G, also known as 
GR-1, expressed on myeloid cells in the bone marrow, on monocytes, and on 
peripheral granulocytes. Stored at 4°C, it is stable for at least lyear. Light sensitive. 
Used for flow cytometry at a concentration of lug/10 6 cells, in FACS buffer. 
FITC-Rat anti Mouse B220 (CD45R; Caltag RM2601; 50ug/0.5m1). Rat 
monoclonal antibody that recognizes B220 epitope on Pan B-lymphocytes. Stored at 
4°C, it is stable for at least lyear. Light sensitive. Used for flow cytometry at a 
concentration of 2ug/10 6 cells, in FACS buffer. 
FITC-Mouse anti-Chick a tubulin (Sigma F2168; 1.5mg/ml). Mouse 
monoclonal (clone DM1A) that recognizes an epitope at the carboxy-terminal of a 
tubulin, and is used to label microtubules. It also reacts with cx tubulin from a variety 
of species, including human, mouse, rat, hamster, cattle and amphibia. Stored at-
20°C for at least lyear. At 2-8°C, it is stable for a maximum of lmonth. Used for 
immunocytochemistry, diluted 1:10 in 5%NGS, and, then, 1:50 in 5% NGS, to a 
final concentration of 3ug/ml. 
Rhodamine-Phalloidin (Molecular Probes, R-415). Phalloidin is a 
Phallotoxin, isolated from the deadly Amanita phalloides mushroom. Phallotoxins 
are used to label F-actin, forming the microfilaments. Stored at-20°C, it is stable for 
at least lyear. Used for immunocytochemistry diluted 1:50 in absolute methanol, 
and, then, 1:80 in 5% NGS, to a final dilution of 1:4000. Once diluted it can be 
stored at 4°C for up to three weeks. 
A.4.2 Secondary Antibodies 
TXR—conjugated goat anti-human IgG. Initial concentration of 1.5mg/mi 
(VectorLaboratories, TI-3000). Used for immunocytochemistry, diluted 1:100 in 
1 %FCS-PBS. 
FITC-conjugated anti-sheep IgG. Initial concentration unknown (a gift 
from Dr. Prim Singh). Used for immunocytochemistry, diluted 1:400 in 10% milk in 
TBS with 0.2%. 
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FITC-conjugated sheep anti-mouse IgG. Initial concentration lOmg/ml 
(Diagnostic Scotland, Z584). Used for immunocytochemistry, diluted 1.50 or 1:100 
in 1%FCS-PBS or 10% milk in TBS with 0.2%. 
FITC conjugated rabbit anti-rat serum (a gift from Dr. Prim Singh). 
Used for inimunocytochemistry, diluted 1:50 in 10% milk in TBS with 0.2%. 
Aliquotted and stored at —20°C. Stable for 1 year. 
FITC conjugated donkey anti-rabbit IgG (10mg/mi; Diagnostic Scotland, 
T076). Used for immunocytochemistry, diluted 1:50 or 1:100 in 10% milk in TBS 
with 0.2%. Aliquotted and stored at —20°C. Stable for 1 year. 
FITC conjugated goat anti-rabbit IgG (400ug/ml, Santa Cruz, Sc-2012). 
Used for flow cytometry, diluted 1:200 in D-PBS with 1.5% goat serum. Stored at 
4°C. Stable for lyear. 
FITC-conjugated goat anti-mouse IgG (2-5mg/ml; Sigma F-5262). Used 
for immunocytochemistry, diluted 1:64 in D-PBS with 0.3% BSA. Stored at-20°C. 
A.4.3 Other 
Vectashield Mounting Medium, with DAPI. It contains the 1 .5ug/mI 4', 
6-diamidino-2-phenylindole (DAPI; VectorLaboratories, H-1200), that stain DNA in 
blue. Light sensitive. Stored at 4°C it is stable for 1-2 years. Used for 
immunocytochemistry, 5-7u1 slide. 
Vectashield Mounting Medium (H1000; VectorLaboratories). Used for 
immunocytochemistry, when Propidium Iodide was used as a DNA stain. 
FITC-conjugated mouse IgGi (lOOug/ml; Caltag, MG101). Isotype 
control for FITC anti-p27 M1 . Stored at 4°C for 1-2 years. Used for flow cytometry, 
diluted 1:30 in D-PBS with 1% FCS. 
Rabbit IgG (500ug/ml; Santa Cruz, Sc-2027). Isotype control for p130 
antibody. Stored at 4°C for 2 years. Used for flow cytometry at a concentration of 
2ug/106 cells/ml (1:250) in D-PBS with 1.5% goat serum. 
Mouse IgG2a (100ug/0.5m1; Sigma M 5409). Isotype control for cyclin Dl 
antibody. Stored at 4°C for 2 years. Used for immunocytochemistry, diluted 1:40 in 
1% FCS-PBS. 
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Goat anti-Rat IgG MicroBeads (Miltenyi Biotec, 48502) and anti-R-PE 
MicroBeads (Miltenyi Biotec, 48801). Colloidal super-paramagnetic Microbeads 
conjugated with Goat anti-Rat IgG used at a concentration of 20u1110 7 total cells, 
labelled with R-PE Rat IgG, recognizing mouse CD25. Cells were separated on MS 
positive selection columns (Miltenyi, 42201), taking a maximum of 10 7 positive 
cells/column. 
A.5 MEDIA AND STOCKS FOR NUCLEAR 
TRANSFER AND EMBRYO CULTURE 
Hepes-CZB (Chatot et at., 1989) was used to collect M11 oocytes and 
fertilised embryos. Hepes-CZB was also used to denude oocytes, supplemented with 
hyaluronidase; to enucleate oocytes, supplemented with cytochalasin B; to resuspend 
and inject donor cells, supplemented with PVP. CZB with Ca 2+  and Mg2 (Chatot et 
at., 1989) was used to incubate enucleated oocytes before injection and before 
activation. CZB without Ca 2+ and Mg2 (Chatot et at., 1989), supplemented with Sr2 
was used to activate reconstructed embryos. M16 medium (Whittingham, 1971) was 
used for culture of reconstructed and fertilised embryos. M2 (Fulton and 
Whittingham, 1978) was used for embryo transfer. Hepes-CZB was also tested for 
embryo culture, but blastocyst quality obtained (embryo cell numbers) were better 
when M16 was used. M2 was used, for a short period of time, to collect and denude 
MIT oocytes and fertilised embryos, but was replaced with Hepes-CZB. M2 and M16 
were initially prepared as described below. More recently they have been purchased 
from Sigma (M2, cat. N o M7167; M16, cat. N° M7292). 
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A.5.1 Stocks for M2 and M16 media 
Stock A (lOx) M2 M16 
Component gIlOOml g/lOOml Product 
NaCl 5.533 4.700 Sigma S 5886 
KC1 0.356 0.356 Sigma P 5405 
KH2PO4 0.162 0.162 Sigma P 5655 
Na lactate (60% syrup) 4.349 4.349 Sigma L 7900 
D+-glucose 1.000 0.350 Sigma G 6152 
Penicillin G 0.060 0.060 Sigma P 7794 
Streptomycin sulfate 0.050 0.050 Sigma 5 9137 
EDTA - 0.037 Sigma E 5134 
Stock B (lOx) 
Component 	 g/lOOml (M2) g/lOOml (M16) Product 
NaHCO3 0.349 	2.101 	 Sigma 5 5761 
Phenol Red 	 0.010 0.010 Sigma P5530 
Stock C (lOOx) 
Component 	 g/lOml (M2) 	gIlOml (M16) 	Product 
Na pyruvate 0.036 	0.040 	 Sigma P 4562 
Stock D (lOOx) 
Component 	 g/50m1 (M2) 	g/50m1 (M16) 	Product 
CaC12 7H20 1.260 	1.260 	 Sigma C 7902 
Stock E (lOx) 
Component 	 g/lOOml (M2) g/lOOml (M16) Product 
Hepes (acid) 4.969 	- 	 Sigma H 4034 
Phenol Red 	 0.010 - Sigma P 5530 
Stock Mg (lOOx) 
Component 	 g/25m1 (M2) 	g/25m1 (M16) Product 
MgS04 7H20 0.7325 	0.7325 	Sigma  1880 
Stock Glutamine (lOOx) 
Component 	 g/lOml (M2) 	g/lOml (M16) Product 
L-glutamine - 	 0.1460 	Gibco 21051016 
All stocks were stored at 4°C. Stocks A, D, E and Mg were stored up to 3 months, 
whereas stocks C and B, had to be made up fresh every two weeks. 
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A.5.2 Preparation of M2 and M16 media from stocks 
Stock lOOmi (M2) 50m1 (M16) Product 
A 10.0ml 5.Oml - 
B 1.6m1 5.Oml - 
C 1.Oml 5.Oml - 
D 1.0ml 0.5m1 - 
E 8.4m1 - - 
Mg 1.Oml 0.5m1 - 
BSA (Fraction V) 0.40mg 0.20mg Sigma A 6003 
L-glutamine - 0.5m1 - 
Essential Amino acids (50x) - 1.Oml Gibco 111-30-036 
Non-essential Amino acids (lOOx) - 0.5m] Sigma M 7145 
M2 medium was prepared by putting all components in a glass beaker and adding 
100m1 ddH20. After all components were dissolved, pH was adjusted to 7.4 using 
NaOH. Medium was filtered into sterile 30m1 universals, and stored at 4°C for 
maximum two weeks. 
M16 medium was prepared by putting all components in a glass beaker and adding 
50m1 ddH20. After all components were dissolved, osmolarity was adjusted to 260-
265 mOsm. Medium was filtered into sterile 30m1 universals, and stored at 4°C for 
maximum one week. 
A.5.3 M2 medium composition 
Component g/lt MW mm 
NaCl 5.533 58.450 94.66 
KC1 0.356 74.557 4.78 
KH2PO4 0.162 136.091 1.19 
Na lactate (60% syrup) 4.349 112.100 23.28 
Glucose 1.000 179.860 5.56 
Penicillin G 0.060 (104  units) - - 
Streptomycin sulfate 0.050 - - 
NaHCO3 0.349 84.020 4.15 
Phenol Red 0.010 - - 
Na pyruvate 0.036 110.000 0.33 
CaC127H20 0.252 147.200 1.71 
Hepes (acid) 4.969 238.300 20.85 
MgS047H20 0.293 246.500 1.19 
BSA 4.000 - - 
ddH20 Up to ilt - - 
Water used was deionized (ddH 20), sterile, glass distilled. Osmolarity:-28OmOsm. 
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A.5.4 M16 medium composition 
Component g/lt MW mm 
NaCl 4.700 58.450 80.40 
KC1 0.356 74.557 4.78 
KH2PO4 0.162 136.091 1.19 
Na lactate (60% syrup) 4.349 112.100 23.28 
D'-Glucose 0.350 179.860 1.95 
Penicillin G 0.060 (104  units) - - 
Streptomycin sulfate 0.050 - - 
EDTA 0.037 372.20 0.1 
NaHCO3 2.101 84.020 25.00 
Phenol Red 0.010 - - 
Na pyruvate 0.040 110.000 0.36 
CaC127H20 0.252 147.200 1.71 
MgS047H20 0.293 246.500 1.19 
BSA 2.0 - - 
L-glutamine 0.1461 146.100 1.00 
Essential Amino acids (1:50) - - 
Non-essential Amino acids (1:100) - - 
ddH20 (deionized) Up to ilt - - 
Water used was deionized (ddH 20), sterile, glass distilled. Osmolarity:-265m0sm. 
A.5.5 CZB, Ca 2+-freeCZB and Hepes-CZB media 
Stocks for CZB media 
Stock (lx) 
Component gI1000ml Product 
NaCl 4.760 Sigma S 5886 
KC1 0.360 Sigma P 5405 
KH2PO4 0.160 Sigma P 5655 
Na lactate (60% syrup) 5.300m1 Sigma L 7900 
D+-glucose 1.000 Sigma G 6152 
EDTA 2Na 0.040 Sigma E 6635 
MgS04 7H20 0.290 Sigma M 1880 
Speciality Media Ultra Pure Water 990m1 Sigma W 1503 
Hepes-CZB stock 
Stock 	 Concentration/500m1 	Product 
CZB stock 	 500m1 	 - 
PVA 	 0.05g Sigma P 8136 
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Preparation of Hepes-CZB from stocks 
Stock Concentration/lOOmi Product 
H-CZB stock 99m1 - 
Hepes (acid) 0.476g Sigma H 4034 
NaHCO3 0.042g Sigma S 5761 
CaC12 .21120 (lOOx) imi Stock D 
Na pyruvate 0.003g Sigma P 4562 
L-glutamine 0.015g Gibco 21051016 
Preparation of CZB and Ca2 -free CZB from stocks 
Stock lOOmi CZB lOOmi Ca2 -free CZB Product 
CZB stock 99m1 lOOm! - 
NaHCO3 0.211g 0.211g Sigma 	5761 
CaC12 2H20 (lOOx) imi - Stock D 
Na pyruvate 0.003g 0.003g Sigma P 4562 
L-glutamine 0.015g 0.015g Gibco 21051016 
BSA 0.500g 0.500g A 6003 
CZB and Ca2 -free CZB media composition 
CZB Ca2 -free CZB 
Component g/lt (MM) g/lt (MM) MW 
NaC1 4.76 (81.43) 4.76 (81.43) 58.450 
KC1 0.36 (4.76) 0.36 (4.76) 74.557 
KH2PO4 0.16(l.76) 0.16(l.76) 136.091 
Na lactate (60% syrup) 5.30m1 5.30m1 - 
D'-glucose 1.00 (5.56) 1.00 (5.56) 179.860 
EDTA 2Na 0.04 (0.11) 0.04 (0.11) 372.200 
MgS0471120 0.29(l.18) 0.29(l.18) 246.500 
Hepes - - - 
NaHCO3 2.11 (25.11) 2.11 (25.11) 84.020 
CaC12 2H20 (lOOx) lOmi - 147.200 
Na pyruvate 0.03 (27.27) 0.03 (27.27) 110.000 
L-glutamine 0.15(l.02) 0.15(l.02) 146.100 
Speciality Media Ultra Pure Water Up to lOOmi Up to lOOmi - 
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Hepes CZB media composition 
Component gIlt MW MM 
NaCI 4.76 58.450 81.43 
KC1 0.36 74.557 4.76 
KH2PO4 0.16 136.091 1.76 
Na lactate (60% syrup) 5.30m1 - - 
D+-glucose 1.00 179.860 5.56 
EDTA.2Na 0.04 372.200 0.11 
MgS047H20 0.29 246.500 1.18 
Hepes (acid) 4.76g 238.3 20.85 
NaHCO3 0.42g 84.020 2.38 
CaC12 2H20 (lOOx) lOmi 147.200 - 
Na pyruvate 0.03 110.000 27.27 
L-glutamine 0.15 146.100 1.02 
Speciality Media Ultra Pure Water Up to lit - - 
A.5.6 Hyaluronidase stock 
Stock was prepared by dissolving hyaluronidase powder (Sigma H 3884) in 
D-PBS, at a concentration of 15000 UIJml. Stock solution was dispensed in 20ul 
aliquots and stored at —20°C. Hyaluronidase was diluted in Hepes-CZB at a working 
dilution of 300UJJml (1 stock aliquot/ml). At this Hyaulronidase concentration, 
cumulus cells removal was complete after 4-5 mm, at room temperature. 
A.5.7 Cytochalasin B stock 
Cytochalasin B (Sigma 6762) stock was prepared in D-PBS at a dilution of 
0.5mg/mi, dispensed in lOul aliquots, and stored at —20°C. Cytochalasin B stock was 
diluted in Hepes-CZB at a working dilution of Sug/ml (1 stock aliquot/ml). 
A.5.8 Sr2 10mM activation medium 
Sr 2,  stock 
gIlt 	 Product 
SrC12 6H20 (lOOx) 	 1.130 Sigma S 0390 
Speciality Media Ultrapure Water 	Up to 25ml 	Sigma S 5761 
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Activation medium with Sr2 10mM 
Component 	 -- - Concentration 	Product 
CZB stock lOOmI 	 - 
Na pyruvate 	 0.003g Sigma P 4562 
L-glutamine 0.015g 	 Gibco 21051016 
NaHCO3 	 0.211g Sigma  5761 
BSA 	 0.500g 	 A 6003 
Speciality Media Ultrapure Water Up to 100 ml 	Sigma S 5761 
Sr2 stock can be stored at 4°C for up to three months, and activation medium for up 
to 1 week. It is extremely important to prepare activation medium on ice, adding 




ABNORMALITIES OBSERVED IN 
DEVELOPMENTALLY ARRESTED CLONED 
EMRBYOS 
B.1 STRUCTURAL ABNORMALITIES 
B.1.1 Experimental design 
Reconstructed embryos from 3 out of 8 nuclear transfer experiments 
(Paragraph 6.4) arrested at different developmental stages were fixed and triple 
stained for chromatin, microtubules and microfilaments with (DAPI/FITC-anti-(X 
tubulinlTXR-phalloidin triple staining, Methods see Paragraph 2.13). The specimens 
were visualised using an epifluorescent, inverted microscope with a 40x 'objective, 
and digitalized images were acquired using the AQM program (methods see 
Paragraph 2.14). DAPI (nuclear staining) was used to visualise the nuclei, phalloidin 
(microfilament staining) to visualise microfilaments and cell boundaries and tubulin 
(microtubule staining) to assess normal or abnormal spindle formation. 
Structural abnormalities were classified as: 
Fragmentation; 
Abnormal nuclear segregation into daughter blastomeres; 
Other, unknown abnormalities. 
B.1.2 Results 
Descriptive studies showed no significant difference in the pattern of 
abnormalities observed in GO and Gi-derived embryos. Both groups showed similar 
(cell cycle effect, p=0.6), high rates of fragmentation (40.2% vs 37.0%; p>0.5) and 
lower rates of abnormal segregation (18.8% vs 19.9%; p=0.83). In both GO and GI 
groups the majority of non-developing embryos had no obvious structural 
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abnormality ("other", 41.0%-43. 1 %, p=O.11). Abnormality patterns were affected by 
the developmental stage at which the embryos were arrested. When considering both 
GO and Gi- derived NT embryos (NT GO+G1) the incidence of fragmentation was 
maximal at the 1-cell stage and then progressively decreases reaching minimal levels 
at the morula stage (Table B.1). An opposite trend was observed in abnormal nuclear 
segregation that was minimal at the 1 and 2-cell stages and significantly higher at the 
4-cell/morula stages (Table B. 1). Up to the 2-cell stage fragmentation was the main 
structural abnormality observed, but after the 2-cell stage abnormal segregation 
became predominant. Fragmentation was the main structural abnormality observed in 
GO and GI-NT embryos arrested at the 1-cell and the 2-cell stages. However: in the 
GO-group abnormal segregation was the main abnormality observed in NT embryos 
arrested at the 4-cell stage and morula stages; in the Gi-group fragmentation was still 
the main abnormality observed in 4-cell arrested embryos, and abnormal segregation 
became predominant only at the morula stage. The percentages of arrested embryos 
with no obvious structural abnormalities were high in all groups. 
B.1.3 Conclusions 
Regardless of the cell cycle stage, nuclear fragmentation appeared to be the 
main feature in developmentally arrested cloned embryos, followed by abnormalities 
in nuclear segregation. Furthermore, high percentages of GO and Gi arrested 
embryos showed no obvious structural abnormality suggesting that, in most cases, 
developmental arrest of NT embryos was linked to more subtle genetic or epigenetic 
abnormalities. High rates of developmental arrest appeared to be a feature of T-cell 
derived embryos, regardless of their cell cycle stage. 
The results of these experiments also indicated that arrest at the 1 and 2-cell 
stages was mainly associated with fragmentation, while arrest at the 4-cell and 
morula stages was mainly associated with abnormal nuclear distribution. The spindle 
abnormalities and incorrect attachment of chromatids to the microtubules similar to 
those observed in the first hours after reconstruction (Paragraph 6.3.1), might 
account for the incorrect segregation of genetic material. A better understanding of 
these mechanisms might improve development of cloned embryos. 
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Table B.1 Structural abnormalities of developmentally arrested GO and G1-NT embryos 
Stage Type 1-cell 2-cell 4-cell M 
NT (GO+G1) abnormal 5\58 (8 .6)a 24\156 (15 .4)a 12\29 (41.4)" 
10\20 (50•O)b 
fragmented 32\58 (55 .2)a 59\156 (37.8)" 
8\29 (276)bc 2\20 (lO.0)c 
other 21\58 (36 .2)a 73\156 (46 . 8)a 9\29 (3 1.0)a 8\20 (40.0)a 
NT GO abnormal 1\24 (4 . 1)a 14\82 (17 . 1)a 6\8 (75.0)" 
1\3 (33•3)a 
fragmented 13\24 (54 .2)a 34\82 (41 . 5)a 0\8 (0.0)" 
0L3 (ØØ) I) 
other 10\24 (41 . 7)a 34\82 (41 . 5)a 2\8 (25 .0)a 2\3 (66.7r 
NT Gi abnormal 4\34 (11 . 8)a 10\74 (13 . 5)a 6\21 (28 .6)1 9\17 (529)0 
fragmented 1934 (559)a 25\74 (338)b 8\21 (381)" 2\17 (118)" 
other 11\34 (32 .3)a 39\74 (57)0 
7\21 (333)ab 6\17 (353)ab 
Data acquired from three out of eight replicate experiments carried out to assess in vitro developmental potential of NT embryos. Non developing 
embryos were fixed and triple stained with anti-phalloidinlanti-tubulin/DAPI to assess nuclear and cell morphology. Embryos were classified as 
being fragmented or abnormal if they had an unequal nuclear/cell distribution. Embryos which did not belong tot he previous two categories 
were classified as "other". Values within rows with different superscripts differ significantly. Chi-square test or Fischer's exact test for 2x2 
contingency (two-tailed, Mid-P-value), where expected frequencies were less than 5 (a=0.05). 
The only difference in the pattern of abnormalities between GO and Gi-
derived embryos was that, in the former group, abnormal segregation peaked at the 
4-cell stage and fragmentation was no longer detected beyond the 2-cell stage, while 
in the latter group at the 4-cell stage fragmentation was still the main feature and 
abnormal segregation became predominant only at the later morula stage (Table B. 1). 
B.2 EPIGENETIC ABNORMALITIES 
B.2.1 Experimental Design 
GO and G1-NT embryos, arrested at the 1 and 2-cell stages were collected in 
two replicate experiments on day 1 and day 2 after reconstruction (see Paragraph 
6.5.2). Embryos that failed to cleave by day 1 (1-cell block embryos) or failed to 
reach the 4-cell stage by day 2 (2-cell block embryos), were fixed and stained for 
DAPJIM31IPCNA or DAPIIH4.Ac5 or H4.Ac12. Analysis focused on embryos that 
had no clear signs of structural abnormalities, such as fragmentation or abnormal 
nuclear segregation, previously classified as "other" (Paragraph B.1). Results were 
compared with those previously obtained for fertilised embryos (Paragraph 6.5.1). 
B.2.2 Results 
Out of 337 reconstructed embryos 174 (51.5%) failed to cleave (1-cell 
block). Of these 128/174 (74.7%) had clear structural abnormalities, such as 
fragmentation or abnormal nuclear segregation, while 46/174 (53.0%) had no signs 
of structural abnormalities and were classified as "other" (Fig.B.1). Most embryos in 
the "other" group were arrested at the pronuclear stage, while lower percentages of 
embryos arrested before pronuclear formation, retaining a condensed chromatin 
(condensed stage) or chromosomes (Premature Chromosome Condensation stage, 
PCC; Fig.13.1). 
Embryos arrested at very early developmental stages ("condensed" and PCC 
stages) were negative for all staining. Embryos arrested at the pronuclear (PN) stage 
had lower percentages of PCNA (p<O.001) and lower percentages of M31 embryos 
(p<0.001), although patterns of M31 staining were similar to controls (only 
Figure B.! Epigenetic abnormalities in developmentally arrested NT embryos 
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____________________ PN (Control) PN (NT) 2-cell (Control) 2-cell (NT) 
PCNA 24\28(85.7)a 
6/18(333)b 12\12(100)a 14/15 (93.0)a 
M3 I +  (total) 24\28 (85 . 7)a 
6/18 (33•3)b 12\12 (100)a 15/15 (100)a 
M31(condensed) 0\28 (0 . 0)a 0/18 (0 . 0)a 
4\12 (333)a 0/15 (00)b 
M31 	(diffused) 24\28 (85 . 7)a 
6/18 (333)b 8\12 (66 . 7)a 5/15 (100) a 
Ac5\124(total) 26\48 (54 . 1)a 8/11 (72 . 8)a 
30\30 (100)a 0/22 (0 . 	 " 
Ac5\12 (peripheral) 
16\48 (33•3)a 4/11 (364)" 
28\30 (933)a 0/22 (0.0)" 
Ac5\12 	(diffused) 10\48 (20 . 8)a 
4/11 (364)b 2\30 (6 . 7)a 0/22 
Developmentally arrested NT embryos with no visible structural abnormality (e.g. abnormal segregation\fragmentation), classified as "other", were stained for 
DAPI\PCNA\M31 or DAPI\F14.Ac5 and Ac 12. Results were compared with those obtained in fertilised control embryos (Paragraph 6.5.1), at the pronuclear 
(PN) and 2-cell stage. Data from two nuclear transfer experiments, referred to NT embryos in "other" group, were analysed using a Pearson Chi-square or a 
Fisher's exact test for 2x2 contingency (two tailed test, Mid-P-value test, (x=0.05), where expected frequencies were less than 5. Values within columns with 
different superscripts are significantly ((x'0.05) different. Embryos arrested at the 1 -cell stage at the "condensed" or PCC stages were not included since they 
were negative for all staining. 
"diffused" pattern was observed). Staining for histone H4 acetylation on lysines 5 
and 12 showed that embryos arrested at the PN stage had similar percentages of 
H4.Ac5/12 embryos (p=0.29). The peripheral acetylation pattern was predominant n 
control, fertilised embryos, while "peripheral" and "diffused" acetylation patterns 
were equally represented in cloned embryos arrested at the PN stage (Fig.B.1). 
The nuclear transfer group arrested at the 2-cell stage had a similar 
proportion of PCNA (p=0.556) and M31 (p=l.0) embryos compared to the control 
group (Fig.B. 1). However the NT group had a lower proportion of M31 + embryos 
with the "condensed" form of M3 1, organised in clusters, colocalised with patches of 
pericentromeric heterochromatin (p=0.028). 
All control embryos, at the 2-cell stage, were acetylated on lysines 5 or 12 
of histone H4, while all NT embryos developmentally arrested at the 2-cell stage 
were deacetylated on lysines 5 or 12 (p<0.0001). 
B.2.3 Conclusions 
Some embryos were arrested at very early stages, "condensed", maybe as a 
result of membrane retention, and at the PCC. 
Abnormal epigenetic patterns observed at the "condensed or PCC stage included: 
Absence of acetylation staining, is in contrast with what observed in 
developing nuclear transfer embryos and described for fertilised embryos 
(Worrad et al., 1995) embryos where DNA appeared to be hyperacetylated 
during early development; 
• 	Absence of M31 staining, that had been observed at least in G1 derived NT 
embryos (no data available from fertilised embryos at this stage). 
Absence of PCNA staining was normal expected at these early stages of 
development. 
Epigenetic abnormalities observed in embryos arrested at the PN stage 
included: 
Lower percentages of PCNA, suggesting DNA replication problems; 
Lower percentages of M3 1 embryos, suggesting abnormalities in chromatin 
organisation; 
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• 	Lower proportions of cloned embryos with peripheral acetylation staining 
pattern, associated with transcriptional activation of donor cell genome. 
Results of immunostaining of nuclear transfer embryos arrested at the 2-cell stage 
showed that they underwent normal DNA replication. However epigenetic 
abnormalities were observed: 
• 	All developmentally arrested embryos failed to organise M31 in clusters 
while "condensed" distribution was observed in 33% of control embryos at 
the s2-cell stage, suggesting the presence of chromatin abnormalities; 
• All NT embryos were negative for acetylation of histone H4, a state 
incompatible with normal transcription, while 100% of control embryos 
were acetylated and 93% of them were potentially transcriptionally active. 
The results of these experiments showed an association between developmental 
arrest and epigenetic instability of cloned embryos. 
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